Articles100
LOS ANGELES, CA - May 1, 2026 (NEWMEDIAWIRE) - Datavault AI (NASDAQ: DVLT), a provider of data monetization, credentialing, digital engagement and real-world asset (“RWA”) tokenization technologies, and CyberCatch, a cybersecurity company offering a patented, AI-enabled platform for continuous compliance and cyber risk mitigation, announced they have entered into a binding letter of intent under which Datavault AI will acquire 100% of CyberCatch in an all-stock transaction valued at about CAD $136.8 million. CyberCatch is expected to operate as a Datavault AI subsidiary, with founder, Chairman and CEO Sai Huda serving as president of the subsidiary. To view the full press release, visit https://ibn.fm/lktOf About Datavault AI Inc. Datavault AI is leading the way in AI experience, valuation, and monetization of assets in the Web 3.0 environment. The company’s cloud-based platform provides comprehensive solutions with a collaborative focus in its Acoustic Science and Data Science Divisions. Datavault AI’s Acoustic Science Division features WiSA(R), ADIO(R) and Sumerian(R) patented technologies and industry first foundational spatial and multichannel wireless HD sound transmission technologies with IP covering audio timing, synchronization and multi-channel interference cancellation. The Data Science Division leverages the power of Web 3.0 and high-performance computing to provide solutions for experiential data perception, valuation and secure monetization. Datavault AI’s cloud-based platform provides comprehensive solutions serving multiple industries, including HPC software licensing for sports & entertainment, events & venues, biotech, education, fintech, real estate, healthcare, energy and more. The Information Data Exchange(R) (IDE) enables Digital Twins, licensing of name, image, and likeness (NIL) by securely attaching physical real-world objects to immutable metadata objects, fostering responsible AI with integrity. Datavault AI’s technology suite is completely customizable and offers AI and Machine Learning (ML) automation, third-party integration, detailed analytics and data, marketing automation and advertising monitoring. The Company is headquartered in Philadelphia, PA. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law
LOS ANGELES, CA - May 1, 2026 (NEWMEDIAWIRE) - Cardiovascular disease continues to place a profound burden on individuals, economies and healthcare systems worldwide, affecting millions of lives while driving substantial medical costs and resource demands. Cardio Diagnostics Holdings (NASDAQ: CDIO) is committed to reducing the impact of heart disease by developing a platform that integrates artificial intelligence and epigenetic and genetic biomarkers to deliver personalized cardiovascular insights from a simple blood sample, positioning itself at the intersection of precision medicine and preventive care. The scale and consequences of cardiovascular disease reinforce why innovation in this space remains essential. The prevalence of cardiovascular risk factors illustrates the scale of the issue. Cardio Diagnostics is addressing this need through its proprietary platform, which combines artificial intelligence with multi-omic biomarker analysis. The scale and consequences of cardiovascular disease reinforce why innovation in this space remains essential. According to the Centers for Disease Control and Prevention (“CDC”), heart disease is the leading cause of death in the United States, accounting for approximately one in every… Read More Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer The latest news and updates relating to CDIO are available in the company’s newsroom at https://ibn.fm/CDIO Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law
DALLAS - May 1, 2026 (NEWMEDIAWIRE) - SPOILER ALERT: The American Heart Association sends fans of the iconic “Devil Wears Prada” movie franchise heartfelt condolences following the sudden death of fictional publishing house Elais Clark chairman Irv Ravitz. The dramatic scene is drawing attention for its emotional impact, but also for what it gets wrong about cardiopulmonary resuscitation (CPR) - mistakes that, in real life, can cost lives. In the sequel released today, a party guest attempts Hands‑Only CPR after Irv, played by actor Tibor Feldman, collapses, but no one calls 9‑1‑1 and the compressions shown are unrealistic and ineffective - details critics and fans have already flagged. “The details of your incompetence do not interest me” … but could save a life “In real life, there is no room for feeling powerless when someone’s heart stops,” said Stacey E. Rosen, M.D., FAHA, volunteer president of the American Heart Association and executive director of the Katz Institute for Women’s Health and senior vice president of women’s health at Northwell Health in New York City. “I can just hear Miranda Priestly saying, ‘Why was no one ready?’ Hands‑only CPR is simple, effective and something anyone can do. You don’t need medical training, perfection or permission - just the willingness to act immediately.” According to the American Heart Association, a global force changing the future of health for all, every minute without high‑quality CPR reduces a person’s chance of survival. When films and television depict CPR inaccurately - or as an afterthought - it can normalize hesitation, confusion and failure in moments when precision saves lives. The Heart Association’s Nation of Lifesavers™ campaign seeks to educate as many as possible and encourage immediate action from anyone who witnesses an emergency. There are two steps to save a life. In a cardiac emergency the best course of action is to: Call 911 immediately. Do Hands-only CPR: If a teen or adult collapses and is unresponsive, push hard and fast in the center of the chest to the beat of a song with 100-120 beats per minute. "RUNWAY" by Devil Wears Prada 2 cameo star Lady Gaga & Doechii (120 BPM)– is perfect for high-fashion lifesaving CPR technique. Learning Hands-Only CPR is easy and can save lives. You can learn the process quickly, online from a simple video on the American Heart Association’s website or become by taking a CPR course at an American Heart Association associated training center. Visit www.heart.org/CPR to learn more. “By all means, move at a glacial pace. You know how that thrills me.” Every minute without CPR during sudden cardiac arrest dramatically reduces a person’s chance of survival. Having bystanders respond to the cardiac emergency with the correct rate and depth of compressions support the chain of survival until medically trained help arrives. When TV shows and movies misrepresent CPR, they reinforce dangerous myths – from stopping too soon to performing it incorrectly – that can make bystanders hesitate in real emergencies. A recent study found CPR is frequently misrepresented in scripted television, including who receives it and where cardiac arrests occur. The Association was recently identified by the Annenberg Public Policy Center as the most trusted public health information source after an individual’s personal health care provider - more than 8 in 10 (82%) U.S. adults say they are confident in the American Heart Association to provide trustworthy information related to public health. The Association is also the largest non-government funder of cardiovascular- related scientific research in the world with more than $6 billion in funding distributed over the last 75 years. As Miranda Priestly might say, “That’s all.” Available for interviews: American Heart Association medical expert on sudden cardiac arrest and CPR Media and health experts on how entertainment shapes public behavior American Heart Association spokesperson on how pop culture moments can save real lives Additional Resources, including downloadable video B roll of Hands Only CPR demonstrations, Bystander CPR infographic, CPR reenactment photo are available on the right column of this release link. About the American Heart Association The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public’s health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on heart.org, Facebook, X or by calling 1-800-AHA-USA1. For Media Inquiries: American Heart Association: Suzanne Grant: Suzanne.Grant@heart.org For Public Inquiries: 1-800-AHA-USA1 (242-8721) heart.org and stroke.org View the original release on www.newmediawire.com
DALLAS - May 1, 2026 (NEWMEDIAWIRE) - Stroke is a leading cause of serious, long-term disability in the U.S., and for many survivors and families, the hard work begins once the hospital stay ends. Nationwide, survivors, caregivers and advocates are creating new paths forward. The American Stroke Association, a division of the American Heart Association, is honoring seven Stroke Heroes whose actions are helping redefine what life after stroke can look like. Recognized each May during American Stroke Month, the Stroke Hero Awards honor survivors of stroke, caregivers, health care professionals and community organizations whose actions support people affected by stroke nationwide. The awards spotlight real‑world efforts that help survivors and caregivers navigate recovery through connection, education and shared experience. Life after a stroke often means navigating lasting physical, emotional and cognitive challenges[1]. This year’s Stroke Heroes show how personal experience can become a source of strength for others - whether caring for a loved one, reducing isolation or helping fellow survivors and caregivers find a path forward. Winners include: Caregiver Hero: Felicia Veasey, Summerville, South Carolina Felicia Veasey divides her life into two eras: before her mother’s second stroke and after it, when she rearranged her life around her mother’s needs and became her full-time caregiver. Despite the intense demands of the caregiving role, Felicia’s care has spurred significant improvements in her mother’s health. Felicia, wanting to help others in the same situation, coordinated and facilitated Empowered Minds and Hearts, a public webinar that explored the mental health and well-being of caregivers. Community Impact Hero: Lamont Causey, Detroit Lamont Causey’s stroke left the Detroit resident unable to speak, swallow or walk in 2019. But with his commitment and resilience, Lamont regained his function and mobility. He didn’t want to stop with his own recovery; he now shares his story throughout his community to educate, encourage and support survivors of stroke and their caregivers. Lamont has a particular passion for helping struggling people in under-resourced communities. B.E. F.A.S.T. Hero: Nasheel Joules, McKinney, Texas When Nasheel Joules noticed her husband, Mark, suddenly struggling to speak, mispronouncing words and unable to repeat sentences, she knew something was wrong. She called 911 immediately. Doctors confirmed Mark had experienced a transient ischemic attack (TIA), and because Nasheel recognized the signs and acted quickly, he received prompt evaluation to help protect his long-term health. Nasheel and Mark continue to turn that experience into action, raising funds for the Association through their annual Christmas light display in McKinney and working with local officials to support rapid emergency response for medical emergencies like stroke. Group Heroes: The Aphasia Recovery Connection, Leland, North Carolina People living with aphasia - difficulty speaking, reading and/or writing after brain injury, frequently from a stroke - often feel lonely and isolated. That is why The Aphasia Recovery Connection exists: to connect people with aphasia to a supportive community, and to provide free aphasia support and education that is available to anyone, regardless of money or geography. The nonprofit serves over 20,000 members and community subscribers, who benefit from the support and compassion as they navigate recovering from strokes and changes in their speech. Pediatric Hero: Marina Ganetsky, Needham, Massachusetts At the age of 10, Marina Ganetsky suffered a ruptured AVM (arteriovenous malformation), a tangled web of veins and arteries so devastating that it caused multiple strokes in her young brain. Marina was unable to walk, talk, swallow, read or write. With a lot of determination, discipline and hard work, Marina, now 15, has made tremendous progress. She helps others by speaking about her strokes at national conferences. She has written a book for children who face strokes and other brain injuries. Survivor Hero: Gabriela Raso, Missouri City, Texas Christmas 2013 brought a life-changing challenge for Gabriela Raso, who experienced an ischemic stroke that wasn’t caught at first. The ER doctors wanted to send her home. But Gabriela, a physician herself, knew something was very wrong and insisted on a CT scan that confirmed the stroke. The diagnosis saved her life. Now Gabriela speaks up for other stroke patients. She co-founded The Stroke Foundation, which advocates for expanded access to the therapies, resources and support that enabled her recovery. Voters’ Choice Hero: Stacie Barber, Peoria, Arizona Stacie Barber, a physical therapist and business owner, refused to accept doctors’ dire outlook after her husband, Logan, had a large bleeding stroke in September 2024. He spent a month in intensive care on a ventilator. Guided by her resolve and professional knowledge, Stacie’s caregiving fueled her husband’s strong recovery, including his return to full-time work. She has tracked each step of Logan’s journey and shares it with her more than 1 million social media followers, who have learned from and been inspired by Stacie’s posts. Winners were selected by a nationwide panel of volunteer judges from the American Stroke Association, except for the Voters’ Choice Award, which was selected by online popular vote. Stroke can happen at any age, and recovery looks different for every person. The Stroke Hero Awards recognize the many ways individuals and communities are supporting survivors and caregivers through connection, advocacy and shared experiences. For more information, visit Stroke.org/HeroAwards. Additional Resources: Photos of each winner are available on the right column of the release link. Spanish news release American Heart Association news release: Knowing stroke signs can save a life when every minute counts | Spanish News Release Follow American Heart Association/American Stroke Association news on X @HeartNews About the American Heart Association The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public’s health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on heart.org, Facebook, X or by calling 1-800-AHA-USA1. About the American Stroke Association The American Stroke Association is a relentless force for a world with fewer strokes and longer, healthier lives. We team with millions of volunteers and donors to ensure equitable health and stroke care in all communities. We work to prevent, treat and beat stroke by funding innovative research, fighting for the public’s health, and providing lifesaving resources. The Dallas-based association was created in 1998 as a division of the American Heart Association. To learn more or to get involved, call 1-888-4STROKE or visit stroke.org. Follow us on Facebook and X. For Media Inquiries: 214-706-1173 Darcy Wallace: 303-801-4683; Darcy.Wallace@heart.org For Public Inquiries: 1-800-AHA-USA1 (242-8721) heart.org and stroke.org [1] www.stroke.org/en/about-stroke/effects-of-stroke View the original release on www.newmediawire.com
Inaugural Episode Features CEO Rich Christopher on DehydraTECH Platform, GLP-1 Market Opportunity, and Commercial Strategy KELOWNA, BRITISH COLUMBIA - May 1, 2026 (NEWMEDIAWIRE) - Lexaria Bioscience Corp. (NASDAQ: LEXX) (“Lexaria” or the “Company”), a global innovator in oral drug delivery platforms, today announced the launch of Reformulated: Into the Mainstream, an ongoing investor communications series designed to support transparency, consistent engagement, and alignment with shareholders and the broader investment community. As Lexaria continues executing its strategy within the rapidly evolving GLP-1 and oral drug delivery landscape, the video series will feature regular interviews and management discussions with Lexaria leadership. Episodes will cover company updates alongside broader market and sector trends, providing investors with consistent context around Lexaria’s business and the environment in which it operates. The inaugural episode features an in-depth conversation with Lexaria CEO Rich Christopher and host Ana Berry. The discussion covers the DehydraTECH platform and its applicability across GLP-1 therapies, CBD, antivirals, and other compounds; the Company’s focus on the GLP-1 market, which generated approximately $75 billion in worldwide revenue in 2025; the completion of five human GLP-1 studies across semaglutide, tirzepatide, and liraglutide; and Lexaria’s multi-pronged commercial strategy, including outlicensing activity under an active Material Transfer Agreement with a global pharmaceutical company. The first installment of Reformulated: Into the Mainstream is now available here: https://www.youtube.com/watch?v=KG9dCWS6x6I “Transparency and consistent communication are foundational to building long-term trust with shareholders,” said Rich Christopher, CEO of Lexaria. “The series reflects our commitment to providing ongoing insight into how we think about oral drug delivery, the GLP-1 opportunity, and the disciplined execution required to advance DehydraTECH toward commercial partnerships.” New episodes will be released periodically, expanding into additional areas of Lexaria’s clinical pipeline, intellectual property portfolio, and industry developments. About Lexaria Bioscience Corp. & DehydraTECH DehydraTECH™ is Lexaria’s patented drug delivery formulation and processing platform technology which improves the way a wide variety of drugs enter the bloodstream, always through oral delivery. DehydraTECH has repeatedly evidenced the ability to increase bio-absorption, reduce side-effects, and deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 65 patents granted and additional patents pending worldwide. For more information, please visit www.lexariabioscience.com. CAUTION REGARDING FORWARD-LOOKING STATEMENTS This press release includes forward-looking statements. Statements as such term is defined under applicable securities laws. These statements may be identified by words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions. Such forward-looking statements in this press release include, but are not limited to, statements by the Company relating to the intended use of proceeds from the offering and relating to the Company’s ability to carry out research initiatives, receive regulatory approvals or grants or experience positive effects or results from any research or study. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that the Company will actually achieve the plans, intentions, or expectations disclosed in these forward-looking statements. As such, you should not place undue reliance on these forward-looking statements. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, market and other conditions, government regulation and regulatory approvals, managing and maintaining growth, the effect of adverse publicity, litigation, competition, scientific discovery, the patent application and approval process, potential adverse effects arising from the testing or use of products utilizing the DehydraTECH technology, the Company’s ability to maintain existing collaborations and realize the benefits thereof, delays or cancellations of planned R&D that could occur related to pandemics or for other reasons, and other factors which may be identified from time to time in the Company’s public announcements and periodic filings with the US Securities and Exchange Commission on EDGAR. The Company provides links to third-party websites only as a courtesy to readers and disclaims any responsibility for the thoroughness, accuracy or timeliness of information at third-party websites. There is no assurance that any of Lexaria’s postulated uses, benefits, or advantages for the patented and patent-pending technology will in fact be realized in any manner or in any part. No statement herein has been evaluated by the Food and Drug Administration (FDA). Lexaria-associated products are not intended to diagnose, treat, cure or prevent any disease. Any forward-looking statements contained in this release speak only as of the date hereof, and the Company expressly disclaims any obligation to update any forward-looking statements or links to third-party websites contained herein, whether as a result of any new information, future events, changed circumstances or otherwise, except as otherwise required by law. INVESTOR CONTACT: George Jurcic – Head of Investor Relations ir@lexariabioscience.com Phone: 250-765-6424, ext 202 View the original release on www.newmediawire.com
DUBAI - May 1, 2026 (NEWMEDIAWIRE) - Utexo, the team pioneering Bitcoin-native yield and payment infrastructure through the RGB protocol, today announced the appointment of Federico Tenga to its advisory board. One of the foremost authorities on RGB and a key architect behind its development, Tenga’s addition marks a major milestone in Utexo’s mission to build the foundational layer for stablecoin issuance and global payments on Bitcoin. Tenga currently serves as R&D Strategist within the Bitfinex and Tether ecosystem, where he leads development of the RGB protocol implementation, the RGB Lightning node, and critical developer tooling powering the next generation of Bitcoin-based assets. His work sits at the core of the infrastructure Utexo is built upon. “Federico is one of the people building the RGB ecosystem at the protocol level,” said Viktor Ihnatiuk, CEO of Utexo. “His decision to join Utexo’s advisory board reinforces how closely aligned we are with the future direction of Bitcoin. Federico brings deep technical expertise, and his insight will help ensure Utexo continues to push forward Bitcoin-native stablecoin infrastructure.” As one of the primary contributors to RGB, Tenga leads the Bitfinex team developing key components, including the RGB Lightning node and Iris Wallet, a mobile application recognized as a user-friendly interface for interacting with RGB-based assets. His team also created rgb-lib, a widely adopted open-source Rust library that simplifies development on RGB. This tooling supports the broader ecosystem Utexo operates within. His appointment also strengthens Utexo’s strategic alignment with Tether, which co-led the company’s $7.5 million seed round. Tenga’s role within the Bitfinex and Tether ecosystem creates a direct technical connection between Utexo and the teams advancing USDT’s integration on Bitcoin via RGB. “Utexo represents one of the most compelling real-world implementations of RGB today,” said Federico Tenga. “The team is focused on solving payment and liquidity challenges using Bitcoin as the base layer. The opportunity to help shape how stablecoins operate natively on Bitcoin at both the protocol and application level is compelling. I look forward to contributing to Utexo’s growth within the RGB ecosystem.” Prior to his current role, Tenga co-founded Chainside, an Italian Bitcoin payment processor that enabled merchants to accept Bitcoin, including through a partnership with itTaxi, Italy’s largest taxi network. He also contributed to blockchain policy as a member of the Italian Ministry of Economic Development’s national blockchain task force. Tenga’s involvement provides Utexo with direct visibility into the evolution of RGB, including emerging standards, performance improvements, and developer tooling. With Tenga joining its advisory board, Utexo continues to expand its technical leadership across Bitcoin, stablecoins, and financial infrastructure. About Utexo Utexo is a Bitcoin-native execution and settlement layer for stablecoin payments. By combining Lightning Network’s instant execution with RGB’s privacy-preserving asset issuance, Utexo’s API and SDK enable payment operators to process USDT transactions instantly with predictable costs and full and private execution. Contact: Jonathan Phillips Utexo@phillcomm.global
FORT LEE, NEW JERSEY - May 1, 2026 (NEWMEDIAWIRE) - Maison Luxe, Inc. (OTC: MASN) (“Maison Luxe” or the “Company”) today announced that it has executed a term sheet with a private company (the “Target”) as part of its ongoing strategic acquisition initiative. Maison Luxe has been actively exploring opportunities, including evaluating an international acquisition. The execution of this term sheet represents a continuation of those efforts. Over the course of its review process, the Company conducted internal due diligence and evaluated various aspects of the Target’s operations, infrastructure, and overall strategic fit. Based on this assessment, management determined that the opportunity warrants further advancement and has entered into a term sheet outlining the principal terms of a potential transaction. Maison Luxe’s management continues to actively evaluate additional opportunities and businesses, both domestically and internationally, that may complement its existing operations and contribute to the development of a more diversified and sustainable business platform. The Company’s approach remains focused on identifying assets with operational substance and potential for long-term value creation. The term sheet is non-binding in nature, except for certain customary provisions, and any proposed transaction remains subject to, among other things, the negotiation and execution of definitive agreements, completion of additional due diligence, and satisfaction of applicable regulatory and closing conditions. ABOUT MAISON LUXE Maison Luxe offers luxury retail consumer items. The Company operates as a niche high-end luxury goods retailer, helping interested consumers obtain rare luxury items that may otherwise not be reliably available due to the nature of the luxury retail marketplace. The Company focuses its efforts primarily within the fine time piece and jewelry segments, both on a wholesale and B2C (business-to-consumer) basis. The Company also owns its Amani Jewelers subsidiary, which operates in the jewelry marketplace, with a strategic focus on the rapidly growing lab-grown diamonds market. In addition, Maison Luxe holds a significant investment position in Aether Diamonds, which was founded in 2020 as the world's first and only known captured carbon lab-grown diamond producer. FORWARD-LOOKING STATEMENTS: This release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements also may be included in other publicly available documents issued by the Company and in oral statements made by our officers and representatives from time to time. These forward-looking statements are intended to provide management's current expectations or plans for our future operating and financial performance, based on assumptions currently believed to be valid. They can be identified by the use of words such as "anticipate," "intend," "plan," "goal," "seek," "believe," "project," "estimate," "expect," "strategy," "future," "likely," "may," "should," "would," "could," "will" and other words of similar meaning in connection with a discussion of future operating or financial performance. Examples of forward-looking statements include, among others, statements relating to future sales, earnings, cash flows, results of operations, uses of cash and other measures of financial performance. Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and other factors that may cause the Company's actual results and financial condition to differ materially from those expressed or implied in the forward-looking statements. Such risks, uncertainties and other factors include, among others. such as, but not limited to economic conditions, changes in the laws or regulations, demand for products and services of the company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward-looking statements. Any forward-looking information provided in this release should be considered with these factors in mind. We assume no obligation to update any forward-looking statements contained in this report. There can be no assurance that the Company will enter into a transaction related to this or any opportunity currently under review. Corporate Contact: Website: www.maisonluxeny.com Email: info@maisonluxeny.com View the original release on www.newmediawire.com
JAKARTA, INDONESIA - May 1, 2026 (NEWMEDIAWIRE) - Wintermar (WINS:JK) records attributable net profit growth of 194% YOY to US$4.8 million for 1Q2026 on 47.8% YOY revenue growth. Owned Vessel Division With more High Tier vessels in operation since December 2025, 1Q 2026 recorded a 53.9% YOY increase in Owned Vessel Revenue amounting to US$22.8 million, resulting in Owned Vessel gross profit doubling to US$12.7 million for 1Q2026 on gross margins of 55.7% compared to 41.1% in 1Q2025. Chartering Division and Other Services Management continued to focus on marketing Owned Vessels and grow the Other services division where margins higher, resulting in a fall in Gross profit from chartering to US$0.03 million (-15% YOY) while Other Services contributed gross profit of US$0.5 million (+17% YOY) with gross margins of 34.1%. Direct Expenses and Gross Profit In line with the larger fleet of High Tier Vessels in operation, depreciation rose by 20.0% YOY to US$4.0 million while Crewing rose by 24.2% YOY to US$2.9 million and Operational costs grew 38.5% to US$1.1 million for 1Q 2026. As more vessels were in operation compared to 1Q2025, maintenance costs were lower by 1.8% YOY at US$1.7 million. Fuel bunker was also lower at US$0.4 million as there were fewer idle vessels, and no significant mobilization costs as compared to 1Q2025 where the Company mobilised vessels for international contracts. Total Gross Profit rose by 101.6% YOY to US$13.3 million largely from a strong performance in the Owned Vessel Division, which enjoyed a utilization rate of 62% compared to 55% in 1Q 2025. Indirect Expenses and Operating Profit Total Indirect Expenses rose by 14.6% YOY to US$2.8 million, largely due to staff expenses which increased by 16.7% YOY to US$2.1 million. This was because the timing of Hari Raya bonuses and annual bonuses falling in the same quarter this year. Marketing costs rose by 33.2% YOY to US$0.2 million, reflecting more tendering activity, while professional fees rose by 46.3% YOY to US$0.08 million due to the upgrading of payroll software. Office utilities fell by 13.0% YOY. Operating Profit rose by 153.0% YOY to US$10.5 million for the first quarter. Other Income, Expenses and Net Attributable Profit Interest expenses fell slightly by 1.2% to US$0.5 million due to refinancing at lower interest rates while interest income fell by 14% YOY to US$0.2 million due to decrease in time deposit interest rates. There were no vessel sales this quarter, but associated companies recorded a net loss of US$0.5 million due to lower utilization of fleet. The Company recorded a lower loss of Forex at US$0.15 million compared to US$0.36 million in 1Q2025, as earnings are in US$. Total attributable Net Profit amounted to US$4.8 million (+194% YOY) for 1Q2026, yielding an Earnings per share of Rp18.4 in 1Q2026 compared to Rp6.3 in 1Q2025. As a result of these better operational conditions, EBITDA rose by 92.2% YOY to US$14.6 million in 1Q2026 compared to US$7.6 million in 1Q2025. Industry Outlook The Iran war has continued into the second quarter of this year, with an uncertain ceasefire providing some relief at the time of writing this newsletter. Oil prices have eased but continue to be volatile and supply of Oil remains restricted with the closure of the Strait of Hormuz. The high risks of relying on Middle Eastern oil has strengthened the resolve of governments across the world towards energy security. Globally, there are up to US$40 billion worth of upstream projects slated for acceleration, including some in Indonesia. Business Prospects With a strong market outlook for OSV demand, the Company is making plans to grow the fleet through investing in new building as well as acquisitions. The Group’s eighth Platform Supply Vessel that was purchased in end 2025 is currently undergoing repair and upgrading, and should be operational in mid 2H2026. At the present time, Wintermar’s vessels are still largely chartered on spot contracts but there are some longer term contracts in the bidding process for 2027. However, Associate Company Fast Offshore Supply Pte Ltd in Singapore has won a long-term contract to build a fleet of Crew Transfer Vessel (CTV) in Singapore and Batam for delivery in 2027, which should start contributing earnings when the vessels commence operations next year. Total contracts on hand as at end March 2026 amount to US$47.8 million. About Wintermar Offshore Marine Group Wintermar Offshore Marine Group (WINS.JK), developed over nearly 50 years with a track record of quality that is both a source of pride and responsibility that we are dedicated to upholding, and sails a fleet of more than 44 Offshore Support Vessels ready for long term as well as spot charters. All vessels are operated by experienced Indonesian crew, tracked by satellite systems and monitored in real-time by shore-based Vessel Teams. Wintermar is the first shipping company in Indonesia to be certified with an Integrated Management System by Lloyd's Register Quality Assurance, and is currently certified with ISO 9001:2015 (Quality), ISO14001:2015 (Environment) and OHSAS 18001:2007 (Occupational Health and Safety). For more information, please visit www.wintermar.com. For further information, please contact: Ms. Pek Swan Layanto, CFA Investor Relations PT Wintermar Offshore Marine Tbk Tel +62-21 530 5201 Ext 401 Email: investor_relations@wintermar.com
DALLAS - May 1, 2026 (NEWMEDIAWIRE) - A stroke can change a life in an instant. In the minutes after symptoms begin, quick action can help protect the brain, reduce long-term disability and save a life, according to the American Stroke Association, a division of the American Heart Association. On average, nearly 2 million brain cells die every minute a stroke goes untreated, making early recognition and treatment critical. During May, American Stroke Month, the Stroke Association is highlighting the importance of recognizing stroke warning signs and understanding how early treatment and prevention can make a meaningful difference when it matters most. Stroke is the fourth-leading cause of death, according to the American Heart Association’s 2026 Heart Disease and Stroke Statistical Update[1], and a leading cause of serious, long-term disability in the United States. Each year, approximately 800,000 people in the U.S. experience a stroke. A stroke can happen to anyone, at any age. 3 things you can do to take action against stroke: Learn B.E. F.A.S.T. to spot a stroke. If you see sudden Balance loss, Eye or vision changes, Face drooping, Arm weakness or Speech difficulty, it’s time to call 911. Explore the signs by playing the B.E. F.A.S.T. Experience at Stroke.org/StrokeMonth. Understand your stroke risk and explore ways to lower it. Identifying personal risk factors - especially high blood pressure, the leading risk factor for stroke - can help you have informed conversations with your health care team about stroke prevention and long‑term brain health. Find support after stroke. Recovery is a journey and connection matters. Explore support services for survivors and care partners, including virtual Stroke Meetups, and sign up for the Stroke Connection e‑newsletter at Stroke.org/StrokeMonth. Recognize Stroke Warning Signs: B.E. F.A.S.T. When a stroke happens, blood flow to the brain is interrupted. The longer treatment is delayed, the greater the risk of lasting damage. Calling 911 is the fastest way to get stroke care. EMS can begin treatment immediately and alert the hospital stroke team before you arrive. B.E. F.A.S.T. is a simple way to remember common stroke warning signs: Balance Loss – Sudden trouble walking, dizziness or loss of coordination Eye (Vision) Changes – Sudden vision loss or trouble seeing in one or both eyes Face Drooping – One side of the face droops or feels numb; a smile may look uneven Arm Weakness – One arm feels weak or numb or drifts downward when raised Speech Difficulty – Slurred speech or trouble speaking Time to Call 911 – If someone shows any of these signs, even if symptoms go away, calling 911 right away can help get lifesaving care started. Noting when symptoms first appeared can also support treatment decisions. Take steps to prevent stroke According to the Heart Association and the Stroke Association, approximately 80% of strokes are preventable. High blood pressure is the leading risk factor for stroke[2], and uncontrolled blood pressure, diabetes and obesity significantly increase risk. A large majority of strokes can be prevented by taking steps to: Manage blood pressure. Lowering and controlling blood pressure reduces the risk of stroke. Regular check‑ups, monitoring at home and following a treatment plan can lower risk and support long‑term brain health. Build healthy habits. Eating well, staying active, not smoking and keeping up with routine health screenings all play an important role in reducing stroke risk. The Heart Association’s Life’s Essential 8TM outlines key steps for improving and maintaining cardiovascular and brain health. Reduce the risk of a second stroke. Prevention takes on added importance for people who have had a stroke or a transient ischemic attack (TIA), sometimes called a “warning stroke.” Nearly 1 in 4 strokes occur in people who have had a previous stroke[3]. Understanding what caused the first stroke and identifying personal risk factors can help guide next steps and reduce the chance of another one. Support that meets you where you are Stroke recovery looks different for everyone, and support can play an important role along the way. The Stroke Association offers resources designed to help survivors and care partners feel informed, connected and supported, including live, virtual Stroke Meetups where participants can share experiences, ask questions and learn from trusted experts. Stay connected with recovery tools and support by signing up for the Stroke Connection e‑newsletter. Stroke can happen suddenly. Knowing the signs with B.E. F.A.S.T. can help you respond when minutes matter. This American Stroke Month, explore trusted resources, practical tools and support Stroke.org/StrokeMonth. The HCA Healthcare Foundation is a national sponsor of the American Stroke Association’s Together to End Stroke® initiative and American Stroke Month. Additional resources: Multimedia, including B.E. F.A.S.T. graphics, are available on the right column of the release link. Spanish News Release VIDEO: B.E. F.A.S.T. PSA Interactive B.E. F.A.S.T. Experience May 4 Live virtual Stroke Meetup: Mental Health After Stroke Follow American Heart Association/American Stroke Association news on X @HeartNews About the American Heart Association The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public’s health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on heart.org, Facebook, X or by calling 1-800-AHA-USA1. About the American Stroke Association The American Stroke Association is a relentless force for a world with fewer strokes and longer, healthier lives. We team with millions of volunteers and donors to ensure equitable health and stroke care in all communities. We work to prevent, treat and beat stroke by funding innovative research, fighting for the public’s health, and providing lifesaving resources. The Dallas-based association was created in 1998 as a division of the American Heart Association. To learn more or to get involved, call 1-888-4STROKE or visit stroke.org. Follow us on Facebook and X. For Media Inquiries: 214-706-1173 Darcy Wallace: Darcy.Wallace@heart.org For Public Inquiries: 1-800-AHA-USA1 (242-8721) heart.org and stroke.org [1] L A Palaniappan; et al Heart Disease and Stroke Statistics - 2026 Update: A Report of US and Global Data From the American Heart Association Circulation. 2026; 153:00–00. DOI: 10.1161/CIR.0000000000001412 [2] D W Jones; et al 2025 AHA / ACC / AANP / AAPA / ABC / ACCP / ACPM / AGS / AMA / ASPC / NMA / PCNA / SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Circulation Volume 152, Issue 11, 16 September 2025; Pages e114-e218 https://doi.org/10.1161/CIR.0000000000001356 [3] L A Palaniappan; et al Heart Disease and Stroke Statistics - 2026 Update: A Report of US and Global Data From the American Heart Association Circulation. 2026; 153:00–00. DOI: 10.1161/CIR.0000000000001412 View the original release on www.newmediawire.com
VANCOUVER, BRITISH COLUMBIA - May 1, 2026 (NEWMEDIAWIRE) - Western Star Resources Inc. (CSE: WSR) (OTC: WSRIF) (the “Company” or “Western Star”) is pleased to announce that it has submitted its application in response to a solicitation from the U.S. Defense Industrial Base Consortium (the “DIBC”) to provide to the United States a reliable supply of critical minerals, focusing on Tungsten (Wo3). In February 2026, the DIBC issued a new request for project proposal (“RPP”) focused on strategic critical minerals. The DoW has prioritized identification of supply chain alternatives for defense-critical minerals used in the production of aircraft, missiles, semiconductors, and other defense technologies. The DIBC is managed by Advanced Technology International (“ATI”) on behalf of the U.S. Department of War (the “DoW”). The DIBC aims to expand and diversify the defense industrial base in the U.S., enable private-sector businesses to work in partnership with the U.S. Government, provide non-dilutive financing for key contractors, and provide the U.S. Government access to commercial solutions for defense requirements. Critical metals are considered essential for the U.S. defense industrial base, and the U.S. Government is engaged in strategic planning, initiatives, and funding to ensure it can access and onshore domestic production capabilities and supply. Blake Morgan, the CEO and President of Western Star, stated, “Western Star Resources is pleased to support DIBC initiatives focusing on strategic critical minerals. Our team will be traveling to Washington in May for meetings to discuss our past-producing tungsten asset. We believe this asset offers significant upside and look forward to demonstrating its potential as we approach our maiden drill program in 2026. Additionally, we will provide further updates shortly regarding the recently announced Rowland exploration program.” Engagement of Plutus The Company announces it has entered into an investor relations and marketing services agreement dated April 28, 2026 (the “Plutus Agreement”) with Plutus Invest & Consulting GmbH. (“Plutus”) pursuant to which Plutus will provide services to the Company for a twelve-month term commencing on May 1, 2026. The services to be provided by Plutus include consultation regarding advertorial marketing and public relations strategies, and designing and implementing an advertisement-based investor awareness campaign focused on the European investment market at financial-news portals, investor newsletters, social-media platforms like X, LinkedIn, YouTube, Reddit, Telegram, paid digital advertising networks: and sponsored articles and video interviews on investor-relations portals. The Company has agreed to pay Plutus a fee of Euro 200,000 payable on the commencement of services. The Plutus Agreement was negotiated through arm’s length negotiations. The term of the Plutus Agreement will end April 30, 2027. Plutus and its principals are arm’s length to the Company. Plutus contact information is as follows: Buchtstrasse 13, Bremen 28195, Germany and can be contacted via email (contact@plutuinves.de) or by phone: (+49 42117540174). The engagement of Plutus is subject to certain conditions including, but not limited to, the submission of all required forms to the Canadian Securities Exchange (the “CSE”). Flow Through Financing The Company is also pleased to announce a non-brokered private placement (the “Offering”) of 833,333 flow-through common shares (“FT Shares”) at a price of $0.60 per FT Share for gross proceeds of $500,000. The gross proceeds received by the Company from the Offering will be used to incur eligible “Canadian exploration expenses” (“CEE”) that are “flow-through mining expenditures” (as such term is defined in the Income Tax Act (Canada)) related to the Company’s Western Star Project and will be used as deemed appropriate for qualifying expenses for the critical mineral tax credit (CMETC). All FT Shares issued under the Offering will be subject to a four-month-and-one-day statutory hold period in accordance with applicable securities laws. Completion of the Offering remains subject to approval by the CSE. About Western Star Resources Western Star Resources is a mineral exploration and development company. The Company’s objective is to increase shareholder value through the development of exploration properties using cost-effective exploration practices, acquiring further exploration properties and seeking partnerships by either joint ventures or sale with industry leaders. The Company currently owns the past producing Rowland property. A past producing Tungsten asset located in Jarbidge Nevada. Western Star also holds nine non-surveyed contiguous mineral claims totaling 4,740 hectares, which are located within the Revelstoke mining division of British Columbia. The Western Star property group is located approximately 50 kilometers southeast of Revelstoke, British Columbia, and 10 kilometers north of the former community of Camborne. Contact Information: Blake Morgan Ceo and Director blake@acvc.vc www.westernstarresources.com Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this press release. Certain of the statements made and information contained herein may constitute “forward-looking information”. In particular references to the private placement and future work programs or expectations on the quality or results of such work programs are subject to risks associated with operations on the property, exploration activity generally, equipment limitations and availability, as well as other risks that we may not be currently aware of. Accordingly, readers are advised not to place undue reliance on forward looking information. Except as required under applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking information, whether as a result of new information, future events or otherwise. View the original release on www.newmediawire.com
STATE COLLEGE, PA - April 30, 2026 (NEWMEDIAWIRE) - Aquinas Senior Living, Inc., a pioneer in tech-enabled, empathetic senior care, today announced the expansion of its integrated resident safety ecosystem powered by Teton, the proactive care platform for senior living communities. Following a benchmark-setting deployment of Teton’s monitoring platform at Heritage Springs Memory Care in Montoursville, ASL has successfully launched the system at its Wynwood House communities in State College and Centre County, achieving near-universal resident and family adoption. Building on this momentum, Aquinas activated the Teton system at the Wynwood House State College location on April 1, 2026. On April 8, 2026, the Wynwood House Nittany Valley site in Centre County also went live. Across these Wynwood House communities, resident and family adoption has reached 99.8%, with only a single family across the entire rollout opting out. How the Technology Works Teton’s AI technology and monitoring system does four things: creates clarity across communities, detects changes in residents’ health early, alerts care staff to act early, and enables more tailored and person-to-person care. Teton is a passive optical sensor installed in resident rooms with a minimal footprint that requires no resident interaction, no wearables, no manual calibration, and no charging. Privacy is engineered into how the system works, not added as an afterthought - no video is streamed live, and no audio is captured, and the system processes movement data locally on-site. Care teams receive safety signals and, when needed, brief anonymized clips, not a live video feed. The platform is HIPAA compliant and SOC 2 certified. This approach is grounded in Teton’s own research: an analysis of more than 2,000 falls across four countries found that measurable signals, including night-time movement patterns, sleep disruption, and changes in respiration, consistently precede falls by hours or days, giving care teams the opportunity to intervene before an incident occurs. The technology integrates directly into clinical workflows, enabling care teams to act on insights within the systems they already use, without adding administrative burden or requiring staff to monitor separate dashboards. The E-call Integration Beta As part of this expansion, one of Aquinas’s Pennsylvania facilities is currently serving as the official Beta test site for the integrated E-call resident call system. This technology folds traditional resident assistance requests directly into the Teton.ai dashboard. By unifying fall detection and manual assistance requests into a single interface, Aquinas is eliminating “alarm fatigue” and allowing staff to prioritize the most critical resident needs in real time. A Growing Footprint of Care The Aquinas roadmap continues to accelerate through the spring: November 2025: Heritage Springs (Montoursville) achieved 100% adoption. April 1, 2026: Wynwood House (State College) went live. April 8, 2026: Wynwood House (Nittany Valley/Centre County) went live. May 2026: Teton platform is scheduled for adoption at the Lewisburg community. About the Partnership “What we saw in Montoursville was the proof of concept; what we are seeing today in State College and Centre County is proof of scale with near universal adoption,” said Stephen J. Schmid, President and CEO of Aquinas Senior Living. “Our residents and their families aren’t just accepting this technology - they are embracing it. They recognize that a ‘proven and fully adopted’ system is the best path to ensure the highest standard of safety in modern senior living communities.” “By integrating Teton’s computer-vision AI with our new E-call resident response system, we are moving away from disparate ‘point solutions’ toward a truly unified ecosystem,” added Jim Burnham, Chief Operating Officer. “This ensures that whether a resident pushes a button or the AI detects a potential risk, our team is there exactly when they are needed.” “The reality of moving care from reactive to proactive is that it goes beyond operational gains, it changes the quality of life for residents. A fall that doesn’t happen, a hospitalization avoided, a family member who sleeps better at night knowing their loved one is safe,” said Katie Grant, President, U.S., Teton. “Memory care is one of the most demanding care environments there is, and it is exactly where having the right information at the right moment makes the greatest difference.” About Teton Teton is leading a fundamental shift in care, moving care and the way it is delivered from reactive to proactive. Our advanced AI and computer vision technology is custom-built for care settings, providing clarity, delivering foresight, enabling action, and driving outcomes. The result is higher-quality care and better-run operations. We are starting with senior care communities and hospitals, and believe our technology can generate significant benefits in any care environment, anywhere in the world. Founded in Denmark and with a presence across the United States and Europe, Teton exists to make amazing care affordable and accessible for all. www.teton.ai About Aquinas Senior Living Aquinas Senior Living, Inc. is a senior housing acquisition and management company serving the Mid-Atlantic region. Guided by a mission to enhance resident well-being through compassionate care and innovative technology, Aquinas is redefining safety and quality standards in senior living. The company’s resident-first approach combines operational excellence with empathy, creating communities where seniors thrive and families have peace of mind. Learn more about Aquinas Senior Living at aquinasseniorliving.com. info@aquinasseniorliving.com Contact President & CEO Stephen Schmid Aquinas Senior Living, Inc. info@aquinasseniorliving.com 610-420-7657 View the original release on www.newmediawire.com
ZURICH - April 30, 2026 (NEWMEDIAWIRE) - The 48th ordinary Annual General Meeting of Kardex Holding AG took place today. The meeting was attended by 74 shareholders. A total of 70.04 % of the Company’s share capital was represented. All motions put forward by the Board of Directors to the Annual General Meeting were approved. The proposed dividend payment of CHF 6.00 per registered share has been approved by the shareholders. The payment will take place on 6 May 2026. All members of the Board of Directors proposed for re-election were confirmed for a further term of office of one year. The 49th ordinary Annual General Meeting of Kardex Holding AG will take place on 29 April 2027 in Zurich. Contact for media and investors Alexandre Muller, Investor Relations Phone: +41 44 419 44 79 / Mobile: +41 (0)79 635 64 13 investor-relations@kardex.com www.kardex.com Agenda 30 July 2026 Publication Interim Report 2026 Conference Call for Media and Analysts 11 March 2027 Publication Annual Report 2026 Conference Call for Media and Analysts 29 April 2027 Annual General Meeting 2027 SIX ConventionPoint, Zurich, Switzerland 29 July 2027 Publication Interim Report 2027 Conference Call for Media and Analysts Kardex Corporate Profile Kardex is a leading global partner for intralogistics solutions in an attractive and growing market. The Group offers premium automated products, standardized systems, and life cycle services that guarantee high availability and low total cost of ownership. Kardex provides an intelligent entry into automation with its dynamic storage and retrieval systems, offers integrated material handling systems, small parts storage systems including multi-shuttle technology, and automated high-bay warehouses. Additionally, Kardex acts as a global AutoStore™ partner, offering flexible and modular storage and order fulfillment solutions. The Group employs around 2’900 people in over 30 countries. Kardex Holding AG has been listed on the SIX Swiss Exchange since 1989. Disclaimer This communication contains statements that constitute “forward-looking statements”. In this communication, such forward-looking statements include, without limitation, statements relating to our financial condition, results of operations and business and certain of our strategic plans and objectives. Because these forward-looking statements are subject to risks and uncertainties, actual future results may differ materially from those expressed in or implied by the statements. Many of these risks and uncertainties relate to factors which are beyond Kardex’s ability to control or estimate precisely, such as future market conditions, currency fluctuations, the behavior of other market participants, the actions of governmental regulators and other risk factors detailed in Kardex’s past and future filings and reports and in past and future filings, press releases, reports and other information posted on Kardex companies’ websites. Readers are cautioned not to put undue reliance on forward-looking statements, which speak only of the date of this communication. Kardex disclaims any intention or obligation to update and revise any forward-looking statements, whether as a result of new information, future events or otherwise. Privacy policy You have registered with us for our ad hoc announcements and are therefore entered in Kardex Holding AG's list of recipients and regularly receive price-sensitive or current information about our company. The protection of your personal data is very important to us and we implement this throughout the entire life cycle of personal data in compliance with the applicable data protection regulations. You can find further information about data protection on our website under Privacy Statement. Recipients of our communications have the option at any time of revoking their registration for ad hoc communications for the future or requesting information from Kardex Holding AG about their own personal data that has been processed or their deletion. Please send us an e-mail to investor-relations@kardex.com. View the original release on www.newmediawire.com
LEIPZIG - April 30, 2026 (NEWMEDIAWIRE) - SBF AG (ISIN: DE000A2AAE22; WKN: A2AAE2, “SBF” for short), a listed specialist for innovative solutions in the fields of rolling stock, lighting, electromechanics and sensor technology, today published its Annual Report 2025. The company generated consolidated revenue of EUR 40.7 million (2024: EUR 47.2 million), at the upper end of the most recently forecast range of EUR 39 million to EUR 41 million. At the same time, SBF significantly increased EBITDA to EUR 1.0 million (2024: EUR 0.6 million). As a result, the EBITDA margin rose to 2.5% (previous year: 1.3%). "Our earnings performance shows that our strategic adjustments are taking us in the right direction. In an exceptionally challenging environment for the manufacturing industry, we were able to significantly improve our profitability despite restructuring-related burdens. We will continue on this path by expanding sales activities, optimizing cost structures and consistently unlocking SBF’s potential," explains Robert Stöcklinger, Member of the Management Board of SBF AG. Challenging market environment and structural adjustments shape business development In the 2025 reporting year, the development of the three business divisions was influenced by different factors. While the Rolling Stock division and the Public and Industrial Lighting division were impacted by market-related and project-related delays, business in the Sensor Technology and Electromechanics division developed more steadily. In the Rolling Stock division, SBF continues to see attractive growth prospects. However, changes in investment behavior as well as capacity and supply chain issues on the customer side led to project postponements during the reporting period. In fiscal year 2025, the segment generated revenue of EUR 18.9 million (previous year: EUR 21.0 million) and EBITDA of EUR 1.8 million (previous year: EUR 2.9 million). In the Public and Industrial Lighting division, project-related delays in the municipal sector as well as restrained investment activity resulted in lower revenue. In fiscal year 2025, the division generated revenue of EUR 9.8 million, thus falling short of plan (previous year: EUR 12.0 million). EBITDA amounted to EUR -1.7 million (privious year: EUR -1.9 million). In addition to weaker capacity utilization, one-off expenses in connection with the complete relocation of production had a negative impact. This relocation is intended to create the basis for efficiency gains from 2026 onward. In the Sensor Technology and Electromechanics division, SBF operated in a growing yet volatile market environment in 2025. AMS Software & Elektronik GmbH generated revenue of EUR 12.7 million (previous year: EUR 14.9 million), as customer call-offs were in some cases lower than expected. Progress in integrating the company acquired in 2024 as well as synergies in purchasing, project management, digitalization and production contributed to EBITDA of EUR 1.5 million, exceeding expectations (previous year: EUR -0.8 million). Strengthened foundation for 2026 through operational and structural optimization In addition to developments in the individual business divisions, SBF implemented key Group-wide measures in the 2025 reporting year to further improve its structural and operational setup. These included efficiency enhancements, the optimization of production capacities and the further development of the site in Ceske Budejovice, Czech Republic. The manufacturing facilities there were expanded so that, in future, mechanical production as well as electronic and mechanical assembly can be provided for all business divisions from a single source. The Annual Report 2025 is available for download on the company’s website: https://www.sbf-ag.com/investor-relations/finanzpublikationen/ About the SBF Group: The listed SBF Group is a specialist for innovative solutions in the fields of rolling stock, lighting, electromechanics and sensor technology. In the group of companies, highly specialized and leading hidden champions in their fields pool their expertise. With a high-quality and forward-looking product and service portfolio, SBF benefits from the megatrends of mobility, climate protection, automation and digitalization. In the “Rolling Stock” business field, the Tier 1 system supplier and development partner supplies the world's leading rolling stock manufacturers with complex interior, ceiling and lighting systems “Made in Germany”. The “Public and Industrial Lighting” business field comprises intelligent and customized LED systems for efficient lighting for industrial, municipal and infrastructural projects. In addition, the “Sensor Technology and Electromechanics” business field develops and produces pioneering components and software for electromechanical products such as circuit boards, sensors and communication technology. For more information, visit https://www.sbf-ag.com. Company contact: SBF AG The Executive Board Zaucheweg 4 04316 Leipzig Phone: +49 (0)341 65235 894 Email: info@sbf-ag.com Press contact: Kirchhoff Consult GmbH Alexander Neblung BorselstraBe 20 22765 Hamburg Phone: +49 (0)40 60 91 86 70 Email: sbf@kirchhoff.de View the original release on www.newmediawire.com
Market: Premium beauty with slower growth rates in mature markets, shifting shopping behavior, and increased focus on pricing and promotion amid customer uncertainty Higher sales at lower margin in Q2: Based on preliminary figures, Group sales increased by 1.1% to 949.7 million euros and adj. EBITDA decreased 5.1% (adj. EBITDA margin: 12.2%) Net result in Q2 impacted by impairments on NOCIBE and Parfumdreams / Niche Beauty DOUGLAS Group adjusts full-year guidance for adj. EBITDA to reflect the environment: Sales at the lower end of the range of 4.65-4.80 billion euros An adj. EBITDA margin of around 16.0% (previously around 16.5%) Net leverage at the upper end of the range between 2.5x and 3.0x as of 30.09.26 DUSSELDORF - April 30, 2026 (NEWMEDIAWIRE) - The DOUGLAS Group, Europe’s number one premium beauty retailer, continued to grow sales in the second quarter of the financial year 2025/26; at the same time, slower growth in mature markets, increased focus on price and promotion, and a weak consumer sentiment in the euro area due to uncertainty among customers weighed down profitability. Based on preliminary figures, the company recorded sales of 949.7 million euros in the period from 1 January to 31 March 2026 (Q2 2024/25: 939.0 million euros), reflecting a growth of 1.1%. Adjusted EBITDA decreased by 5.1% to 116.1 million euros, resulting in a margin of 12.2% (PY: 13.0%). The adjusted EBIT amounted to 19.1 million euros (PY: 32.4 million euros). Sander van der Laan, CEO of the DOUGLAS Group, said: “We operate in a market that has undergone a fundamental shift and is now stabilizing at a new level. Growth rates in mature premium beauty markets have normalized compared to the exceptional post‑pandemic period, while geopolitical and macroeconomic uncertainty continues to weigh on consumer sentiment. In this environment, our focus for the short- and mid-term is clear: omnichannel, differentiation, and profitable growth.” The net loss in the second quarter of 2025/26 amounts to a high-double-digit to low-triple-digit million euro figure. This is primarily attributable to impairments amounting to a mid- to high-double-digit million euro figure on goodwill relating to the business activities at the French business (NOCIBE) and Parfumdreams/Niche Beauty, as well as further impairments on assets amounting to a low-double-digit million euro figure. Guidance for 2025/26 adjusted Reflecting the changes in the premium beauty market and the current geopolitical and economic environment, the Management Board of the DOUGLAS Group has today adjusted the guidance for the financial year 2025/26. The company now expects: Sales at the lower end of the range of 4.65-4.80 billion euros An adj. EBITDA margin of around 16.0% (previously around 16.5%) Net leverage at the upper end of the range between 2.5x and 3.0x as of 30.09.26 Strategic focus on omnichannel, differentiation, and profitable growth The company is sharpening its strategic direction: Driving the differentiation in services and product offering, its leading omnichannel model, and a future-ready infrastructural backbone will be the key levers for sustainable growth in the current environment, in addition to a strict cost discipline. Sander van der Laan: “Our omnichannel model is a structural advantage in this ‘new normal’. The strategic direction we took with ‘Let it Bloom’ already put us in a good position, and we are further narrowing down this path and accelerating our efforts to excel in the execution of our initiatives. These measures are not short‑term reactions to the challenging environment: They are deliberate investments in the foundation on which we will deliver sustainable, profitable growth.” The full set of financial figures for the second quarter of the financial year 2025/26 will be published on 12 May 2026. About the DOUGLAS Group The DOUGLAS Group, with its commercial brands DOUGLAS, NOCIBE, Parfumdreams and Niche Beauty, is the number one omnichannel premium beauty destination in Europe. The DOUGLAS Group is inspiring customers to live their own kind of beauty by offering a unique assortment online and in around 1,970 stores. With unparalleled size and access to customers, the DOUGLAS Group is the partner of choice for brands and offers a premium range of selective and exclusive brands as well as own corporate brands. The assortment includes fragrances, color cosmetics, skin care, hair care, accessories as well as beauty services. Strengthening its successful omnichannel positioning while consistently developing superior customer experience is at the heart of the DOUGLAS Group strategy “Let it Bloom”. The winning business model is underpinned by the Group’s omnichannel proposition, leading brands, and data capabilities. In the financial year 2024/25, the DOUGLAS Group generated sales of 4.58 billion euros and employed more than 19,900 people across Europe. The DOUGLAS Group (Douglas AG) is listed at the Frankfurt Stock Exchange. For further information please visit the DOUGLAS Group Website. Press Contact Peter Wubben SVP Group Communications & Sustainability Phone: +49 211 16847 6644 Mail: newsroom@douglas.de Investor Contact Dafne Sanac Director / Senior Principal Investor Relations Phone: +49 151 55675545 Mail: ir@douglas.de View the original release on www.newmediawire.com
BASEL, SWITZERLAND - April 30, 2026 (NEWMEDIAWIRE) - BioVersys AG (SIX: BIOV), a multi-asset, clinical stage biopharmaceutical company focusing on research and development of novel antibacterial products for serious life-threatening infections caused by multi-drug resistant (MDR) bacteria, announced today the results of its Annual General Meeting with all proposals by the Board of Directors voted in favor by the shareholders. Dr. Seng Chin Mah, Chairman of the Board of Directors of BioVersys: “On behalf of the Board of Directors and Management, I would like to thank our shareholders for their continued trust in us and for their unwavering support for the BioVersys mission. Having achieved FPFV for the global BV100 Phase 3 trial, we are completely focused on eventually bringing this therapeutic option to patients in dire need. Our teams are equally determined to progress alpibectir and our preclinical pipeline with our partners. We thank Dr. William Jenkins for his invaluable contributions during his Board tenure, and welcome Ms. Simona Skerjanec to the Board of Directors.” BioVersys’ shareholders approved all items on the agenda, including: The 2025 Annual Report, the annual financial statements, the consolidated financial statements, and voted to acknowledge the Auditors’ reports. The re-election of Seng Chin Mah as Chairman of the Board of Directors, the re-election of David Hunstad, Marc Gitzinger, Marina von Schonau and Ulrik Schulze, as well as the election of Ms. Simona Skerjanec as Members of the Board of Directors. The maximum aggregate amount of compensation for the Board of Directors for the term of office until AGM 2027, and the maximum aggregate amount of compensation for the members of the Executive Committee for the financial year 2027. The minutes and the relevant documents relating to the shareholders’ meeting, including the Annual Report, are available on the Company’s website under the following links: Annual Report: https://ir.bioversys.com/investor-relations/financials/financial-reports AGM: https://ir.bioversys.com/investor-relations/governance-csr/annual-general-meeting About BioVersys BioVersys AG is a multi-asset, clinical stage biopharmaceutical company focused on identifying, developing and commercializing novel antibacterial products for serious life-threatening infections caused by multi-drug resistant (“MDR”) bacteria. Derived from the company’s two internal technology platforms (TRIC and Ansamycin Chemistry), candidates are designed and developed to overcome resistance mechanisms, block virulence production and directly affect the pathogenesis of harmful bacteria towards the identification of new treatment options in the antimicrobial and microbiome fields. This enables BioVersys to address the high unmet medical need for new treatments against life-threatening resistant bacterial infections and bacteria-exacerbated chronic inflammatory microbiome disorders. The company’s most advanced research and development programs address nosocomial infections of Acinetobacter baumannii (BV100, Phase 3), and tuberculosis (alpibectir, Phase 2, in collaboration with GlaxoSmithKline (GSK) and a consortium of the University of Lille, France). BioVersys is located in the biotech hub of Basel, Switzerland. BioVersys contact Anca Cighi, Head of IR and Communication, Tel. +41 79 949 33 09; E-Mail: anca.cighi@bioversys.com For IR and Media: IR@bioversys.com Website: www.bioversys.com Disclaimer This communication expressly or implicitly contains certain forward-looking statements, such as "believe", "assume", "expect", "forecast", "project", "may", "could", "might", "will" or similar expressions concerning BioVersys and its business, including with respect to the progress, timing and completion of research, development and clinical studies for product candidates. Such statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of BioVersys to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. BioVersys is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise. View the original release on www.newmediawire.com
LOS ANGELES, CA - April 30, 2026 (NEWMEDIAWIRE) - Datavault AI (NASDAQ: DVLT) announced a multi-component strategic transaction with King Mining Capital that includes a planned equity stake, a stock-funded purchase of 20,000 ounces of physical gold bullion and the launch of a $150 million-plus GoldVault(TM) tokenization program. The initiative leverages Datavault AI’s blockchain platform to enable digital ownership of gold-backed assets while aligning the Company with long-term mineral asset performance and expanding access to tokenized precious metals tied to production-based royalty streams. To view the full press release, visit https://ibn.fm/ZdjEx About Datavault AI Inc. Datavault AI is leading the way in AI experience, valuation, and monetization of assets in the Web 3.0 environment. The company’s cloud-based platform provides comprehensive solutions with a collaborative focus in its Acoustic Science and Data Science Divisions. Datavault AI’s Acoustic Science Division features WiSA(R), ADIO(R) and Sumerian(R) patented technologies and industry first foundational spatial and multichannel wireless HD sound transmission technologies with IP covering audio timing, synchronization and multi-channel interference cancellation. The Data Science Division leverages the power of Web 3.0 and high-performance computing to provide solutions for experiential data perception, valuation and secure monetization. Datavault AI’s cloud-based platform provides comprehensive solutions serving multiple industries, including HPC software licensing for sports & entertainment, events & venues, biotech, education, fintech, real estate, healthcare, energy and more. The Information Data Exchange(R) (IDE) enables Digital Twins, licensing of name, image, and likeness (NIL) by securely attaching physical real-world objects to immutable metadata objects, fostering responsible AI with integrity. Datavault AI’s technology suite is completely customizable and offers AI and Machine Learning (ML) automation, third-party integration, detailed analytics and data, marketing automation and advertising monitoring. The Company is headquartered in Philadelphia, PA. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law View the original release on www.newmediawire.com
LOS ANGELES, CA - April 30, 2026 (NEWMEDIAWIRE) - Greenland Energy (NASDAQ: GLND), an energy company focused on Greenland’s Jameson Land Basin, announced the closing of its previously announced public offering for gross proceeds of approximately $70 million, before deducting placement agent fees and offering expenses. Proceeds are expected to fund execution of the Company’s exploration plan, including OPW1 & OPW2 procurement, long-lead materials, field readiness, workforce mobilization, winter-preparation equipment and tug-and-barge logistics ahead of planned October 2026 drilling operations. To view the full press release, visit https://ibn.fm/tUuSg About Greenland Energy Company Greenland Energy Company is an energy exploration company focused on responsibly developing Greenland’s hydrocarbon resources, with an emphasis on the Jameson Land Basin. It aims to advance oil and gas exploration and create a publicly traded platform for Arctic energy development. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law
LOS ANGELES, CA - April 30, 2026 (NEWMEDIAWIRE) - D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave” or the “Company”), the only dual-platform quantum computing company providing both annealing and gate-model systems, software and services, today announced that it will host its first-ever Investor Day, on June 1, 2026, at the New York Stock Exchange and online. Themed “The D-Wave Difference,” the event will provide investors with an in-depth look at the Company’s technology leadership, product roadmap, commercial momentum and long-term growth strategy. Designed to bring greater clarity to a rapidly evolving sector, the event will provide investors with D-Wave’s perspective on the quantum computing landscape, the Company’s differentiated approach and how it is translating innovation into commercial opportunity. To view the full press release, visit https://ibn.fm/vZf4R About D-Wave Quantum Inc. D-Wave is a leader in the development and delivery of quantum computing systems, software, and services. It is the world’s first commercial supplier of quantum computers, and the first and only to offer dual-platform quantum computing products and services, spanning both annealing and gate-model quantum computing technologies. D-Wave’s mission is to help customers realize the value of quantum today through enterprise-grade systems available on-premises and via its LeapTM quantum cloud service, which offers 99.9% availability and uptime. More than 100 organizations across commercial, government and research sectors trust D-Wave to address complex computational challenges using quantum computing. Learn more about realizing the value of quantum computing today and how D-Wave is shaping the quantum-driven industrial and societal advancements of tomorrow: https://dwavequantum.com. Forward-Looking Statements Certain statements in this press release are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by the following words: “believe,” “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “trend,” “estimate,” “predict,” “project,” “potential,” “seem,” “seek,” “future,” “outlook,” “forecast,” “projection,” “continue,” “ongoing,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management’s control, including the risks discussed under the caption “Item 1A. Risk Factors” in Part I of our most recent Annual Report on Form 10-K or any updates discussed under the caption “Item 1A. Risk Factors” in Part II of our Quarterly Reports on Form 10-Q and in our other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this press release in making an investment decision, which are based on information available to us on the date hereof. We undertake no duty to update this information unless required by law. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law
LOS ANGELES, CA - April 30, 2026 (NEWMEDIAWIRE) - HeartBeam (NASDAQ: BEAT), a medical technology company focused on cardiac care innovation, will host a conference call on May 13, 2026, at 4:30 p.m. Eastern time to discuss first-quarter results ended March 31, 2026, and provide updates on key growth initiatives, including its limited commercial launch for arrhythmia assessment, extended-wear patch development, heart attack detection and AI programs. To view the full press release, visit https://ibn.fm/yN939 About HeartBeam, Inc. HeartBeam, Inc. is a medical technology company dedicated to transforming the detection and monitoring of critical cardiac conditions. The Company is creating the first-ever cable-free device capable of collecting ECG signals in 3D, from three non-coplanar directions, and synthesizing the signals into a 12-lead ECG. This platform technology is designed for portable devices that can be used wherever the patient is to deliver actionable heart intelligence. Physicians will be able to identify cardiac health trends and acute conditions and direct patients to the appropriate care – all outside of a medical facility, thus redefining the future of cardiac health management. HeartBeam’s 3D ECG technology received FDA clearance for arrhythmia assessment in December 2024 and the 12-lead ECG synthesis software in December 2025. The Company holds over 20 issued patents related to technology enablement. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer The latest news and updates relating to BEAT are available in the company’s newsroom at https://ibn.fm/BEAT Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law
LOS ANGELES, CA - April 30, 2026 (NEWMEDIAWIRE) - Beeline Holdings (NASDAQ: BLNE), a fast-growing digital mortgage platform, has debuted a new automated lending pathway designed to streamline the home financing process. “The company recently introduced its Self-Service Mortgage Experience (‘SSME’), a platform feature that allows borrowers to explore customized loan options, model mortgage scenarios and lock interest rates entirely online. According to a company announcement, the first phase of the feature launched on March 11 and is currently available to roughly half of conventional mortgage applicants using Beeline’s platform,” reads an article discussing the launch. “Beeline’s platform allows borrowers to complete several steps of the mortgage process independently. After submitting an application through the company’s digital portal, the system processes borrower data and produces customized loan rate options within seconds. Borrowers can then explore scenarios and request a rate lock at any time. The system operates continuously, giving customers the option to progress through early stages of the mortgage process without waiting for business hours or scheduling a call with a loan officer. A digital assistant known as ‘Bob’ is embedded in the platform to answer questions during the process. Borrowers can still connect with Beeline loan specialists if they prefer human guidance.” To view the full article, visit https://ibn.fm/TGseV About Beeline Financial Holdings Inc. Beeline Financial Holdings is a trailblazing mortgage fintech transforming the way people access property financing. Through its fully digital, AI-powered platform, Beeline delivers a faster, smarter path to home loans - whether for primary residences or investment properties. Headquartered in Providence, Rhode Island, Beeline is reshaping mortgage origination with speed, simplicity, and transparency at its core. The company is a wholly owned subsidiary of Beeline Holdings and also operates Beeline Labs, its innovation arm focused on next-generation lending solutions Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law View the original release on www.newmediawire.com
Hong Kong's International Trade Strength on Display as Cross-Sector Opportunities Open New Markets for Global Businesses HONG KONG - April 30, 2026 (NEWMEDIAWIRE) - The Hong Kong Trade Development Council (HKTDC) today successfully concluded seven flagship lifestyle and licensing events, attracting over 95,000 buyers from 134 countries and regions for sourcing and business negotiations. Among the lifestyle fairs, the Hong Kong Gifts & Premium Fair attracted over 32,000 buyers, Home InStyle drew some 20,000 buyers, and Fashion InStyle gathered some 12,000 buyers, while the Hong Kong International Printing & Packaging Fair and DeLuxe PrintPack Hong Kong saw over 9,600 buyers attend the concurrent events. Meanwhile, the Hong Kong International Licensing Show (HKILS) attracted over 21,000 buyers, and the Asian Licensing Conference (ALC) featured over 20 international licensing industry leaders as speakers. Non-local buyers at these fairs came primarily from Chinese Mainland, Taiwan, and Japan, while significant growth was also recorded in buyer numbers from the Philippines, Canada, and Türkiye, underscoring the fairs' strong international appeal. Jenny Koo, HKTDC Deputy Executive Director, said: “In alignment with the national 15th Five-Year Plan, Hong Kong will continue to actively develop its role as a regional intellectual property trading hub, further enhancing its international competitiveness in the cultural and creative industries and IP transactions. The seven flagship events fully showcased Hong Kong's distinctive strengths in lifestyle, cultural and creative design, brand development, and intellectual property, offering global buyers a rich and diverse array of sourcing options, while connecting exhibitors with international buyers and partners to unlock business opportunities. HKTDC will continue to leverage Hong Kong's unique advantage of connecting Chinese Mainland with the rest of the world, foster cross-sector international trade collaboration, and reinforce Hong Kong's status as an international trade hub." Nearly half of respondents expect sales growth, industries actively explore new markets To further gauge the latest trends in the lifestyle products market, HKTDC conducted a questionnaire survey of 1,541 exhibitors and buyers during the Gifts & Premium Fair, Home InStyle, and Fashion InStyle. The key findings are as follows: Market and industry outlook: - Nearly half (49.0%) of respondents expected their overall sales would rise in the next one to two years, while 44.6% foresaw that sales will remain stable. The greatest operational challenges identified were fluctuations of global economy (47.8%), conflict-led crisis such as geopolitical tensions, energy and food insecurity, supply chain chaos (37.2%) and growing protectionist measures (33.7%) - Respondents believed sales prospects are promising or very promising over the next two years in ASEAN countries (69.0%), Taiwan (67.9%), India (66.7%), Korea (65.2%) and Chinese Mainland (63.0%) - The markets that exhibitor respondents are actively exploring include Europe (34.0%), ASEAN countries (18.3%), North America (16.0%), Middle East (13.6%) and Australia (12.8%) Product trends: - In the gifts and premiums market, respondents believed the strongest growth potential lies in: cultural gifts (19.7%), sustainable gifts (18.6%), and tech gifts (18.6%) - In the furniture and home products market, designer furniture & houseware products (27.3%), interior decoration & handicrafts (27.1%), and smart home technology (23.0%) were considered to have the most growth potential - In the fashion market, respondents believed designer clothing / branded clothing (42.4%), urban clothing (34.5%), and womenswear (31.9%) have the strongest growth potential Cross-sector opportunities and synergies help exhibitors tap into new markets The seven annual lifestyle and licensing events span diverse industries and cultural creativity. Semk Holdings International Limited, a major player in character IP licensing, exhibited at the Gifts & Premium Fair, showcasing a range of B.Duck co-branded IP products. CK Kwok, the company’s Co-founder, Executive Director & VP said the company successfully draw strong buyer interest and connected with buyers from Mexico, Canada, Europe and Southeast Asia. The UAE made its debut at the Gifts & Premium Fair this year. Mohanmed Alayat, Founder of Dubai exhibitor Alpha Art, said: “On the first day alone, we connected with around 40 new clients from Asia, Europe, the United States and Africa, and received enquiries for customised products. We anticipate potential orders over the course of the fair to total around US$1 million.” Gifts & Premium Fair seals three MOUs, deepening Hong Kong’s trade ties with the Chinese Mainland and overseas markets The Gifts & Premium Fair also highlighted Hong Kong’s role as an international trade platform bridging markets worldwide. The China Council for the Promotion of International Trade Shanxi Provincial Committee and the China Council for the Promotion of International Trade Fujian Sub-Council signed memoranda of understanding (MOU) with the HKTDC respectively, aiming at encouraging enterprises from Shanxi and Fujian to leverage Hong Kong’s platform to “go global”, while further strengthening their trade ties with Hong Kong. In addition, the Busan Economic Promotion Agency also signed an MOU with the HKTDC to promote gift products from Busan, Korea, to international markets through Hong Kong’s platform, unlocking new business opportunities for companies in the gift sectors of both Hong Kong and Korea. Innovative materials help exhibitors discover new fashion opportunities Fashion InStyle featured the returning NEXT@Fashion InStyle (NEXT), a key highlighted zone organised by HKTDC, sponsored by the HKSAR Government's Cultural and Creative Industries Development Agency, with over 60 world-wide new material exhibitors. Textile Library from Hangzhou, returned to NEXT this year after successfully connecting with a Thai exhibitor at last year’s edition. It also collaborated with a Hong Kong designer brand Ponder.er, applying its patented, self-developed epoch-poly fabrics to create dynamic and expressive designs. Mary Ma, Founder of Textile Library, stated: "This year, we have brought two latest self-developed materials to Hong Kong, warp-print fabrics and the ice-crack series of crackle finishing, showcasing the perfect fusion of traditional craftsmanship and modern technology. The materials drew strong interest and praise from international buyers and have already yielded several concrete cooperation intentions and promising follow-up business opportunities.” Some exhibitors achieved remarkable results on their first participation of Fashion InStyle. Hin Pi, Operations Manager of New High Limited, a local exhibitor specialising in swimwear and sportswear, said: “We connected with some 50 potential buyers from around the world. It was particularly surprising and encouraging to meet buyers from Dubai and North Africa, which will greatly facilitate our expansion into new overseas markets. Four to five buyers have already expressed clear interest in cooperation, with expected total orders totally about US$100,000.” In addition, Baek Kyunghoon, Procurement Manager of Kolon Industries FnC, a leading Korean fashion group, connected with suppliers from Sweden, Germany, Indonesia, Thailand, the Philippines, and Vietnam at the fair. The company plans to apply sustainable and high-tech materials to its sports collections. Vanessa Tirol Lacerda, Creative Director of Brazilian e-commerce fashion brand Amaro, said the diverse range of innovative materials was highly inspiring, especially the salmon skin leather and pineapple fibre fabrics. She has already established cooperation with exhibitors from India and Chinese Mainland, with an expected initial order of approximately US$100,000. Many internationally renowned brands and major retailers, including New Zealand’s Karen Walker, the United Kingdom’s The Business Fashion, Thailand’s Jaspal Group, and India’s SD Retail, successfully identified potential business collaborations. Home InStyle this year introduced innovative materials for homeware and home textiles for the first time. Hong Kong exhibitor Lotux International Holdings Co. Limited presented biodegradable cutlery and food containers made from lotus stems, alongside deodorising cat litter made from lotus fibre. Daphne Wan, the company's Sales Director, said: “Our innovative eco-friendly materials and pet products attracted strong interest from visitors. We are currently in discussions with a houseware company on the joint development of eco-friendly straws. The Hong Kong Furniture and Decoration Trade Association has also expressed interest in using our sustainable materials in furniture production.” Driving the development of high value-added gerontechnology and cultural & creative design Industries Home InStyle attracted exhibitors showcasing new products. Exhibitor allcareAI Limited, which specialises in gerontechnology, debuted its infection-prevention mobile toilet at the fair. CEO Phil Woo stated: "In the first two days alone, we received over 20 enquiries, including from local care homes, medical and rehabilitation service providers, as well as potential partners from Chinese Mainland, Japan, Australia, Europe and Southeast Asia. This reflects the sector’s growing demand for gerontechnology and infection-control care solutions." He also shared that the Reimagine themed floor, which brought together the innovative products of Gifts & Premium Fair and Home InStyle, helped raising the profile of the gerontech industry and showcased its diverse applications to industry players from different sectors, offering a single platform to explore the latest trends in innovative materials and home lifestyle. In addition, TFE Holdings Limited showcased a distinctive concrete coffee machine at the Cultural and Creative Avenue. Ivan Wong, Executive Director and Product Director, said: “We have engaged with over 20 potential buyers from Hong Kong, France, Dubai, as well as Southeast Asian markets including Malaysia and Thailand. We expect to secure around 15 orders worth about US$1 million in total.” The Hong Kong International Printing & Packaging Fair and DeLuxe PrintPack Hong Kong attracted global buyers seeking sourcing opportunities. Among them was buyer Hot Packaging LLC from Middle East, which visited the Printing & Packaging Fair to source eco-friendly packaging solutions. Anas Bin Haneef, the company’s Senior Commercial Officer, said: “I connected with around 12 new suppliers from the Chinese Mainland. We expect to place initial trial orders for innovative corrugated paper bags and other sustainable products, with an estimated value of US$35,000 to US$75,000. We plan to introduce corrugated paper bags, biodegradable moulded fibre products and bagasse paper bags to the e-commerce market in the UAE and across the Middle East as greener alternatives to traditional plastic packaging.” Packaging design also created new opportunities for exhibitors. W.H.Y. Brand Consultancy Limited participated in DeLuxe PrintPack Hong Kong for the first time this year, connected with printers and design firms, including companies from Southeast Asia and Korea, opening up potential collaboration on branding solutions for major enterprises. Founder William Yeung also shared that a Thai trade media outlet, which had initially approached the company for an exhibitor interview, later expressed interest in becoming a client, a clear demonstration of the fair’s ability to turn exposure into tangible business opportunities. He added that the company's participation is expected to generate around US$400,000 in business. Buyers also affirmed the fairs as efficient sourcing platforms. Henry Huang, Vice President, Global Product Development at Umbra Ltd, a Canadian buyer at Home InStyle, said: “We identified around 20 potential suppliers from Hong Kong, the Chinese Mainland, Thailand and Taiwan, offering products such as photo frames, desktop novelties and shoe racks. We also joined six business matching meetings during the fair and expect total orders to reach up to US$100,000.” Meanwhile, Jaime Gonzalez, Commercial Director of Mexico’s Promo Life and a buyer at the Gifts & Premium Fair, said the Reimagine themed floor brought together cultural creative, innovative and design elements, enabling buyers to capture market trends and evolving lifestyle in one place. He added that featured zones such as the Smart Design Global Awards, Selection of ASEAN and The Bespoke Hub also helped buyers discover design-led, customised and regionally inspired gift ideas. He also revealed plans to spend US$200,000 on keychains and magnets from a Hong Kong exhibitor. Licensing industry goes global through HKTDC platform At the Hong Kong International Licensing Show, Hong Kong exhibitor Postgal Workshop has reached an agreement with Malaysia based M&M Creations Holdings Sdh. Bhd., involving its IP “Din Dong”, with the collaboration estimated to be worth over US$200,000. CEO of M&M Creations Holdings Sdn. Bhd. commented that “Hong Kong International Licensing Show has sparked many new ideas. We look forward to collaborate with more Hong Kong IPs for the Malaysia market.” At the Asian Licensing Conference, industry leaders shared emerging trends in the licensing industry, including shifts in consumer behaviour, and new IP development models. Maura Regan, President and CEO of Licensing International, stated: " We remain convinced that we'll see significant growth across property types. Overall, the licensing industry is not slowing down. Consumers continue to demand immersive experiences, from theme parks to branded hotels to pop-up shops to retail experiences.” Photo download: https://bit.ly/4cDT1II Websites HKTDC Media Room: https://mediaroom.hktdc.com/en Hong Kong Gifts & Premium Fair: https://www.hktdc.com/event/hkgiftspremiumfair/en Home InStyle: https://www.hktdc.com/event/homeinstyle/en Fashion InStyle: https://www.hktdc.com/event/fashioninstyle/en Hong Kong International Printing & Packaging Fair: https://www.hktdc.com/event/hkprintpackfair/en DeLuxe PrintPack Hong Kong: https://www.hktdc.com/event/deluxeprintpackhk/en Hong Kong International Licensing Show and Asian Licensing Conference: https://www.hktdc.com/event/hklicensingshow/en Media enquiries For enquiries, please contact: Home InStyle, Fashion InStyle, HK Gifts & Premium Fair, HK International Printing & Packaging Fair and DeLuxe PrintPack Hong Kong Pandagon: Fraser Li Tel: 6083 5623 Email: pandagon.limited@gmail.com HKTDC’s Communications & Public Affairs Department: Clayton Lauw Tel: 2584 4472 Email: clayton.y.lauw@hktdc.org HK International Licensing Show and Asian Licensing Conference Raconteur: Molisa Lau Tel: 6187 7786 Email: molisalau@raconteur.hk Betsy Tse Tel: 9742 7338 Email: betsytse@raconteur.hk HKTDC’s Communications & Public Affairs Department: Winnie Kan Tel: 2584 4055 Email: winnie.wy.kan@hktdc.org HKTDC Newsroom: http://mediaroom.hktdc.com/en About HKTDC The Hong Kong Trade Development Council (HKTDC) celebrates its 60th anniversary this year. The HKTDC is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in the Chinese Mainland, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus.
Following Buyer Introduction at European Film Market in Berlin, MSR Media International to Continue International Distribution Push at Upcoming Cannes Film Festival Amazon’s “The Summer I Turned Pretty” Star Leads Ensemble Cast; Project Now in Post-Production HOUSTON, TX and LONDON, UK - April 30, 2026 (NEWMEDIAWIRE) - PickleJar Entertainment Group, Inc. (OTC Pink: PKLE) (“PickleJar” or the “Company”), a live entertainment technology company, today announced it is providing marketing technology and fan engagement capabilities for the feature film Sunflower Child, drawing on its integrated platform that connects radio, digital channels, and live venues. The film stars Gavin Casalegno (Amazon’s “The Summer I Turned Pretty,” The Unhealer) and rising talent Jennifer James (The Newspaper, Curiouser), who also wrote the screenplay. Sunflower Child is produced by Joseph Goldman for Double J Productions, in association with Nebel Productions and in collaboration with PickleJar Entertainment Group. The project has completed principal photography and is currently in post-production, with filming having taken place in the U.K., including at the historic Twickenham Studios and on location throughout London. Sunflower Child marks the feature directorial debut of award-winning cinematographer Jamie Touche (Cerebrum, Trinou) and also features Daniela Norman (“Tiny Pretty Things,” Cats), Muhannad Ben Amor (Disney+’s “Andor,” Netflix’s “Extraction”), and Maddie Close (BBC’s “The Other Bennet Sister”). International Distribution Momentum MSR Media International is handling worldwide sales and introduced the film to international buyers at the European Film Market (EFM) in Berlin in February 2026. The team will continue building international distribution momentum at the upcoming Cannes Film Festival in May 2026, where they will engage with global distributors and territory buyers. Expanding PickleJar’s Content Ecosystem The Sunflower Child engagement represents a strategic expansion of PickleJar’s growing content portfolio, including its nationally syndicated radio show PickleJar Up All Night, distributed via Local Radio Network partnerships, original programming, and artist development initiatives. In connection with the film’s release, PickleJar will activate its integrated platform - including FanVivo, PickleJar Up All Night, and PickleJar Plus - to extend Sunflower Child’s audience reach across radio, digital, and venue channels. Additional details regarding PickleJar’s integrated marketing and fan-activation campaign for Sunflower Child will be announced in the coming weeks, in connection with the film’s continued international distribution push. “This collaboration reflects PickleJar’s commitment to expanding beyond core technology and into supporting original content that resonates with audiences,” said Kristian Barowsky, President and Co-Founder of PickleJar Entertainment Group. “Film is a natural extension of our entertainment ecosystem. With Sunflower Child, we’re working alongside exceptional creative talent and positioning PickleJar in connection with a project of strong international market appeal. For our shareholders, this represents another step in building a diversified entertainment company with multiple revenue streams and content touchpoints.” About the Film Caught between the promise of Hollywood fame and the corruption of her artistic voice, a young screenwriter (James) unexpectedly falls for an aspiring director (Casalegno). Together, they come face to face with betrayal, the cost of success, and the choice between the wrong version of a dream and following your heart. “This project became one of those rare experiences that took on a life of its own, unfolding in unexpected and beautiful ways,” said writer and lead Jennifer James. “I set out to tell a story I ultimately realized I had to fully live before I could share it. The result is an anthem for authenticity, for indie filmmakers, and what it really takes to get a foot in the door.” “Sunflower Child is the culmination of a five-year collaboration with Jennifer and Double J Productions,” said director Jamie Touche. “I’m overjoyed that my directorial debut has love at its core - both a love for the work itself and for the people around us.” “We are thrilled to represent Sunflower Child, a film that exudes authenticity and heart,” said Karinne Behr of MSR Media International. “It’s a story that we believe will truly connect with audiences everywhere.” Cast and Representation Gavin Casalegno most recently starred as Jeremiah Fisher in Amazon’s hit series “The Summer I Turned Pretty,” based on Jenny Han’s bestselling novels. He began his career as a child actor, appearing in Darren Aronofsky’s Noah alongside Russell Crowe, Jennifer Connelly, and Anthony Hopkins, and played the young Damon Salvatore in “The Vampire Diaries.” Next up, Casalegno will star in the YA romance film Chasing Red, Amazon MGM’s thriller The Devil’s Mouth, and is set to lead the feature film version of “The Summer I Turned Pretty.” Jennifer James is a writer, producer, and actress behind the acclaimed short films Blueberry Pancakes & Blank Pages and Curiouser. She has appeared on television in series such as “Peaky Blinders” and continues to develop original film and TV projects through Double J Film Productions. Daniela Norman gained attention for her role as June Park in Netflix’s ballet drama “Tiny Pretty Things” and made her feature-film debut as Demeter in Cats (2019), appearing alongside Taylor Swift and James Corden. Muhannad Ben Amor is best known for his role as Wilmon Paak in Disney+’s “Andor” and appeared in Netflix’s action-thriller series “Extraction.” Maddie Close stars as Jane Bennet in the upcoming BBC series “The Other Bennet Sister.” Jamie Touche is an award-winning cinematographer with over ten years’ experience. His work has screened at BAFTA and Oscar-qualifying festivals worldwide, earning individual cinematography awards and two nominations for the British Society of Cinematographers (BSC) Short Film Cinematography Award. Casalegno is represented by UTA, Bold Agency, Luber Roklin Entertainment, and Skrzyniarz & Mallean; James by Beresford Management; Norman by Beresford Management and Authentic Talent and Literary Management; Amor by Hamilton Hodell and Linden Entertainment; Close by Revolution Talent. Related-Party Disclosure PickleJar’s involvement in Sunflower Child is consistent with the Company’s broader support of emerging independent filmmakers, including its sponsorship of the Nashville Film Festival in 2024 and the development of PickleJar Flix as a service in 2025. Jennifer James is the daughter of PickleJar Chairman and Chief Executive Officer Jeff James. In 2025, PickleJar made a £25,000 investment in the Sunflower Child production. The investment and the Company’s ongoing platform engagement were reviewed and approved by the Company’s independent directors on arms-length terms. About PickleJar Entertainment Group, Inc. PickleJar Entertainment Group, Inc. (OTC Pink: PKLE) is a live entertainment technology company developing integrated software and services connecting fans with emerging artists, mid-sized venues, and global brands. PickleJar’s platform combines secure payment technology, data intelligence, and content distribution to support artist promotion programs, venue-managed services, and related fan-engagement capabilities. The Company is headquartered in Houston, Texas. For more information, visit picklejar.com. About Double J Productions Double J Productions is a British-American film production company built on the belief that storytelling comes first, blending high-quality production values, cost-efficient practices, and fearless creativity to deliver exceptional work at any scale. With an eclectic slate spanning all genres, no two Double J projects are ever the same. Short films have earned international recognition, including The Newspaper, which premiered at Raindance Film Festival. About MSR Media International MSR Media International is a boutique international sales company focused on commercial feature films and television series for audiences worldwide. Headquartered in the United States, their commercially driven principals bring years of industry experience - combining finance, production, and marketing expertise. Cautionary Note Regarding Forward-Looking Statements This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and is intended to qualify for the safe harbor provided by the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by words such as “anticipate,” “believe,” “expect,” “intend,” “plan,” “project,” “will,” “would,” and similar expressions, and include, without limitation, statements regarding PickleJar’s strategy and growth plans; the Company’s objective of becoming a fully reporting issuer with the SEC and the timing and outcome of any such registration; the Company’s ability to remediate identified material weaknesses in internal control over financial reporting and the timing of such remediation; the Company’s ability to continue as a going concern, to obtain additional financing, and to extend, restructure, convert, or otherwise resolve existing obligations, including obligations in default; the Company’s ability to develop profitable operations; and any other statements that are not historical facts. Forward-looking statements are based on management’s current expectations and assumptions and are subject to significant risks, uncertainties, and changes in circumstances that could cause actual results to differ materially. These risks include, without limitation: substantial doubt about the Company’s ability to continue as a going concern; the existence of material weaknesses in internal control over financial reporting; recurring net losses and negative cash flow from operations; reliance on related-party financing; the existence of indebtedness in default and the absence of executed extensions, waivers, or restructurings as of the date the audited financial statements were issued; the Company’s working capital deficit; risks associated with the Company’s revolving credit facility, including the previously disclosed event of default; concentration of beneficial ownership; and the other risks described in the audited financial statements and accompanying footnotes. Readers are cautioned not to place undue reliance on any forward-looking statement, which speaks only as of the date made. PickleJar undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as required by law. Contact: Anna Benson Anna@picklejar.com View the original release on www.newmediawire.com
CARACAS, VENEZUELA - April 30, 2026 (NEWMEDIAWIRE) - Catalyst Crew Technologies Corp. (OTC: CCTC) (the “Company”), an artificial intelligence-driven healthcare technology company focused on scalable digital health solutions for emerging markets, today announced that its Chief Executive Officer, Kevin Roldan Levy, has initiated a capital structure initiative pursuant to which up to fifty percent (50%) of his restricted common stock holdings are expected to be canceled in exchange for a newly designated class of preferred equity. This initiative is intended to support the Company’s broader capital structure objectives, including optimization of its common equity base, enhancement of long-term strategic flexibility, and alignment of executive equity participation with broader corporate development goals. Management believes that, upon implementation, the transaction is expected to contribute to a more disciplined equity framework and support the Company’s evolving long-term strategic initiatives, including future financing opportunities, strategic partnerships, and broader operational development. The Company also believes that this capital structure initiative is expected to strengthen alignment between executive leadership and long-term corporate performance objectives while reinforcing management’s commitment to disciplined growth and shareholder-oriented development. “This initiative reflects my long-term commitment to the Company’s strategic development and disciplined capital structure management,” said Kevin Roldan Levy, Chief Executive Officer of Catalyst Crew Technologies Corp. “As we continue advancing our broader healthcare technology strategy, I believe proactive capital structure planning will support stronger long-term positioning while reinforcing our commitment to sustainable shareholder value creation.” The Company is currently finalizing the structure and designation of the new preferred equity as part of the implementation process and expects to provide additional updates as final corporate actions are completed. Catalyst Crew continues to advance its transition into AI-enabled healthcare, with a focus on telehealth infrastructure, remote patient monitoring, and data-driven clinical insights across underserved markets. The Company will continue to evaluate strategic initiatives designed to support its long-term development and will provide additional updates as appropriate. For more information, please visit https://catalystcrewai.com or review the Company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov. About Catalyst Crew Technologies Corp. Catalyst Crew Technologies Corp. is an artificial intelligence-driven healthcare technology company focused on developing scalable digital health solutions for emerging markets, with an initial emphasis on Latin America. The Company is actively executing its strategic transition into AI-enabled healthcare and pursuing opportunities across telehealth infrastructure, remote patient monitoring, healthcare data analytics, and integrated digital care platforms designed to improve access, efficiency, and care coordination. Through technology development initiatives, strategic partnerships, and targeted acquisitions, CCTC is building an integrated healthcare technology platform positioned to address the growing demand for modernized healthcare delivery systems across emerging markets. Forward-Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements include, but are not limited to, statements regarding the Company’s business strategy, leadership initiatives, strategic transactions, operational execution, regulatory matters, and future operations. Forward-looking statements are based on current expectations and assumptions that involve risks and uncertainties. Actual results may differ materially from those expressed or implied due to various factors, including but not limited to the Company’s ability to successfully implement its business plan, secure financing, complete acquisitions, comply with regulatory requirements, and general market and economic conditions. The Company undertakes no obligation to update any forward-looking statements except as required by applicable law. Disclaimer This press release is provided for informational purposes only and does not constitute an offer to sell or the solicitation of an offer to buy any securities of the Company. The Company is a development-stage enterprise and has not generated revenues from its current business direction. There can be no assurance that the Company will successfully implement its business plan, complete acquisitions, secure financing, obtain regulatory approvals, or generate revenues. Any investment decision should be made solely on the basis of information contained in the Company’s filings with the U.S. Securities and Exchange Commission and other publicly available documents. The Company’s securities involve a high degree of risk. Prospective investors are urged to carefully review all risk factors and disclosures contained in the Company’s SEC filings before making any investment decision. No representation or warranty, express or implied, is made as to the accuracy or completeness of the information contained herein. Investor Relations Contact +1 (787) 476-2350 ir@catalystcrew.ai View the original release on www.newmediawire.com
Portfolio Spotlights Key Innovations Supporting Compliant, Tokenized Securities Lifecycle, Upgradeable Smart Contract Infrastructure and Broker-Dealer Interoperability NEW YORK, NY - April 30, 2026 (NEWMEDIAWIRE) - tZERO Group, Inc., a leading innovator in blockchain-powered multi-asset infrastructure, has been undertaking a strategic review of its intellectual property portfolio since the leadership change at the end of 2025, and highlighting several foundational patents supporting the development of compliant, tokenized securities infrastructure. As part of this review, tZERO is providing initial perspective into five of tZERO’s 23 patent families, encompassing 103 patents, that underpin key elements of the security token lifecycle, including compliance-aware transfer logic, upgradeable smart-contract frameworks, scalable corporate-action handling and broker-dealer-level identity interoperability. These patents reflect work initiated during the early formation of the security token market and continue to inform the architecture of regulated on-chain capital markets infrastructure today. “We have invested for years in building technology designed specifically for regulated digital asset securities,” said Alan Konevsky, Chief Executive Officer of tZERO. “As institutional adoption of tokenized assets accelerates, we believe it is an appropriate time to begin highlighting components of our intellectual property portfolio that support compliant issuance, trading and lifecycle management of tokenized securities and form an important part of our infrastructure provision and asset base. As I mentioned before, we look forward to developing new products that utilize our patents, as well as aggressively identifying other market opportunities where our intellectual property rights may be utilized, monetized or otherwise enforced.” The initial patent families highlighted relate to the following technologies: Self-Enforcing Security Token Compliance System (US11216802B2, US11829997B2, US12223496B2) 7 Patents Issued Worldwide The Self-Enforcing Security Token Compliance System is a blockchain-based architecture that programmatically enforces regulatory rules directly within the token transfer logic. Developed early in the evolution of smart contract technology applications for securities, with a related patent priority date of August 10, 2018, this technology innovated the standard for on-chain compliance. By utilizing a security token smart contract that references a global registry of investor attributes (such as KYC/AML status and other eligibility criteria), the system automatically evaluates compliance conditions at the moment of transfer without relying on manual oversight. tZERO’s method enforces compliance automatically and on-chain at the moment of transfer, making it atomic, trustless and fully auditable without relying on any external infrastructure. Using this patented technology we can help industry participants to minimize or eliminate off-chain services during the transfer process, eliminating latency and external trust dependencies on legacy technologies. Upgradable Security Token Architecture (US11410159B2) 6 Patents Issued Worldwide The Upgradable Security Token architecture includes a method for updating blockchain-based security tokens while maintaining the historical state and auditability of previous smart contract versions. The process involves deploying a new "child" contract and utilizing an upgrade pointer within the original contract to facilitate the migration of token balances. This architecture ensures that even as the token’s logic or features evolve, the ancestral contracts remain on-chain to provide a permanent, auditable record. By bridging the gap between flexible software development and the immutable nature of blockchain, this system allows regulated assets to adapt to changing technical or legal requirements, with more seamless auditing and version control for issuers and digital transfer agents than alternative methods. Splittable Security Token Structure (US11961067B2) 5 Patents Issued Worldwide The Splittable Security Token architecture includes a scalable method for managing token splits on a blockchain without requiring immediate balance updates for all holders. By storing the split ratio as on-chain metadata and applying it dynamically only when tokens are transferred or accessed, the system avoids the computationally expensive process of mass account updates by spreading costs to the wallet holder at the time of transfer. This “lazy” application model can support issuers and digital transfer agents to effect essential corporate actions like stock and reverse splits, providing a bridge between traditional equity market mechanics and distributed ledger technology. Federated PII Service for Broker-Dealers (US11449634B2, US12306991B2) 4 Patents Issued Worldwide The Federated Personally Identifiable Information (PII) Service architecture includes a specialized computing system designed to securely link private identity data with public trading records. The system utilizes a server that receives user requests for PII related to a specific account's trading history. It then identifies which broker-dealer database contains that PII and verifies if the requesting user has the necessary permissions to access it. If authorized, the server retrieves public transaction data from a blockchain, which stores anonymized trade details like asset types and quantities. Finally, the platform generates "mapped information" by overlaying the private PII with the public ledger data, allowing for transparent reporting and auditability while keeping sensitive personal information off the public chain. Broker-dealers integrating into the open tokenized securities ecosystem can use this technology to more seamlessly integrate. Crypto Integration Platform (US10171245B2, US10673634B2, US11394560B2) 13 Patents Issued Worldwide This technology establishes a foundational architectural bridge between legacy institutional trading systems and blockchain-native cryptocurrency infrastructure. It enables a regulated Alternative Trading System (ATS) to simultaneously accept orders through traditional FIX protocol interfaces and cryptocurrency exchange interfaces using a unified matching engine. The core technology utilizes asymmetric cryptography, requiring orders to be digitally signed by a customer’s private key to verify both the transaction and the commitment of assets. To prevent "double-spending" without manual reconciliation, the system employs a dual-account model that locks assets in a dedicated "committed account" during the life of a pending order. Ultimately, the technology enables the essential mechanics of modern tokenized securities trading, positioning it as a licensing asset as traditional financial institutions move toward blockchain-native settlement. Together, these technologies address core infrastructure requirements for tokenized securities markets, including compliance enforcement, contract evolution, corporate-action processing and identity-linked transaction traceability. tZERO will continue evaluating additional components of its intellectual property portfolio and intends to provide further updates as part of this ongoing review process. The company’s intellectual property strategy reflects its broader focus on supporting regulated, interoperable infrastructure for tokenized capital markets across issuance, trading, custody and lifecycle management. Market participants interested in licensing this technology should contact us at sales@tzero.com. For more information about tZERO, visit www.tzero.com. tZERO Media Contact: Julie Ros, Head of Marketing & Communications jros@tzero.com About tZERO tZERO Group, Inc. (tZERO) and its broker-dealer subsidiaries provide an innovative liquidity platform for private companies and assets. We offer institutional-grade solutions for issuers looking to digitize their capital table through blockchain technology, and make such equity available for trading on an alternative trading system. tZERO, through its broker-dealer subsidiaries, democratizes access to private assets by providing a simple, automated, and efficient trading venue to broker-dealers, institutions, and investors. All technology services are offered through tZERO Technologies, LLC. For more information, please visit our website. Intellectual Property Intellectual property holding company tZERO IP, LLC is a wholly owned subsidiary of tZERO Group, Inc. tZERO IP, LLC owns intellectual property, which may include any described patents, patent applications, trademarks, and/or copyrights. Investor Notice Digital asset securities, as well as any particular investment, may not be suitable or appropriate for everyone. Investors should note that investing or trading in securities could involve substantial risks, including no guarantee of returns, costs associated with selling and purchasing, and no assurance of liquidity which could impact their price and investor’s ability to sell, and possible loss of principal invested. There is always the potential of losing money when you invest in securities. There are also unique risks specific to digital asset securities, including, without limitation, fraud, manipulation, theft, and loss. No Offer, Solicitation, Investment Advice or Recommendations This release is for informational purposes only and does not constitute an offer to sell, a solicitation to buy, or a recommendation for any security, nor does it constitute an offer to provide investment advisory or other services by tZERO or any of its affiliates, subsidiaries, officers, directors or employees. No reference to any specific security constitutes a recommendation to buy, sell, or hold that security or any other security. Nothing in this release shall be considered a solicitation or offer to buy or sell any security, future, option or other financial instrument or to offer or provide any investment advice or service to any person in any jurisdiction. Nothing contained in this release constitutes investment advice or offers any opinion with respect to the suitability of any security, and the views expressed in this release should not be taken as advice to buy, sell or hold any security. In preparing the information contained in this release, we have not taken into account the investment needs, objectives, and financial circumstances of any particular investor. This information has no regard to the specific investment objectives, financial situation, and particular needs of any specific recipient of this information and investments discussed may not be suitable for all investors. Any views expressed in this release by us were prepared based upon the information available to us at the time such views were written. Changed or additional information could cause such views to change. All information is subject to possible corrections. Information may quickly become unreliable for various reasons, including changes in market conditions or economic circumstances. Forward-Looking Statements by tZERO This release contains forward-looking statements. In addition, from time to time, tZERO, its subsidiaries, or its representatives may make forward-looking statements orally or in writing. These forward-looking statements are based on expectations and projections about future events, which is derived from currently available information. Such forward-looking statements relate to future events or future performance, including financial performance and projections; growth in revenue and earnings; and business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including, without limitation: the ability of tZERO and its subsidiaries to change the direction; tZERO’s ability to keep pace with new technology and changing market needs; performance of individual transactions; regulatory developments and matters; and competition. These and other factors may cause actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this release and other statements made from time to time by tZERO, its subsidiaries or their respective representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties and assumptions. tZERO, its subsidiaries, and its representatives are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this release and other statements made from time to time by tZERO, its subsidiaries or its representatives might not occur.
Ron McClurg to Retire as CFO Effective June 30 and Remain as Senior Advisor Through December 31 to Support Transition Current NeuroOne Chief Operating Officer Chris Volker, CFA, to Assume Permanent CFO Role EDEN PRAIRIE, MINN. - April 30, 2026 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company dedicated to transforming the surgical diagnosis and treatment of neurological disorders, today announced that Ron McClurg will retire as CFO effective June 30, 2026. Mr. McClurg will remain with the Company as a Senior Advisor through December 31, 2026 to support a smooth and orderly transition. Chris Volker, NeuroOne’s current Chief Operating Officer, will assume the role of Chief Financial Officer on a permanent basis, and David Wambeke, the Company’s newly appointed Chief Business Officer, will assume many of Mr. Volker’s current responsibilities. Mr. Volker brings more than 25 years of progressive operational and financial leadership experience, including extensive experience in the medical device industry. He is a CFA® charterholder and earned his MBA from The Wharton School of the University of Pennsylvania. “On behalf of the entire NeuroOne organization, I want to express our sincere gratitude to Ron for more than five years of outstanding service and the meaningful contributions he has made to the Company,” said Dave Rosa, Chief Executive Officer of NeuroOne. “Ron’s retirement marks the culmination of a long and successful career, and we are grateful for his leadership, stewardship, and commitment to NeuroOne. We are also fortunate that he will remain actively involved as a Senior Advisor to help ensure a smooth transition. Rosa continued, “We are pleased to also announce the appointment of Chris Volker as our next Chief Financial Officer. Chris brings deep leadership experience across medtech, finance, strategy and commercial operations, and I believe he is the right person to step into this role as we continue advancing NeuroOne’s technologies and growth strategy. I look forward to continuing to work with Chris in his new role and am confident he will continue building on the strong foundation Ron has helped establish.” McClurg commented, “It has been a privilege to serve as NeuroOne’s Chief Financial Officer for over five years and to work alongside such a talented team. I am proud of this team and the benefits our products are providing for patients. After many rewarding years in the industry, I have decided the time is right for me to retire. I remain fully committed to supporting NeuroOne through this transition period and look forward to working closely with Chris and the leadership team.” Volker added, “I am honored to take on the role of Chief Financial Officer and appreciate the confidence the Board and the management team have placed in me. NeuroOne has built strong momentum, both in advancing our product pipeline and commercially, and I look forward to working closely with the team, as well as with Ron during this transition, to support the Company’s strategic, operational, and financial objectives.” Mr. Volker has extensive experience in the medtech industry, including senior leadership roles at Abbott, Cardiovascular Systems, Inc. (“CSI”), and St. Jude Medical. At CSI, he served as Vice President & General Manager of International and had direct responsibility for international P&L and commercial expansion, including sales, training & education, marketing, business development and program management. Prior to CSI, Mr. Volker held executive leadership roles at St. Jude Medical, including senior roles in corporate finance where he reported directly to St. Jude Medical’s Chief Financial Officer. He began his career in healthcare and technology investment banking at Dain Rauscher, where he developed expertise in financial analysis, mergers and acquisitions, strategic planning, growth equity investments and financings. Mr. Volker earned a Bachelor of Arts degree from St. John’s University and a Master of Business Administration in Finance from the Wharton School at the University of Pennsylvania. Mr. Volker holds the Chartered Financial Analyst® designation. About NeuroOne NeuroOne Medical Technologies Corporation is a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders. NeuroOne markets a minimally invasive and high-definition/high-precision electrode technology platform with four FDA-cleared product families: Evo® Cortical Electrodes, Evo® sEEG Electrodes, OneRF® Ablation System (for brain), and OneRF® Trigeminal Nerve Ablation System. These solutions offer the potential to reduce the number of hospitalizations and surgical procedures, lower costs, and improve patient outcomes by offering diagnostic and therapeutic functions. The Company is engaged in research and development for drug delivery, basivertebral nerve ablation and spinal cord stimulation programs. For more information, visit nmtc1.com. Forward Looking Statements This press release may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Except for statements of historical fact, any information contained in this press release may be a forward looking statement that reflects NeuroOne's current views about future events and are subject to known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements. In some cases, you can identify forward looking statements by the words or phrases "may," "might," "will," "could," "would," "should," "expect," "intend," "plan," "forecasts," "objective," "anticipate," "believe," "estimate," "predict," "project," "potential," "target," "seek," "contemplate," "continue, "focused on," "committed to" and "ongoing," or the negative of these terms, or other comparable terminology intended to identify statements about the future. Forward looking statements may include statements regarding the Company’s CFO succession plan. Although NeuroOne believes that we have a reasonable basis for each forward-looking statement, we caution you that these statements are based on a combination of facts and factors currently known by us and our expectations of the future, about which we cannot be certain. Our actual future results may be materially different from what we expect due to factors largely outside our control, including risks related to whether the Company will continue to maintain compliance with all Nasdaq continued listing requirements, risks that our strategic partnerships may not facilitate the commercialization or market acceptance of our technology whether due to supply chain disruptions, labor shortages or otherwise risks that our technology will not perform as expected based on results of our pre-clinical and clinical trials risks related to uncertainties associated with the Company's capital requirements to achieve its business objectives and ability to raise additional funds: the risk that we may not be able to secure or retain coverage or adequate reimbursement for our technology uncertainties inherent in the development process of our technology risks related to changes in regulatory requirements or decisions of regulatory authorities that we may not have accurately estimated the size and growth potential of the markets for our technology risks related to clinical trial patient enrollment and the results of clinical trials that we may be unable to protect our intellectual property rights and other risks, uncertainties and assumptions, including those described under the heading "Risk Factors" in our filings with the Securities and Exchange Commission. These forward looking statements speak only as of the date of this press release and NeuroOne undertakes no obligation to revise or update any forward looking statements for any reason, even if new information becomes available in the future. IR Contact MZ Group – MZ North America NMTC@mzgroup.us View the original release on www.newmediawire.com
MIAMI, FL - April 30, 2026 (NEWMEDIAWIRE) - Travaleo (OTCID: GNIS) announced its participation in a private, invitation-only event held in Miami during the Miami Grand Prix week, bringing together ultra-high-net-worth individuals and global investors to showcase the highly anticipated Miami Tropic Jean-Georges Residences, an ultra-luxury branded residential development redefining the city’s high-end living landscape. This event is part of a broader series of curated experiences that Miami Real Investment, Aurami Capital and Travaleo are jointly developing, designed to engage global investors, strengthen strategic relationships, and showcase premium branded real estate opportunities within key international markets. These initiatives reflect a coordinated effort to elevate both platforms’ visibility while expanding access to high-quality investment opportunities. The event was promoted and led by Hans Baumgartner, Co-CEO of Travaleo and President-Broker at Miami Real Investment (MRI), in collaboration with one of Miami’s premier luxury developers, Terra Group. The gathering highlighted the Miami Tropic Jean-Georges Residences, a visionary project curated in partnership with renowned chef Jean-Georges Vongerichten, blending world-class hospitality, design, and lifestyle into a new benchmark for branded luxury real estate. A central highlight of the evening was the featured appearance of F1 driver Pierre Gasly, who participated as a special guest of the event and was formally presented as part of the development’s broader brand narrative. Gasly, who has secured a residence within the project, took part in the evening’s program and was highlighted in front of attending investors and industry leaders, reinforcing the project’s global appeal and positioning. The event attracted a curated audience of ultra-high-net-worth individuals, international investors, and key market participants, further underscoring Miami’s emergence as one of the most dynamic luxury real estate markets in the United States. The timing of the gathering during this week reflects the city’s growing global prominence, as the Miami Grand Prix continues to gain significance among the world’s premier racing circuits, drawing elite audiences, international capital, and global attention. Oscar Brito, Co-CEO of Travaleo, attended the event alongside strategic partners, engaging directly with prospective investors and industry stakeholders. While the primary focus of the evening centered on the Miami Tropic Jean-Georges Residences, Travaleo’s presence provided an opportunity to introduce its digital investment framework, designed to expand access to institutional-grade branded luxury real estate opportunities. The participation of globally recognized figures such as Gasly also reflects a broader strategic alignment within the Travaleo ecosystem, where world-class athletes and public figures are increasingly integrated into the branding and positioning of premium real estate opportunities. This approach complements Travaleo’s vision of aligning influential global networks with curated investment access, enhancing both visibility and engagement across its platform. “As both a market participant and platform builder, Hans has played a pivotal role in bringing together the right audience and opportunities at the right time,” said Oscar Brito. “The convergence of global events like Formula One with the continued growth of Miami’s luxury market highlights why we are focusing on this city as a key hub for the future of branded real estate investing.” The event reflects a broader alignment between premier developers, global brands, and next-generation investment platforms, as demand for rare, high-quality real estate assets continues to grow among global investors. Travaleo continues to work alongside strategic partners to support the structuring and distribution of opportunities within this emerging segment, reinforcing its role in shaping branded luxury real estate into a defined and investable asset class. About Aurami Capital Aurami Capital is a real estate investment platform focused on branded luxury residential and hospitality opportunities and operates as a subsidiary of Miami Real Investment. info@auramicapital.com About Miami Real Investment (MRI) With over 20 years of experience, Miami Real Investment is a leading brokerage firm specializing in branded luxury pre-construction real estate in Miami. With a track record of handling transactions for VIP clients, F1 drivers, public figures, and international investors, Miami Real Investment offers unmatched expertise and dedicated service, ensuring client satisfaction at every step of the buying process. The company offers a 360 approach, including investment portfolio design, market analysis, tax planning, and legal advice from top real estate lawyers. https://miamirealinvestment.com/ info@miamirealinvestment.com About Travaleo Travaleo is a branded real estate investment and development platform wholly owned by Genesis Holdings, Inc. (OTC: GNIS), focused on identifying, structuring, and managing income-producing and development-oriented real estate projects. The platform emphasizes professionally underwritten assets, brand-driven developments, and disciplined execution aligned with long-term ownership strategies. Travaleo’s digital investment infrastructure enables accredited investors to participate in curated branded luxury real estate opportunities through structured investment vehicles designed to enhance transparency, efficiency, and investor access. https://www.travaleo.com/ X: @Travaleo_ invest@travaleo.com About Genesis Holdings, Inc. Genesis Holdings is a publicly traded holding company focused on the development, acquisition, and management of operating businesses and real-asset-related initiatives. The Company emphasizes disciplined capital allocation, sound governance practices, and long-term value creation for shareholders. https://www.regen.digital/ X: @regnisnyc Forward-Looking Statements This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements that are not historical in nature, including the words “anticipate,” “expect,” “suggest,” “plan,” “believe,” “intend,” “estimates,” “targets,” “projects,” “should,” “could,” “would,” “may,” “will,” “forecast” and other similar expressions are intended to identify forward-looking statements. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. There are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements, including: general economic and business conditions, competitive and technological factors, markets, services, products and prices, the failure to retain management and/or key employees, availability and cost of capital, success of growth initiatives, limited operating history, failure to successfully close any proposed transactions, failure to raise sufficient capital, failure to file any required filings properly, and other risks discussed in the Company’s filings with the OTC Markets. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Genesis Holdings assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. View the original release on www.newmediawire.com
BROSSARD, QUEBEC - April 30, 2026 (NEWMEDIAWIRE) - CHARBONE CORPORATION (TSXV: CH; OTCQB: CHHYF; FSE: K47) (“CHARBONE” or the “Company”), a vertically integrated industrial gases company focused on production, distribution and storage of clean ultra-high purity (“UHP”) hydrogen and other strategic industrial gases, today announces its financial and operational results for the year ending December 31, 2025. Since Q4 2025, CHARBONE began generating revenues from industrial gases such as clean UHP hydrogen sourced from its Sorel-Tracy facility Phase 1A, UHP helium and UHP oxygen. CHARBONE is now progressing well with its Phase 1B at Sorel-Tracy to increase its hydrogen production capacity in Q3 2026 while continuing to expand its other specialty gases platform. 2025 HIGHLIGHTS: - Net loss decreased by 6% to $2,676,116 in 2025, down from $2,837,693 in 2024 (activities still tightening general and administrative expenses). - Gas income generated $201,277 in 2025 ($nil in 2024). - Recognition of revenues following the advancement of activities from the Master Collaborative Agreement to support the deployment of a Malaysian green hydrogen project development. - The Company closed a private placement of $1,012,980, units for debt settlement of $1,776,827, shares for the management debt settlement of $310,000, exercised warrants totalling $1,943,034 ($866,994 in 2024) and an additional $303,634 in convertible debentures. - Following the signature of an Asset Purchase Agreement with Harnois Energies Inc., CHARBONE completed the acquisition and reinstallation of the operational hydrogen production and refueling equipment at its Sorel-Tracy site. On October 6, 2025, the Company issued 13,333,334 common shares at $0.075 per share, representing $1 million in equity consideration to Harnois Energies Inc. as a part of the payment of the acquisition transaction. - As of December 31, 2025, CHARBONE had a cash balance of $1,016,292. The Company then closed a private placement of $3,100,000 on January 12, 2026, and $3,000,000 as a first drawdown of its new $10 million secured convertible loan on April 29, 2026 with optional drawdowns during the term of the loan. “CHARBONE’s disciplined financial management, operational execution and successful completion of new financings, position the Company to continue its growth as a vertically integrated industrial gases producer and distributor,” said Benoit Veilleux, Chief Financial Officer and Corporate Secretary of CHARBONE. “CHARBONE is moving into execution mode to unlock its strong growth potential. Financials Financials Annual General and Extraordinary Meetings of Shareholders The Company has reserved June 18, 2026 for its 2024 and 2025 Annual General and Extraordinary Meetings of Shareholders (the “AGSM”). Further details will be sent to the Company's shareholders as of April 29, 2026. Omnibus Incentive Plan The Company is pleased to announce that it has obtained approval from its Board of Directors for the adoption of a new omnibus equity incentive plan (the “Omnibus Plan”), subject to the TSX Venture Exchange approval. The Company will include the Omnibus Plan in the circular that will be sent to obtain shareholder’s approval at the upcoming AGSM. As of June 18, 2026, the Omnibus Plan, if approved, will replace the Company's current stock option plan that was last reconducted on March 28, 2025 (the “Previous Plan”). The board of directors determined that it is desirable to have a wide range of incentive awards, including stock options (“Options”), restricted share units (“RSUs”), performance share units (“PSUs”), and deferred share units (“DSUs”) (collectively, the “Awards”) to attract, retain and motivate employees, directors, executive officers and consultants of the Company. The aggregate number of common shares reserved for issuance pursuant to Awards of DSUs, RSUs, PSUs and Options granted under the Omnibus Plan (including the Predecessor Options currently outstanding under the Previous Plan) shall not exceed 10% of the Company’s total issued and outstanding common shares from time to time. The Company has also cancelled 2,050,000 Options that had been granted on September 9, 2022 at an exercise price of $0.60 per share for a term of 5 years. About CHARBONE CORPORATION CHARBONE is a vertically integrated industrial gases company focused on developing and operating a network of supply hubs for the production, storage, and distribution of Ultra-High Purity (UHP) strategic industrial gases. The Company serves customers across sectors including semiconductors, artificial intelligence and data centers, advanced pharmaceuticals, and aerospace and defense technologies, where UHP gases are critical for high-precision manufacturing processes and operational performance. CHARBONE is advancing a network of clean UHP hydrogen production facilities across North America and selected international markets. The Company’s modular, decentralized, and demand-driven approach, combined with its integrated storage and distribution platform for all UHP gases, supports scalable growth, enhances operational flexibility, and enables more stable and diversified revenue generation. This model allows CHARBONE to efficiently serve mid-tier industrial gas customers with a reliable supply of UHP gases, including hydrogen, helium, oxygen, and any others that are in high-demand gases that are often difficult to source. The Company is committed to supporting the global transition to a lower-carbon economy by providing accessible, decentralized clean hydrogen and specialty gases, while addressing supply gaps for underserved industrial customers and accelerating the shift towards localized clean energy. CHARBONE is listed on the TSX Venture Exchange (TSXV: CH), the OTC Markets (OTCQB: CHHYF), and the Frankfurt Stock Exchange (FSE: K47). For more information, please visit: www.charbone.com. Forward-Looking Statements This news release contains statements that are “forward-looking information” as defined under Canadian securities laws (“forward-looking statements”). These forward-looking statements are often identified by words such as “intends”, “anticipates”, “expects”, “believes”, “plans”, “likely”, or similar words. The forward-looking statements reflect management's expectations, estimates, or projections concerning future results or events, based on the opinions, assumptions and estimates considered reasonable by management at the date the statements are made. Although Charbone believes that the expectations reflected in the forward-looking statements are reasonable, forward-looking statements involve risks and uncertainties, and undue reliance should not be placed on forward-looking statements, as unknown or unpredictable factors could cause actual results to be materially different from those reflected in the forward-looking statements. The forward-looking statements may be affected by risks and uncertainties in the business of Charbone. These risks, uncertainties and assumptions include, but are not limited to, those described under “Risk Factors” in the Corporation’s Filing Statement dated March 31, 2022, which is available on SEDAR at www.sedar.com; they could cause actual events or results to differ materially from those projected in any forward-looking statements. Except as required under applicable securities legislation, Charbone undertakes no obligation to publicly update or revise forward-looking information. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Contact Charbone Corporation Telephone: +1 450 678 7171 Email: ir@charbone.com Benoit Veilleux CFO and Corporate Secretary View the original release on www.newmediawire.com
Statement Highlights: New American Heart Association Presidential Advisory warns that U.S. health care affordability has reached a crisis point. Rising health care costs, driven largely by chronic disease, are forcing many people in America to delay or avoid care altogether, and contribute to worsening health outcomes and increasing medical debt for families nationwide. The advisory outlines five core principles to inform policies toward a more affordable, sustainable health care system. DALLAS - April 30, 2026 (NEWMEDIAWIRE) - With health care costs constituting a major source of concern across the U.S., the American Heart Association, a relentless force changing the future of health for everyone, everywhere, today released a Presidential Advisory warning that health care affordability in this country has reached crisis levels and outlining key principles to address the problem. Total health care spending nationwide is approaching $5 trillion annually and is projected to consume 20% of the nation’s gross domestic product within the next decade, according to the advisory, placing unsustainable pressure on patients, families and the health care system. The Heart Association projects that health care costs related to cardiovascular disease will quadruple by 2050. At the same time, a recent public opinion survey from Gallup indicated that people across the country are worried about being able to access and afford health care. According to a survey from political pollster McLaughlin & Associates, more than half (51%) of voters say health insurance is their top health concern. Other top worries include hospital bills (11%) and the cost of medicines (10%). The Presidential Advisory details how rising costs threaten the long-term sustainability of the health care system in the United States and jeopardize patients’ access to care, putting the health of families and communities nationwide at risk. “Health care affordability is one of the defining challenges of our time,” said Dhruv S. Kazi, M.D., M.S., American Heart Association volunteer and writing committee chair, director of the Cardiac Critical Care Unit at Beth Israel Deaconess Medical Center and Associate Professor at Harvard Medical School in Boston, MA. “This advisory outlines core guiding principles for action to ensure everyone in this country has access to the care they need and the health care system is sustainable for generations to come.” Rising costs have real-world consequences, including forcing patients to delay or forgo care, which worsens health outcomes and contributes to financial hardship and medical debt. Medical debt, a uniquely American problem among high-income countries, is a leading cause of personal bankruptcy. The advisory warns that rising costs are impacting patients, families, employers, clinicians and communities nationwide. The advisory identifies a complex set of interconnected drivers behind rising health care costs, including: High prices for treatments and services Administrative complexity Underinvestment in prevention and public health Demographic shifts Cost shifting to patients The Heart Association suggests that affordability cannot be addressed through cuts alone -- strategic investments in the health care workforce, infrastructure, primary care, data and public health also are necessary to improve outcomes while controlling long-term costs. The Heart Association outlines five core principles to guide policymakers and stakeholders toward a more affordable and sustainable health care system, including: Access to high-quality care without financial hardship. Minimal or no-cost-sharing for high-value, cost-effective care, including preventive services. Shared accountability across the health care ecosystem for advancing a more efficient, transparent and cost-conscious health care system. Strategic investments in the health care workforce, infrastructure and data. Strengthen the public health infrastructure and address health inequities. The American Heart Association Presidential Advisory was informed by an extensive research and writing group process that included interviews and listening sessions conducted with key stakeholders -- including patients, clinicians, payer representatives, employer representatives, health system leaders and public health experts -- to better understand the drivers and consequences of the health care affordability crisis and shape a framework to guide solutions. “We at the American Heart Association believe everyone deserves access to quality health care without financial hardship,” said Nancy Brown, chief executive officer of the American Heart Association. “Affordability is not just an economic issue – it is a health issue that directly affects lives. By laying out clear, evidence-based principles for action, we are doubling down on our commitment to advance policies and solutions that improve access to care, strengthen prevention and build a more sustainable health care system.” The Heart Association encourages and challenges policymakers, health care leaders and stakeholders to use this advisory as a roadmap for meaningful action across all sectors to address the nation’s health care affordability crisis. The Heart Association emphasizes that reducing financial barriers to evidence-based, cost-effective care, prioritizing prevention and investing strategically in the health care workforce, infrastructure and public health are necessary to address health care affordability, which is essential to improving health outcomes and ensuring a more sustainable health care system for future generations. The advisory was created by a volunteer writing group of experts on behalf of the Heart Association. Presidential advisories, policy statements and scientific statements promote greater awareness about cardiovascular disease and stroke and help facilitate informed health care decisions and policy and systems changes. They outline what data and evidence are known about a specific policy topic and what areas need additional research. Co-authors and their disclosures are listed in the manuscript. The Association receives funding primarily from individuals. Foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific Association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and biotech companies, device manufacturers and health insurance providers, and the Association’s overall financial information are available here. More than 8 in 10 (82%) U.S. adults say they are confident in the American Heart Association to provide trustworthy information related to public health, according to a recent Annenberg Policy Center poll. The Association ranked second only to an individual’s personal health care provider. Additional Resources: Multimedia, including a video interview with Dhruv S. Kazi, M.D., M.S., is available on the right column of the release link. Health Care Affordability in the United States, From Crisis to Action Population shifts, risk factors may triple U.S. cardiovascular disease costs by 2050 | American Heart Association 6 in 10 U.S. women projected to have at least one type of cardiovascular disease by 2050 | American Heart Association Forecasting the Economic Burden of Cardiovascular Disease and Stroke in the United States Through 2050: A Presidential Advisory From the American Heart Association | Circulation Advancing Healthcare Reform: The American Heart Association’s 2020 Statement of Principles for Adequate, Accessible, and Affordable Health Care: A Presidential Advisory From the American Heart Association | Circulation American Heart Association Advocate story - Danielle Allen American Heart Association Advocate story - Aqualyn Kennedy Follow American Heart Association news on X @HeartNews About the American Heart Association The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public’s health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on heart.org, Facebook, X or by calling 1-800-AHA-USA1. For Media Inquiries: 214-706-1173 Julie Thomm – Julie.Thomm@heart.org For Public Inquiries: 1-800-AHA-USA1 (242-8721) heart.org and stroke.org View the original release on www.newmediawire.com
HONG KONG - April 30, 2026 (NEWMEDIAWIRE) - FWD Group Holdings Limited (“FWD Group” or “FWD”) today announced strong first quarter new business highlights for the three months ended 31 March 2026. - New business sales were up four per cent to US$720 million compared to the same period in 2025 on an annualised premium equivalent (APE) basis. - New business contractual service margin was US$556 million, with year-on-year growth of 18 per cent. - Introduced 11 new products around the region; the FWD Group consumer outlook survey released in February 2026 showed that the majority of Asia’s middle-class feel financially anxious and underprepared for retirement. Huynh Thanh Phong, Group Chief Executive Officer and Executive Director of FWD Group, said, “This is another strong set of results, reflecting our consistent track record of performance, growth, and the diversified pan-Asian footprint and distribution model of FWD Group. Japan and our Expansion Markets in Southeast Asia were key drivers of growth, alongside another solid performance from Hong Kong SAR, despite the high base effect from a record first quarter comparison in 2025.” “At FWD Group, we have confidence over the long-term that the rising middle-class trend in Asia will continue, despite the near-term impacts of external shocks on economies and consumers in the region. The outlook for the high-net-worth segment, served by FWD Private, remains positive, particularly given the strength and confidence in financial hubs in the region like Hong Kong SAR where we are headquartered,” added Huynh Thanh Phong. The Hong Kong SAR & Macau SAR reporting segment delivered continued growth in the first quarter of 2026 compared to the record high first quarter in 2025, reflecting both domestic and financial hub related demand. Japan reported strong growth, reflecting the boost from its strategic expansion into the retirement and savings segment in mid 2025, alongside its long-standing protection business. The Expansion Markets segment - comprised of Indonesia, Malaysia, the Philippines, Singapore, and Vietnam - posted excellent growth, driven by the broker and independent financial advisor channel and solid bancassurance results. In the Thailand & Cambodia segment, the focus on developing quality new business continued, given sustained growth headwinds from the lower rate environment in Thailand. As previously announced, Khun Knattapisit Krutkrongchai (KK) will join FWD as Chief Executive Officer, Thailand, effective 11 May 2026, subject to relevant regulatory approvals. KK is a seasoned insurance executive with almost 30 years of experience, including most recently as Chief Executive Officer of Krungthai-AXA. About FWD Group FWD Group (1828.HK) is a pan-Asian life and health insurance business that serves approximately 40 million customers across 10 markets, including BRI Life in Indonesia. FWD’s customer-led and tech-enabled approach aims to deliver innovative propositions, easy-to-understand products and a simpler insurance experience. Established in 2013, the company operates in some of the fastest-growing insurance markets in the world with a vision of changing the way people feel about insurance. FWD Group is listed on the main board of the Hong Kong Stock Exchange under the stock code 1828. For more information, please visit www.fwd.com For media inquiries, please contact: groupcommunications@fwd.com Source: FWD Group Holdings Limited *The unaudited results are for the three months ended 31 March 2026 and are compared to the same period in 2025. Growth rates are represented on a constant exchange rate basis. New business sales are calculated on an APE basis, based on 100 percent annualised first year premiums and 10 percent single premiums. View the original release on www.newmediawire.com
HAMBURG, GERMANY - April 29, 2026 (NEWMEDIAWIRE) - Dr Stefan Tweraser (CEO) and Andrea Behrendt (CFO) invite all interested investors, analysts and journalists to the Earnings Call on the occasion of the publication of the Quarterly Statement Q1/2026 on Wednesday, 6 May 2026, at 10:00 a.m. (CEST) In order to attend the webcast, please register before the conference at the following registration link: LINK You can download both the presentation and the Quarterly Statement on the morning of the publication from our company website at the following link: https://zealnetwork.de/investors/reports-presentations/ There you will also have the opportunity to access a recording of the Earnings Call during the course of the reporting day. The conference language is English. About ZEAL Network SE: ZEAL Network SE is the leading German provider of lotteries on the internet. Through the portals LOTTO24 and Tipp24 of the subsidiary LOTTO24, the company brokers customers' tickets to the state lottery companies and to charity lottery operators. The product range includes LOTTO 6aus49, Spiel 77, Super 6, Eurojackpot, GlucksSpirale, lottery clubs, Keno, the Deutsche Fernsehlotterie, Scratch Games, the Deutsche Traumhauslotterie and freiheit+. Founded in Germany in 1999, ZEAL started out as a German lottery broker under the name Tipp24. In 2005, the company went public on the Frankfurt Stock Exchange (Prime Standard) as one of the most successful IPOs in Germany at the time. In 2019, ZEAL took over LOTTO24 AG. Contact: Frank Hoffmann, CEFA Investor Relations ZEAL Network SE StraBenbahnring 11 20251 Hamburg T: +49 (0)40 809036042 frank.hoffmann@zealnetwork.de View the original release on www.newmediawire.com
Nomination of Dr. Wolfgang Hofmann as independent Supervisory Board member to further strengthen oversight and governance capabilities Conclusion of cooperation agreement with MAK Capital following constructive discussions, reflecting Evotec’s commitment to open shareholder dialogue Annual General Meeting to vote on the appointments of Supervisory Board members and proposed expansion of Supervisory Board, supporting effective oversight and long‑term value creation HAMBURG, GERMANY - April 29, 2026 (NEWMEDIAWIRE) - Evotec SE (NASDAQ: EVO; Frankfurt Prime Standard: EVT) today announced the nomination of Dr. Wolfgang Hofmann for election as an independent member of the Supervisory Board at the company’s upcoming Annual General Meeting (AGM) to be held on June 11, 2026. The AGM agenda also includes the previously announced nomination of Dieter Weinand as Chairman of the Supervisory Board, as well as a proposal to increase the size of the Supervisory Board from six to seven members. Following constructive discussions, Evotec has entered into a cooperation agreement with MAK Capital Fund LP (“MAK Capital”), a key shareholder of the company. Under the terms of the agreement MAK Capital has agreed to customary voting and cooperation commitments among other provisions. Prof. Dr. Iris Low-Friedrich, Chairwoman of Evotec’s Supervisory Board, said: “We are pleased to nominate Wolfgang for election at the upcoming AGM. His appointment would contribute oversight and governance capabilities through additional industry, scientific and governance expertise, complementing our existing Board structure as we continue to implement our transformation plans to grow shareholder value. The agreement reached, reflects Evotec’s commitment to constructive shareholder engagement, supporting the long‑term success of the Company.” Michael A. Kaufman, Chief Executive Officer of MAK Capital, said: “We appreciate the constructive dialogue and welcome Wolfgang’s nomination to the Supervisory Board. We look forward to continuing our collaboration with the Supervisory Board and Management Board to support Evotec's ongoing transformation.” About Evotec SE Evotec is a life science company that is pioneering the future of drug discovery and development. By integrating breakthrough science with AI-driven innovation and advanced technologies, we accelerate the journey from concept to cure - faster, smarter, and with greater precision. Our expertise spans small molecules, biologics, cell therapies and associated modalities, supported by proprietary platforms such as Molecular Patient Databases, PanOmics and iPSC-based disease modeling. With flexible partnering models tailored to our customers’ needs, we work with all Top 20 Pharma companies, over 800 biotechs, academic institutions, and healthcare stakeholders. Our offerings range from standalone services to fully integrated R&D programs and long-term strategic partnerships, combining scientific excellence with operational agility. Through Just - Evotec Biologics, we redefine biologics development and manufacturing to improve accessibility and affordability. With a strong portfolio of over 100 proprietary R&D assets, most of them being co-owned, we focus on key therapeutic areas including oncology, cardiovascular and metabolic diseases, neurology, and immunology. Evotec’s global team of more than 4,500 experts operates from sites in Europe and the U.S., offering complementary technologies and services as synergistic centers of excellence. Learn more at www.evotec.com and follow us on LinkedIn and X/Twitter @Evotec. Forward-looking statements This announcement contains forward-looking statements concerning future events, including the proposed offering and listing of Evotec’s securities. Words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “potential,” “should,” “target,” “would” and variations of such words and similar expressions are intended to identify forward-looking statements. Such statements include comments regarding Evotec’s expectations for revenues, Group EBITDA and unpartnered R&D expenses. These forward-looking statements are based on the information available to, and the expectations and assumptions deemed reasonable by Evotec at the time these statements were made. No assurance can be given that such expectations will prove to have been correct. These statements involve known and unknown risks and are based upon a number of assumptions and estimates, which are inherently subject to significant uncertainties and contingencies, many of which are beyond the control of Evotec. Evotec expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Evotec’s expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based. Investor Relations and Media Contact Dr. Sarah Fakih EVP Head of Global Communications & Investor Relations Sarah.Fakih@evotec.com View the original release on www.newmediawire.com
Revenue of EUR 289.8 million in FY 2025 (+4.1% y-o-y), in line with preliminary figures and guidance Adjusted EBITDA increases to EUR 51.9 million (+6.4% y-o-y), margin improves to 17.9% Pro-forma Adjusted EBITDA amounts to EUR 58.3 million (+15.6% y-o-y) FY 2026 Outlook: Single-digit revenue growth; target of maintaining or slightly improving the adjusted EBITDA margin compared to the prior year; continued focus on execution of inorganic customer acquisition strategy in 2026 FURTH, GERMANY - April 29, 2026 (NEWMEDIAWIRE) - ONLINEPRINTERS Group (“OP”, the “Company”, the “Group”), one of the leading online printing companies in Europe, confirms its preliminary figures for fiscal year 2025 with today’s publication of its Annual Report 2025 and provides guidance for the financial year 2026. Overall, the Company has recorded positive business performance in FY 2025, which was primarily driven by continued top-line growth and further improved profitability. OP consistently executed its growth strategy, combining organic expansion with targeted strategic acquisitions. In 2025, the Company successfully completed six acquisitions, further strengthening its market position and laying the foundation for future growth. FY 2025 results confirmed in line with guidance In FY 2025, the Group increased its revenue by EUR 11.3 million to EUR 289.8 million (previous year: EUR 278.6 million), corresponding to growth of 4.1% year-on-year and in line with the previously communicated guidance of low to mid-single-digit growth. From a segment perspective, revenue in the Online segment amounted to EUR 164.3 million compared to EUR 168.5 million in the previous year. In contrast, the Roll-up segment recorded revenue of EUR 128.5 million compared to EUR 113.9 million in the prior year, with growth primarily driven by acquisitions and complemented by slightly positive organic development. Adjusted EBITDA rose from EUR 48.8 million to EUR 51.9 million, representing an increase of 6.4% year-on-year. This development is also in line with the previously communicated guidance of low to mid-single-digit growth. The adjusted EBITDA margin improved by 0.4 percentage points to 17.9%. On a pro-forma basis, including full-year effects of acquisitions completed in 2025 and run-rate savings from business reorganisation measures, adjusted EBITDA would have amounted to EUR 58.3 million, corresponding to an increase of 15.6% year-on-year. These pro-forma figures are not part of the audited financial statements. Outlook for 2026 The printing and online printing industry is expected to continue its structural transformation, with digital, customized and platform-based business models gaining further importance. In this environment, the Group intends to continue its strategic direction in 2026. Assuming a moderate stabilization of the macroeconomic environment, OP expects single-digit revenue growth in FY 2026, supported in part by full-year effects from acquisitions completed in 2025. At the same time, the Group expects the adjusted EBITDA margin to remain at the previous year’s level or to improve slightly. The outlook does not include any potential additional M&A transactions, although the Company continues to actively pursue its inorganic customer acquisition strategy in 2026. CFO transition In addition, the Company announces a change in its Chief Financial Officer position. Kai Zhu succeeds Tobias Volgmann and joined the Company on 1 March 2026. Mr. Zhu’s previous roles include CFO positions at Invacare Holdings Corporation and the Fire Fighting Group of CNH Industrial, as well as senior finance roles within the Danaher KaVo Kerr Group. His extensive financial expertise and international leadership experience make him ideally suited to support the Company’s further development. Tobias Volgmann will step down from his position as CFO and leave the Company to pursue new professional opportunities. He has contributed to preparing the Company for its next phase of growth. Sustainability and CSRD reporting Environmental considerations remain a high priority for the Group and have been defined as a key factor for long-term competitiveness. In 2025, OP made further progress in strengthening its environmental responsibility by implementing targeted measures to enhance energy efficiency and sustainability. These included the increased use of renewable energy, the transition to electric-powered vehicles in production and the systematic replacement of conventional lighting with energy-efficient alternatives. The sustainability statement for FY 2025 in accordance with CSRD has also been published today and is available online at: https://investorrelations.onlineprinters.com/sustainability-reports/. A separate ESG report for 2025 will be published in the course of the year. Further information on the fiscal year 2025 can be found in the Annual Report 2025, which is available online at: https://investorrelations.onlineprinters.com/financial-reports/ In connection with the publication of the interim report for the first quarter of 2026 at the end of May, the Company will host a conference call, during which management will present the results and be available to answer questions. About Onlineprinters Onlineprinters is one of the leading online printing companies in Europe, with a strong presence across multiple countries. Our commitment to excellence is evident in the work of our dedicated team, who operate across six locations. Every day, they pour their passion and expertise into bringing our customers’ print projects to life. Since our establishment in 1984, we have consistently pushed the boundaries of print technology, leveraging cutting-edge machinery and advanced production processes to deliver high-quality products for clients across Europe. We strategically use AI to expand and optimize our service offering, delivering greater value at scale. OP HoldCo GmbH has issued a 2024/2029 bond with a volume of EUR 225 million, which is listed on the Open Market of the Frankfurt Stock Exchange and on the regulated market of Euronext Oslo. Contact Investor Relations Email: investor.relations@onlineprinters.com View the original release on www.newmediawire.com
New “Project Profiles” Series Marks a Major Evolution for the Podcast, Pairing Industry-Leading Insight With In-Depth Explorations of Completed, High-Performance Buildings SYDNEY, NOVA SCOTIA and WILMINGTON, NC - April 29, 2026 (NEWMEDIAWIRE) - Better Buildings for Humans, the leading podcast exploring the intersection of architecture, human performance, and wellness, powered by Advanced Glazings, today announced a major expansion of its format with the launch of its new Project Profiles series, a high-impact initiative designed to take audiences inside the world’s most forward-thinking buildings. Since launch, the podcast has established itself as a go-to platform for architects, engineers, and built environment leaders seeking serious, experience-driven insight into how buildings impact human outcomes. Now, the show is moving beyond conversation alone. The Project Profiles series brings the industry’s ideas into full view, featuring leading firms walking through recently completed projects in detail, from concept through execution to real-world performance. “This is the format the show has been building toward,” said Joe Menchefski, host of Better Buildings for Humans. “We’ve spent years unpacking the principles behind better buildings. Now we’re showing exactly how those principles are applied, project by project, decision by decision. You’re not just hearing what matters. You’re seeing what works.” Each episode will take listeners and viewers deep inside a finished project, guided by the architects and teams responsible. These are not surface-level case studies. They are detailed breakdowns of how high-performance buildings are actually delivered. Episodes will explore the full picture: How design decisions directly impact human comfort, cognitive performance, and well-being The integration of daylighting, materials, and systems to balance sustainability with usability The tradeoffs, constraints, and breakthroughs encountered during execution What the building is doing now that it’s complete, how it performs, and what it teaches At the same time, the format creates space to understand the firms behind the work - their philosophies, specialties, and what differentiates them in a market that is rapidly shifting toward measurable performance. “The conversation around buildings is changing fast,” said Dr. Doug Milburn, Chairman of Advanced Glazings. “Owners and operators are no longer satisfied with design intent alone. They want outcomes. What this series does is connect those outcomes to real projects and real decisions, which is exactly what the industry needs right now.” Production on Project Profiles episodes is already underway, with initial projects currently being filmed and prepared for release. Architecture and design firms interested in being featured are invited to submit projects for consideration at BBFH@PhillComm.Global. With this expansion, Better Buildings for Humans is positioning itself not just as a forum for ideas, but as a definitive platform for understanding how better buildings are actually conceived, built, and experienced. About Better Buildings for Humans Better Buildings for Humans is a podcast focused on how the built environment shapes human health, performance, and experience. Through in-depth conversations with leading architects, engineers, and innovators, the show explores the ideas and technologies defining the next generation of buildings. About Advanced Glazings Advanced Glazings is a leader in high-performance daylighting systems, with solutions spanning commercial, institutional, and residential applications. Its Solera® family of products is designed to optimize natural light, reduce energy consumption, and improve human comfort at scale. Contact: Jonathan Phillips AdvancedGlazings@PhillComm.Global View the original release on www.newmediawire.com
Developed by Dr. Edwin Ishoo, Flexlift™ Is an Innovative, Office-Based Face and Neck Rejuvenation Procedure Designed to Deliver Natural, Long-Lasting Results With Minimal Downtime BOSTON - April 29, 2026 (NEWMEDIAWIRE) - Regeneris is excited to announce the introduction of Flexlift™, an innovative, evidence-based face and neck rejuvenation procedure developed by Facial Plastic and Reconstructive Surgeon, Dr. Edwin Ishoo, MD, FACS based on his over 30 years of experience and thousands of procedures. Flexlift™ is a groundbreaking face and neck lift combination procedure, performed safely and cost-effectively under local anesthesia that delivers dramatic results for many looking to reverse the signs of aging but wish to avoid the downtime and complications associated with traditional surgical facelifts. This proprietary procedure will be offered exclusively at the Regeneris clinic in Westwood, bringing a flexible and transformative, office-based alternative to traditional facelift surgery to patients in the greater Boston and the entire New England area. Flexlift™ is an advanced solution that draws on decades of experience and modern understanding of facial aging and the role of loosening and sagging of the superficial muscular aponeurotic system, known as the SMAS and deep facial retaining ligaments as well as loss of midface volume. The SMAS layer supports the facial soft tissues and plays a central role in lifting procedures. Traditional facelift approaches often involve extensive skin delamination or deep-plane dissection, which typically requires general anesthesia and longer recovery periods in addition to increasing risks of major complications. Flexlift™ represents a significant advance and evolution in office-based facial rejuvenation which instead uses a modified multi-plane lift and midface fat volumization approach, tailored to each individual’s anatomy, aesthetic goals and lifestyle demands. Flexlift™ aims to reverse the early signs of aging more effectively by correcting facial tissue laxity, volume deficiency or excess. The procedure is designed to restore and strengthen the underlying ligaments responsible for structural support of facial soft tissues (fat and muscle) in their original, elevated position by combining a face and neck lift into one comprehensive procedure along with selective neck, buccal and jowl fat reduction and targeted midface fat augmentation. Key facial retaining ligaments of superficial and deep planes are selectively released, elevated and resuspended to allow for natural repositioning and restoration of facial soft-tissues while limiting the extent of surgical dissection to minimize recovery time and the stigmata of the typical “facelift look”. By focusing on targeted structural readjustments of lower face and neck rather than wide tissue dissection, the procedure aims to reduce swelling, bruising, risk of nerve injury, asymmetry and shorten recovery while preserving a natural appearance. Flexlift™ is ideal for individuals in their 40s to 60s looking for meaningful, long-term correction of the mid-face, jawline, and neck. "Flexlift™ is the next generation of facial rejuvenation," states Dr. Edwin Ishoo. "People are no longer looking for drastic changes, but rather to restore a younger version of themselves. This technique allows us to provide that in a safe, comfortable, office-based environment, enabling patients to return to their daily lives quickly without the extensive downtime associated with traditional facelifts". Additionally, “Flexlift™ delivers refreshed, natural-looking and long-lasting results comparable to a full-facelift without the downtime, cost, or risks associated with traditional facelift surgery usually in less than two hours.” Dr. Ishoo describes the procedure as a flexible, multi-layer and multi-component approach that addresses both surface and deeper facial structures. “The goal is not simply tightening the skin. Flexlift™ allows us to restore the underlying support structures and youthful proportions and contour of the face while tailoring the operation to the patient’s anatomy and recovery timeline.” Noted by Dr Ishoo, who adds, "This transformative in-office procedure is a game-changer for patients who want to achieve dramatic and lasting results comparable to the traditional facelifts without the increased risk, cost and recovery time associated with such procedures. Our patients can often return to most of their daily activities within days." The Flexlift™ technique is able to incorporate small-volume fat transfer, typically harvested from areas such as the individual’s own abdomen or inner thigh. Fat grafting may restore midface volume and restore a youthful “Ogee” facial contour and balance. Because the procedure is customizable to each individual’s anatomy and extent of aging, it can be tailored for individuals who primarily need lifting, those who require volume restoration, or individuals who benefit from a combination of both. Flexlift™ can be combined with other procedures such as upper and lower eyelid lifts as well as LASER skin resurfacing tailored and customized for each patient based on the unique way each individual shows the signs of aging. As Dr. Ishoo notes, “The procedure is flexible and adapts to the patient’s anatomy and recovery timeline.” A Flexlift™ can be truly transformative, and patients often maintain their results for up to ten years after their treatment. However, lifestyle choices such as sun exposure, smoking, and chronic stress all play a role in the longevity of the results. The Benefits of Flexlift™ The Flexlift™ procedure offers a multitude of benefits, including: Efficient procedure: Combines a facelift and neck lift in one, reducing the need for multiple surgeries. Hidden incisions: Leaves concealed incisions, minimizing visible scarring. High-quality outcomes: Delivers exceptional results without compromising the quality of the final look. Safe and Comfortable: We perform this procedure under local anesthesia, eliminating the need for a hospital operating room and long recovery times. Shorter social recovery time: Results in a shorter recovery period, with a 10-14 day healing time compared to the 3-4 weeks required for standard facelifts. Natural results: Restores a natural, youthful appearance by tightening deeper facial layers and augmenting midface volume with own fat. Affordable: Performed as an in-office procedure, avoiding additional anesthesia and facility fees makes the procedure affordable on almost any budget. Shorter surgery: Typically takes under two hours, minimizing the time spent in the operating room. The addition of Flexlift™ marks the expansion of Regeneris’ clinical offerings into facial plastic surgery procedures. The practice has previously focused on regenerative medicine, aesthetic treatments, and advanced wellness care. Dr. Ishoo will lead the program as the Facial Plastic and Reconstructive surgeon directing facial aesthetic procedures at Regeneris. Individuals interested in learning more about Flexlift™ or scheduling a consultation can contact Regeneris in Westwood for additional information. About Regeneris and Dr. Edwin Ishoo: Regeneris is a medical practice based in Westwood, Massachusetts, specializing in regenerative medicine, aesthetic treatments, and advanced wellness care. The clinic integrates modern surgical techniques with regenerative therapies to improve both physical function and appearance. Dr. Edwin Ishoo is a facial plastic and reconstructive surgeon with over 30 years of experience, and has achieved... Board-certification by the American Board of Otolaryngology–Head and Neck Surgery Membership in the American Academy of Facial Plastic and Reconstructive Surgeons and the American Academy of Cosmetic Surgery Fellow membership of the American Academy of Otolaryngology–Head and Neck Surgery and the prestigious American College of Surgeons. Media Contact: Veronica Welch VEW Media ronnie@vewpr.com
E-commerce, Location-Based Entertainment and Emotional Economy Among Latest Licensing Trends HONG KONG - April 29, 2026 (NEWMEDIAWIRE) - Asia’s annual flagship licensing events, the Hong Kong International Licensing Show and the Asian Licensing Conference, concluded successfully today. Organised by the Hong Kong Trade Development Council (HKTDC), the three-day extravaganza for the licensing trade ran from 27 to 29 April, attracting more than 330 exhibitors and showcasing over 600 brands and licensing projects. The Asian Licensing Conference brought together some 20 international licensing experts to explore key industry topics, including global licensing trends and the industry outlook, intellectual property (IP) licensing strategies for overseas expansion, sports licensing, location-based entertainment, food and beverage licensing, and creative marketing strategies. The two events served as cross-regional and cross-sectoral business expansion platforms across multiple categories, creating global business opportunities for participants and promoting regional IP trade development. Jenny Koo, Deputy Executive Director of the HKTDC, said: “Under the support of the national 15th Five-Year Plan, Hong Kong continues to deepen its role as a regional IP trading hub. As one of Asia’s most mature licensing markets, the city boasts a well-established industry ecosystem, with the licensing sector serving as a core engine for IP trade. We are pleased to see licensing applications expanding from traditional character merchandising to cover location-based entertainment, food and beverage, e-commerce and a host of other fields, forming a complete licensing industry chain that helps to create more business opportunities for the industry globally.” In response to the rapid development and growing popularity of e-commerce, this year’s Licensing Show introduced the new IP and e-Commerce Support Services Zone. In collaboration with the E-commerce Association of Hong Kong, Hong Kong eCommerce Supply Chain Association and the Hong Kong Federation of E-Commerce, the zone hosted multiple workshops on building online shops, digital marketing and livestream commerce, helping small and medium-size enterprises (SMEs) capitalise on e-commerce to sell their IP products globally. Among the participants was Digitify Online Growth, an e-commerce platform specialising in digital marketing and e-commerce operation solutions. Kay Leung from the company said: “The greatest value of this new dedicated zone lies in ‘promotion’ and ‘education’. In the current economic climate, industries across different sectors are actively seeking new avenues to expand their business. This zone serves as an essential foundation for SMEs, raising awareness of how to effectively leverage e-commerce as a springboard to promote their brands and sell their IP products to the global market.” Prof. Charles Ng from another exhibitor, StarLite IPC Limited, said: “This year's Licensing Show has truly played the role of an ‘all-rounded accelerator’ in driving industry growth. During this critical period of economic recovery in the Asian market, the show has successfully brought together leading licensors, licensing agents and brand owners from around the world, providing an efficient business matchmaking platform for IP licensing-focused enterprises like ours." Commenting on the impact of the new IP and e-Commerce Support Services Zone, Jenny Koo said: “This aligns well with the direction of the Hong Kong SAR Government’s policy to enhance the competitiveness of Hong Kong SMEs in relation to cross-border e-commerce. The HKTDC will continue to provide an ideal platform for the global licensing industry to showcase more diversified brand licensing projects, strengthening Hong Kong's position as an international licensing hub.” The Licensing Show continued to feature the DLAB Hong Kong Pavilion, bringing together nearly 40 exhibitors to showcase multiple Hong Kong original brands and IPs. Among them, local designer Kirsten Lie presented her original IPs and secured collaboration opportunities with overseas shopping malls. She said: “The current negotiations are highly encouraging, with enthusiastic responses all around. We are now in serious discussions with two overseas shopping malls and will meet with their senior management next week to move the partnership forward.” Another participating designer, James Ho, said “This year's Licensing Show provides an excellent brand promotion platform for local designers, enabling us to reach and engage with potential partners from diverse sectors on a broad scale.” In addition, this year’s Hong Kong Licensing Force Showcase featured The Hang Seng University of Hong Kong, Hong Kong Baptist University and The Hong Kong Polytechnic University, with the newly participating Hong Kong Design Institute joining to showcase creative designs by emerging local talents. Key topics at this year’s Asian Licensing Conference included how non-traditional toy IPs resonate with young consumers in the emotional economy along with new development models for food and beverage licensing. George Wood, Managing Director of The Luna Entertainment Group, shared on location-based entertainment during the session, saying: “We learned that one of the non-negotiables has to do is with the depth of affection, which is often related to the number of hours the audience has spent with the IP”. He also expressed his belief that transforming entertainment brands into experiences is one of the revenue engines offering long-term value. In another session, Mark Kingston, CEO and Co-founder of Libertas Brands Ltd, mentioned the rising popularity of non-traditional toys such as Fugglers, whose deliberately designed “ugly-cute” appearance echoes the rise of the emotion economy. “We want to ensure that every Fuggler engages different individuals, and that every individual can find a Fuggler that suits their personality or particular mood. That is key to the storytelling nature of Fugglers,” Mr Kingston said. Mainland institutions exhibit with distinctive cultural and creative brands The Chinese Mainland Pavilion brought together more than 150 institutions from regions including Beijing, Shaanxi, Jiangsu, Guangdong, Sichuan and more. Popular IPs such as Nailoong, Suchao, Tang Fugui, the Sun and Immortal Birds made their debut at the event, demonstrating the innovative vitality of the mainland’s cultural tourism IPs. Among the exhibitors in the pavilion were more than 20 cultural and museum institutions including Guangdong Museum, Nanjing Museum and the Xu Beihong Memorial Museum, showcasing the richness of the nation’s historical and cultural resources. This year, the distinctive Beijing Museums brand from the Beijing Municipal Cultural Heritage Bureau made its first overseas appearance. World cultural heritage sites such as the Great Wall and the Summer Palace collectively presented the unique character of Beijing’s heritage. Multiple MoUs signed to deepen collaboration and exchange in the licensing industry Several memoranda of understanding were signed during the two major licensing events, including one between the Beijing Municipal Cultural Heritage Bureau and the HKTDC. Building on their longstanding cooperation, both parties now aim to continue deepening cultural and economic exchange and collaboration under the broader framework of Beijing-Hong Kong cooperation. The MoU encourages both parties to actively build a cultural and museum cooperation platform, facilitating Beijing institutions to make use of the HKTDC’s platforms to explore aligning Beijing’s cultural and museum IPs and museum collections with Hong Kong’s professional strengths in the areas of creative design, IP transformation and licensing services, promoting the commercialisation, internationalisation and digital development of cultural and museum resources, and providing an effective way of telling China's stories. Another MoU was signed between the Innovative Entrepreneur Association (IEA) and the Shantou Cultural and Creative Tourism Industry Association, aiming to strengthen cultural and creative industry collaboration between Hong Kong and Shantou and promote the deep integration and coordinated development of the two cities’ cultural, creative and tourism industries. This collaboration was facilitated by the HKTDC following a study mission by a Hong Kong licensing industry delegation to the Greater Bay Area and South China market in January this year to explore development opportunities and business prospects. The signing of the MoU represents a further deepening of exchange and cooperation between industry players in both cities. Photo download: https://bit.ly/3QDbhJJ Websites Hong Kong International Licensing Show: https://www.hktdc.com/event/hklicensingshow/en Asian Licensing Conference: https://www.hktdc.com/event/hklicensingshow/en/programme'category=all&date=all HKTDC Media Room: http://mediaroom.hktdc.com/en Media enquiries For more information, please contact Raconteur: Molisa Lau Tel: 6187 7786 Email: molisalau@raconteur.hk Betsy Tse Tel: 9742 7338 Email: betsytse@raconteur.hk HKTDC’s Communications & Public Affairs Department: Winnie Kan Tel: 2584 4055 Email: winnie.wy.kan@hktdc.org About HKTDC The Hong Kong Trade Development Council (HKTDC) celebrates its 60th anniversary this year. The HKTDC is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in the Chinese Mainland, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels.
Asia Summit on Global Health and Medical Fair to Offer One-Stop Platform for the Entire Medical and Healthcare Industry Chain HONG KONG - April 29, 2026 (NEWMEDIAWIRE) - The fifth edition of the International Healthcare Week, organised by the Hong Kong Trade Development Council (HKTDC), will be held in Hong Kong from 11 to 31 May. The two flagship events – the sixth Asia Summit on Global Health (ASGH), jointly organised by the Government of the Hong Kong Special Administrative Region and the HKTDC, and the 17th Hong Kong International Medical and Healthcare Fair (Medical Fair), organised by the HKTDC and co-organised by the Hong Kong MedTech Association – serve as a comprehensive business platform covering the entire medical and healthcare industry chain, including technology R&D, investment matching, medical equipment manufacturing, medical products and services. The events will be held concurrently to maximise synergy at the Hong Kong Convention and Exhibition Centre in Wan Chai next month. The ASGH will take place on 11 and 12 May, while the Medical Fair will run from 11 to 13 May. Sophia Chong, Executive Director of the HKTDC, said: “The medical and healthcare landscape is undergoing a profound and rapid transformation. Hong Kong, by leveraging its preeminence as an international financial centre, its world-class research ecosystem and its unique positioning bridging the Chinese Mainland and the world, serves as an ideal platform for scientific excellence, strategic investment and financing, and international trade for medical and healthcare innovation. The National 15th Five-Year Plan prioritises health development. The HKTDC will actively align with the Plan through the two flagship events of the International Healthcare Week – the ASGH and the Medical Fair. The events will focus on high-growth areas such as biopharmaceuticals, AI-empowered healthcare, the silver economy and modernisation of traditional Chinese medicine, and will help to accelerate commercialisation of research outcome, facilitate high-impact business matching, and boost cross-border investment. Collectively, the twin events reinforce the ‘Healthy China’ initiative, solidify Hong Kong’s position as Asia’s leading biotech and investment hub, and demonstrate Hong Kong’s role as a superconnector and super value-adder.” Speaker line-up features Nobel Prize Laureate The sixth ASGH, themed “Fuelling Healthcare Breakthroughs”, will convene a prestigious assembly of international health officials, scientific, medical and industry experts, start-ups and investors. Through various sessions, they will exchange valuable insights and navigate the latest frontiers in public health, medtech, international trade and investment, while unlocking the future prospects and untapped business opportunities of the industry. The opening session will feature welcome remarks by Prof Frederick S Ma, Chairman of the HKTDC, and opening remarks by John Lee, the Chief Executive of the Hong Kong Special Administrative Region, followed by special remarks of Prof Zeng Yixin, Vice Minister of the National Health Commission of the People’s Republic of China. On the morning of the first day, two plenary sessions will be held. Plenary Session I: Strengthening Pandemic Preparedness through Global Collaboration will begin with a keynote speech by Prof Lo Chung-mau, Secretary of Health of the HKSAR government. The session will be moderated by Prof Leo Poon, Daniel CK Yu Professor in Virology at the School of Public Health of the University of Hong Kong and Co-Director of The Hong Kong Jockey Club Global Health Institute. Speakers include Prof Ibrahim Abubakar, Vice-Provost (Health) and Professor of Infectious Disease Epidemiology at University College London; Dr Leung Yiu-hong, Head of Emergency Response and Programme Management Branch, Department of Health; Dr Kumanan Rasanathan, Executive Director of the WHO Alliance for Health Policy and Systems Research; Prof Wang Yu, Chairman, Chinese Foundation for Hepatitis Prevention and Control, also Former Director-General, Chinese Center for Disease Control and Prevention; and Dr In-Kyu Yoon, Acting Deputy Director General for Integrated Development and Pandemic Preparedness at the International Vaccine Institute. They will delve into critical strategies such as pathogen surveillance, data sharing, multinational collaboration and equitable access to medical resources to bolster the resilience of global health infrastructure and institutionalise perpetual preparedness for potential future pandemics. Plenary Session II: Fuelling Healthcare Breakthroughs will examine how cross-sector collaboration catalyses the commercialisation of research outcomes, propels biopharmaceutical advancement, and unlocks investment and market potential in the sector. The session will feature a special address by Leng Weiqing, Chairman of Shanghai Industrial Investment (Holdings), the Strategic Partner of the Summit. It will be moderated by Victor Chu, Chairman and CEO of First Eastern Investment Group, with speakers including Jonathan Symonds, Chairman of the Board of GSK; Prof Song Ruilin, Eminent President and Chief Expert of the China Pharmaceutical Innovation and Research Development Association; Dr Mehmood Khan, CEO of The Hevolution Foundation; Clara Chan, Chief Executive Officer of Hong Kong Investment Corporation Limited; David Lau, Vice Chair of Investment Banking for Asia Pacific and Head of Healthcare Investment Banking for Asia Pacific at JP Morgan Securities; and Theresa Tse, Chairwoman of the Board, Sino Biopharmaceutical Limited. On the afternoon of the first day, the Dialogue with Global Pioneer in Health session will feature 2013 Nobel Prize Laureate in Chemistry, Prof Michael Levitt, Robert W and Vivian K Cahill Professor in Cancer Research at Stanford University. Prof Levitt will share his distinguished journey in scientific discovery and envision the transformative impact of technology on future healthcare and scientific research. A pioneer in computational biology, he was among the first to simulate molecular dynamics of DNA and proteins. He was awarded the Nobel Prize for developing multiscale models of complex chemical systems. With rapid advances in AI drug discovery, oncology, and precision medicine, the summit introduces a dedicated CSO Insights: Catalysing Scientific Breakthroughs and Investments for Future Health session on the morning of the second day. Chief Scientific Officers and R&D leaders from leading biotech and pharmaceutical companies, including Fosun Pharma, Omico, Zhaoke Ophthalmology, and more, will share how they set scientific strategy, build high-velocity, high-quality R&D engines, and forge partnerships that accelerate time-to-impact. Thematic sessions address market trends and the National 15th Five-Year Plan The pervasive adoption of AI is driving a paradigm shift across industries, including healthcare. This year’s summit will feature two thematic sessions, including Intelligence at Scale: How AI is Powering Real-World Healthcare Revolution, co-organised with Gleneagles Hospital Hong Kong, and Transforming Healthcare through Digital Health & AI Innovations. Speakers will examine pragmatic integration and pioneering breakthroughs of AI within the healthcare system. The silver economy represents a high-growth frontier. This year’s Summit will once again feature a dedicated Silver Health Chapter to address the complexities of an ageing demographic and unlock the sector’s burgeoning market potential. In the session Unlocking Growth in Silver Health: From Precision Medicine to Smart Ageing Innovations, distinguished speakers will discuss breakthroughs in the prevention, diagnosis and treatment of age-related diseases. In response to the National 15th Five-Year Plan, and to catalyse the Healthy China initiative and regional collaboration, the Summit will include a session titled The Next Frontier in China's Healthcare Industry which will review the latest trends in medical innovation and investment in China. The session Driving Chinese Medicine Development Through Standardisation and Innovation will address the National 15th Five-Year Plan’s emphasis on the inheritance and innovation of traditional Chinese medicine. Speakers will share insight on traditional Chinese medicine innovation, cross-sector collaboration and regulatory matters. Over the two days, the Summit will cover a wide range of topical issues in the medical and healthcare sector, including sustainable healthcare systems, gene and cell therapy, rare disease treatments, medical robotics and devices, and IP financing strategies for pharmaceuticals and medtech. Supporting the expansion needs of medical/healthcare enterprises In addition to the plenary and thematic sessions, the Summit will feature the ASGH Business Hub and InnoHealth Showcase, which presents innovative technologies from some 180 medical and healthcare companies across 11 countries and regions. These include exhibitor delegations from Australia, Finland, the UK, Xiamen and Jiangsu, as well as start-ups and projects from the Innovation and Technology Commission, Cyberport, Hong Kong Science and Technology Parks, and five local universities. Many of the exhibitors have received prestigious awards. The Project Pitching session will provide start-ups with the opportunity to present their innovations to potential investors, while the ASGH Deal-making facilitates one-to-one meetings, both online and offline, to channel capital to healthcare projects and promote collaboration. Medical and healthcare enterprises can also access the “GoGlobal Connect” Zone and Business of Healthcare Advisory Zone to consult with service providers and institutions on overseas expansion, fundraising, R&D collaboration and other areas. Their professional advice will help companies formulate more effective business and “go global” strategies. The Summit will also host a workshop titled Hong Kong as a SuperConnector to Empower Global Expansion of Pharmaceutical Enterprises, where medical and business leaders will share how pharmaceutical companies can leverage Hong Kong’s platform and international professional services to seize overseas business opportunities. The Medical Fair’s three key categories: MedTech, GeronTech & Preventive Healthcare The 17th Hong Kong International Medical and Healthcare Fair will be held from 11 to 13 May. Themed Innovations Boosting Smart Health Experience. The Fair will provide an ideal platform for research and development institutions, manufacturers, public healthcare organisations, hospitals, clinics, distributors, and healthcare professionals from around the world to establish global business connections and understand the latest trends in the medical industry. This year has seen a doubling in the number of exhibitors offering smart ageing products and green solutions, reflecting strong market demand for related products. Furthermore, several exhibitors will showcase innovative products and solutions integrating AI and robotic technology, offering buyers top-tier medical and healthcare solutions. The Medical Fair will gather some 300 exhibitors from 10 countries and regions, including Hong Kong, the Chinese Mainland, Taiwan, Korea, as well as new participants from Macao, Australia, Canada, New Zealand, Vietnam, and the United States. The exhibition will feature seven major zones, including the Startup Zone, Hospital Equipment and Digital Health, Biotechnology and Lab Diagnostics, Laboratory Technologies and Healthcare Services, Medical Supplies and Disposables, Rehabilitation and Elderly Care, and the World of Health and Wellness, showcasing the latest medical technologies and innovative solutions across the sector. The Fair will focus on three key areas: MedTech, GeronTech and Preventive Healthcare, presenting breakthrough technologies and products. Among the highlights, an exhibitor will introduce a smart health wearable watch that integrates concepts from both Chinese and Western medicine. By combining modern biosensing technology with traditional Chinese medicine theories and analysing indicators such as heart rate variability (HRV) to assess the functions of the five major internal organs, the device translates complex physiological data into a clear and easy-to-understand daily health score and personalised recommendations, helping users identify potential health risks at an early stage. Another exhibitor will demonstrate an augmented reality (AR) surgical platform designed for orthopaedic surgeons. The technology has already been applied in local hospitals and provides real-time 3D navigation during surgical procedures. By accurately overlaying medical imaging onto the surgical field, the platform enhances surgical precision and improves clinical decision-making efficiency. The technology was recognised with an award at the 2025 EQT Impact Challenge, where the project emerged as a winner after multiple rounds of selection and evaluation by a professional judging panel. The international startup competition aims to identify and support innovative solutions with positive social impact, underscoring the platform’s technological innovation and medical application value. In addition, an exhibitor will present a world-first smart knee brace that integrates artificial intelligence, wearable technology and rehabilitation applications. Designed for use in healthcare institutions such as wellness centres, hospitals and rehabilitation clinics, the product supports post-knee surgery recovery and sports injury rehabilitation. Through adjustable straps and a mobile application, the non-invasive device enables real-time monitoring of joint angles, thigh circumference and swelling changes during daily activities, rehabilitation therapy and training. It provides healthcare professionals with both real-time and historical data insights, enhancing the accuracy of rehabilitation monitoring, while also aiding injury prevention and extending athletes’ professional careers. The Medical Fair actively promotes collaborative innovation across government, industry, academia, research, and investment. A number of leading research and academic institutions will participate, including nine local universities, over 30 innovation and technology enterprises led by Hong Kong Science and Technology Parks, as well as some 20 medical enterprises brought by the Hong Kong MedTech Association (HKMTA). A startup will showcase innovative voice assistive technology products featuring a one touch speech reconstruction function. The solutions provide personalised support for individuals with speech and communication difficulties, helping them regain clear communication abilities and improve their quality of life. This innovation highlights the application excellence of local startups in both medical technology and social care, demonstrating how technology can address real societal needs with meaningful impact. More than 50 themed forums and seminars will be held during the fair, providing industry players with insights into the latest market trends. Highlights include “Accelerating Mental Health Innovation through AI Research and Adoption”, in association with Tung Wah College; “Decoding the Demand for Gerontechnology”, in association with the Hong Kong Council of Social Service; and the “HKMTA Medical Fair Forum 2026: The Medtech Solutions - Greater Bay Area & Overseas”, which will discuss the latest developments in the field. The exhibition will continue to adopt the “EXHIBITION+” hybrid model. The physical fair will take place from 11 to 13 May at the HKCEC. Global exhibitors, industry professionals, and buyers can engage in discussions via the “Click2Match” smart business matching platform from 4 May until 20. As the two flagship events of International Healthcare Week, the Asia Summit on Global Health and the Hong Kong International Medical and Healthcare Fair will gather global healthcare forces to create a cross-sector exchange platform. International Healthcare Week will be held in Hong Kong from 11 to 31 May, covering 17 healthcare-related conferences, seminars, roundtables, and networking activities. It aims to promote innovation and investment exchange in the Asian healthcare industry, further creating industry synergies and driving Hong Kong's development as a regional medical innovation hub. The Asia Summit on Global Health Date 11-12 May 2026 (Monday to Tuesday) 9:00am to 6:00pm The Opening Session will begin at 10:00 am on 11 May Venue Hong Kong Convention and Exhibition Centre (HKCEC) Hall 3FG Hong Kong International Medical and Healthcare Fair Date 11-12 May 2026 (Monday to Tuesday) 10:00am to 6:00pm 13 May 2026 (Wednesday) 10:00am to 5:00pm Venue Hong Kong Convention and Exhibition Centre (HKCEC) Hall 3DE Photo download: https://bit.ly/48tQH4B Websites The Asia Summit on Global Health: https://www.asiasummitglobalhealth.com/conference/asgh/en'ref_source=GrayMenu&ref_medium=vep-conference Programme: https://www.asiasummitglobalhealth.com/conference/asgh/en/programme'ref_source=GrayMenu&ref_medium=vep-conference Speakers: https://www.asiasummitglobalhealth.com/conference/asgh/en/speaker'ref_source=GrayMenu&ref_medium=vep-conference Hong Kong International Medical and Healthcare Fair: https://www.hktdc.com/event/hkmedicalfair/en'ref_source=GrayMenu&ref_medium=vep-tradeshow List of Product: https://www.hktdc.com/event/hkmedicalfair/en/product'ref_source=GrayMenu&ref_medium=vep-tradeshow Activity schedule: https://www.hktdc.com/event/hkmedicalfair/en/programme'ref_source=GrayMenu&ref_medium=vep-tradeshow International Healthcare Week: https://internationalhealthcareweek.hktdc.com/en Members of the media interested in interviewing ASGH speakers, please send requests to lsong@yuantung.com.hk or tleung@yuantung.com.hk on or before 4 May 2026. Media enquiries Yuan Tung Financial Relations: Jasmine Zhang Tel: (852) 3428 3278 Email: jzhang@yuantung.com.hk Louise Song Tel: (852) 3428 5691 Email: lsong@yuantung.com.hk Tiffany Leung Tel: (852) 3428 2361 Email: tleung@yuantung.com.hk HKTDC’s Communications & Public Affairs Department: Noah Qiu Tel (852) 2584 4575 Email: noah.yl.qiu@hktdc.org Navin Law Tel: (852) 2584 4525 Email: navin.cm.law@hktdc.org Jane Cheung Tel: (852) 2584 4137 Email: jane.mh.cheung@hktdc.org About HKTDC The Hong Kong Trade Development Council (HKTDC) celebrates its 60th anniversary this year. The HKTDC is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in the Chinese Mainland, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Follow us on @hktdc and LinkedIn
HONG KONG - April 29, 2026 (NEWMEDIAWIRE) - The Census and Statistics Department today released the latest external merchandise trade statistics. In March 2026, the total value of Hong Kong’s merchandise exports recorded a year-on-year increase of 35.8% to HK$618.4 billion. For the first quarter of 2026, the total value of exports of goods amounted to HK$1,546.2 billion, representing a robust growth of 32.0% compared with the same period last year. Commenting on the outlook, Bruce Pang, Director of Research at the Hong Kong Trade Development Council, said Hong Kong’s exports are expected to remain steady at least in the near term, despite elevated energy prices arising from ongoing tensions in the Middle East. He noted Hong Kong’s external trade has continued to exhibit clear growth momentum, underpinned primarily by sustained global demand for electronic items and other intermediate goods that are integral to regional and global supply chains. In particular, resilient input demand from the Chinese Mainland and other ASEAN production sites, together with stable demand from major overseas markets, has provided a solid buffer against external headwinds. While geopolitical uncertainties persist and energy prices are likely to remain relatively high, continued industrial activity in major markets, as well as ongoing supply-chain realignments, are expected to lend ongoing support to Hong Kong’s trade flows. “Overall, we maintain a cautiously optimistic outlook for Hong Kong’s trade performance, while remaining mindful of potential volatility arising from geopolitical developments and cost pressures,” Pang added. HKTDC Media Room: https://mediaroom.hktdc.com/en Media enquiries Please contact the HKTDC’s Communications & Public Affairs Department: Jane Cheung Tel: (852) 2584 4137 Email: jane.mh.cheung@hktdc.org About HKTDC The Hong Kong Trade Development Council (HKTDC) celebrates its 60th anniversary this year. The HKTDC is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in the Chinese Mainland, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. View the original release on www.newmediawire.com
BROSSARD, QUEBEC - April 29, 2026 (NEWMEDIAWIRE) - CHARBONE CORPORATION (TSXV: CH; OTCQB: CHHYF; FSE: K47) (“CHARBONE” or the “Company”), a North American producer and distributor of clean ultra-high purity (“UHP”) hydrogen and industrial gases, is pleased to announce the closing of the secured convertible loan facility (the “Convertible Loan”) with RiverFort Global Opportunities PCC Ltd. (“RiverFort” or “Lender”) for up to $10 million as previously announced on March 31 and April 23, 2026. Transaction Overview Pursuant to the definitive agreements executed with RiverFort, CHARBONE has successfully completed the initial drawdown in the amount of $3 million (the “Initial Drawdown”) under the Convertible Loan, representing the first tranche of up to $10 million in total committed financing. The Convertible Loan is structured as a multi-drawdown secured facility, with additional tranches available to the Company over the term of the agreement, subject to customary conditions and mutual agreement between the parties. Key Terms of the Convertible Loan - Total facility size: Up to $10 million secured Convertible Loan, structured in multiple drawdowns. - Drawdowns: The Initial Drawdown of $3 million is now closed. The second drawdown of up to $3 million may be advanced to the Company prior to the date falling 6 calendar months from the first drawdown closing and subject to mutual agreement, and the remaining $4 million will be available to be drawn in aggregate during the Convertible Loan term, subject to mutual agreement between the Company and RiverFort and customary conditions set out in the Convertible Loan agreement. - Term: Drawdowns under the Convertible Loan are available for a three-year term, with each drawdown repayable over 18 months. Initial Drawdown maturity date is on October 29, 2027. - Interest: 12% per annum, payable in cash every 4 months. Default interest capped at 24%. - Conversion: The first drawdown is convertible, at the option of the Lender, into units composed of one common share of the Company and 0.3 of a warrant, at a conversion price of $0.15 per unit. If not converted before, 10% of the first drawdown shall be repaid at the end of 6 months, 20% at the end of 12 months and 70% on maturity date in 18 months. The securities issued upon any conversion of the principal amount of the Convertible Loan will be subject to the statutory four-month hold period in Canada. - Warrants: Each whole warrant issued in connection with the first drawdown of $3 million will be exercisable to acquire one additional common share in the capital of CHARBONE, at a price per share of $0.195, for a period of 48 months, subject to a maximum of 5 years from the Convertible Loan closing date. - Security: Secured with a first ranking hypothec over the universality of all present and future movable property of each of Charbone Hydrogène Québec Inc. (Sorel-Tracy project) and Charbone Hydrogen Corporation. - An implementation fee of 5% of the first drawdown will be paid in cash on closing and a non-refundable $20,000 due diligence fee has already been paid. Use of Proceeds The Convertible Loan is a key component of CHARBONE’s broader strategy to scale hydrogen production capacity and expand its industrial gas platform across North America. The proceeds from the Initial Drawdown are expected to be used to: - Accelerate development timelines of the Company’s clean UHP hydrogen production facilities - Support capital expenditures and equipment deployment - Provide general working capital to accelerate near-term growth initiatives CHARBONE and RiverFort will continue to evaluate subsequent drawdowns under the Convertible Loan facility, which may be advanced over time in accordance with the agreement and the Company’s capital requirements. “This closing represents an important milestone for CHARBONE as we continue to execute on our growth strategy,” said Benoit Veilleux, CHARBONE’s Chief Financial Officer and Corporate Secretary. “The partnership with RiverFort provides flexible, staged capital that aligns with our development timeline and supports the acceleration of our hydrogen infrastructure buildout.” About RiverFort RiverFort provides debt and equity-based capital to high-growth companies. As an international business operating from offices in London, Australia and Gibraltar along with a strong presence in Europe, and Canada, RiverFort has a multi-sector and global orientation. RiverFort prides itself in creating mutually beneficial partnerships between its alternative funding sources, including family office co-investors, and investee companies it believes in. The RiverFort team has executed in excess of US$15 billion of growth financing transactions. About CHARBONE CORPORATION CHARBONE is a vertically integrated industrial gases company focused on developing and operating a network of supply hubs for the production, storage, and distribution of Ultra-High Purity (UHP) strategic industrial gases. The Company serves customers across sectors including semiconductors, artificial intelligence and data centers, advanced pharmaceuticals, and aerospace and defense technologies, where UHP gases are critical for high-precision manufacturing processes and operational performance. CHARBONE is advancing a network of clean UHP hydrogen production facilities across North America and selected international markets. The Company’s modular, decentralized, and demand-driven approach, combined with its integrated storage and distribution platform for all UHP gases, supports scalable growth, enhances operational flexibility, and enables more stable and diversified revenue generation. This model allows CHARBONE to efficiently serve mid-tier industrial gas customers with a reliable supply of UHP gases, including hydrogen, helium, oxygen, and any others that are in high-demand gases that are often difficult to source. The Company is committed to supporting the global transition to a lower-carbon economy by providing accessible, decentralized clean hydrogen and specialty gases, while addressing supply gaps for underserved industrial customers and accelerating the shift towards localized clean energy. CHARBONE is listed on the TSX Venture Exchange (TSXV: CH), the OTC Markets (OTCQB: CHHYF), and the Frankfurt Stock Exchange (FSE: K47). For more information, please visit: www.charbone.com. Forward-Looking Statements This news release contains statements that are “forward-looking information” as defined under Canadian securities laws (“forward-looking statements”). These forward-looking statements are often identified by words such as “intends”, “anticipates”, “expects”, “believes”, “plans”, “likely”, or similar words. The forward-looking statements reflect management's expectations, estimates, or projections concerning future results or events, based on the opinions, assumptions and estimates considered reasonable by management at the date the statements are made. Although Charbone believes that the expectations reflected in the forward-looking statements are reasonable, forward-looking statements involve risks and uncertainties, and undue reliance should not be placed on forward-looking statements, as unknown or unpredictable factors could cause actual results to be materially different from those reflected in the forward-looking statements. The forward-looking statements may be affected by risks and uncertainties in the business of Charbone. These risks, uncertainties and assumptions include, but are not limited to, those described under “Risk Factors” in the Corporation’s Management’s Discussion & Analysis for the period ended September 30, 2025, which is available on SEDAR+ at www.sedarplus.ca; they could cause actual events or results to differ materially from those projected in any forward-looking statements. Except as required under applicable securities legislation, Charbone undertakes no obligation to publicly update or revise forward-looking information. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Contact Charbone Corporation Telephone: +1 450 678 7171 Email: ir@charbone.com Benoit Veilleux CFO and Corporate Secretary View the original release on www.newmediawire.com
TULSA, OK - April 29, 2026 (NEWMEDIAWIRE) - AppSwarm, Corp. (OTC: SWRM), a publicly traded technology company specializing in the accelerated development and publishing of mobile applications, released its AI-driven application AniPet Nature on Google Play: AniPet Nature is an AI-powered application now available for Android users at: https://play.google.com/store/apps/details?id=com.anipet.app The AniPet Nature app transforms everyday encounters with nature into captivating, educational adventures. Users snap a photo or upload an image of any animal, pet, bird, or wildlife, and the app delivers instant species identification along with comprehensive details - including scientific names, habitats, diets, behaviors, and fun trivia. Designed for nature enthusiasts, birdwatchers, pet owners, families, and educators, AniPet Nature fosters curiosity and appreciation for biodiversity through its intuitive interface, personal discovery collection feature, and broad species coverage. This Android release follows the successful iOS debut of the app (https://apps.apple.com/us/app/anipet/id6752426639), marking a key milestone in AppSwarm's strategy to broaden accessibility and reach a global audience across multiple platforms. Christopher Bailey, President of AppSwarm, commented: "Expanding AniPet to the Google Play Store is an exciting step forward in our mission to deliver innovative, user-centric mobile experiences. This app showcases how AI can enhance everyday activities, explore the natural world, and drive engagement and learning. We're thrilled to make this tool available to Android users and look forward to continued growth and releases of our portfolio.” About APPSWARM AppSwarm is a collective of creative and technological minds focused on gaming app development, business app development, web development, and white-label technology solutions. AppSwarm partners with and assists other firms in technology development and business management. For more information, visit us at www.app-swarm.com or follow us on Facebook: www.facebook.com/AppSwarm Twitter: https://twitter.com/AppSwarm or Instagram: https://www.instagram.com/appswarm/ Forward-Looking Statements: “Safe Harbor” statement under the Private Securities Litigation Reform Act of 1995: This press release may contain forward-looking statements that are subject to risk and uncertainties including, but not limited to, the impact of competitive products, product demand, market acceptance risks, fluctuations in operating results, political risk, and other risks detailed from time to time in the Company’s filings with OTCMarkets.com and as required to the Securities and Exchange Commission. These risks could cause SWRM’s actual results to differ materially from those expressed in any forward-looking statements made by, or on behalf of, the Company. Investor and Media Contacts: AppSwarm, Corp. 918-706-5497 info@app-swarm.com
KELOWNA, BC - April 29, 2026 (NEWMEDIAWIRE) - Lexaria Bioscience Corp. (NASDAQ: LEXX) (“Lexaria” or the “Company”), a global innovator in oral drug delivery platforms, provides this update on the Material Transfer Agreement (“MTA”) originally entered into on August 30, 2024 with a pharmaceutical company (“PharmaCO”) to evaluate Lexaria’s DehydraTECHTM technology in a pre-clinical setting. The original agreement has been successfully extended through December 31, 2026, to accommodate time required for PharmaCO’s receipt and review of Lexaria’s 2026 research & development (“R&D”) results related to GLP-1. This allows the two parties to continue their relationship under the MTA, keep the temporary exclusive license active and in force, and contemplate additional strategic planning discussions with PharmaCO’s human clinical and business development teams. Over the past 12 months, Lexaria has taken important steps in advancing its GLP-1 development program. This includes recently announced progress in each of its 2026 R&D studies: Human Study #7; Animal Study #1; and Animal Study #2. All of these studies are within the GLP-1 sector and have been designed with the goal of providing fulsome evidence to better allow additional collaboration and potential licensing of Lexaria’s technology. Each of the studies mentioned above are in process and are fully funded with existing corporate resources. Results are expected during Q3 and Q4 of this calendar year. About Lexaria Bioscience Corp. & DehydraTECH DehydraTECH™ is Lexaria’s patented drug delivery formulation and processing platform technology which improves the way a wide variety of drugs enter the bloodstream, always through oral delivery. DehydraTECH has repeatedly evidenced the ability to increase bio-absorption, reduce side-effects, and deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 65 patents granted and additional patents pending worldwide. For more information, please visit www.lexariabioscience.com. CAUTION REGARDING FORWARD-LOOKING STATEMENTS This press release includes forward-looking statements. Statements as such term is defined under applicable securities laws. These statements may be identified by words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions. Such forward-looking statements in this press release include, but are not limited to, statements by the Company relating to the intended use of proceeds from the offering and relating to the Company’s ability to carry out research initiatives, receive regulatory approvals or grants or experience positive effects or results from any research or study. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that the Company will actually achieve the plans, intentions, or expectations disclosed in these forward-looking statements. As such, you should not place undue reliance on these forward-looking statements. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, market and other conditions, government regulation and regulatory approvals, managing and maintaining growth, the effect of adverse publicity, litigation, competition, scientific discovery, the patent application and approval process, potential adverse effects arising from the testing or use of products utilizing the DehydraTECH technology, the Company’s ability to maintain existing collaborations and realize the benefits thereof, delays or cancellations of planned R&D that could occur related to pandemics or for other reasons, and other factors which may be identified from time to time in the Company’s public announcements and periodic filings with the US Securities and Exchange Commission on EDGAR. The Company provides links to third-party websites only as a courtesy to readers and disclaims any responsibility for the thoroughness, accuracy or timeliness of information at third-party websites. There is no assurance that any of Lexaria’s postulated uses, benefits, or advantages for the patented and patent-pending technology will in fact be realized in any manner or in any part. No statement herein has been evaluated by the Food and Drug Administration (FDA). Lexaria-associated products are not intended to diagnose, treat, cure or prevent any disease. Any forward-looking statements contained in this release speak only as of the date hereof, and the Company expressly disclaims any obligation to update any forward-looking statements or links to third-party websites contained herein, whether as a result of any new information, future events, changed circumstances or otherwise, except as otherwise required by law. INVESTOR CONTACT: George Jurcic – Head of Investor Relations ir@lexariabioscience.com Phone: 250-765-6424, ext 202 View the original release on www.newmediawire.com
Near-Term Clinical Milestones and Combination Strategy Position Program for Next Stage of Value Creation ATLANTA, GA - April 29, 2026 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today outlined near-term development milestones and strategic priorities for its oncology program, Gedeptin®, as the Company advances toward Phase 2 clinical initiation and potential partnership opportunities. With oncology treatment increasingly defined by combination regimens, the ability to integrate into established therapeutic backbones is becoming a key factor in clinical and commercial success. GeoVax believes the convergence of upcoming clinical milestones and increasing industry focus on combination approaches creates a timely opportunity to advance Gedeptin’s development and strategic positioning. Advancing Toward Phase 2 Clinical Execution GeoVax is advancing Gedeptin with a focus on integration into combination treatment regimens, particularly alongside immune checkpoint inhibitors (ICIs) and other established oncology backbones. The Company believes this approach aligns with the evolving treatment landscape and may support broader applicability across multiple tumor types. GeoVax is preparing to initiate a Phase 2 clinical trial evaluating Gedeptin, in combination with an ICI, as a first-line neoadjuvant treatment in patients with resectable locally advanced head and neck cancer, with trial initiation targeted for 2027. The study is designed to evaluate: Tumor response in the neoadjuvant setting Biomarker-driven immune activation Event-free survival outcomes This trial is expected to represent a key step in establishing clinical validation for Gedeptin in combination immuno-oncology strategies. Expanding Development Across Additional Solid Tumors In parallel with its lead clinical program, GeoVax is planning to advance preclinical and translational work evaluating Gedeptin across additional solid tumor indications. These efforts are intended to (a) identify tumor settings where combination approaches may provide the greatest clinical benefit, (b) support expansion beyond head and neck cancer and, (c) inform future clinical development strategies. Positioned for Strategic Collaboration GeoVax is actively pursuing opportunities to advance Gedeptin through clinical development partnerships, combination-focused collaborations and potential licensing or co-development arrangements. “We are entering an important phase of development for Gedeptin, with a focus on clinical execution and advancing discussions around potential partnerships,” said David A. Dodd, Chairman and Chief Executive Officer of GeoVax. “As combination therapy becomes more common across oncology, we believe Gedeptin is well positioned to be integrated into these regimens and contribute to improved treatment outcomes.” Supported by an Established Clinical and Scientific Foundation GeoVax has established a clinical and scientific foundation to support Gedeptin’s advancement into its next stage of development, including: Completed Phase 1/2 clinical experience in advanced head and neck cancer Engagement of an Oncology Advisory Board with deep immuno-oncology expertise Expanded intellectual property supporting combination use with checkpoint inhibitors This foundation is intended to support both continued clinical progression and engagement with potential partners. About Gedeptin® Gedeptin® is a gene-directed enzyme prodrug therapy (GDEPT) delivered intratumorally using a non-replicating viral vector encoding purine nucleoside phosphorylase (PNP). Following administration of a systemically delivered prodrug, the encoded enzyme converts the prodrug into a cytotoxic agent directly within the tumor microenvironment. About GeoVax GeoVax Labs, Inc. is a clinical-stage biotechnology company focused on the development of vaccines and immunotherapies addressing high-consequence infectious diseases and solid tumor cancers. GeoVax’s priority program is GEO-MVA, a Modified Vaccinia Ankara (MVA)-based vaccine targeting mpox and smallpox. The program is advancing under an expedited regulatory pathway, with plans to initiate a pivotal Phase 3 clinical trial in the second half of 2026, to address critical global needs for expanded orthopoxvirus vaccine supply and biodefense preparedness. In oncology, GeoVax is developing Gedeptin®, a gene-directed enzyme prodrug therapy (GDEPT) designed to enhance immune checkpoint inhibitor activity. Gedeptin has completed a multicenter Phase 1/2 clinical trial in advanced head and neck cancer and is being advanced into combination strategies, including planned neoadjuvant and first-line settings. GeoVax’s broader pipeline includes the development of GEO-CM04S1, a next-generation COVID-19 vaccine candidate being evaluated in immunocompromised and other patient populations. GeoVax maintains a global intellectual property portfolio supporting its infectious disease and oncology programs and continues to evaluate strategic partnerships and funding opportunities aligned with its development priorities. For more information, visit www.geovax.com. Forward-Looking Statements This release contains forward-looking statements regarding GeoVax’s business plans. The words “believe,” “look forward to,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Actual results may differ materially from those included in these statements due to a variety of factors, including whether: GeoVax is able to obtain acceptable results from ongoing or future clinical trials of its investigational products, GeoVax’s immuno-oncology products and preventative vaccines can provoke the desired responses, and those products or vaccines can be used effectively, GeoVax’s viral vector technology adequately amplifies immune responses to cancer antigens, GeoVax can develop and manufacture its immuno-oncology products and preventative vaccines with the desired characteristics in a timely manner, GeoVax’s immuno-oncology products and preventative vaccines will be safe for human use, GeoVax’s vaccines will effectively prevent targeted infections in humans, GeoVax’s immuno-oncology products and preventative vaccines will receive regulatory approvals necessary to be licensed and marketed, GeoVax raises required capital to complete development, there is development of competitive products that may be more effective or easier to use than GeoVax’s products, GeoVax will be able to enter into favorable manufacturing and distribution agreements, and other factors, over which GeoVax has no control. Further information on our risk factors is contained in our periodic reports on Form 10-Q and Form 10-K that we have filed and will file with the SEC. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law. Company Contact: info@geovax.com 678-384-7220 Media Contact: Jessica Starman media@geovax.com View the original release on www.newmediawire.com
CHEYENNE WYOMING - April 29, 2026 (NEWMEDIAWIRE) - Invech Holdings, Inc. (OTC PINK: IVHI), a Nevada corporation headquartered in Wyoming, specializes in the development of Software as a Service (SaaS) and general applications, has recently signed a Letter of Intent to buy two platforms in the brokerage billing and Bridge space. The company identified these platforms as vital to early revenue options. Currently these platforms operate under a business umbrella out of the United Kingdom with several contracts generating revenue. However, those contracts have expired and are up for renewal generating over $900,000 USD per year. Invech Holdings, Inc. has negotiated the purchase of these platforms as “Asset Purchases” instead of buying the company as a business. We opted to spend less in order to assume the specific assets into Invech Holdings, Inc. If we had bought the company as a business we would be spending north of $6m in equity plus cash. Whereas we have negotiated with the seller to sell the platforms as assets at $750,000 in equity + $135,000 USD. Invech Holdings, Inc. has identified at least 3 potential licensed broker dealer clients that would sign up to use these platforms under the Invech Holdings, Inc. Umbrella. This would put Invech Holdings, Inc. in a position where as the current management who took control half way through Quarter one would by end of Quarter 2 potentially achieve revenue generation. The CEO and majority owner, Alexander M. Woods-Leo, stated, “These platforms represent a fast tracked approach to achieving the listing requirements to NASDAQ. Our team has the fund, (GHS Investments) and the licensed broker dealer (Craft Capital Management, LLC), and is now generating asset acquisitions to increase balance sheet strength. Our generalized plan is based on controlling the excess dilution to value ratios so that we can work to achieve the necessary price acquisition needed for our listing goals.” About Sporty Pick, Inc. Invech Holdings Inc. recently purchased a Fantasy Sports Platform https://www.sec.gov/ix?doc=/Archives/edgar/data/0001009919/000168316826003159/invech_8k.htm The company then created a wholly owned subsidiary “Sporty Pick, Inc. and moved the asset into the wholly owned subsidiary. Sporty Pick, Inc. is a Sports Betting company incorporated out of Nevada that currently has 2 games completed. The company is actively seeking new B2B deals and has recently identified its interest in the B2C market. The company is seeking to get a gambling license in Canada. Management Progress to Date Management has been in control for less than 3 months and has already achieved the following: Change of Control Negotiated with Prior management to reduce the debt Acquisition of www.paragonrentals.ai Contracted Financing Through a Fund GHS Investments Engaged a Licensed Broker Dealer Drafted and filed a S-1 registration Received Effectiveness by the SEC for the S-1 Conducted our first draw down on the S-1 ELOC Facility Acquired a Fantasy Sports SaaS platform Hired a New Senior Tech Manager Signed an LOI for 2 more SaaS platforms with high early Revenue Potential About www.paragonrentals.ai The platform Paragon Rentals is a primarily seller subscription-based platform to allow sellers to pay 0% commissions for listings. Buyers have a flat rate per booking of $5 + payment processing fees + booking cost. About Invech Holdings Inc. Our services include FINRA corporate filings, drafting incorporation and corporate documents, drafting OTC Markets Disclosure Statements, and general public company compliance. IVHI acts as an outside consulting firm for these services. Invech Holdings, Inc. also specializes in Software development, particularly in the SAAS (Software as a Service) space. The company both creates its own SAAS platforms, as well as develops and invests in other platforms. New Social Media Invech Holdings, Inc. has introduced our new X account @InvechHoldings where we will post links to our filings, our news links, and our product and service updates as well. We encourage all shareholders to follow our company as we expand and execute our business plan. New Website The company has recently created and updated its new website. This website will continue to be updated and enhanced. www.invechholdings.com The newest acquisitions section is periodically updated to reflect the developments of the company. Safe Harbor Statement This press release contains “forward-looking statements” which are based on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as "believe," "expect," "may," "should," "could," "seek," "intend," "plan," "goal," "estimate," "anticipate" or other comparable terms. All statements other than statements of historical facts included in this news release regarding our strategies, prospects, financial condition, operations, costs, plans, and objectives are forward-looking statements. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations, and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: our ability to successfully market our products and services; the acceptance of our products and services by customers; our continued ability to pay operating costs and ability to meet demand for our products and services; the amount and nature of competition from other security and telecom products and services; the effects of changes in the cybersecurity and telecom markets; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, strategic alliance agreements, licensing and supplier arrangements; our ability to comply with applicable regulations; and the other risks and uncertainties described in our prior filings with the Securities and Exchange Commission. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether because of new information, future developments or otherwise. Contact: Info@invechholdings.com 877-281-1466 www.invechholdings.com Social Media Twitter (X): https://x.com/InvechHoldings View the original release on www.newmediawire.com
MIAMI, FL - April 29, 2026 (NEWMEDIAWIRE) - Genesis Holdings, Inc. (OTCID: GNIS) (“Genesis”), through its Travaleo platform, today announced the official launch of its strategic partnership with Aurami Capital (“Aurami”), the investment arm of Miami Real Investment (MRI), marked by the release of a newly developed platform designed to reflect the combined capabilities, experience, and relationships of both organizations. This milestone builds upon the previously announced collaboration and represents the transition from strategic alignment to active joint execution. The updated platform has been developed not as a standalone product initiative, but as a direct expression of the partnership itself - integrating Aurami’s investment platform and ecosystem with Travaleo’s digital infrastructure and compliance framework. A Unified Representation of Track Record and Relationships The newly released platform reflects the collective history and execution capabilities of both Genesis and Aurami, bringing together: A track record of participation across high-value branded luxury real estate transactions Long-standing relationships with leading developers and project sponsors within the premium segment Access to a curated pipeline of institutional-quality residential and hospitality opportunities Aurami, through MRI, contributes an established presence in the branded luxury segment, having participated in over $1 billion of transactions within the past several years, working alongside top-tier developers and a global investor base. The platform now incorporates these relationships and historical execution into a cohesive, forward-facing framework, designed to reflect not only individual opportunities, but the broader network behind them. Formalizing Branded Luxury as a Defined Investment Segment At the core of the partnership is a shared objective: to structure and deliver branded luxury real estate as a distinct and repeatable investment segment, rather than a series of isolated transactions. By aligning Aurami’s sourcing and sponsorship capabilities with Travaleo’s digital and compliance infrastructure, the partnership aims to: Introduce consistency and scalability to a traditionally fragmented segment Provide structured access to curated, high-end real estate opportunities Establish a repeatable investment framework aligned with institutional real estate models Enhance transparency and operational efficiency across the investment lifecycle The platform serves as the operational interface of this model, presenting not only opportunities, but the structure and relationships that support them. Defined Roles Within a Coordinated Operating Model Under the partnership: Aurami Capital is responsible for originating, sponsoring, and managing investment vehicles Travaleo provides the digital infrastructure, compliance systems, and administrative framework supporting their structuring and operation This clear division of roles allows the partnership to operate in a manner consistent with traditional private equity structures, while leveraging modern infrastructure to improve efficiency and accessibility. Management Commentary Oscar Brito, CEO of Genesis Holdings and Co-CEO of Travaleo, commented: “The launch of this platform marks the moment where the partnership becomes fully visible and operational. It reflects not only what we are building going forward, but the collective experience and relationships that underpin it. Our focus is to provide the infrastructure that allows this segment - branded luxury real estate - to be structured and delivered in a consistent and scalable way.” Hans Baumgartner, CEO of Aurami Capital and Co-CEO of Travaleo, added: “What this platform represents is the integration of our network, our relationships, and our execution history into a single, structured framework. We have spent years operating within this segment, and this partnership allows us to present and manage opportunities in a more coordinated and disciplined manner.” Market Context The partnership is focused on the branded luxury segment of the Miami real estate market, which continues to benefit from sustained demand driven by international capital flows, limited premium inventory, and increasing global interest in high-quality residential and hospitality assets. Aurami’s established relationships within this segment - ombined with Travaleo’s infrastructure - position the partnership to operate within a highly curated and relationship-driven market environment. Regulatory Framework All investment opportunities will comply with applicable securities laws: Non-U.S. investors will participate pursuant to Regulation S U.S. investors, where applicable, will be limited to accredited investors under Rule 506(c) Travaleo will act solely as a technology and compliance provider, and will not act as a placement agent, broker-dealer, or capital raiser. About Aurami Capital Aurami Capital is a real estate investment platform focused on branded luxury residential and hospitality opportunities and operates as a subsidiary of Miami Real Investment. info@auramicapital.com About Miami Real Investment (MRI) With over 20 years of experience, Miami Real Investment is a leading brokerage firm specializing in branded luxury pre-construction real estate in Miami. With a track record of handling transactions for VIP clients, F1 drivers, public figures, and international investors, Miami Real Investment offers unmatched expertise and dedicated service, ensuring client satisfaction at every step of the buying process. The company offers a 360 approach, including investment portfolio design, market analysis, tax planning, and legal advice from top real estate lawyers. https://miamirealinvestment.com/ info@miamirealinvestment.com About Travaleo Travaleo is a branded real estate investment and development platform wholly owned by Genesis Holdings, Inc. (OTC: GNIS), focused on identifying, structuring, and managing income-producing and development-oriented real estate projects. The platform emphasizes professionally underwritten assets, brand-driven developments, and disciplined execution aligned with long-term ownership strategies. Travaleo’s digital investment infrastructure enables accredited investors to participate in curated real estate opportunities through structured investment vehicles designed to enhance transparency, efficiency, and investor access. https://www.travaleo.com/ X: @Travaleo_ invest@travaleo.com About Genesis Holdings, Inc. Genesis Holdings is a publicly traded holding company focused on the development, acquisition, and management of operating businesses and real-asset-related initiatives. The Company emphasizes disciplined capital allocation, sound governance practices, and long-term value creation for shareholders. https://www.regen.digital/ X: @regnisnyc Forward-Looking Statements This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements that are not historical in nature, including the words “anticipate,” “expect,” “suggest,” “plan,” “believe,” “intend,” “estimates,” “targets,” “projects,” “should,” “could,” “would,” “may,” “will,” “forecast” and other similar expressions are intended to identify forward-looking statements. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. There are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements, including: general economic and business conditions, competitive and technological factors, markets, services, products and prices, the failure to retain management and/or key employees, availability and cost of capital, success of growth initiatives, limited operating history, failure to successfully close any proposed transactions, failure to raise sufficient capital, failure to file any required filings properly, and other risks discussed in the Company’s filings with the OTC Markets. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Genesis Holdings assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.
BEIJING - April 29, 2026 (NEWMEDIAWIRE) - LakeShore Biopharma Co., Ltd (“LakeShore Biopharma” or the “Company”) (OTCPK: LSBCF; OTCPK: LSBWF), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that it has entered into Amendment No. 1 to Agreement and Plan of Merger with Oceanpine Skyline Inc. (“Parent”) and Oceanpine Merger Sub Inc. (“Merger Sub”), a wholly owned subsidiary of Parent, which amends the Agreement and Plan of Merger, dated November 4, 2025, by and among the Company, Parent and Merger Sub (the “Original Merger Agreement,” and the Original Merger Agreement as so amended, the “Amended Merger Agreement”). Pursuant to the Amended Merger Agreement and subject to the terms and conditions thereof, Merger Sub will be merged with and into the Company, with the Company continuing as the surviving company and becoming a wholly owned subsidiary of Parent (the “Merger”), in a transaction implying an equity value of the Company of approximately US$2.7 million. As a result of the Merger, the Company will become a direct and wholly owned subsidiary of Parent, which will be owned by Oceanpine Investment Fund II LP, Oceanpine Capital Inc., Crystal Peak Investment Inc., Adjuvant Global Health Technology Fund, L.P., Adjuvant Global Health Technology Fund DE, L.P., Superstring Capital Master Fund LP, MSA Growth Fund II, L.P., and Epiphron Capital (Hong Kong) Limited (collectively, the “Rollover Shareholders,” and together with Parent and Merger Sub, the “Buyer Group”). The amendment follows the Company’s receipt of a letter dated March 24, 2026 (the “Revised Proposal”) from Parent and Merger Sub proposing to reduce the merger consideration under the Original Merger Agreement, which was announced by the Company on March 25, 2026. At the effective time of the Merger (the “Effective Time”), each ordinary share of the Company (each, a “Share”) issued and outstanding immediately prior to the Effective Time, other than the Excluded Shares and the Dissenting Shares (each as defined in the Amended Merger Agreement), will be cancelled in exchange for the right to receive US$0.066 in cash per Share without interest (the “Amended Per Share Merger Consideration”). The Amended Per Share Merger Consideration represents a premium of approximately 46.7% to the closing price of the Shares on March 24, 2026, the last trading day prior to the Company’s announcement of its receipt of the Revised Proposal, and a premium of approximately 23.3% to the volume-weighted average closing price of the Shares during the last 10 trading days prior to and including March 24, 2026. In addition to reducing the merger consideration per Share from US$0.90 to US$0.066, the Amended Merger Agreement also extends the termination date upon which either the Company or Parent may terminate the Amended Merger Agreement to the date falling 9 months from the date of the Amended Merger Agreement, and reduces the Company Termination Fee (as defined in the Amended Merger Agreement) to US$50,000 and the Parent Termination Fee (as defined in the Amended Merger Agreement) to US$100,000. The Merger will be funded through a combination of (i) cash contribution from Oceanpine Capital Inc. pursuant to an amended and restated equity commitment letter, and (ii) equity rollover by the Rollover Shareholders of Shares held in the Company pursuant to an amended and restated rollover and support agreement. The board of directors of the Company (the “Board”), acting upon the unanimous recommendation of a committee of independent and disinterested directors established by the Board (the “Special Committee”), approved the Amended Merger Agreement and the Merger, and resolved to recommend that the Company’s shareholders vote to authorize and approve the Amended Merger Agreement and the Merger. The Special Committee evaluated the Revised Proposal and negotiated the terms of the Amended Merger Agreement with the assistance of its financial and legal advisors. The Merger is currently expected to close during the third quarter of 2026 and is subject to customary closing conditions, including the authorization and approval of the Amended Merger Agreement by no less than two-thirds of the votes cast by holders of Shares as being entitled to do so at a general meeting of the Company’s shareholders. Each Rollover Shareholder has agreed to vote, or cause to be voted, all Shares held directly or indirectly by them, which represent approximately 53.35% of the voting rights attached to the issued and outstanding Shares, in favor of the authorization and approval of the Amended Merger Agreement and the consummation of the Merger. If completed, the Merger will result in the Company becoming a privately held company, and its Shares will no longer be quoted on the OTC Pink Open Market. Kroll, LLC is serving as the financial advisor to the Special Committee. Gibson, Dunn & Crutcher LLP is serving as U.S. legal counsel to the Special Committee. Maples and Calder (Hong Kong) LLP is serving as Cayman Islands legal counsel to the Special Committee. White & Case LLP is serving as U.S. legal counsel to the Buyer Group. Additional Information About the Merger The Company will furnish to the U.S. Securities and Exchange Commission (the “SEC”) a current report on Form 6-K regarding the Merger, which will include as an exhibit thereto the Amended Merger Agreement. All parties desiring details regarding the Merger are urged to review these documents, which will be available at the SEC’s website (http://www.sec.gov). In connection with the Merger, the Company will prepare and mail to its shareholders a proxy statement that will include a copy of the Amended Merger Agreement. In addition, in connection with the Merger, the Company and certain other participants in the Merger will prepare and disseminate to the Company’s shareholders a Schedule 13E-3 Transaction Statement that will include the Company’s proxy statement (the “Schedule 13E-3”). The Schedule 13E-3 will be filed with the SEC. INVESTORS AND SHAREHOLDERS ARE URGED TO READ CAREFULLY AND IN THEIR ENTIRETY THE SCHEDULE 13E-3 AND OTHER MATERIALS FILED WITH THE SEC WHEN THEY BECOME AVAILABLE, AS THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE COMPANY, THE MERGER, AND RELATED MATTERS. Shareholders also will be able to obtain these documents, as well as other filings containing information about the Company, the Merger, and related matters, without charge from the SEC’s website (http://www.sec.gov). This announcement is neither a solicitation of proxy, an offer to purchase nor a solicitation of an offer to sell any securities, and it is not a substitute for any proxy statement or other materials that may be filed with or furnished to the SEC should the proposed merger proceed. About LakeShore Biopharma Co., Ltd LakeShore Biopharma, previously known as YS Biopharma, is a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA® immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Hepatitis B, Influenza, and other virus infections. The Company operates in China, Singapore, and the Philippines, and is led by a management team that combines rich local expertise and global experience in the biopharmaceutical industry. For more information, please visit https://investors.lakeshorebio.com/. Safe Harbor Statement This press release contains statements that may constitute “forward-looking” statements. These forward-looking statements include, without limitation, the Company’s business plans and development, which can be identified by terminology such as “may,” “will,” “expect,” “anticipate,” “aim,” “future,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. LakeShore Biopharma may also make written or oral forward-looking statements in its periodic reports to the SEC, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about LakeShore Biopharma’s beliefs, plans and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the possibility that competing offers will be made; the possibility that financing may not be available; the possibility that various closing conditions for the transaction may not be satisfied or waived; and other risks and uncertainties discussed in documents filed with the SEC by the Company, as well as the Schedule 13E-3 and the proxy statement to be filed by the Company; the Company’s goals and strategies; the Company’s future business development, financial condition and results of operations; its ability to provide efficient services and compete effectively; its ability to maintain and enhance the recognition and reputation of its brands; general economic and business conditions globally and in China and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks, uncertainties or factors is included in the Company’s filings with the SEC. All information provided in this press release is as of the date of this press release, and the Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under applicable law. For investor inquiries, please contact: IR Team Tel: +86 (10) 8920-2086 Email: ir@lakeshorebio.com View the original release on www.newmediawire.com
SALT LAKE CITY, UT - April 29, 2026 (NEWMEDIAWIRE) - tZERO Group, Inc., a leading innovator in blockchain-powered multi-asset infrastructure, today announced that the required majority of the holders of its Preferred Equity Tokens, Series A (“TZROP”), have approved the conversion of each share of TZROP into three shares of tZERO Series B preferred stock and eight shares of tZERO common stock. 1,594 holders voted a total of 15,164,076 shares which represent 72.2% of outstanding TZROP shares. Of the shares voted, 12,841,906 or 84.6% were cast in favor of the proposal, and 2,322,170 or 15.4% were cast against the proposal. 1,423 or 89.3% of the holders who voted supported the proposal, and 171 or 10.7% voted against the proposal. The proposal received in excess of the required simple majority support from 12,841,906 shares, which represent 61.2% of the aggregate issued and outstanding TZROP shares. “We are grateful for the participation and support from the TZROP investor community,” said Alan Konevsky, Chief Executive Officer of tZERO Group, Inc. “This vote addresses the structural complexities in our capital structure and seeks to drive meaningful alignment among the company and its investors - including our early TZROP supporters, who will now own approximately one-third of each of our Class B shares, common stock and, consequently, fully diluted shares based on the current capitalization of tZERO. It represents an important step forward as we continue executing on our strategy to commercialize independent, integrated, regulated infrastructure supporting the entire lifecycle of tokenized assets.” tZERO will provide updates as the steps in the conversion process are consummated in the coming days. As previously announced, Bed, Bath & Beyond, Inc., tZERO’s largest shareholder, has indicated its intention to lead up to $10 million in additional capital through a proposed convertible note financing (which may be secured) following completion of the conversion process. Eligible existing tZERO investors and other qualified parties who wish to participate in this financing on similar terms may contact tZERO at ir@tzero.com. tZERO Media Contact: Julie Ros, Head of Marketing & Communications jros@tzero.com About tZERO tZERO Group, Inc. (tZERO) and its broker-dealer subsidiaries provide an innovative liquidity platform for private companies and assets. We offer institutional-grade solutions for issuers looking to digitize their capital table through blockchain technology, and make such equity available for trading on an alternative trading system. tZERO, through its broker-dealer subsidiaries, democratizes access to private assets by providing a simple, automated, and efficient trading venue to broker-dealers, institutions, and investors. All technology services are offered through tZERO Technologies, LLC. For more information, please visit our website. Investor Notice Digital asset securities, as well as any particular investment, may not be suitable or appropriate for everyone. Investors should note that investing or trading in securities could involve substantial risks, including no guarantee of returns, costs associated with selling and purchasing, and no assurance of liquidity which could impact their price and investor’s ability to sell, and possible loss of principal invested. There is always the potential of losing money when you invest in securities. There are also unique risks specific to digital asset securities, including, without limitation, fraud, manipulation, theft, and loss. No Offer, Solicitation, Investment Advice or Recommendations This release is for informational purposes only and does not constitute an offer to sell, a solicitation to buy, or a recommendation for any security, nor does it constitute an offer to provide investment advisory or other services by tZERO or any of its affiliates, subsidiaries, officers, directors or employees. No reference to any specific security constitutes a recommendation to buy, sell, or hold that security or any other security. Nothing in this release shall be considered a solicitation or offer to buy or sell any security, future, option or other financial instrument or to offer or provide any investment advice or service to any person in any jurisdiction. Nothing contained in this release constitutes investment advice or offers any opinion with respect to the suitability of any security, and the views expressed in this release should not be taken as advice to buy, sell or hold any security. In preparing the information contained in this release, we have not taken into account the investment needs, objectives, and financial circumstances of any particular investor. This information has no regard to the specific investment objectives, financial situation, and particular needs of any specific recipient of this information and investments discussed may not be suitable for all investors. Any views expressed in this release by us were prepared based upon the information available to us at the time such views were written. Changed or additional information could cause such views to change. All information is subject to possible corrections. Information may quickly become unreliable for various reasons, including changes in market conditions or economic circumstances. Forward-Looking Statements by tZERO This release contains forward-looking statements. In addition, from time to time, tZERO, its subsidiaries, or its representatives may make forward-looking statements orally or in writing. These forward-looking statements are based on expectations and projections about future events, which is derived from currently available information. Such forward-looking statements relate to future events or future performance, including financial performance and projections; growth in revenue and earnings; and business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including, without limitation: the ability of tZERO and its subsidiaries to change the direction; tZERO’s ability to keep pace with new technology and changing market needs; performance of individual transactions; regulatory developments and matters; and competition. These and other factors may cause actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this release and other statements made from time to time by tZERO, its subsidiaries or their respective representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties and assumptions. tZERO, its subsidiaries, and its representatives are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this release and other statements made from time to time by tZERO, its subsidiaries or its representatives might not occur.
VANCOUVER, BRITISH COLUMBIA - April 29, 2026 (NEWMEDIAWIRE) - Fitzroy Minerals Inc. (TSXV: FTZ, OTCQX: FTZFF, FSE: C3Y) (“Fitzroy Minerals” or the “Company”) is pleased to announce the results of the helicopter-borne MobileMT airborne electromagnetic and magnetic survey (“MobileMT”) completed by Expert Geophysics Services Inc. (“EGS”) over the Caballos Project, Valparaiso Region, Chile (“Caballos” or the “Caballos Project”). The survey has identified multiple conductivity and resistivity anomalies, interpreted to be consistent with porphyry-style hydrothermal systems and that are connected to the mineralization intersected in 2025 diamond drilling by Fitzroy Minerals (Figure 1). Highlights 694 line-km flown over the main Caballos concession block covering approximately 194 km2, including a 200 m spacing infill survey completed over the Central Target area. Recognition of a large circular strongly conductive feature (approximately 5 km diameter), interpreted as a porphyry-related hydrothermal system that is directly connected to copper-molybdenum-gold-rhenium mineralization identified by drilling at the Chincolco Prospect, Caballos in 2025. Identification of linear conductive anomalies directly connected to Chincolco mineralized drill hole intercepts and potential southwards continuation for 2.5 kilometres. Merlin Marr-Johnson, President and CEO of Fitzroy Minerals, commented: “The MobileMT survey shows that Caballos hosts the type of plumbing architecture and conductive anomalies that are often associated with world-class mineral systems in Chile. The standout anomaly is a huge circular feature about five kilometres across that connects to the sulphide mineralization we intersected in drilling last year. There are also conductive anomalies that suggest the Chincolco sulphide mineralization might continue for several kilometres to the south, just below the surface. We will follow up with further integrated data-processing, and a ground Deep IP survey to gain chargeability information and improve target ranking, ahead of drilling. Fitzroy Minerals aims to make major copper discoveries in Chile, and this round of geophysics at Caballos has identified large targets that will be drilled soon. The plan is that future cash flow from the Buen Retiro Heap Leach operation will fund non-dilutive exploration drilling.” Expert Geophysics Surveys Inc. The survey was completed by EGS using the proprietary Expert Geophysics Limited airborne MobileMT™ broadband electromagnetic system, designed to resolve deep crustal-scale conductive features associated with mineralized systems. EGS is a geophysical consulting company specializing in airborne geophysical surveys worldwide with advanced electromagnetic systems with combined or separate magnetic field measurements and VLF-EM. Conductive Anomalies Linked to 2025 Chincolco Breccia Cu-Mo-Au Drill Hole Intercepts The MobileMT survey identified several conductive zones spatially associated with the Chincolco Creek Breccia, where copper-molybdenum-gold sulphide mineralization was intersected during drilling in 2025. Figure 1. MobileMT 175 Hz (approximately 500 m depth-slice) plan view. A strong conductive feature dips eastward for approximately 1.5-2.0 km before merging into a larger circular conductive body (Figure 2) measuring approximately 5 km in diameter and interpreted as part of a broader hydrothermal system. Overlying Miocene Farrellones Formation volcanoclastic rocks appear as a resistive cap above this conductive domain. The anomaly retains a strong cylindrical aspect at depth, with roots extending beyond the penetration of the MobileMT survey (greater than 2 km deep). EGS interprets the anomaly as representing a structurally controlled zone of hydrothermal alteration and sulphide development, consistent with a porphyry-related mineralizing environment. Closer to the north-south axis of the Chincolco Prospect, a linear conductive anomaly approximately 1.5 km long is evident. Diamond drill hole CAB-DDH004A was the southernmost drill hole along the breccia (Figure 1), and the anomaly continues to the southeast from that drill hole which intersected 176 m @ 0.31% Cu, 249 ppm Mo, 0.04 g/t Au (0.47% CuEq1) from 156 metres [News Release dated January 13, 2026]. Drill hole CAB-004A intersected a weak portion of the anomaly and the deeper, stronger portion of the anomaly remains untested (Figure 2). The linear Chincolco conductive anomaly is interrupted by a cross-cutting fault and then resumes again, reaching a distance of 2.5 kilometres to the southeast of drill hole CAB-DDH004A. The southern extension of the Chincolco Creek Breccia Anomaly is covered by a low plateau of flat-lying Miocene volcaniclastic rocks of the Farrellones Formation. The anomaly is evident in shallow images, suggesting that the overlying Miocene volcanic rocks may represent thin cover. Figure 2. MobileMT Resistivity 2D Inversion Section for Line 4180, through drill hole CAB-DDH004A. Deep-Rooted Conductive Corridor Identified Along the Pocuro Fault Zone The MobileMT survey identified a prominent north-south conductive corridor extending approximately 14 km across the Caballos Project area, spatially coincident with the mapped trace of the regional Pocuro Fault Zone (Figure 1). Interpretation by EGS indicates that the anomaly represents a major crustal-scale permeable structure, interpreted as a potential pathway for mineralizing magmatic fluids. Such deep-seated structures are commonly associated with porphyry copper systems and related hydrothermal alteration corridors. Porphyry-Style Resistivity Patterns Identified to the North Further north within the survey block, MobileMT inversion results identified resistivity patterns interpreted by EGS to be characteristic of hydrothermal breccia-associated porphyry systems, comparable to those observed at El Teniente (Cu-Mo-Au-Ag) and La Huifa (Cu-Mo) in Chile. According to EGS technical interpretation, two Caballos anomalies display responses similar to those observed over these major deposits, supporting the interpretation of a district-scale mineralizing system. The conductive responses are interpreted to represent combinations of conductive alteration halos, sulphide-bearing fracture networks, pyrite-rich hydrothermal zones, and structurally controlled feeder pathways. These conductive zones are variably associated with magnetic highs and lows, consistent with differing intensities of hydrothermal overprint and alteration styles typically observed in porphyry environments. Fitzroy Minerals will target further delineation of these anomalies in due course. Survey Provides Framework for Next-Stage Drill Targeting All planned survey lines were completed successfully and passed field and office-based quality control. The MobileMT survey produced high-quality broadband electromagnetic, VLF-EM, and magnetic datasets, providing a robust geophysical framework for exploration targeting across the Caballos property. The results materially enhance Fitzroy Minerals’ understanding of the structural architecture and hydrothermal footprint of the Caballos system and will be integrated with geology, geochemistry and drilling results to define priority drill targets for upcoming exploration programs. Next Steps EGS has been commissioned to complete a 3D inversion of the key areas mentioned above, with the aim of resolving the relief complexity and providing higher resolution results. The whole Caballos dataset will be added to the MobileMT data and interrogated using advanced techniques proprietary to EGS. The combination of the MobileMT data plus drilling results, structural interpretation, alteration mapping, and geochemical datasets, through AI-enhanced processing should refine high-priority porphyry-style drill targets across the Caballos Project area. A deep Induced Polarization (“Deep IP”) survey is planned in Q2 2026 (Figure 1), to gain information on sulphides and alteration mineralogy, in addition to the structure and resistivity information gained through the MobileMT survey. The aim is to upgrade conductivity anomalies into ranked drill targets. Deep IP measures chargeability, which responds strongly to disseminated sulphides, stockwork mineralization, alteration halos, and porphyry-style systems. Grant of Stock Options The Company is also pleased to announce that it has granted 5,770,000 stock options (each, an “Option”) to purchase up to 5,770,000 common shares (“Common Shares”) of the Company to certain directors, officers, and consultants of the Company under the Company’s stock option plan (the “Plan”). The Options are exercisable at the price of $0.50 per Common Share until April 29, 2031, subject to any earlier termination in accordance with the Plan. All Options vested immediately on the date of grant. All Options and the Common Shares underlying such Options are subject to a hold period of four months and one day from the date of issuance. The grant of Options to certain directors and officers constitutes a related party transaction pursuant to Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“MI 61-101”). The Company is exempt from the requirements to obtain a formal valuation and minority shareholder approval in connection with the grant of Options to related parties in reliance on the exemptions contained in sections 5.5(b) and 5.7(1)(a) of MI 61-101, respectively, as the Company is not listed on a specified market and the fair market value of the Options does not exceed 25% of the Company’s market capitalization. Qualified Person Dr. Scott Jobin-Bevans (P.Geo., Ph.D., PMP), a QP as defined by NI 43-101 and independent geological consultant to the Company, has reviewed and approved the technical information provided in this news release and verified the data disclosed, including any sampling, analytical and test data underlying the technical information contained in this news release. Specifically, the QP verified selected laboratory assay results against the reported drill core intervals as well as drill core logs against the geology, as supplied by the Company. About Fitzroy Minerals Fitzroy Minerals is focused on exploring and developing copper-focused mineral assets with substantial upside potential in the Americas. The Company’s current property portfolio includes the Buen Retiro Copper Project located near Copiapó, Chile, the Caballos Copper and Polimet Gold-Copper-Silver projects located in Valparaiso, Chile, the Taquetren Gold Project located in Rio Negro, Argentina, and the Caribou Project in British Columbia, Canada. Fitzroy Minerals’ shares are listed on the TSX Venture Exchange under the symbol FTZ and on the OTCQX under the symbol FTZFF. On behalf of the board of Fitzroy Minerals Inc. Merlin Marr-Johnson President and CEO For further information, please contact: Merlin Marr-Johnson +447803712280 mmj@fitzroyminerals.com For more information on Fitzroy Minerals, please visit the Company's website: www.fitzroyminerals.com For an accompanying video discussing the news release, see here. Neither Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release. CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION This news release includes certain statements and information that constitute forward-looking information within the meaning of applicable Canadian securities laws. All statements in this news release, other than statements of historical facts are forward-looking statements. Such forward-looking statements and forward-looking information specifically include, but are not limited to, statements that relate to the potential mineralization on the Company’s mineral properties, future exploration plans on the Company’s mineral properties and the timing and results of future exploration. Statements contained in this release that are not historical facts are forward-looking statements that involve various risks and uncertainty affecting the business of the Company. Such statements can generally, but not always, be identified by words such as "expects", "plans", "anticipates", "intends", "estimates", "forecasts", "schedules", "prepares", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur. All statements that describe the Company's plans relating to operations and potential strategic opportunities are forward-looking statements under applicable securities laws. These statements address future events and conditions and are reliant on assumptions made by the Company's management, and so involve inherent risks and uncertainties, as disclosed in the Company's periodic filings with Canadian securities regulators, including without limitation, the dangers inherent in exploration, development and mining activities; actual exploration or development plans and costs differing materially from the Company’s estimates; the ability to obtain and maintain any necessary permits, consents or authorizations required for mining activities; environmental regulations or hazards and compliance with complex regulations associated with mining activities; climate change and climate change regulations; fluctuations in exchange rates; the availability of financing; operations in foreign and developing countries and the compliance with foreign laws, remote operations and the availability of adequate infrastructure; fluctuations in price and availability of energy and other inputs necessary for mining operations; shortages or cost increases in necessary equipment, supplies and labour; regulatory, political and country risks, including local instability or acts of terrorism and the effects thereof; the reliance upon contractors, third parties and joint venture partners; challenges to title or surface rights; the dependence on key personnel and the ability to attract and retain skilled personnel; the risk of an uninsurable or uninsured loss; adverse climate and weather conditions; litigation risk; and competition with other mining companies. As a result of these risks and uncertainties, and the assumptions underlying the forward-looking information, actual results could materially differ from those currently projected, and there is no representation by the Company that the actual results realized in the future will be the same in whole or in part as those presented herein. the Company disclaims any intent or obligation to update forward-looking statements or information except as required by law. Readers are referred to the additional information regarding the Company's business contained in the Company's reports filed with the securities regulatory authorities in Canada. Although the Company has attempted to identify important factors that could cause actual actions, events, or results to differ materially from those described in forward-looking statements, there may be other factors that could cause actions, events or results not to be as anticipated, estimated or intended. For more information on the Company and the risks and challenges of its business, investors should review the Company's filings that are available at www.sedarplus.ca. 1 CuEq calculated using assuming metal recovery metals of 85% for Cu, 85% for Mo, and 70% for Au. CuEq is calculated using the formula CuEq % = 0.85 Cu % + (0.6808 * Au g/t) + (5.32 * Mo g/t /10,000) and three year trailing average prices for 2022, 2023 and 2024: Cu $3.99/lb, Au $2,043/oz, Mo $21.37/lb.
Research Highlights: Methamphetamine (meth) use accounted for about 1 in 6 heart attacks among adults treated at one Northern California hospital over a 10-year period. Meth users who had a heart attack were often younger adults or males. Their heart attacks were less likely to be caused by traditional heart disease risk factors, such as high cholesterol, obesity or Type 2 diabetes, compared to other heart attack patients, according to the study. DALLAS - April 29, 2026 (NEWMEDIAWIRE) - Methamphetamine (meth) use accounted for nearly 15% of heart attacks for a decade in a northern California study, published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association. “Even though meth users were generally younger and didn’t have typical cardiovascular disease-related conditions like high cholesterol, Type 2 diabetes or obesity, they were twice as likely to die after a heart attack when compared to non-users,” said study author Susan Zhao, M.D., staff cardiologist and medical director of the Coronary Care Unit at Santa Clara Valley Medical Center in San Jose, California, and an associate clinical professor of medicine (affiliated) at Stanford School of Medicine. “People who use meth need to be aware of the serious health risks associated with it, and medical professionals should closely monitor heart attacks in patients who appear healthy and lack typical risk factors, such as Type 2 diabetes or high cholesterol.” Methamphetamine, a highly addictive, illegal synthetic central nervous system stimulant, has seen a dramatic increase in use in the U.S. in recent decades. Most meth in the U.S. is illegally made and usually appears as a powder or crystals known as “crystal meth.” In this study, the largest analysis on acute coronary syndrome (ACS) and methamphetamine use to date, researchers reviewed the medical records of over 1,300 heart attack patients treated at one hospital in Northern California. The analysis found: Meth use accounted for about 1 in 6 heart attacks during the period reviewed. People who used meth and had a heart attack were younger (median age 52 years) and were more likely to be male compared to those who had a heart attack but did not use meth (median age 57 years). Meth users were less likely to have common risk factors for heart disease, such as high cholesterol and Type 2 diabetes, but were more likely to smoke cigarettes, use alcohol and experience homelessness than heart attack patients in this study who did not use meth. Adults who used meth were readmitted to the hospital for repeat heart attacks (42.3%) more often and had a higher risk of death from any cause (22.2%) than people who didn’t use meth (14.4%). Only 59.3 % of meth users were likely to have procedures to open clogged arteries or to be sent home with standard heart medications, in part because their heart attacks didn’t involve blocked arteries, compared to 75% of non-meth users. “As meth use rises on the West Coast of the U.S. and this trend moves eastward, heart attacks associated with meth use will increasingly occur in areas beyond California,” Zhao said. “We want to raise awareness that acute coronary syndrome and meth use affect different groups of people, such as young to middle-aged men without traditional risk factors. These groups have different risk factors and health issues, and they also can have a higher chance of dying from them. “These findings show that we need specific prevention and treatment plans for meth users - a vulnerable and high-risk group. New plans should also focus on helping people stop using meth,” she said. Robert L. Page II, Pharm.D., M.S.P.H., FAHA, chair of the writing group for the American Heart Association’s 2020 cannabis statement, said, “As with cannabis, methamphetamine is becoming a major risk factor for developing premature heart disease in young adults, which can lead to serious cardiovascular events. It is important to understand that methamphetamine can harm the heart by causing issues like damaged blood vessels and increased aging of the vascular system. Page added, “People who have used methamphetamine are diagnosed with heart disease about 8 years earlier than those who haven’t used it. Research shows that men are more likely to have heart attacks related to methamphetamine, and women may also be more vulnerable to heart disease from using stimulants compared to women who don’t use them. These findings highlight the need for health care professionals to discuss these serious risks with their patients to emphasize the potential harms of stimulant abuse.” Page is also a professor in the department of clinical pharmacy and the department of physical medicine/rehabilitation at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences in Aurora, Colorado, and was not a part of this study. Study design, details and background: The study was conducted at Santa Clara Valley Health Care (SCVH), a public safety-net hospital in Northern California, and included 1,309 adults aged 18 to 65 who were treated for heart attacks between 2012 and 2022, among whom were 194 people who were meth users. Meth use was determined by reviewing electronic records for substance abuse reported by patients and results from urine tests. Of the heart attack patients who were meth users, about 15% were women; half were white adults; and 25% of patients self-reported they were of Hispanic ethnicity. The study excluded heart attack patients with aortic disease, congenital heart disease, heart inflammation, spreading cancer, trauma, type 2 heart attack (heart muscle does not get enough oxygen due to a mismatch between supply and demand, rather than a direct blockage in a coronary artery), valve disease or cocaine users. The study might not be able to fully show the impact of meth on heart attacks because not all heart attack patients are screened for drug use, or because some cases of meth-induced cardiac events might be incorrectly classified in hospital records. Other limitations include that the study is a review of health records and includes patients treated for heart attack at a single hospital, so the results may not apply to other population groups or patients treated at other hospitals. Co-authors, disclosures and funding sources are listed in the manuscript. Studies published in the American Heart Association’s scientific journals are peer-reviewed. The statements and conclusions in each manuscript are solely those of the study authors and do not necessarily reflect the Association’s policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. The Association receives more than 85% of its revenue from sources other than corporations. These sources include contributions from individuals, foundations and estates, as well as investment earnings and revenue from the sale of our educational materials. Corporations (including pharmaceutical, device manufacturers and other companies) also make donations to the Association. The Association has strict policies to prevent any donations from influencing its science content and policy positions. Overall financial information is available here. Additional Resources: Multimedia is available on the right column of release link. Spanish news release After April 29, view the manuscript online. American Heart Association news release: Illicit drugs, high alcohol consumption both linked to first-time, irregular heart rhythm (Nov. 2021) American Heart Association news release: Methamphetamine use drove surge in heart failure hospitalizations, costs in California (July 2021) American Heart Association health information: Illegal Drugs and Heart Disease Follow American Heart Association/American Stroke Association news on X @HeartNews Follow news from the Journal of the American Heart Association @JAHA_AHA About the American Heart Association The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public’s health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on heart.org, Facebook, X or by calling 1-800-AHA-USA1. For Media Inquiries and American Heart Association Expert Perspective: 214-706-1173 Bridgette McNeill: Bridgette.McNeill@heart.org For Public Inquiries: 1-800-AHA-USA1 (242-8721) heart.org and stroke.org View the original release on www.newmediawire.com
BOZEMAN, MT - April 28, 2026 (NEWMEDIAWIRE) - PandoAlts, a leading platform focused on transforming access and distribution across private capital markets, today announced that its Founder and CEO, Ralph “Cash” Lafferty, will be featured in a live interview on Fintech.TV on Tuesday, April 28, at 9:50 AM (ET). The interview will provide insight into how PandoAlts is addressing one of the most critical challenges in private markets today: fragmentation across onboarding, access, and execution. Viewers can tune in live at: fintech.tv Driving Innovation in Private Markets During the interview, Lafferty will discuss: The growing demand for simplified onboarding and unified access across private investments The evolution of infrastructure supporting wealth managers, asset managers, and broker-dealers How PandoAlts is building a connectivity layer across alternative investments The role of technology, data, and integration in scaling private market participation Founder Perspective “We’ve been focused on solving real problems in private markets - making it easier for participants to access opportunities and operate within a connected system,” said Ralph Lafferty, Co-Founder and CEO of PandoAlts. “There’s a clear shift happening. The market is demanding better infrastructure, better access, and a more seamless experience. That’s what we’ve built PandoAlts to deliver.” About PandoAlts PandoAlts is a technology platform designed to connect wealth managers, asset managers, broker-dealers, and service providers through a unified data infrastructure for alternative investments. The platform enables streamlined onboarding, operational efficiency, and improved access to private market opportunities. Media Contact PandoAlts Email: info@pandoalts.com Website: pandoalts.com View the original release on www.newmediawire.com
Dividend of CHF 1.50 per share approved (+20%) Dr. Monika Krusi elected as new Chair of the Board of Directors Re-election and election of the remaining Board members approved BADEN, SWITZERLAND - April 28, 2026 (NEWMEDIAWIRE) - Shareholders of Accelleron Industries AG approved all proposals put forward by the Board of Directors at today’s Annual General Meeting 2026. 20% dividend increase approved At the Annual General Meeting of Accelleron Industries AG, shareholders approved all proposals submitted by the Board of Directors, including the appropriation of profits for the 2025 financial year. Shareholders will receive a dividend of CHF 1.50 per share (previous year: CHF 1.25). The dividend will be paid on May 8, 2026. As previously announced, Oliver Riemenschneider, who has served as Chair of the Board of Directors since 2022, did not stand for re-election at the Annual General Meeting 2026. The Annual General Meeting elected Dr. Monika Krusi as the new Chair of the Board of Directors. In addition, the Annual General Meeting approved by a large majority the election of Mieke Van de Capelle and Reto Suter as members of the Board of Directors. Gabriele Sons, who has been a member of the Board of Directors since 2022, also did not stand for re-election. The remaining members of the Board of Directors were confirmed for re-election. Shareholders further approved the maximum total remuneration for the members of the Board of Directors for the term of office until the next Annual General Meeting 2027, as well as the maximum total remuneration for the Executive Committee for the 2027 financial year (both unchanged). In a consultative vote, the Annual General Meeting also approved the 2025 Compensation Report with 94.99% of the votes cast. In addition, shareholders approved the report on non-financial matters included in the 2025 Sustainability Report with 91.62%. A total of 497 shareholders with voting rights attended the Annual General Meeting in person, and 53.18% of the total share capital was represented. Accelleron Industries Ltd (ACLN: SIX Swiss Ex) is accelerating sustainability in the marine and energy industries as a global technology leader in turbocharging, fuel injection, and digital solutions for heavy-duty applications. Building on a heritage of over 100 years as a trusted industry partner, the company serves customers in more than 100 locations in over 50 countries. Accelleron’s more than 3,200 employees are continuously innovating to deliver best-in-class products, services, and solutions that are mission-critical for the energy transition. Important dates 2026 May 6, 2026: Trading of shares ex-dividend May 8, 2026: Payout of dividend August 27, 2026: Half-year report 2026 Media resources Images and other digital assets are available at: https://accelleron.com/media/media-resources For more information please contact: Investor Relations Michael Daiber Phone: +41 79 698 60 85 Email: investors@accelleron-industries.com Media Relations Nicole Wesch Phone: +41 79 442 64 07 Email: media@accelleron-industries.com Accelleron Industries Ltd Bruggerstrasse 71A 5400 Baden Schweiz https://accelleron.com Additional features: File: Media release (PDF)
LOS ANGELES, CA - April 28, 2026 (NEWMEDIAWIRE) - Datavault AI (NASDAQ: DVLT) announced it has executed a binding term sheet with Scilex Holding Company for a $120 million upfront cash contribution tied to a revenue participation agreement supporting the deployment of its quantum-ready, zero trust edge network. Under the terms, Scilex will receive a tiered share of network revenues until defined caps are met, while Datavault AI retains ownership and upside as it advances a nationwide rollout targeting 100 U.S. cities, with initial deployments expected in New York and Philadelphia in the second quarter of 2026 and scaled expansion planned over the next 36 months. To view the full press release, visit https://ibn.fm/66e9Y About Datavault AI Inc. Datavault AI is leading the way in AI experience, valuation, and monetization of assets in the Web 3.0 environment. The company’s cloud-based platform provides comprehensive solutions with a collaborative focus in its Acoustic Science and Data Science Divisions. Datavault AI’s Acoustic Science Division features WiSA(R), ADIO(R) and Sumerian(R) patented technologies and industry first foundational spatial and multichannel wireless HD sound transmission technologies with IP covering audio timing, synchronization and multi-channel interference cancellation. The Data Science Division leverages the power of Web 3.0 and high-performance computing to provide solutions for experiential data perception, valuation and secure monetization. Datavault AI’s cloud-based platform provides comprehensive solutions serving multiple industries, including HPC software licensing for sports & entertainment, events & venues, biotech, education, fintech, real estate, healthcare, energy and more. The Information Data Exchange(R) (IDE) enables Digital Twins, licensing of name, image, and likeness (NIL) by securely attaching physical real-world objects to immutable metadata objects, fostering responsible AI with integrity. Datavault AI’s technology suite is completely customizable and offers AI and Machine Learning (ML) automation, third-party integration, detailed analytics and data, marketing automation and advertising monitoring. The Company is headquartered in Philadelphia, PA. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law.
LOS ANGELES, CA - April 28, 2026 (NEWMEDIAWIRE) - Greenland Energy (NASDAQ: GLND) announced the pricing of a public offering of 17.5 million shares, or pre-funded warrants in lieu thereof, at $4.00 per share, each sold with an accompanying warrant exercisable at $5.00 per share over five years, for expected gross proceeds of $70 million before fees and expenses. The warrants are approved for listing on the Nasdaq Global Market under the symbol “GLNDW” and are expected to begin trading on April 28, 2026, with the offering anticipated to close April 29, 2026, as the Company plans to use proceeds for general corporate purposes including working capital and operating expenses. ThinkEquity is acting as the sole placement agent for the offering. To view the full press release, visit: https://nnw.fm/Y1EAx About Greenland Energy Company Greenland Energy Company is an energy exploration company focused on responsibly developing Greenland’s hydrocarbon resources, with an emphasis on the Jameson Land Basin. It aims to advance oil and gas exploration and create a publicly traded platform for Arctic energy development. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law View the original release on www.newmediawire.com
KYOTO, JAPAN - April 28, 2026 (NEWMEDIAWIRE) - OMRON Healthcare Co., Ltd., a global leader in clinically proven medical devices for home health monitoring and treatment, today announced its support for May Measurement Month 2026, the annual blood pressure screening and awareness campaign held in conjunction with World Hypertension Day (May 17). This year, OMRON Healthcare will support screening and awareness activities across participating countries through the donation of approximately 3,000 blood pressure monitors worldwide, including models capable of detecting the possibility of atrial fibrillation (AFib). Hypertension is the leading risk factor for cardiovascular disease worldwide, contributing to more than 10 million deaths each year. However, while early detection and effective management can significantly reduce the risk of complications such as stroke and heart disease, in many regions awareness and treatment rates remain suboptimal. Launched in 2017, May Measurement Month aims to highlight the risks associated with hypertension and the importance of regular blood pressure monitoring. To date, the campaign has screened more than 7 million people globally, identifying over 1 million individuals with previously untreated hypertension. OMRON Healthcare has supported May Measurement Month since the campaign’s inception, contributing to screening activities in around 120 countries and regions through the donation of approximately 33,000 blood pressure monitors to date. This year will see the company provide a further 3,000 devices, including models capable of screening for AFib, a common but underrecognized arrhythmia that often goes undiagnosed despite being a major risk factor for stroke and heart failure. The May–July campaign will raise awareness through screening events and educational activities worldwide, including blood pressure measurement sessions and guidance on dietary and other lifestyle changes for the management of hypertension. Professor Neil R. Poulter, Chief Investigator and Chair of Trustees of May Measurement Month, commented, “Hypertension (high blood pressure) is the leading risk factor for cardiovascular diseases, including stroke, heart attacks, heart failure, and the potentially life-threatening arrhythmia atrial fibrillation. Furthermore, it is increasingly clear that regular home blood pressure monitoring improves hypertension management, which in turn reduces these major adverse cardiovascular events and the risk of atrial fibrillation. By donating blood pressure monitors that are also capable of detecting probable atrial fibrillation, this initiative can enhance early detection and treatment of hypertension and atrial fibrillation, ultimately helping to save more lives around the world from cardiovascular diseases.” “Since the launch of our first home blood pressure monitor in 1973, we have worked alongside healthcare professionals to promote the importance of blood pressure monitoring and improve access to home measurement,” said Ayumu Okada, President and CEO of OMRON Healthcare Co., Ltd. “The goals of May Measurement Month align closely with our own Going for ZERO vision, which aims to eliminate cerebro-cardiovascular events worldwide, and we will continue to collaborate with May Measurement Month to improve global cardiovascular health outcomes through the further expansion of this important initiative.” For more information about May Measurement Month, please visit: https://maymeasure.org About OMRON Healthcare Committed to advancing health and empowering people worldwide to live life to the fullest, OMRON Healthcare is a global leader in the field of clinically proven, innovative medical equipment for home health monitoring and treatment. Aiming to realize its vision, “Going for ZERO, Preventive Care for the Health of Society,” the company develops products for cardiovascular condition management, respiratory care, and pain therapy. Building on this, it has introduced a new digital health ecosystem that bridges patients and healthcare professionals, helping to reduce cerebro-cardiovascular events, the worsening of respiratory diseases, and limitations caused by chronic pain. With over 400 million units sold globally, OMRON provides the world's most recommended blood pressure monitors by healthcare professionals. Throughout its history, OMRON Healthcare has striven to improve lives and contribute to a better society by developing innovations that help people prevent, treat, and manage their medical conditions, providing products and services in over 130 countries. For more information, please visit: Website: https://healthcare.omron.com/ LinkedIn: https://www.linkedin.com/company/omron-healthcare-co-ltd-/ Media Enquiries This press release is disseminated by Kyodo PR on behalf of OMRON Healthcare. For more information or for interview opportunities, please contact: OMRON Healthcare Press Desk: omronhealthcare-pr@kyodo-pr.co.jp View the original release on www.newmediawire.com
Company is Continuing the Payment of Its Annual Cash Dividend of $0.01 Per Share of Common Stock for Second Year, Paid Calendar Quarterly at a Rate of $0.0025 Per Share Per Quarter Dividend Payment Results in Additional Value Provided to Shareholders FISHERS, IN - April 28, 2026 (NEWMEDIAWIRE) - Royalty Management Holding Corporation (Nasdaq: RMCO) (“Royalty Management” or the “Company”), a forward leaning royalty company building shareholder value by acquiring and developing high value assets in a variety of resource-driven and emerging technology industries, is pleased to announce that the Company has completed its first successful year of dividends to shareholders and its Board of Directors has approved the continuation of the Company’s cash dividend to holders of common stock for the 2026 calendar year. The annual dividend of $0.01 per share is paid on a calendar quarterly basis in the amount of $0.0025 per share, with the first quarterly payment paid to shareholders of record on June 30, 2026 and payable on July 10, 2026. Additional payments of $0.0025 per share will be paid on the three calendar quarters thereafter, to shareholders of record on September 30, 2026, December 31, 2026, and March 31, 2027. Thomas Sauve, Chief Executive Officer of the Company, commented, “We appreciate the Board of Directors of Royalty Management approving the payment of the annual dividend for another 12 months. As our Company continues to execute on its investments and as its portfolio holdings mature in operations, we view the payment of the annual dividend as a great method of returning capital to shareholders. With that in mind, we are continuously evaluating the balance of portfolio investments against the amount of dividend and the potential for stock repurchases and will evaluate if an increase in the dividend rate is warranted as the Company’s cash flow expands.” About Royalty Management Holding Corporation Royalty Management Holding Corporation (NASDAQ: RMCO) is a royalty company building shareholder value to benefit both its shareholders and communities by acquiring and developing high value assets in a variety of market environments. The model is to acquire and structure cash flow streams around assets that can support the communities by monetizing the current existing cash flow streams while identifying transitionary cash flow from the assets for the future. For more information visit www.royaltymgmtcorp.com. Forward-Looking Statements This press release contains statements that constitute “forward-looking statements,” including with respect to the initial public offering. No assurance can be given that the matters discussed above will be completed on the terms described, or at all. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those that will be set forth in the “Risk Factors” section of the Company’s filings with the SEC. The information contained in this release is as of the date first set forth above. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law. Company Contact: Thomas Sauve Chief Executive Officer www.royaltymgmtcorp.com (646) 245-2465 SOURCE: Royalty Management Holding Corporation View the original release on www.newmediawire.com
GRANDE PRAIRIE, AB - April 28, 2026 (NEWMEDIAWIRE) - ANGKOR RESOURCES CORP. (TSXV: ANK) (“ANGKOR”) announces its energy subsidiary, EnerCam Exploration Ltd. (“EnerCam”), has entered into an Amended and Restated Joint Strategic Alliance Agreement (the "Agreement") with 358140 Alberta Ltd. ("358") to increase Angkor’s ownership interest from 20% to 75% in the Block VIII oil and gas concession in Cambodia. The fundamental terms of the Agreement provide that Angkor's interest in the 4,095 square kilometre Block VIII concession will increase from 20% to 75% by assuming the responsibility of funding the drilling program and making a payment of USD2 million to 358 by no later than June 30, 2026. The Agreement also provides Angkor with the option to make the USD2 million payment by issuing common shares to 358, with the issuance price of the shares to be the 30 days' volume-weighted average trading price prior to the payment date, subject to approval of the TSX. On completion of the drilling program, the Block VIII interests will convert to a working interest and 358 will be obligated to contribute its 25% of development costs after all drilling has been completed. “This is a positive deal for both companies but especially benefits EnerCam / Angkor and its shareholders by increasing our interest substantially to 75%,” says Mike Weeks, President of EnerCam. "With funding from 358 at the very early high-risk stages, 358 took on the greatest risk to our benefit; 358 made it possible for EnerCam/Angkor to advance the license, and now we have drill targets and hold a 75% interest as we move towards drilling. 358 keeps its involvement with a working interest and we have the option to convert 358’s ownership investment into shares of Angkor." With 358’s financial contributions to date exceeding CAD 3.6 million, EnerCam was able to undertake and complete: 1) final licensing costs to initiate exploration, 2) an Initial Environmental Impact Assessment, 3) the addition and permitting of an additional 220 square kilometres in the northeast segment of the original license as part of Block VIII, 4) a 350 kilometer 2-D seismic assessment of the concession, and 5) the determination of four drill targets on subbasins within Block VIII (ANGKOR RESOURCES’ SUBSIDIARY IDENTIFIES DRILL TARGETS ON BLOCK VIII OIL & GAS, CAMBODIA - Angkor Resources Corp). The Block VIII concession is held in Angkor's Cambodian subsidiary EnerCam Resources Co. Ltd. and is administered by Angkor’s wholly owned EnerCam Exploration Ltd. of Canada. The terms of the Agreement are subject to approval of the TSX Venture Exchange. ABOUT ANGKOR RESOURCES CORP. ANGKOR Resources Corp. is a public company, listed on the TSX-Venture Exchange, and is a leading resource explorer and developer in Cambodia working towards mineral and energy solutions across Cambodia. Angkor’s Cambodian energy subsidiary, EnerCam Resources Co., Ltd., was granted an onshore oil and gas license in the southwest quadrant of Cambodia called Block VIII. The original 7,300 km² license was reduced to approximately 4,300 km² upon voluntary removal of parks and protected areas, subsequently adjusted through government remapping directed by the Ministry of Mines and Energy, and then expanded by 220 km² with the addition of the Kirirom Basin in the northeast, resulting in the current area of approximately 4,095 km². EnerCam is actively advancing oil and gas exploration activities onshore to meet its mission to prove Cambodia as a nation with its own oil and gas resources. The Company completed 2D-seismic in 2025 and has identified multiple drill targets with multiple target zones. As it now works to complete an additional Environmental Impact Assessment on the drilling target areas, the Company plans to follow with drilling Cambodia’s first privately financed onshore exploratory oil and gas wells under a Production Sharing Contract. The company’s mineral subsidiary, Angkor Gold Corp. Co., Ltd. held three mineral exploration licenses during 2024 and 2025 and disposed of its Oyadao North license in mid 2025. The company continued to disclose that it held three licenses, although only two were active, until the Company had confirmation from the Ministry of Mines that the transfer of Oyadao North license was 100% complete, which was verified by the end of October, 2025. The mineral subsidiary currently holds two mineral exploration licenses in Cambodia with multiple prospects in copper and gold. Both licenses are in their first two-year renewal term. CONTACT: Delayne Weeks - CEO Email: info@angkorresources.com Website: angkorresources.com Telephone: +1 (780) 831-8722 Please follow @AngkorResources on LinkedIn, Facebook, Twitter, Instagram and YouTube. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of the Company, including, but not limited to oil and gas risks of the seismic interpretation uncertainty and the preliminary nature of structural closure estimates; drilling risk and the absence of a drilled well on the Concession; reservoir and fluid uncertainty; PSC compliance obligations and the risk of relinquishment for non-performance; oil price exposure; and Cambodia-specific sovereign and regulatory risk. As well, additional uncertainties on the mineral projects exist regarding the potential for gold and/or other minerals at any of the Company’s properties, the prospective nature of any claims comprising the Company’s property interests, the impact of general economic conditions, industry conditions, dependence upon regulatory approvals, uncertainty of sample results, timing and results of future exploration, and the availability of financing. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. View the original release on www.newmediawire.com
MINNEAPOLIS, MN - April 28, 2026 (NEWMEDIAWIRE) - Onsetto, a fintech platform helping financial institutions win and activate business banking relationships, today announced it has raised $9 million in Seed II funding led by Canapi Ventures, with participation from existing investors including EJF Ventures, Idea Fund of La Crosse, and The Perch Fund. Over the past decade, banks have made significant investments in digital account opening, making it easier than ever for businesses to open new accounts. However, opening an account is not the same as winning the relationship. Across the industry, financial institutions acquire new business accounts every day, yet many never become the customer’s primary operating account. Payroll often remains with the incumbent bank, while receivables and payables continue to flow through existing systems, leaving new accounts underutilized or secondary. Moving a commercial banking relationship is complex. Businesses must update payroll providers, accounts receivable systems, vendor platforms, and internal workflows, often across dozens of disconnected systems. The process can take months and frequently results in incomplete transitions, preventing financial institutions from fully capturing the relationship. Onsetto addresses this challenge through a model it calls structured activation, a guided and coordinated process for moving a business’s payroll, receivables, payables, and operating activity into a new financial institution at the moment of onboarding. By identifying dependencies across a business’s financial systems and generating a structured transition plan, the platform enables banks to guide customers through the switching process with greater clarity, speed, and completion rates. “Business banking growth is not determined by accounts opened. It is determined by how quickly operating activity moves,” said Cale Johnston, Founder and CEO of Onsetto. “Onsetto removes the friction from switching, giving banks a clear and structured way to help businesses transition and begin operating from their new account with confidence.” Rather than relying on manual processes and prolonged follow-up, Onsetto leverages advances in AI-driven workflow automation to help execute the transition of financial activity across systems. Tasks that previously required significant manual effort can now be coordinated more efficiently, reducing timelines and increasing the likelihood that a new account becomes the business’s primary operating account. “At Canapi, we work closely with financial institutions and see firsthand how difficult it is to capture the primary operating relationship,” said Neil Underwood, Co-Founder and General Partner at Canapi Ventures. “Banks have built strong systems to acquire accounts, but they have not built the infrastructure required to activate them. Onsetto addresses this gap directly, and we believe their approach will become an important part of how banks compete for and grow business relationships.” Onsetto is led by Founder and CEO Cale Johnston, who previously founded ClickSWITCH, a leading consumer account switching platform that scaled to hundreds of financial institutions before being acquired by Q2 Holdings. With Onsetto, Johnston is applying that experience to the more complex challenge of commercial banking relationships, where activation and primacy define long-term success. The new funding will be used to expand Onsetto’s platform capabilities, grow its team, and accelerate adoption among financial institutions nationwide. About Onsetto Onsetto helps financial institutions win and activate business banking relationships by guiding the transition of payroll, receivables, payables, and operating activity into new accounts. By removing the friction from switching, Onsetto enables banks to establish primary relationships faster and drive sustainable deposit growth. The platform is designed to be fast to implement and does not require core or digital banking integration. Learn more at www.onsetto.com. About Canapi Ventures Canapi is a financial technology venture platform investing in early- to growth-stage companies offering disruptive alternatives to outdated business models and technologies. Backed by the Canapi Alliance - a network of nearly 70 leading financial institutions across the United States - Canapi brings deep sector expertise, strong industry connections, and operational insight to help founders scale. Contact: Lindsey Johnston lindsey@onsetto.com View the original release on www.newmediawire.com
PCAOB-Registered Firm Issues Unqualified Audit Opinion; Fiscal 2024 Revenue Grew 138%; Operational Loss Narrowed 45% HOUSTON, TX - April 28, 2026 (NEWMEDIAWIRE) - PickleJar Entertainment Group, Inc. (OTC Pink: PKLE) (“PickleJar” or the “Company”), a music and entertainment software company, today announced the completion of the audit of its financial statements for the fiscal years ended December 31, 2024 and December 31, 2023. The audit, conducted by Astra Audit & Advisory, LLC, a firm registered with the Public Company Accounting Oversight Board (PCAOB), resulted in an unqualified opinion and confirms a year of meaningful operational progress: revenue grew approximately 138% to $557,585 in fiscal 2024, and loss from operations narrowed approximately 45% to $1,537,352. Completion of the audit is also a foundational step in PickleJar’s stated objective of becoming a fully reporting issuer with the U.S. Securities and Exchange Commission. No assurance can be given regarding the timing or completion of any such registration. Selected Fiscal Year 2024 Results (Audited) Total revenue of $557,585, compared with $233,762 for fiscal 2023 - an increase of approximately 138% year-over-year. Gross profit of $405,483, compared with $155,155 for fiscal 2023. Loss from operations of $1,537,352, compared with $2,786,231 for fiscal 2023 - an improvement of approximately 45%. Net loss of $1,975,754, compared with net income of $1,206,415 for fiscal 2023 (which included a non-cash gain of approximately $4.4 million on the fair-value remeasurement of Simple Agreements for Future Equity in connection with the November 2023 reverse recapitalization, and is not indicative of operating performance). Accumulated deficit of $6,046,945 and working capital deficit of $6,331,207 as of December 31, 2024. The full audited financial statements, including the report of the Independent Registered Public Accounting Firm and accompanying footnotes, are available on the OTC Markets Disclosure & News Service and at investors.picklejar.com. Statement from the Chief Executive Officer “Completing a PCAOB audit of two full fiscal years is a meaningful milestone for PickleJar,” said Jeff James, Chief Executive Officer. “It gives our investors, our label and distribution partners, and our commercial counterparties a common, independently verified set of facts to work from. We are proud of the operational progress reflected in these results, and we are clear-eyed about the work ahead - strengthening internal controls, addressing near-term liquidity, and executing toward SEC-reporting status. We intend to do that work transparently and deliberately.” About PickleJar Entertainment Group, Inc. PickleJar Entertainment Group, Inc. (OTC Pink: PKLE) is a music and entertainment software company that develops integrated software and services connecting fans with emerging artists, mid-sized venues, and global brands. PickleJar’s platform combines secure payment technology, data intelligence, and content distribution to support artist promotion programs, venue-managed services, and related fan-engagement capabilities. The Company is headquartered in Houston, Texas. For more information, visit picklejar.com. Additional Disclosures from the Audited Financial Statements As disclosed in Note 2 to the audited financial statements, recurring operating losses, accumulated and working-capital deficits, and certain notes payable at or past their stated maturity dates as of December 31, 2024 give rise to substantial doubt about PickleJar’s ability to continue as a going concern for one year from the date the financial statements were issued. Management’s plans to address these conditions include obtaining additional financing and extending, restructuring, or converting existing obligations. Investors are encouraged to review the audited financial statements in their entirety, including disclosures regarding the Company’s revolving credit facility, related-party transactions, and subsequent events. In connection with the audit, PickleJar is implementing a remediation plan to address material weaknesses in internal control over financial reporting. The plan includes expanding financial reporting resources through additional personnel and qualified external specialists, formalizing policies and procedures, strengthening journal-entry review and approval, enhancing monitoring activities, and improving information technology general controls. The material weaknesses, which relate to the design and operation of a control environment commensurate with SEC-registrant requirements, are described in the audited financial statements. Remediation is expected to occur over multiple reporting periods. Cautionary Note Regarding Forward-Looking Statements This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and is intended to qualify for the safe harbor provided by the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by words such as “anticipate,” “believe,” “expect,” “intend,” “plan,” “project,” “will,” “would,” and similar expressions, and include, without limitation, statements regarding PickleJar’s strategy and growth plans; the Company’s objective of becoming a fully reporting issuer with the SEC and the timing and outcome of any such registration; the Company’s ability to remediate identified material weaknesses in internal control over financial reporting and the timing of such remediation; the Company’s ability to continue as a going concern, to obtain additional financing, and to extend, restructure, convert, or otherwise resolve existing obligations, including obligations in default; the Company’s ability to develop profitable operations; and any other statements that are not historical facts. Forward-looking statements are based on management’s current expectations and assumptions and are subject to significant risks, uncertainties, and changes in circumstances that could cause actual results to differ materially. These risks include, without limitation: substantial doubt about the Company’s ability to continue as a going concern; the existence of material weaknesses in internal control over financial reporting; recurring net losses and negative cash flow from operations; reliance on related-party financing; the existence of indebtedness in default and the absence of executed extensions, waivers, or restructurings as of the date the audited financial statements were issued; the Company’s working capital deficit; risks associated with the Company’s revolving credit facility, including the previously disclosed event of default; concentration of beneficial ownership; and the other risks described in the audited financial statements and accompanying footnotes. Readers are cautioned not to place undue reliance on any forward-looking statement, which speaks only as of the date made. PickleJar undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as required by law. Contact: Anna Benson Anna@picklejar.com View the original release on www.newmediawire.com
EDEN PRAIRIE, MINN. - April 28, 2026 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company dedicated to transforming the surgical diagnosis and treatment of neurological disorders, will release financial results for its fiscal second quarter ended March 31, 2026, before market open on May 12, 2026. Management will host an investor conference call and webcast at 8:30 a.m. Eastern time on Tuesday, May 12, 2026, to discuss the Company’s fiscal second quarter 2026 financial results, provide a corporate update, and conclude with Q&A from telephone participants. To participate, please use the following information: Fiscal Second Quarter 2026 Earnings Conference Call Date: Tuesday, May 12, 2026 Time: 8:30 a.m. Eastern time U.S. Dial-In (Toll Free): 888-506-0062 International Dial-In: 973-528-0011 Participant Access Code: 224785 Webcast: NMTC FY Q2 2026 Earnings Call Webcast Please join at least five minutes before the start of the call to ensure timely participation. A playback of the call will be available through Tuesday, May 26, 2026. To listen to the replay, please call 877-481-4010 within the United States or 919-882-2331 when calling internationally, using replay passcode 53948. A webcast replay will also be available using the webcast link above through Wednesday, May 12, 2027. About NeuroOne NeuroOne Medical Technologies Corporation is a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders. NeuroOne markets a minimally invasive and high-definition/high-precision electrode technology platform with four FDA-cleared product families: Evo® Cortical Electrodes, Evo® sEEG Electrodes, OneRF® Ablation System (for brain), and OneRF® Trigeminal Nerve Ablation System. These solutions offer the potential to reduce the number of hospitalizations and surgical procedures, lower costs, and improve patient outcomes by offering diagnostic and therapeutic functions. The Company is engaged in research and development for drug delivery, basivertebral nerve ablation, and spinal cord stimulation programs. For more information, visit nmtc1.com. IR Contact MZ Group – MZ North America NMTC@mzgroup.us View the original release on www.newmediawire.com
WEST COVINA, CA - April 28, 2026 (NEWMEDIAWIRE) - Focus Universal Inc. (NASDAQ: FCUV) ("Focus" or the "Company"), a provider of patented hardware and software technologies for IoT, 5G, and AI-driven SEC financial reporting automation, today announced the development of Deterministic AI - a new class of artificial intelligence that addresses the limitations of Generative AI and represents a breakthrough in task execution AI as opposed to consultative AI, especially with relation to financial software and financial reporting. The Company believes a common misconception exists that equates ‘AI’ solely with generative models such as ChatGPT. Generative AI is inherently probabilistic, while real-world problems include both probabilistic and non-probabilistic or deterministic elements that must be addressed differently. The Company explains that the core issue is not how advanced probabilistic AI has become, but rather that probabilistic systems are fundamentally unsuited to solving non-probabilistic problems. Traditional generative AI cannot guarantee exact correctness in scenarios that require strict rules, consistency, and validation. To address these elemental and intrinsic gaps, Focus Universal has developed Deterministic AI - an approach designed specifically for non-probabilistic problem domains. The Company continues that while Generative AI excels at interpreting language, generating drafts, identifying patterns, and producing plausible outputs, it does not inherently provide guarantees of correctness, system-wide consistency, auditability, or regulatory defensibility. Deterministic AI, by contrast, enforces explicit rules and constraints, ensures cross-document consistency, and validates outputs against formal structures. It is designed to deliver reproducible correctness, traceable reasoning, and legal accountability. Both Generative AI and Deterministic AI are essential. Real-world applications require a combination of the two. The prevailing view of AI as merely a text-generation tool is a flawed abstraction. In enterprise workflows such as SEC reporting, the most resource-intensive task is not idea generation or consulting; it is within the detail work, ensuring that every number, disclosure, and statement is consistent, reconciled, and audit-ready. The Company also believes that because Generative AI is probabilistic, it cannot guarantee this level of precision. The true opportunity lies in system-level AI: a hybrid model where generative AI handles interpretation and drafting, while Deterministic AI enforces structure, consistency, and compliance. This integrated approach does more than improve workflows - it has the potential to eliminate entire layers of manual reconciliation and validation within legacy enterprise reporting systems. Chief Executive Officer of Focus Universal illustrates in a real-world example of the power of this new class of AI, “Deterministic AI is highly effective at identifying inconsistencies that are difficult to detect - even in filings that have already passed rigorous validation checks from the strongest and most trusted sources. These data feed into a myriad of downstream uses that pull from these crucial sources, ultimately used by the entire financial community to facilitate millions of important subsequent economic decisions, even feeding into Generative AI. Even on these central and vital data sources, errors, which could be corrected by Deterministic AI, are present. For example, when reviewed in publicly available filings directly on administrative websites, such as the SEC website, https://www.sec.gov/cgi-bin/viewer?action=view&cik=789019&accession_number=0000950170-25-100235&xbrl_type=v# and https://www.sec.gov/cgi-bin/viewer?action=view&cik=789019&accession_number=0000950170-24-087843&xbrl_type=v#, our Deterministic AI identified inconsistencies in the “Total” values within certain tables, whereby the figures do not appear to reconcile correctly. These examples illustrate the foundational strengths of Deterministic AI. This new class is not to replace Generative AI but should work well hand-in-hand with all types of AI with the end goal to strengthen and produce better integral results; It not only detects inconsistencies in financial reports but can also help uncover potential bugs or structural limitations in existing validation software.” “I’m incredibly proud of what our development team has achieved with Deterministic AI, a breakthrough that overcomes the inherent trade-offs of Generative AI,” said Desheng Wang, “This is not incremental progress - it is a fundamental paradigm shift. Our technology goes far beyond Generative AI, addressing the industry’s core challenge of accuracy and enabling fully automated, high-precision execution of complex and principle financial information workflows.” According to industry analysis and statistics, the global financial reporting software market was valued at approximately $13.9 billion in 2022 and is projected to reach $36.6 billion by 2030, driven by increasing regulatory complexity and demand for automation. Focus Universal believes its AI-driven platform is well positioned to address this growing commercial demand by replacing manual, error-prone workflows with intelligent, scalable automation solutions. About Focus Universal Inc. Focus Universal Inc. is a provider of patented hardware and software design technologies for Internet of Things (IoT) and 5G. The company has developed five disruptive patented technology platforms with 26 patents and patents pending in various phases and eight trademarks pending in various phases to solve the major problems facing hardware and software design and production within the industry today. For maintenance cost control, the company has also omnibus patents encompassing these patents into patent family groups. These technologies combined to have the potential to reduce costs, product development timelines and energy usage while increasing range, speed, efficiency, and security. Focus currently trades on the Nasdaq Markets. Forward-Looking Statements The foregoing material may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, each as amended. Forward-looking statements include all statements that do not relate solely to historical or current facts, including without limitation statements regarding the Company’s product development and business prospects, and can be identified by the use of words such as “may,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “believe,” “potential,” “should,” “continue” or the negative versions of those words or other comparable words. Forward-looking statements are not guarantees of future actions or performance. These forward-looking statements are based on information currently available to the Company and its current plans or expectations and are subject to a number of risks and uncertainties that could significantly affect current plans. Should one or more of these risks or uncertainties materialize, or the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended, or planned. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, performance, or achievements. Except as required by applicable law, including the security laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to actual results. For company inquiries, please contact: Investor Relations 626-272-3883 ir@focusuniversal.com
TORONTO, ON - April 28, 2026 (NEWMEDIAWIRE) - Ventripoint Diagnostics Ltd. (“Ventripoint” or the “Company”) (TSX-V:VPT, OTC:VPTDF), is proud to announce that its strategic partner, Lishman Global Inc., has formally submitted Ventripoint’s VMS+™ 4.0 system to China’s National Medical Products Administration (NMPA), commonly referred to as the Chinese FDA, for regulatory approval. Importantly, Lishman Global has qualified for the NMPA’s “green channel” pathway, an expedited review process designed to accelerate the approval of innovative medical technologies that address significant clinical needs. This designation is expected to streamline the regulatory timeline and facilitate faster access to the Chinese market. This submission represents a significant milestone in Ventripoint’s global expansion strategy and reflects growing demand for advanced, accessible cardiac imaging solutions in one of the world’s largest healthcare markets. China represents a substantial and rapidly growing opportunity in cardiology. Cardiovascular disease remains the leading cause of mortality in the country, with an estimated 330 million patients affected. At the same time, echocardiography is the most widely used cardiac imaging modality in China due to its cost-effectiveness, portability, and scalability across urban and rural healthcare settings. However, variability in image interpretation and limited access to advanced imaging modalities such as MRI have created a strong need for AI-driven tools that can improve diagnostic accuracy and workflow efficiency. Ventripoint’s VMS+™ 4.0 addresses this need by providing MRI-equivalent volumetric measurements using standard 2D echocardiography. Powered by the Company’s proprietary Knowledge Based Reconstruction technology, the platform enables clinicians to assess all four chambers of the heart with high accuracy, supporting diagnosis and management of conditions such as congenital heart defects, heart failure, pulmonary hypertension, cardiotoxicity, and valvular disease. “We are excited to take this important step toward bringing VMS+™ 4.0 to the Chinese market,” said Paul Gibson, Chief Technology Officer of Lishman Global Inc. “Qualification for the NMPA’s green channel underscores the clinical relevance and innovation of VMS+™ 4.0 and provides a clear pathway to accelerated adoption. China’s scale, combined with its increasing focus on improving cardiovascular outcomes, makes it an ideal environment for this technology.” “Hitting this regulatory milestone with Lishman Global is a key validation of both our technology and our international strategy,” said Hugh MacNaught, President and Chief Executive Officer of Ventripoint Diagnostics. “China is one of the most important cardiac care markets in the world. With the benefit of an expedited review pathway, we are well positioned to bring VMS+™ 4.0 to clinicians and patients more quickly. By enabling more accurate and reproducible cardiac measurements using existing ultrasound infrastructure, VMS+ has the potential to significantly expand access to high-quality cardiac care.” The Company will provide further updates as the regulatory review process progresses. About Ventripoint Diagnostics Ltd. Ventripoint is an industry leader in the application of AI (Artificial Intelligence) to echocardiography. Ventripoint's VMS+™ products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI. This affordable, gold-standard alternative allows cardiologists greater confidence in the management of their patients. Providing better care to patients serves as a springboard and basic standard for all of Ventripoint's products that guide our future developments. In addition, VMS+™ is versatile and can be used with all ultrasound systems from any vendor supported by regulatory market approvals in the U.S., Europe, and Canada. About Lishman Global Lishman Global was establish in 2012 to assist companies to safely enter the Chinese Market. Our partnership model allows foreign companies to navigate the complex network of regulatory approvals and multi-level distribution channels common in the Chinese medical device market. For further information, please contact: Hugh MacNaught hmacnaught@ventripoint.com 604-671-4201 Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release. Forward Looking Statements This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. The use of any of the words "expect", "anticipate", "continue", "estimate", "objective", "ongoing", "may", "will", "project", "should", "believe", "plans", "intends'' and similar expressions are intended to identify forward-looking information or statements. The forward-looking statements and information are based on certain key expectations and assumptions made by the Company. Although the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information because the Company can give no assurance that they will prove to be correct. Since forward-looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. Factors which could materially affect such forward-looking information are described in the risk factors in the Company's most recent annual management's discussion and analysis that is available on the Company's profile on SEDAR at www.sedar.com. Readers are cautioned that the foregoing list of factors is not exhaustive. The forward-looking statements included in this news release are expressly qualified by this cautionary statement. The forward-looking statements and information contained in this news release are made as of the date hereof and the Company undertakes no obligation to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws. View the original release on www.newmediawire.com
Hong Kong Expected to Maintain Its Solid Performance HONG KONG - April 28, 2026 (NEWMEDIAWIRE) - Standard Chartered and the Hong Kong Trade Development Council (HKTDC) jointly released the latest Standard Chartered Greater Bay Area Business Confidence Index (GBAI), revealing that business sentiment among companies in the Greater Bay Area (GBA) remained stable in the first quarter of 2026 despite ongoing geopolitical and trade headwinds, notably oil price shocks and continued repercussions from the Middle East conflict. Maintaining Momentum Amid Headwinds The Q1 findings largely captured activity and business sentiment since the Middle East conflict began in late February, which has remained highly uncertain and weighed on overall business and market sentiment. Despite a reduced appetite for expansion amid persistent geopolitical uncertainties, business sentiment remained steady across the GBA. The “current performance” index for business activity in Q1 edged down marginally to 49.9 from 50.3 in the previous quarter, while the “expectation” index moderated to 50.4 from 51. Both indices hovered around the 50-neutral mark, indicating GBA corporates’ resilience, supported by favourable policies announced by the Chinese Government aimed at boosting the domestic economy, which in turn would partially offset the fallout of the Middle East conflict. The “current performance” index came down mainly driven by “raw material inventory”, “fixed asset investment” and “financing scale”. The latter two readings were believed to reflect more cautious sentiment among businesses in light of the Middle East conflict. Meanwhile, “production/ sales”, “prices of finished goods/ services” and “profits” all experienced quarter-on-quarter expansion. The “expectations” index remained modestly positive, despite heightened external uncertainties. “New orders” held steady at 51.5, while “prices of finished good/ services” rose to 58.5. However, “profits” fell below the 50-watershed level, implying surveyed companies did not view price increases as sufficient to offset a likely rise in energy and material costs. Hong Kong to Sustain a Still-solid Growth Pace By city, Hong Kong is expected to maintain a solid performance going forward. Although both the “current” and “expectation” sub-indices edged down to 52.7, these readings still comfortably stayed in expansionary territory, supported by improvements in “financial services” and “innovation and technology” sectors. Tommy Wu, Senior Economist, Greater China and North Asia, Standard Chartered, said: “In addition to the initial impact of surging global energy and freight costs, there are concerns about second-round impacts, such as higher input costs and weaker global demand. This is aligned with the latest reading, which shows a 2.3-point decline in “new export orders” to 47.5 for “current performance”, indicating a more cautious outlook for export demand. With the prolonged Middle East conflict, we anticipate global energy prices to be higher for longer and the second-round effects to become more visible in the coming months. These will likely weigh on business sentiment and appetite on making fixed investment. Nevertheless, Hong Kong has once again demonstrated its resilience amid market turbulence, and such resilience is expected to attract more global capital into HKD and Renminbi assets as safe-haven allocation.” Demand-boosting Measures Favour GBA Businesses The survey also investigated the impacts of a series of supportive policies from the Chinese government aimed at stimulating domestic demand in its thematic section. Among the new policy measures introduced by the Ministry of Finance in January, most respondents cited “loan interest subsidies for small, medium and micro-sized enterprises” (38.4%), “large-scale equipment upgrade subsidies” (36.9%) and “consumer goods trade-in subsidies” (31.7%) as the top domestic demand-boosting policies likely to have the most positive impact on their business. Wing Chu, Deputy Director of Research, HKTDC, said: “Demand-boosting stimulus is generating tangible benefits for GBA companies, helping to cushion external challenges amid the Middle East conflict. Targeted support, including loan interest subsidies, alongside measures aimed at stimulating consumer spending, is underpinning demand and supporting business activity across the GBA. Overall, policy-led demand support continues to serve as a meaningful tailwind for GBA businesses. While cost pressures and market competition remain key concerns, respondents are considering stepping up investment in talent and market promotion to sustain further business growth.” While many respondents believe stimulative policies could benefit their businesses by boosting online sales (36.6%) and reducing operating costs (33.8%), challenges faced by GBA corporates remain. Specifically, 54.9% of respondents identified labour costs as the biggest pressure point for their businesses, followed by rental costs (41.7%) and market competition (33.3%). Zooming into Hong Kong respondents, market competition was viewed as a more pressing challenge than rental costs, likely due to the increase in cross-border travel and change in consumption behaviours in recent years. In these circumstances, 38.7% would prioritise their investment in talent recruitment, followed by market promotion (38.1%) and personnel training (36.7%). About the GBAI The GBAI is the first forward-looking quarterly survey in the market that looks at the business sentiment and synergistic effects in cities and industries across the GBA. It is compiled based on a survey of more than 1,000 companies in the GBA covering the manufacturing and trading, retail and wholesale, financial services, professional services and innovation and technology sectors. The index enables investors and businesses to better understand the current business climate, gauge future performance prospects and formulate their market strategies for the GBA. Related materials Standard Chartered GBA Business Confidence Index Report: https://www.sc.com/hk/gba/gba-index-report/ HKTDC Research: https://research.hktdc.com/en/article/MjMwNjM2MTgxMQ Report and photos download: https://bit.ly/4u3izEM Media enquiries Corporate Affairs Department Standard Chartered Bank (Hong Kong) Limited Flora Chiu Tel: (852) 3843 2285 Email: flora.chiu@sc.com Communications & Public Affairs Department HKTDC Christy Lee Clayton Lauw Tel: (852) 2584 4369 Tel: (852) 2584 4472 Email: christy.wn.lee@hktdc.org Email: clayton.y.lauw@hktdc.org About Standard Chartered We are a leading international banking group, with a presence in 54 of the world’s most dynamic markets. Our purpose is to drive commerce and prosperity through our unique diversity, and our heritage and values are expressed in our brand promise, here for good. Standard Chartered PLC is listed on the London and Hong Kong stock exchanges. The history of Standard Chartered in Hong Kong dates back to 1859. It is currently one of the Hong Kong SAR’s three note-issuing banks. Standard Chartered incorporated its Hong Kong business on 1 July 2004, and now operates as a licensed bank in Hong Kong under the name of Standard Chartered Bank (Hong Kong) Limited, a wholly owned subsidiary of Standard Chartered PLC. For more stories and expert opinions please visit Insights at sc.com. Follow Standard Chartered on X, LinkedIn, Instagram and Facebook. About HKTDC The Hong Kong Trade Development Council (HKTDC) celebrates its 60th anniversary this year. The HKTDC is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in the Chinese Mainland, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Follow us on @hktdc and LinkedIn
Licensing Opportunities Converge, Fashion InStyle Showcases Crossover Applications of New Materials on a Global Scale HONG KONG - April 28, 2026 (NEWMEDIAWIRE) - The Hong Kong Trade Development Council (HKTDC) today officially opened its seven flagship lifestyle and licensing events. The Hong Kong Gifts & Premium Fair, Home InStyle and Fashion InStyle are being held at the Hong Kong Convention and Exhibition Centre (HKCEC), while the Hong Kong International Printing & Packaging Fair and DeLuxe PrintPack Hong Kong at AsiaWorld-Expo, from today until 30 April. The Hong Kong International Licensing Show and Asian Licensing Conference are running concurrently from today until 29 April, also at HKCEC. Together, the six trade fairs have attracted some 5,600 exhibitors from over 30 countries and regions. HKTDC Executive Director Sophia Chong said: "Hong Kong has long served as the key gateway for global businesses connecting with the Chinese Mainland, playing the role of super connector and super value-adder that bridges the Chinese Mainland's vast market with the rest of the world. Backed by its solid strengths, well developed innovation ecosystem and robust intellectual property infrastructure, Hong Kong is the ideal base for companies to grow their businesses, pursue creativity and innovation, and bring them to commercial fruition." Creative gifts and home products converge; Gifts & Premium Fair and Home InStyle serve as platforms for new product launches The Gifts & Premium Fair and Home InStyle continue to offer buyers a diverse range of gifts and home products spanning cultural creativity, sustainability, innovative materials and gerontechnology. Selected highlights from both fairs are brought together on the new "Reimagine" themed floor at HKCEC Hall 5, giving buyers a one-stop overview of the latest global trends in lifestyle homeware and gifting products, while inspiring the industry to envision future product possibilities with fresh perspectives and inspiration. Both fairs are also attracting exhibitors to unveil latest products. Wei Yit Vacuum Flask Manufactory (Booth: 1E-D02), an exhibitor at the Gifts & Premium Fair, is debuting the Camel Brand MINI20 thermos blind box, created by Hong Kong illustrator Pen So and Hong Kong contemporary artist Jerry Cho. With the Camel Brand celebrating its 85th anniversary – the same year as Bruce Lee’s 85th birth anniversary - the exhibitor is also launching another special co-branded thermos. Home InStyle exhibitor PREN Ltd (Booth: 5E-C20) is making its first-ever public introduction of an infection-prevention mobile toilet - an installation-free, waterless unit requiring no repeated disinfection and no direct contact with waste before and after use, incorporating health monitoring capabilities that seamlessly bring professional care into modern households. Gifts & Premium Fair spotlights design-led gifts The Hall of Fine Designs at the Gifts & Premium Fair, located at HKCEC Hall 1, once again gathers over 100 local and international exhibitors, featuring premium, design-led products ranging from stationery and home accessories to smart collectibles incorporating the latest technologies. Star Industrial Co., Ltd (Booth: 1C-G03) presents the Red A "Made in Hong Kong" mini-series blind boxes, evoking nostalgic memories of Hong Kong daily life from the 1960s to the 1990s through iconic household items. Moral Team Holdings Ltd (Booth: 1C-E05) introduces the Napier Coded backpack designed for pickleball enthusiasts, crafted from recycled materials and combining sports with sustainability elements. Home InStyle shapes the future of home living Funded by the Innovation and Technology Commission, Home InStyle this year presents the Gerontech and Innovative Material Pavilion (Booth: 5E-C20), showcasing over 20 local enterprises to feature gerontechnology products, smart living solutions and home products made from innovative materials. Scan Infinity Ltd presents the TechFitX Smart Sports Training System, which uses interchangeable modules and gamified training to help seniors easily build an exercise routine at home. The United Nations University Hub on Humanitarian Innovation and Technology at Lingnan University showcases IntuCREW, a smart power-assist solution designed to reduce the physical burden on caregivers when maneuvering wheelchairs. Other highlights include Sinomax's bionic ultrasonic sleep soother, German Pool's Natural Wellness Machine, and Afontane's self-cleaning bedding system. On the innovative materials front, Lotux International Holdings Co., Limited’s biodegradable tableware and food containers are made from lotus stems alongside lotus fibre deodorising cat litter; Editecture showcases the reEDIT upcycled chair made from recycled plastic bottles and bottle cap fragments; and Mush Composites presents bio-based tiles produced from agricultural by-products and mycelium for decorative surface applications. Another focal point of Home InStyle, the Cultural and Creative Avenue, gathers design institutions and culturally inspired brands from over 10 countries and regions. Highlights include Indonesia's PT MANAMU ANAIA SUMBA (Booth: 5E-C09A) with its Banoura bracelets; Czech exhibitor Izaak Reich Crystal s.r.o. (Booth: 5E-A14), featuring handcrafted glass with over 150 years of heritage; UK exhibitor Block Design (Booth: 5E-C09B) with double-sided sculptural glass vases; Taiwan exhibitor Karari (Booth: 5E-A18) with incense accessories; and a Macao exhibitor (Booth: 5E-A16) featuring 3D-printed creations. Pantone returns as colour partner, presenting home décor trends through the PANTONE 2026 Colour of the Year "Cloud Dancer". Fashion InStyle showcases global innovation in fashion materials The highlighted zone NEXT@Fashion InStyle (NEXT), organised by the HKTDC and sponsored by the HKSAR Government's the Cultural and Creative Industries Development Agency (CCIDA), returns this year to demonstrate how material innovation is driving industry transformation and advancing sustainability across the fashion sector. The Philippines joins as the featured partner, powered by the Philippine Trade and Investment Centre – Hong Kong (PTIC-HK) and the Center for International Trade Expositions and Missions (CITEM). NEXT brings together over 60 exhibitors from across the globe. Exhibitors include Belgium's Bloom Biotech (Booth: 3F-F09), showcasing microalgae leather, the world's first carbon-neutral leather alternative produced through scalable green technology; At Booth: 3F-E04, Finland's Spinnova PLC’s SPINNOVA® is a next-generation textile fibre derived from wood or waste cellulose, and compatible with conventional textile processes and seamlessly blendable with cotton to deliver scalable, recyclable solutions for apparel and beyond; and Vietnam's Thai Son S.P Co., Ltd. (Booth: 3F-F03), has a range of fabrics that includes ramie fabric, a material with over 3,000 years of history and celebrated for its outstanding performance and natural antibacterial properties. The NEXT zone also features exhibitors from Chinese Mainland, Hong Kong, Iceland, Indonesia, Sweden, Thailand, and the United States, among others. Returning as project ambassador, Han Chong, founder and creative director of internationally acclaimed brand self-portrait, leads six local designer brands, each drawing on forward-looking materials selected from eight participating material suppliers to create cross-disciplinary collections. In a first for the project, materials sourced from beyond Hong Kong and Chinese Mainland are incorporated this year, bringing fresh creative momentum to the field of fashion material innovation. For example, design label WILSONKAKI fuses the world's lightest H2 fabric from French supplier Chargeurs PCC, mycelium leather from Indonesian supplier MYCL-Mycotech Lab, and natural fibres from Hong Kong supplier Texwinca Holdings Ltd, to craft everyday pieces that balance lightweight protection with a natural tactile quality through lamination and bonding techniques. The full design collection will be unveiled at tomorrow's NEXT fashion parade. Fashion InStyle also features dedicated zones including the Designer Spotlight, Materials Bazaar, Fashion Accessories, Women in Style, Bridal & Evening Wear, and Athleisure, presenting a rich selection of ready-to-wear and accessories. Glory G International Limited (Booth: 3G-B31) presents its "Resilience" collection of lightweight suede denim, challenging the conventional perception of heavy denim outerwear; Hong Kong Haiyuan Limited (Booth: 3G-F18) showcases decorative and functional tassel ornaments designed to be attached to handbags, keys and everyday accessories; while Bibi Hanum from Uzbekistan (Booth: 3F-G29) brings traditional silk ikat patchwork wrap skirts. Printing & Packaging Fair and DeLuxe PrintPack Hong Kong present green solutions and high-end craftsmanship The Hong Kong International Printing & Packaging Fair and DeLuxe PrintPack Hong Kong,co-organised by the HKTDC and CIEC Exhibition Company (HK) Limited, continue to highlight innovative, eco-friendly and premium printing and packaging solutions. Elements Printing and Packaging Limited (Booth: 3-E01) introduces FSC Transparent Non-plastic packaging products and FSC Glassine Paper Bag, championing plastic-free, recyclable design principles. BSN International Hong Kong Limited (Booth: 3-E02) offers radio frequency identification (RFID) () labels incorporating paper-based inner layers for sustainable design. Guangzhou Xingqiyuan Trading Co., Ltd. (Booth: 3-E11) presents eco-friendly wet-press paper-pulp packaging made from agricultural waste. At DeLuxe PrintPack Hong Kong, Ijen Enterprises Ltd. (Booth: 3-A05) presents 3D rotating music boxes and vintage phonograph gift packaging that integrate music, storage and packaging. Marshallom (Holdings) Limited (Booth: 3-A08) showcases a floral-and-bird paper lantern canister with a dual-purpose design that extends the product lifecycle, alongside the "Victoria Harbour Day & Night" gift box combining light and shadow effects with storage and premium food packaging. Licensing Show launches IP and e-Commerce Support Services zone for the first time The Hong Kong International Licensing Show welcomes more than 330 exhibitors from Hong Kong, Chinese Mainland and across Asia, showcasing more than 600 brands and intellectual property (IP) projects spanning arts and culture, animation and characters, brand extension, lifestyle, entertainment and sports licensing. In line with direction of the HKSAR Government's policy to strengthen Hong Kong businesses' competitiveness on cross-border e-commerce, the fair introduces for the first time a dedicated IP and e-Commerce Support Services zone. The zone unites e-commerce platforms, KOLs, marketing and PR firms - including e-commerce platform Digitify Online Growth (Booth: 5G-E04) and marketing firm Matrix Promotion Limited (Booth: 5G-F01) - to support brands and IPs in capitalising on the new opportunities generated by e-commerce growth. Throughout the fair, e-commerce associations will conduct workshops on topics including establishment of e-commerce platforms, global market expansion via e-commerce channels, and livestreaming commerce, equipping the industry to stay ahead of the curve. Headline IPs at the Licensing Show include Potatoz by 9GAG Limited (Booth: 5G-D20), LuLu the Piggy by Toyzeroplus Limited (Booth: 5G-A24), Café de Bollo by Yogurt Studio Ltd. (Booth: 5F-G20), along with Chinese Mainland IP Quby (Booth: 5G-A22), Korean IP LOTTY FRIENDS (Booth: 5F-G36) and Thai IP Warbie Yama (Booth: 5G-A51). Organised by the Innovative Entrepreneur Association (IEA) and sponsored by Cultural and Creative Industries Development Agency (CCIDA) of the HKSAR Government, the Design Licensing and Business (DLAB) Support Scheme again stages the DLAB Hong Kong Pavilion at the Hong Kong International Licensing Show, featuring close to 40 exhibitors showcasing a diverse portfolio of Hong Kong original brands and IPs. The HKTDC also continues its collaboration with the Hang Seng University of Hong Kong, Hong Kong Baptist University and The Hong Kong Polytechnic University, with Hong Kong Design Institute joining as a new partner this year, to present the Hong Kong Licensing Force Showcase, spotlighting the creativity of Hong Kong's emerging talents. The concurrent Asian Licensing Conference invites industry leaders to examine key market developments. Today's programme features Maura Regan, President and CEO of Licensing International, presenting the "Global Licensing Trends to Watch in 2026". With the FIFA World Cup taking place this year, the conference also welcomes Alessandro Villa, Senior Licensing Manager of FIFA, and Ivan Chan, Founder and CEO of Promotional Partners Worldwide to share the commercial strategies underpinning successful sports licensing. Mark Mao, Executive Vice President and Head of Sales at COVER Corporation will explore how Virtual YouTubers forge connections with GenZ through strategic social media engagement on the next day. Industry seminars and forums explore emerging market opportunities. To help industry professionals keep pace with the latest developments, around 60 thematic seminars, buyer forums, product presentations and launch events will be held throughout the fairs, covering trending topics including the silver economy, market trends, culture and innovation, and sustainability. Among the seminar highlights, the Printing & Packaging Fair and DeLuxe PrintPack Hong Kong will present a seminar co-organised by the HKTDC and the Hong Kong Digital Printing Association, titled “From Prompt to Reality: Revolutionizing Visual Design and Printing with Generative AI and Digital Printing”, examining how generative AI and digital printing are driving innovative transformation across the industry. The Gifts & Premium Fair and Home InStyle will host “Re-Gifted: Trends and Triumphs in Sustainable Home & Gift Design”, exploring new directions in sustainable design. Fashion InStyle will stage the seminar “Cultural Fusion in Lifestyle Design: The Surreal Aesthetics of Motifx”, offering the industry the latest market insights, innovative thinking and practical strategies. Photo Download: https://bit.ly/4vQE39E Websites HKTDC Media Room: https://mediaroom.hktdc.com/en Hong Kong Gifts & Premium Fair: https://www.hktdc.com/event/hkgiftspremiumfair/en Home InStyle: https://www.hktdc.com/event/homeinstyle/en Fashion InStyle: https://www.hktdc.com/event/fashioninstyle/en Hong Kong International Printing & Packaging Fair: https://www.hktdc.com/event/hkprintpackfair/en DeLuxe PrintPack Hong Kong: https://www.hktdc.com/event/deluxeprintpackhk/en Hong Kong International Licensing Show and Asian Licensing Conference: https://www.hktdc.com/event/hklicensingshow/en Media enquiries For enquiries, please contact: Home InStyle, Fashion InStyle, HK Gifts & Premium Fair, HK International Printing & Packaging Fair and DeLuxe PrintPack Hong Kong Pandagon: Fraser Li Tel: 6083 5623 Email: pandagon.limited@gmail.com HKTDC’s Communications & Public Affairs Department: Clayton Lauw Tel: 2584 4472 Email: clayton.y.lauw@hktdc.org HK International Licensing Show and Asian Licensing Conference Raconteur: Molisa Lau Tel: 6187 7786 Email: molisalau@raconteur.hk Betsy Tse Tel: 9742 7338 Email: betsytse@raconteur.hk HKTDC’s Communications & Public Affairs Department: Winnie Kan Tel: 2584 4055 Email: winnie.wy.kan@hktdc.org HKTDC Newsroom: http://mediaroom.hktdc.com/en About HKTDC The Hong Kong Trade Development Council (HKTDC) celebrates its 60th anniversary this year. The HKTDC is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in the Chinese Mainland, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus.
Revenue Up 17% Year-Over-Year to $50.1 Million Returns to Profitability with Net Income of $2.2 Million Adjusted EBITDA Up 26% Year-Over-Year to $6.3 Million, Exceeding Guidance Strengthened Balance Sheet With Cash of $16.2 Million and Net Debt Reduced 62% Year-Over-Year LAS VEGAS, NV - April 28, 2026 (NEWMEDIAWIRE) - Meridian Holdings Inc. (NASDAQ: MRDN) (“Meridian” or the “Company”), a global B2B/B2C operator and licensor of online sports betting and gaming platforms across 25+ regulated markets, today announced financial results for the first quarter ended March 31, 2026. The Company delivered revenue in line with guidance, exceeded its Adjusted EBITDA target, and returned to GAAP profitability - the first such quarter under the Meridian Holdings brand - while materially strengthening its balance sheet. First Quarter 2026 Financial Highlights Revenue of $50.1 million, an increase of $7.4 million or 17% year over year, in line with prior guidance and reflecting continued scale in core Meridianbet operations. Gross profit of $28.1 million, up 16% year over year, with gross margin of 56.2% broadly consistent with the prior-year period. Returned to GAAP profitability with net income of $2.2 million, or $0.18 per diluted share, compared with a net loss of $(0.3) million, or $(0.02) per diluted share, in the prior-year period. Adjusted EBITDA of $6.3 million, up 26% year over year, exceeding previously-issued guidance of $6.1 million. Adjusted EBITDA margin expanded approximately 86 bps to 12.6%. Balance sheet strength: cash of $16.2 million, total debt of $29.7 million (-54% YoY), net debt of $13.4 million (-62% YoY), and net debt leverage of 0.53x - the strongest capital structure in Company history. Operating cash flow of $5.2 million, supporting ongoing deleveraging and disciplined reinvestment in technology and regulated-market expansion. William Scott, Interim CEO of Meridian, commented, “Q1 2026 marks our first GAAP-profitable quarter under the Meridian Holdings brand and reflects the disciplined execution of our growth plan. We delivered revenue in line with guidance, exceeded our Adjusted EBITDA target, and continued to strengthen the balance sheet - all while expanding our licensed footprint and investing in proprietary technology. We remain focused on scaled execution across our 25+ markets, continued technology integration, and disciplined capital allocation as we position the Company for sustained, profitable growth through 2026 and beyond.” Segment Performance Meridianbet Group (B2C sports betting & online casino) - Revenue of $34.9 million, up 26% YoY, representing 69.6% of Company revenue at a 69.3% gross margin. Segment operating income grew 37% YoY to $6.6 million. Zoran Milosevic, CEO of Meridianbet Group, stated, “The first quarter of 2026 demonstrates the scalability of our platform across multiple regulated markets. At Meridianbet, new customer registrations reached 428,400, up 41% year over year, with depositors up 27% to 283,000 and active users up 21% to 333,700. Our operational foundation is stronger than ever, and we continue to see substantial pipeline across market and product expansion opportunities." Expanse Studios (in Meridianbet Group) - Expanded its operator network to 1,519 active sites during Q1 2026, adding 175 new sites in the quarter on a cumulative basis, with 77 proprietary game titles, including six new titles launched during the quarter. The subsidiary has filed for system certification in Ontario, Canada, pending regulatory approval, and secured new certifications in Latvia, Estonia, Sweden, and Portugal during the quarter. RKings & Classics for a Cause - Combined revenue of $12.1 million, up 9% year over year, representing 24% of Company revenue. RKings Revenue reached $7.7 million, up 12% year over year on improving unit economics, with average order value up 29% to $16.91 and value per new registration up 15% to $17.72. At Classics for a Cause, new users rose 18% year over year to 9,813, total transactions grew 12% sequentially, and VIP subscriptions surpassed 10,000 for the first time in 12 months, ending Q1 at 10,750. GMAG (B2B iGaming aggregation, including MexPlay) - Revenue of $3.1 million in Q1 2026 compared with $3.8 million in the prior year period, representing 6% of Company revenue. The segment onboarded 12 new providers in Q1 2026, compared with 2 in Q1 2025, and deployed 1,382 new games, up 65% year over year from 836. MexPlay, the segment's Mexico-facing online casino, continued to expand its customer base, with registrations reaching 74,000 (up 271% year over year) and first-time depositors climbing to 6,101 (up 198% year over year). Second Quarter 2026 Preliminary Outlook Revenue: The Company is issuing Q2 2025 Revenue guidance of $51 million to $53 million, representing 18% to 23% growth over Q2 2025 revenue of $43.2 million. The outlook reflects continued momentum in core Meridianbet operations, incremental contribution from newly certified Expanse markets, and seasonal uplift in retail and online wagering activity. Rich Christensen, CFO of Meridian, commented, “In the first quarter of 2026 we delivered revenue at guidance and exceeded our Adjusted EBITDA target while materially strengthening the balance sheet. Total debt declined 54% year over year and net debt fell 62%, taking leverage to 0.53x. With $16.2 million of cash, a clean deleveraging trajectory, and accelerating growth, we have meaningful financial flexibility to invest behind the growth plan we have laid out for 2026.” Earnings Call & Investor Resources A full visual presentation and the earnings call replay are available at the Meridian Holdings investor relations website: https://meridian-holdings.com/quarterly-results/. About Meridian Holdings Meridian Holdings Inc. (NASDAQ: MRDN), headquartered in Las Vegas, Nevada, is an established B2B and B2C gaming technology group operating across 25+ international regulated markets. The Company’s B2C division is led by Meridianbet Group, a leading online sports betting and gaming operator founded in 2001 and licensed across Europe, Africa, and South America. Meridian’s B2B division - comprising game developer Expanse Studios and iGaming platform GMAG - develops, licenses, and distributes proprietary gaming technology to a global client base. Additional subsidiaries include RKings Competitions (pay-to-enter prize competitions in the UK), MexPlay (regulated online casino in Mexico), and Classics for a Cause (Australia’s leading subscription-based digital memberships and trade-promotion lottery). The Company’s software automatically declines gaming or redemption requests originating in the United States, in strict compliance with U.S. law. For more information, visit www.meridian-holdings.com or email ir@meridian-holdings.com. Non-GAAP Financial Measures Adjusted EBITDA, Net Debt, and Net Debt Leverage Ratio are non-Generally Accepted Accounting Principles (GAAP) financial measures presented as supplemental indicators of the Company’s performance and capital structure. These measures are not presented in accordance GAAP Adjusted EBITDA represents net income before interest expense, interest income, income taxes, depreciation and amortization, and further excludes stock-based compensation expense, restructuring costs, and unrealized foreign exchange gain or loss. We present Adjusted EBITDA because we believe it provides investors with additional useful information regarding our core operating performance and the effects of certain non-cash or non-recurring items during the period. Net Debt is defined as total debt less cash and cash equivalents. Net Debt Leverage Ratio is defined as Net Debt as of the balance sheet date divided by annualized Adjusted EBITDA for the period then ended. We believe these measures provide investors with additional insight into the Company’s leverage and liquidity position, illustrating our ability to service and repay debt using operating performance and available cash resources. Adjusted EBITDA, Net Debt, and Net Debt Leverage Ratio are non-GAAP measures, are unaudited, and have inherent limitations as analytical tools. These measures should not be considered in isolation, or as substitutes for analysis of the Company’s results as reported under GAAP. Some of these limitations include: they do not reflect cash expenditures or future capital requirements; they do not reflect working capital requirements or contractual commitments; they do not reflect significant interest expense, principal, or income tax payments; although depreciation and amortization are non-cash charges, the assets being depreciated or amortized may require replacement in the future; and other companies may calculate these measures differently, limiting comparability. The Company’s presentation of these measures should not be construed as implying that future results will be unaffected by unusual or non-recurring items. For additional information regarding these non-GAAP financial measures, please refer to the sections titled “Reconciliation of U.S. GAAP Net Income (Loss) to EBITDA and Adjusted EBITDA (Unaudited)”, and “Reconciliation of Net Debt and Leverage Calculation (Unaudited)”, included at the end of this release. The Company does not provide a reconciliation of forward-looking Adjusted EBITDA to the most directly comparable GAAP financial measure because it is unable to do so without unreasonable effort due to the inherent uncertainty in forecasting certain items, including, but not limited to, stock-based compensation, transaction-related expenses, and other non-recurring or non-cash items; accordingly, a reconciliation is not available without unreasonable effort, and the unavailable information could have a material impact on the Company’s future GAAP financial results. Forward-Looking Statements Certain statements made in this press release contain forward-looking information within the meaning of applicable securities laws, including within the meaning of the Private Securities Litigation Reform Act of 1995 (“forward-looking statements”). Words such as “strategy,” “expects,” “continues,” “plans,” “anticipates,” “believes,” “would,” “will,” “estimates,” “intends,” “projects,” “goals,” “targets” and other words of similar meaning are intended to identify forward-looking statements but are not the exclusive means of identifying these statements. Important factors that may cause actual results and outcomes to differ materially from those contained in such forward-looking statements include, without limitation, (a) the Company’s need for significant additional financing to grow and expand our operations, complete acquisitions and satisfy post-closing obligations, including in connection with the MeridianBet acquisition; (b) dilution resulting from the conversion of preferred stock and warrants, and from acquisitions; (c) the Company’s ability to complete acquisitions, the availability of funding for such transactions, and disruptions and other risks associated therewith; (d) the Company’s reliance on third-party suppliers of gaming content and the cost of such content; (e) the Company’s ability to obtain and maintain required gaming licenses; (f) the Company’s ability to maintain the listing of its common stock on the Nasdaq Capital Market; (g) the Company’s ability to effectively manage growth; (h) the Company’s expectations regarding future growth, revenues and profitability; (i) the Company’s expectations regarding future plans and the timing thereof; (j) the Company’s reliance on its management team; (k) the fact that Aleksandar Milovanović has voting control over the Company; (l) related party relationships and potential conflicts of interest; (m) the effects of economic downturns, recessions, inflation, interest rate changes, global conflicts and other market conditions, including impacts on discretionary spending and the cost of capital; (n) the Company’s ability to protect its proprietary information and intellectual property; (o) our ability to compete effectively in our markets; (p) the impact of current and future regulations, the Company’s ability to comply with such regulations, potential penalties for non-compliance, and changes in the interpretation or enforcement of laws; (q) risks associated with gaming fraud, user cheating and cyber-attacks; (r) risks associated with system failures and disruptions to technology and infrastructure, including cybersecurity and hacking risks; (s) risks relating to inventory management; (t) foreign exchange and currency risks; (u) the outcome of contingencies, including legal proceedings; (v) competition from existing and new market participants; (w) the Company’s ability to manage expenses related to sales and marketing and required general, administrative and technology investments; (x) general consumer sentiment and economic conditions affecting discretionary spending on the Company’s products; (y) the risk of loss if customers or counterparties fail to meet contractual obligations, including with respect to receivables and financial institutions holding the Company’s funds; (z) the risk that the Company may have difficulty meeting its financial liabilities as they come due; (aa) the risk that changes in market prices, including foreign exchange and interest rates, may affect the Company’s income or the value of financial instruments; (bb) risks relating to the protection of players’ deposits; and (cc) risks that participants in sporting events may intentionally alter outcomes, resulting in higher than expected payouts. Although we believe that our plans, intentions and expectations reflected in or suggested by the forward-looking statements we make in this press release are reasonable, we provide no assurance that these plans, intentions or expectations will be achieved. Other important factors that may cause actual results and outcomes to differ materially from those contained in the forward-looking statements included in this communication are described in the Company’s publicly-filed reports, including, but not limited to, under the “Special Note Regarding Forward-Looking Statements,” “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of the Company’s periodic and current filings with the SEC, including the Form 10-Qs and Form 10-Ks, including, but not limited to, the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 and future periodic reports on Form 10-K and Form 10 Q. These reports are available at www.sec.gov. The Company cautions that the foregoing list of important factors is not complete and does not undertake to update any forward-looking statements except as required by applicable law. All subsequent written and oral forward-looking statements attributable to the Company or any person acting on behalf of the Company are expressly qualified in their entirety by the cautionary statements referenced above. Other unknown or unpredictable factors also could have material adverse effects on the Company’s future results. The forward-looking statements included in this press release are made only as of the date hereof. The Company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, the Company undertakes no obligation to update these statements after the date of this release, except as required by law, and takes no obligation to update or correct information prepared by third parties that is not paid for by the Company. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements. Preliminary Outlook The preliminary outlook for the first quarter of 2026 (the "Preliminary Outlook") included herein was prepared by Meridian in good faith using assumptions believed to be reasonable. A significant number of assumptions about the operations of the business of Meridian were based, in part, on economic, competitive, and general business conditions prevailing at the time the Preliminary Outlook was developed. Any future changes in these conditions, may materially impact the ability of Meridian to achieve the financial results set forth in the Preliminary Outlook. The Preliminary Outlook is based on numerous assumptions, including realization of the operating strategy of Meridian; industry performance; no material adverse changes in applicable legislation or regulations, or the administration thereof, or generally accepted accounting principles; general business and economic conditions; competition; retention of key management and other key employees; absence of material contingent or unliquidated litigation, indemnity, or other claims; minimal changes in current pricing; no significant increases in interest rates or inflation; and other matters, many of which will be beyond the control of Meridian, and some or all of which may not materialize. Additionally, to the extent that the assumptions inherent in the Preliminary Outlook are based upon future business decisions and objectives, they are subject to change. Although the Preliminary Outlook is presented with numerical specificity and is based on reasonable expectations developed by Meridian's management, the assumptions and estimates underlying the Preliminary Outlook are subject to significant business, economic, and competitive uncertainties and contingencies, many of which will be beyond the control of Meridian. Accordingly, the Preliminary Outlook is only an estimate and is necessarily speculative in nature. It is expected that some or all of the assumptions in the Preliminary Outlook will not be realized and that actual results will vary from the Preliminary Outlook. Such variations may be material and may increase over time. In light of the foregoing, readers are cautioned not to place undue reliance on the Preliminary Outlook. The projected financial information contained herein should not be regarded as a representation or warranty by Meridian, its management, advisors, or any other person that the Preliminary Outlook can or will be achieved. Meridian cautions that the Preliminary Outlook is speculative in nature and based upon subjective decisions and assumptions. As a result, the Preliminary Outlook should not be relied on as necessarily predictive of actual future events. Contacts Investors & Press: ir@meridian-holdings.com Investor Relations: Brett Milotte Brett.milotte@icrinc.com Meridian Holdings Inc. and Subsidiaries Consolidated Balance Sheets As of March 31, 2026 (Unaudited) As of December 31, 2025 (Audited) ASSETS Current assets: Cash and cash equivalents $ 16,234,441 $ 18,078,300 Accounts receivable, net 5,498,687 7,954,116 Accounts receivable – related parties 476,710 465,691 Taxes receivable 468,208 595,434 Inventory 4,863,081 5,524,570 Prepaid expenses 665,289 652,224 Other current assets 2,276,108 2,167,818 Total current assets 30,482,524 35,438,153 Non-current assets: Goodwill & intangible assets, net 35,070,728 34,914,920 Property, plant & equipment, net 27,360,672 28,963,866 Investments 3,569,647 3,650,526 Deposits 6,319,264 6,315,584 Operating lease right-of-use assets 6,090,193 6,296,336 Other non-current assets 2,974,242 2,499,415 Total non-current assets 81,384,746 82,640,647 Total assets $ 111,867,270 $ 118,078,800 LIABILITIES AND SHAREHOLDERS’ EQUITY Current liabilities: Accounts payable and accrued liabilities $ 18,374,031 $ 20,572,774 Accounts payable - related parties 438,458 295,165 Current portion of operating lease liability 2,698,136 2,656,508 Current portion of long-term loan 8,032,261 10,581,035 Taxes payable 4,481,640 5,011,261 Other current liabilities 1,136,603 1,592,958 Deferred revenues 1,076,788 1,111,332 Contingent liability 233,988 228,667 Current portion of consideration payable – related parties 15,905,672 16,199,672 Current portion of consideration payable 881,947 1,317,526 Total current liabilities 53,259,524 59,566,898 Non-current liabilities: Non-current portion of operating lease liability 3,304,088 3,562,859 Non-current portion of long-term loan 4,854,214 6,590,907 Other non-current liabilities 19,044 19,510 Total non-current liabilities 8,177,346 10,173,276 Total liabilities $ 61,436,870 $ 69,740,174 Shareholders’ equity: Preferred stock: $0.00001 par value; 20,000,000 shares authorized - - Preferred stock, Series C: $0.00001 par value, 1,000 shares designated, 1,000 and 1,000 shares issued and outstanding, respectively - - Common stock: $0.00001 par value; 25,000,000 shares authorized; 12,640,919 and 12,641,023 shares issued and outstanding, respectively $ 126 $ 126 Stock payable 102,006 102,006 Stock payable – related party 573,154 573,154 Additional paid-in capital 83,180,297 82,933,355 Treasury stock, at cost (17,062 and 17,062 shares, respectively) (244,208) (244,208) Accumulated other comprehensive income (loss) (4,076,810) (3,753,485) Accumulated earnings (30,804,827) (33,065,622) Total shareholders’ equity of MRDN 48,729,738 46,545,326 Noncontrolling interests 1,700,662 1,793,300 Total equity 50,430,400 48,338,626 Total liabilities and equity $ 111,867,270 $ 118,078,800 Meridian Holdings Inc. and Subsidiaries Consolidated Statements of Operations and Comprehensive Income (Unaudited) Three Months Ended March 31, 2026 2025 Revenues $ 50,103,870 $ 42,723,053 Cost of goods sold (21,959,630) (18,527,092) Gross profit 28,144,240 24,195,961 Operating expenses Selling, general and administrative expenses 24,987,116 24,301,978 Income (loss) from operations 3,157,124 (106,017) Other income (expense): Interest expense (353,726) (1,471,360) Interest earned 5,999 43,936 Foreign exchange loss/gain (412,194) 433,668 Other income 467,088 505,503 Total other income (expense) (292,833) (488,253) Net income (loss) before tax 2,864,291 (594,270) Provision for income taxes 696,134 (336,053) Net income (loss) $ 2,168,157 $ (258,217) Less: Net loss attributable to noncontrolling interest (92,638) (26,609) Net income (loss) attributable to MRDN $ 2,260,795 $ (231,608) Weighted average ordinary shares outstanding: Basic 12,640,999 10,977,405 Diluted 12,785,352 10,977,405 Net earnings (losses) per ordinary share attributable to MRDN: Basic $ 0.18 $ (0.02) Diluted $ 0.18 $ (0.02) Net income (loss) $ 2,168,157 $ (258,217) Foreign currency translation adjustments (323,325) 1,371,048 Comprehensive income 1,844,832 1,112,831 Less: Net loss attributable to noncontrolling interest (92,638) (26,609) Comprehensive income attributable to MRDN $ 1,937,470 $ 1,139,440 Meridian Holdings Inc. and Subsidiaries Consolidated Statements of Cash Flow (Unaudited) Three Months Ended March 31, 2026 2025 Cash flows from operating activities: Net income (loss) $ 2,168,157 $ (258,217) Adjustments to reconcile net (loss) income to cash provided by operating activities: Fair value of stock-based compensation 248,057 1,040,325 Non-cash interest expense related to debt discount amortization 75,670 952,546 Amortization of intangible assets 1,025,175 2,152,640 Depreciation of property, plant and equipment 1,435,955 1,436,247 Bad debt expense 102,176 73,208 Changes in operating assets and liabilities: (Increase) decrease in accounts receivable 2,357,254 (897,968) (Increase) decrease in accounts receivable – related party (39,250) 49,188 (Increase) decrease in taxes receivable 127,226 141,625 (Increase) decrease in prepaid expenses (15,305) (69,053) (Increase) decrease in other current assets (106,021) 295,349 (Increase) decrease in inventories 597,556 (820,433) (Increase) decrease in deposits (3,680) 145,038 (Increase) decrease in other non-current assets 14,369 22,962 Increase (decrease) in accounts payable and accrued liabilities (1,863,677) 4,122,296 Increase (decrease) in accounts payable – related party 142,627 210,082 Increase (decrease) in taxes payable (534,454) (880,465) Increase (decrease) in deferred revenues (36,875) 31,180 Increase (decrease) in customer deposit (564,203) 60,944 Increase (decrease) in other current liabilities 108,107 122,138 Increase (decrease) in other liabilities (641,246) (310,649) Increase (decrease) in operating lease liabilities 557,819 120,654 Net cash provided by operating activities $ 5,155,437 $ 7,739,637 Cash flows from investing activities: Cash paid for intangible assets (1,405,432) (2,339,700) Cash paid for investments - (7,373) Proceeds from sale of property, plant and equipment 37,227 (1,107,424) Cash paid for purchase of subsidiaries (806,390) (426,700) Cash distribution to former owners of MeridianBet Group in connection with the Purchase (294,000) (1,459,642) Net cash used in investing activities $ (2,468,595) $ (5,340,839) Cash flows from financing activities: Repayment on debt (3,791,674) (4,428,626) Repayment of lease (780,668) (571,438) Payments of fractional shares (1,115) - Net cash used in financing activities $ (4,573,457) $ (5,000,064) Effect of exchange rate changes on cash 42,756 2,137,248 Net increase in cash and cash equivalents (1,843,859) (464,018) Cash and cash equivalents at beginning of year 18,078,300 30,125,944 Cash and cash equivalents at end of the quarter $ 16,234,441 $ 29,661,926 Supplemental cash flows disclosures Interest paid $277,110 $ 514,864 Tax paid $705,152 $ 758,934 Non-cash financing activities Common stock issued for vested RSUs $ - $ 9 Debt conversion $ - $ 1,666,949 Acquisition of minority interest $ - $ 393,038 Reconciliation of U.S. GAAP Net Income (Loss) to EBITDA and Adjusted EBITDA (Unaudited) Three Months Period Ended March 31, 2026 March 31, 2025 Net income (loss) $ 2,168,157 $ (258,217) + Interest expense 353,726 1,471,360 - Interest income (5,999) (43,936) + Taxes 696,134 (336,053) + Depreciation 1,435,955 1,436,247 + Amortization 1,025,175 2,152,640 EBITDA $ 5,673,148 $ 4,422,041 + Stock-based compensation 248,057 1,040,325 + Restructuring costs - 149,934 - Unrealized foreign exchange gain or loss 368,174 (617,913) Adjusted EBITDA $ 6,289,379 $ 4,994,387 Reconciliation of Net Debt and Leverage Calculation (Unaudited) Debt $ 29,674,094 Less: cash and cash equivalents 16,234,441 Net debt 13,439,653 Divided by: annualized Q1 2026 Adjusted EBITDA 25,157,516 Net debt leverage ratio 0.53 View the original release on www.newmediawire.com
Statement Highlights: An individual’s brain health is influenced by their psychological health, environment, sleep quality, social conditions and chronic health conditions over a lifetime. Life events and experiences even in early life also affect long-term brain development and brain health. Healthy lifestyle habits, such as eating a healthy diet; getting adequate physical activity and sleep; avoiding smoking, heavy alcohol or illicit substance use; and reducing stress, can improve brain health throughout life. The new scientific statement identifies opportunities to protect brain health and reduce the risk of stroke, cognitive decline and dementia by promoting healthy lifestyle behaviors, improving environmental conditions, expanding health care access and increasing social support for mental health and well-being. DALLAS - April 28, 2026 (NEWMEDIAWIRE) - Brain health isn’t determined only by genetics or what happens later in life. A growing body of research shows that a range of factors - from mental health and sleep to environment, lifestyle and social conditions - play a powerful role in shaping how the brain functions and ages. A new American Heart Association scientific statement highlights how experiences starting early in life and continuing through life may influence brain health and affect the risk of stroke, cognitive decline or dementia in later years, according to a new American Heart Association scientific statement, published today in the Association’s peer-reviewed scientific journal Stroke. The new scientific statement, “Brain Health Across the Life Span: A Framework for Future Studies,” highlights opportunities for early detection, prevention and intervention to protect brain health and support healthy aging. According to the U.S. Census Bureau, the number of U.S. adults ages 65 and older is projected to increase from 58 million in 2022 to 82 million by 2050, a 42% increase, and the 65-and-older age group’s share of the total population is projected to rise from 17% to 23%. The aging of the U.S. population is expected to increase the prevalence of brain conditions that affect memory, thinking, communication skills and mental health. “As medical and scientific advancements have extended life expectancies, brain health has become increasingly important,” said the Chair of the scientific statement’s writing group Elisabeth Marsh, M.D., FAHA, a professor of neurology and associate director of the neurology residency program at The Johns Hopkins University School of Medicine and director of the Stroke Center at Johns Hopkins Bayview Medical Center in Baltimore. “The number of people with age-related cognitive impairment is rising rapidly, creating significant personal, emotional, and health care system burdens.” According to the American Heart Association’s 2026 Heart Disease and Stroke Statistics, stroke is now the #4 leading cause of death in the U.S. A 2023 American Heart Association/American Stroke Association scientific statement on cognitive impairment after stroke highlighted that more than half of people who survive a stroke develop cognitive impairment within the first year after their stroke, and as many as 1 in 3 may develop dementia within 5 years. Previous research about brain health has considered factors that damage blood vessels and reduce blood flow to the brain, which can increase the risk of developing stroke, cognitive decline and/or dementia. Recent research has also focused on the role of psychological, environmental, lifestyle and social factors, that affect brain health over a lifetime. “We’ve long focused on managing risk factors like blood pressure and cholesterol, which remain critical for heart and brain health, however, this statement spotlights research on external factors like sleep quality, the gut microbiome and social conditions that are also linked to brain health,” said Marsh. “One of the most important messages in this scientific statement is that brain health is shaped across the entire life span. What happens early in life can matter decades later, which also means there are opportunities at every life stage to support healthier brain aging,” she added. What factors affect brain health? Recent research shows that numerous mental, physical, environmental and social factors influence brain health across the life span. Mental Health: A 2021 American Heart Association scientific statement on the mind-heart-body connection stated that negative psychological factors and mental health disorders can negatively impact cardiovascular health. Over time, chronic stress, depression and anxiety may change the brain in ways that increase the risk of memory loss, dementia and stroke. These physiological and structural changes may include inflammation, stress-related damage, and loss of brain cells and connections. Long-term psychological stress that keeps stress hormones elevated contributes to atherosclerosis (buildup of plaque in arteries) and impaired glucose metabolism, both of which can have damaging effects on brain health over time. Adverse Childhood Experiences: Children who experience abuse, neglect, exposure to domestic violence, or parental separation or divorce, incarceration or illicit substance use or dependence, may be at increased risk for learning and attention difficulties in childhood, as well as mental health conditions and cognitive decline and dementia as they age. Chronic Inflammation: Long-term inflammation can damage brain cells and blood vessels over time. When inflammation begins early in life, it may interfere with healthy brain development. It can be triggered by infection during pregnancy or ongoing stress. Over time, this may increase the risk of learning, thinking and mental health challenges. In adulthood, persistent inflammation is linked to memory loss and neurodegenerative conditions, such as Alzheimer’s and Parkinson’s disease. Gut Microbiome: The gut and brain are closely connected and communicate through nerves, immune signals and hormones. Healthy gut bacteria produce substances that help protect the brain and regulate inflammation. When this balance is disrupted, inflammation can increase and place stress on the brain. Gut health may be especially important at certain stages of life, including early development, adolescence and older age, when changes in gut bacteria may have lasting effects on brain health. In later life, altered gut microbes have been linked to conditions such as Alzheimer’s and Parkinson’s disease. Obesity: Excess body weight can be harmful to overall health and is an important risk factor for brain health across the life span. Obesity can increase inflammation, disrupt hormones and damage blood vessels, which, over time, can harm brain structure and cognitive function at all stages of life. Sleep: Healthy sleep is essential to keeping the brain balanced and functioning well at every age. Some research has described sleep as an investment in brain health that builds over time. In children, sleep supports brain growth and long-term memory formation. In teens and adults, consistent, high-quality sleep supports memory, attention, decision-making, work performance, and long-term physical and mental health, making it an integral component in healthy development and aging. Inadequate sleep and sleep disorders like sleep apnea may increase inflammation and increase the risk of memory loss and cognitive decline. Social drivers of health: Current research confirms that lower socioeconomic status, including fewer years of education and lower income, is linked with a higher risk of health conditions like Type 2 diabetes and high blood pressure, both of which can contribute to memory loss, cognitive decline and dementia. Limited access to healthy foods, health care and stable housing can also increase the risk of cognitive decline over time. Environmental Exposures: Current research suggests that exposure to air pollution, heavy metals, microplastics and other environmental pollutants such as particulate matter from wildfires can slowly damage the brain by triggering inflammation, stressing brain cells and harming the blood vessels that supply it. Over time, this makes it harder to repair damage and may increase the risk of memory loss, dementia and stroke. What are ways to improve brain health? “Together, the evidence underscores that brain health is shaped throughout a person’s lifetime and that healthy lifestyle behaviors can make a difference. Addressing modifiable factors such as mental health, environmental exposures, sleep and social conditions may support brain development and healthy aging,“ Marsh said. Research suggests that healthy lifestyle habits such as those outlined in the American Heart Association’s Life’s Essential 8 may support brain health. Getting regular physical activity, controlling blood pressure and cholesterol, practicing healthy sleep habits, avoiding smoking and managing stress have shown consistent benefits. Healthy eating patterns such as those detailed in the Association’s 2026 Dietary Guidance are also a key factor in shaping gut and brain health. Following a Mediterranean-style diet and eating fiber-rich, plant-based foods and fermented foods, like yogurt and kefir, support beneficial gut bacteria, while diets high in processed foods and added sugars can disrupt the gut microbiome. Avoiding heavy alcohol or substance use, increasing social support , and reducing financial stress may also improve mental health. What should health care professionals and other leaders do to support brain health? The statement urges health care professionals and policymakers to protect and promote optimal brain health from before birth through adulthood across all communities. Prioritizing mental health screening and support and expanding access to timely, effective health care that supports Life’s Essential 8 can help to improve brain health across the life span. More research is needed to understand the approaches that may work best in different communities. To address the growing burden of age-related cognitive impairment, the American Heart Association and the Paul G. Allen Frontiers Group have created the AHA-Allen Initiative in Brain Health and Cognitive Impairment. The two organizations, along with additional contributors, have committed more than $43 million toward research to advance the understanding of brain health and improve lives. More information about the awards given to fund brain health research is available here. In addition, the Association’s Strategically Focused Research Network on Inflammation in Cardiac and Neurovascular Disease awarded $15 million to researchers to study inflammation’s impact on heart and brain health. “Brain health is a lifelong journey, influenced by our mental well-being, environment and lifestyle choices from childhood through late adulthood,” according to Mitchell Elkind, M.D., M.S., FAHA, the American Heart Association’s Chief Science Officer for Brain Health and Stroke and a past volunteer president of the Association (2020-2021). “This scientific statement comes at a timely moment, just as the American Heart Association is increasing its focus, research and programming in brain health. The exciting science in this area reminds us that every stage of life offers a new opportunity to nurture our brains and minds, supporting healthier aging and reducing the risk of cognitive decline, dementia, stroke, depression and other brain disorders.” This scientific statement was prepared by the volunteer writing group on behalf of the American Heart Association’s Stroke Council; the Council on Cardiovascular and Stroke Nursing; the Council on Cardiovascular Surgery and Anesthesia; and the Council on Clinical Cardiology. American Heart Association scientific statements promote greater awareness about cardiovascular diseases and stroke issues and help facilitate informed health care decisions. Scientific statements outline what is currently known about a topic and what areas need additional research. While scientific statements inform the development of guidelines, they do not make treatment recommendations. American Heart Association guidelines provide the Association’s official clinical practice recommendations. Co-authors are Vice Chair Helen Lavretsky, M.D., M.S.; Nadine Kasparian, Ph.D.; Nancy Pike, Ph.D., R.N., FAHA; Kristian Doyle, Ph.D.; Neelum Aggarwal, M.D.; Heather Fullerton, M.D., M.A.S.; Autumn Ivy, M.D., Ph.D.; and Nomazulu Dlamini, M.B.B.S, M.Sc., Ph.D, FAHA. Authors’ disclosures are listed in the manuscript. The Association receives more than 85% of its revenue from sources other than corporations. These sources include contributions from individuals, foundations and estates, as well as investment earnings and revenue from the sale of our educational materials. Corporations (including pharmaceutical, device manufacturers and other companies) also make donations to the Association. The Association has strict policies to prevent any donations from influencing its science content and policy positions. Overall financial information is available here. Additional Resources: Available multimedia is on right column of release link. After April 28, 2026, view the manuscript online. American Heart Association news release: Two scientists to receive 2026 Ralph L. Sacco Scholarships for Brain Health (April 2026) American Heart Association news release: What do we mean by “brain health” and why should you care about it? (March 2025) American Heart Association scientific statement news release: Heart failure, atrial fibrillation & coronary heart disease linked to cognitive impairment (Oct. 2024) American Heart Association scientific statement news release: Cognitive impairment after stroke is common, and early diagnosis and treatment needed (May 2023) American Heart Association scientific statement: A Primary Care Agenda for Brain Health (March 2021) American Heart Association scientific statement news release: Mental health is important to overall health, and heart disease prevention and treatment (Jan. 2021) American Heart Association infographic: Brain Health and Healthy Aging Follow American Heart Association/American Stroke Association news on X @HeartNews Follow news from Stroke, the American Heart Association/American Stroke Association journal, @StrokeAHA_ASA About the American Heart Association The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public’s health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on heart.org, Facebook, X or by calling 1-800-AHA-USA1. For Media Inquiries: 214-706-1173 Amanda Ebert: Amanda.Ebert@heart.org For Public Inquiries: 1-800-AHA-USA1 (242-8721) heart.org and stroke.org View the original release on www.newmediawire.com
LONDON, UNITED KINGDOM - April 28, 2026 (NEWMEDIAWIRE) - Payfuture, the global payments company building financial infrastructure in emerging markets, today announced a strategic partnership with Profee, an international payments platform serving consumers across Europe and beyond. Through the partnership, Profee will leverage Payfuture’s infrastructure to enable INR-denominated payouts into India, supporting fast, reliable delivery of funds to both individual and business recipients via local payment rails. India is one of the world’s largest and most complex payout markets, where high transaction volumes are matched by strict regulatory requirements and a fragmented mix of banks and local payment methods. By integrating Payfuture’s infrastructure, Profee gains direct access to local banking and payment systems, enabling faster settlement in INR, improved delivery rates, and lower operational friction across this key corridor. Building on this initial rollout, the partnership is designed to scale across the wider Indian subcontinent, where demand for efficient, compliant cross-border payouts continues to grow. Manpreet Haer, Co-Founder and CEO of Payfuture, said: “As cross-border volumes into India grow, the ability to deliver funds locally and reliably becomes critical. By connecting directly to local banking and payment systems, we enable Profee to ensure funds reach both individuals and businesses quickly and consistently.” Sergey Romanov, Chief Commercial Officer at Profee, said: “India has been the world’s largest international transfer recipient for years. At Profee, we launched transfers to India in 2023 and had the destination in focus since then: we strived to provide competitive FX rates to INRs, added UPI as a receiving option, and carried out high-impact marketing campaigns. We are always open to new partnerships to help us operate more efficiently, and with Payfuture’s infrastructure we are sure that the funds reach recipients quickly and predictably.” The partnership reflects a broader shift across the fintech landscape. As cross-border payments enter high-growth markets, providers are increasingly prioritising payout performance, local execution, and regulatory compliance over broad but shallow global coverage. Infrastructure partners like Payfuture are playing a central role in enabling this shift, helping rapidly growing services like Profee expand into markets that have traditionally been difficult to serve. About Payfuture Payfuture is a global payments technology company helping businesses operate and expand in the world’s fastest-growing emerging markets. The company enables merchants, platforms, and payment providers to manage local payment acceptance and cross-border fund movement across complex regions. With a strong presence across Africa, Asia, and the Middle East, Payfuture combines deep local market expertise with compliant settlement infrastructure to support international growth. Founded in 2019 and headquartered in London, Payfuture works with global businesses to navigate the regulatory, operational, and payment challenges of cross-border commerce. For more information. Learn more: https://www.payfuture.net/ About Profee Profee is a global financial service providing fast, secure, and smart money transfers to over 90 destinations with strong focus on Africa, Asia and Eastern Europe. Available via web and apps for Android and iOS, Profee simplifies global remittances and ensures financial connectivity across borders. It primarily focuses on expats, offering competitive exchange rates to over 40 currencies, local payout options, and a comprehensive interface. As of April 2026, the total number of Profee’s clients exceeds one million. Profee is actively implementing new features, like digital accounts. Learn more: https://www.profee.com/ Press Contact: Veronica Welch VEW Media ronnie@vewpr.com View the original release on www.newmediawire.com
Revenue rises by around 33% to EUR 490.0 million; EBITDA more than doubles to EUR 32.1 million Ticket sales also reach an all-time high of over 12 million - providing strong visibility for the remainder of the financial year Buy-and-build strategy consistently pursued; minority interests reduced as planned Further improvement in EBITDA margin expected; ticket sales forecast to remain at a consistently high level BERLIN - April 27, 2026 (NEWMEDIAWIRE) - DEAG Deutsche Entertainment AG (“DEAG”) reports a very successful financial year 2025, achieving new record highs in both revenue and earnings. DEAG once again increased the number of tickets sold for concerts and events, successfully continued its buy-and-build strategy, reduced minority interests in its holdings as planned, and further expanded its international footprint. Revenue rose by around 33% to EUR 490.0 million during the reporting period, with EUR 167.2 million attributable to the fourth quarter alone (+42.9% year-on-year). Earnings before interest, taxes, depreciation and amortisation (EBITDA) amounted to EUR 32.1 million, more than doubling compared to the previous year (prior year: EUR 14.4 million). The EBITDA margin increased significantly from 3.9% to 6.6% in 2025. In addition, the number of tickets sold increased to more than 12 million, significantly exceeding the previous year’s level of 11 million, with a substantial proportion of ticket sales generated via DEAG’s proprietary ticketing platforms. By the end of 2025, DEAG had already sold around 3 million tickets for events scheduled to take place in 2026. These advance sales provide a solid foundation for the remainder of the financial year and ensure a high level of visibility and planning reliability. The resulting revenue already secured amounts to EUR 151.5 million. In financial year 2026, DEAG expects ticket sales to remain at a consistently high level. DEAG continued to successfully pursue its buy-and-build strategy in 2025. Among other activities, the company further strengthened its market position in the festival segment and acquired a majority stake in the ROCKHARZ Festival. With over 25,000 visitors annually, ROCKHARZ is the largest Rock and Metal festival in eastern Germany and one of the largest in Germany. In addition, the success of the strategic measures was also evident at the international level: the Italian company MC2 Live reported an exceptionally positive business performance already in its first full financial year following its acquisition in 2024. In parallel, DEAG continued, as planned, to reduce minority interests in its particularly successful Group companies and increased its stake in Fane Productions, the fast-growing and highly profitable market leader in the Spoken Word & Literary Events segment, as well as in the UK ticketing platform gigantic.com, to 100% in each case. In 2025, DEAG once again successfully organised a large number of concerts and tours featuring artists such as Ed Sheeran, Sam Fender, Stereophonics, Iron Maiden on a tour of Germany, Italy and Switzerland, Marilyn Manson, Maite Kelly, Tream, Böhse Onkelz and Till Lindemann, for whose European tour a total of more than 190,000 tickets were sold. The event series “An Evening with…” and the lit.COLOGNE literature festival within the Spoken Word & Literary Events segment were once again major successes, as were DEAG’s Christmas Gardens, which attracted around 1.6 million visitors, and events such as “Disney on Ice,” Cavalluna and the Gianni Versace Retrospective. In addition, DEAG recorded a strong festival summer with its open-air events in the EDM, Rock/Pop and Classics & Jazz genres, including Indian Spirit, NATURE ONE, Belladrum Tartan Heart and the Kessel Festival. The current financial year 2026 is likewise characterised by a high density of events. Besides tours and concerts by artists like Judas Priest, Die Toten Hosen, Bring Me The Horizon, Bausa, Tokio Hotel, Deep Purple and Gorillaz, visitors can also look forward to events such as the monster truck show “Monster Jam” at the Schalke arena, “The Lord of the Rings – The Fellowship of the Ring in Concert” with the London Royal Philharmonic Orchestra, cooking shows with Yotam Ottolenghi, who will also present his new book “SIMPLE TOO”, and exciting evenings as part of the “An Evening with…” format, featuring, among others, actor Bryan Cranston and Formula 1 world champion Damon Hill. DEAG has continued to consistently pursue its M&A activities even after the end of the reporting period. In the first quarter of 2026, the company acquired all remaining minority interests in the concert and tour promoters Wizard Live and LiveGeist Entertainment and in Wizard Communications, as well as a majority participation in the music festival “Juicy Beats”. Furthermore, DEAG acquired a majority stake in conneccted: EVENTS & LIVE MARKETING GmbH via its subsidiary Mewes Entertainment Group. As part of the ongoing consolidation of the Live Entertainment industry in Europe, DEAG intends to continue playing an active role and to further drive its growth through M&A. DEAG has a robust financial structure, which has been further strengthened by the placement of the new Corporate Bond 2025/2029 with an issue volume of EUR 75 million, and is supported by strong proprietary ticketing platforms as well as a diversified event portfolio. Accordingly, DEAG considers itself well positioned to continue its medium- and long-term growth trajectory, subject to possible macroeconomic developments. Notwithstanding this, Group revenue for financial year 2026 is expected to be temporarily below the previous year’s level due to the cyclical nature of the Live Entertainment industry and the event calendar. With revenue still expected to exceed EUR 400 million, the EBITDA margin is expected to increase further. For subsequent years, the company anticipates a further phase of growth. Detlef Kornett, Group CEO of DEAG, said: “The measures we implemented in the transformation year 2024 to enhance our competitiveness, profitability and efficiency had a clearly positive impact in financial year 2025. We are very pleased with the strong business performance, to which all parts of our Group contributed equally. DEAG is therefore very well positioned to sustainably continue its organic and inorganic growth strategy trajectory going forward.” The full Annual Financial Report 2025 is available for download on DEAG’s corporate website in the Investor Relations/Financial Reports section. About DEAG DEAG Deutsche Entertainment AG (“DEAG”), founded in Berlin in 1978, is a leading provider of Live Entertainment, Ticketing, and Entertainment Services in Europe. With Group companies at 25 locations, DEAG is present in its core markets of Germany, the United Kingdom, Ireland, Switzerland, Denmark, Spain, and Italy. As a Live Entertainment service provider with an integrated business model and a strong international partner network, DEAG has extensive expertise in the conception, organisation, promotion, and production of live events of all genres and sizes. The Live Entertainment segment includes the core business areas of Music – covering Rock/Pop, including Urban and Electronic Dance Music, Classics & Jazz - and Non-Music, such as the Spoken Word & Literary Events and Family Entertainment. Every year, DEAG organises over 6,000 live events and sells more than 10 million tickets, a steadily growing share of which are sold via the DEAG Group’s ticketing platforms: myticket.de, myticket.at, myticket.co.uk, gigantic.com and tickets.ie. Live Entertainment for all generations and target groups, the development of international markets and the strengthening of the ticketing area are central building blocks of DEAG’s ongoing development. Investor & Public Relations Axel Muhlhaus, edicto GmbH Eschersheimer LandstraBe 42 60322 Frankfurt/Main Tel: +49 69 905505-52 Email: deag@edicto.de View the original release on www.newmediawire.com
Revenue of RMB 73.69 billion Net profit attributable to shareholders of the parent company of RMB 4.65 billion, up sequentially compared to Q4 2025 Basic EPS of RMB 0.50 China operating profit grew year-on-year; excluding North America, the Company’s combined operating profit advanced more than 10% year-on-year. 74.54 million A-shares designated for cancellation; D-share buy-back-for-cancellation proposed. QINGDAO, SHANGHAI, FRANKFURT and HONG KONG - April 27, 2026 (NEWMEDIAWIRE) - Haier Smart Home Co., Ltd. (A-share: 600690.SH; H-share: 06690.HK; D-share: 690D.DE), a global leader in smart home solutions, today announced its results for the quarter ended 31 March 2026. Management Commentary This was a quarter of contrasts. Both China and our core international markets sustained healthy momentum. North America faced meaningful headwinds from the evolving trade policy landscape and severe winter weather. We are running a clear playbook in North America: reshaping our local supply chain, advancing sourcing actions, moving the product mix upmarket, and driving cost productivity. We have transitioned from the initial response phase into the next chapter, focused on operational efficiency and capability rebuilding. We expect this work to return our North America business to a more resilient, higher-quality operating model and position it to capture the long-term opportunity ahead. Our globally-enabled, local-for-local model - built across a portfolio of brands and core markets - gives us the confidence to navigate complex environments. We will continue to deliver high-quality growth and stronger returns to shareholders through any cycle. - Li Huagang, Chairman and Chief Executive Officer, Haier Smart Home Co., Ltd. Operational Review China Operating profit in China grew year-on-year, with margin expansion offsetting short-term revenue pressure in a home appliance market that contracted 6.2% by retail value (according to All View Cloud (AVC)). Profit growth reflected a continued mix shift toward premium categories, which lifted domestic gross margin. Residential air conditioning grew revenue against a sharp industry decline and extended its high-end leadership, now ranking No. 1 in the RMB 11,000+ price band, up from its prior top position in the RMB 15,000+ segment (according to GfK). In water solutions, top-rated energy-efficient gas water heaters accounted for a materially higher share of the Company’s portfolio than the industry average (GfK). AI and digital capabilities also lifted operating efficiency, with gains in inventory turnover, fulfilment and resource allocation, and a year-on-year decline in the selling expense ratio. International Overseas revenue declined 3.2% year-on-year. Outside North America, both revenue and operating profit grew, with Europe, South Asia and Southeast Asia all delivering steady growth. North America: GE Appliances was pressured in Q1 2026 by severe winter weather and the evolving trade policy landscape. The business has been advancing supply chain and sourcing actions, mix and price initiatives, and cost productivity to rebuild competitiveness for the new trade environment. Europe: Revenue continued to grow, with HVAC up more than 20% year-on-year. Profitability improved as the benefits of 2025’s restructuring flowed through, and the premium Horizon refrigerator line accelerated its rollout. Emerging markets: South Asia grew by 17% year-on-year in terms of revenue and profitability improved; Southeast Asia grew by 12%. New Growth Businesses The Company advanced its initiative - announced at the end of 2025 - to bring residential air conditioning, smart building and water solutions onto a unified platform. In Q1 2026, the platform delivered its first integrated solution, with its public debut at a domestic HVAC industry expo in Shijiazhuang. The Company also launched a new residential central air conditioning unit featuring ultra-wide frequency operation from 4Hz, built on the platform’s shared technology architecture. Smart Building Solutions completed more than 100 commercial AI deployments across data centres and building energy management. Recent acquisitions: CCR (Carrier Commercial Refrigeration) and Kwikot each delivered double-digit revenue growth in the quarter, extending the strong trajectory established since joining the Company. Shareholder Returns The Company is stepping up shareholder returns through a sustained programme of buybacks and cancellations. 74.54 million A-shares repurchased during 2023–2026 are designated for cancellation, accretive to EPS upon completion. In March 2026, the Company launched a new A-share buyback of RMB 3-6 billion over 12 months, of which RMB 600 million has been deployed to date. The Company has also proposed a separate voluntary D-share buy-back-for-cancellation offer of up to approximately 81 million shares, subject to shareholder approval and other pre-conditions. Contacts Investor Relations: Haier Smart Home (Hong Kong) T: +852 2169 0000 E: ir@haier.hk Media Contacts: CROSS ALLIANCE communication GmbH Irmi Aigner / Sven Pauly T: +49 (0) 89 1250903 33 E: ia@crossalliance.de About Haier Smart Home Co., Ltd. Haier Smart Home is the world’s largest home appliance company and a global leader in smart home solutions. Its core appliance portfolio spans refrigerators, washing machines and kitchen appliances, complemented by an integrated HVAC platform - covering residential air conditioning, smart building solutions and water solutions - and a commercial refrigeration business, all connected through its smart home platform. Operating localised R&D, manufacturing and commercial capabilities across its core markets worldwide, the Company’s portfolio of brands - Haier, Casarte, Leader, GE Appliances, Candy, Fisher & Paykel and AQUA - serves consumers across the full price spectrum in over 200 countries and regions. This ‘global enablement, local execution’ model underpins the Company’s competitive position in every market it serves. The Company is committed to evolving from a global appliance leader into a user-centric, platform-based smart home ecosystem company, with premiumisation, global operations, digitalisation and AI-enabled capabilities as its core strategic pillars. Forward-Looking Statements The forward-looking statements contained in this press release are based on management’s current expectations, estimates and assumptions, and involve known and unknown risks and uncertainties, including but not limited to: changes in the macroeconomic and financial market environment; currency fluctuations; adjustments to international trade policy (including tariffs and export controls); shifts in consumer demand in the Company’s key markets; evolving industry competition; volatility in raw material and energy prices; progress in technology and product development; the realisation of post-acquisition integration benefits and synergies; and regulatory developments in relevant jurisdictions. These factors could cause actual results to differ materially from those expressed or implied by the forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements on the basis of the risk factors above or any other unforeseen factors, except as required by applicable law or regulation. View the original release on www.newmediawire.com
WEST COVINA, CA - April 27, 2026 (NEWMEDIAWIRE) - Focus Universal Inc. (NASDAQ: FCUV) (the “Company”), a provider of patented hardware and software design technologies for the Internet of Things (IoT), 5G, and AI-driven SEC financial reporting automation software, announced today that Focus Universal Inc. closed the acquisition of a five-level, Class A office and commercial building along with a four-level parking structure and land parcels, located at 901 Corporate Center Drive, Monterey Park, CA 91754. The surveyed aggregate land area of the purchase amounts to 464,955 square feet or 10.73 acres, which is divided into four separate parcels (Parcel Numbers, 5237-022-014, 046, 047, and 5237-002-021). The Property provides approximately 100,743 sq. ft. in rentable Class A office space over five levels, and has a parking ratio of 4.1/1,000, offering a blend of surface parking and adjacent four-level parking structure with a canopy of solar panels that are currently leased. Currently, the Property is 99.2% occupied by approximately 16 tenants. The Company does not intend to alter the terms of lease agreements in place with the current tenants, most of which have a term of 5 to 8 years. The Company plans to occupy approximately 2,000 square feet of space. The Company funded the purchase with a standard term loan agreement with East West Bank, as detailed in the 8-K filing. The Company has retained Lee and Associates to manage the property while the previous management, Jamison Services, will remain for 30 days to facilitate the transition. “We are very happy with our building purchase of $17.7 million, which was discounted further from the $17.7 million purchase price by over $419,000 due to rent prorations, security deposits, and other such reconciliation amounts. The building will serve as corporate headquarters, holding a very high capitalization rate for Los Angeles County of over 10%. We believe high-value Class A commercial buildings in Los Angeles area with cap rates above 10% with 100% occupancy, upon Focus moving into the building, are exceedingly rare,” remarked Chief Financial Officer Irving Kau. “From a financial perspective, we also believe there is significant value here as the building has a Los Angeles County Assessor assessed aggregate value of $28.3 million in 2026, over $10 million above our purchase price, despite the two valuation numbers being unrelated. The building also generated monthly rental income of over $257,000 in 2025, amounting to roughly $3.1 million in annual rents,” continued Irving Kau. “If we consider the $257,000 monthly rental income, without considering any already contracted rent increases, coupled with our monthly principal and interest payments of under $68,700, we believe this additional cash flow will benefit the company. In addition to the calculated monthly cash flow, we also believe this particular asset purchase also significantly reduces corporate rent and some corporate expense burden and bolsters our overall equity and asset value for our company.” Irving Kau concluded, “Lastly, one of the parcels is zoned residential and remains undeveloped and holds Los Angeles County Assessor assessed value over $600,000. This high value land with a city view also presents option value to our company as we can still develop the parcel through partners or divest the parcel, which would add also to the overall value for the company. We sincerely thank our shareholders for their unwavering support and belief in the equity value and future upside of our growth and company will allow us to realize our strategic growth plans and accelerate value creation for our shareholders.” About Focus Universal Inc. Focus Universal Inc. is a provider of patented hardware and software design technologies for Internet of Things (IoT) and 5G. The company has developed five disruptive patented technology platforms with 26 patents and patents pending in various phases and eight trademarks pending in various phases to solve the major problems facing hardware and software design and production within the industry today. For maintenance cost control, the company has also omnibus patents encompassing these patents into patent family groups. These technologies combined to have the potential to reduce costs, product development timelines and energy usage while increasing range, speed, efficiency, and security. Focus currently trades on the Nasdaq Markets. Forward-Looking Statements The foregoing material may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, each as amended. Forward-looking statements include all statements that do not relate solely to historical or current facts, including without limitation statements regarding the Company’s product development and business prospects, and can be identified by the use of words such as “may,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “believe,” “potential,” “should,” “continue” or the negative versions of those words or other comparable words. Forward-looking statements are not guarantees of future actions or performance. These forward-looking statements are based on information currently available to the Company and its current plans or expectations and are subject to a number of risks and uncertainties that could significantly affect current plans. Should one or more of these risks or uncertainties materialize, or the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended, or planned. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, performance, or achievements. Except as required by applicable law, including the security laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to actual results. For company inquiries, please contact: Investor Relations 626-272-3883 ir@focusuniversal.com View the original release on www.newmediawire.com
LOS ANGELES, CA - April 27, 2026 (NEWMEDIAWIRE) - Greenland Energy (NASDAQ: GLND) announced it has signed an agreement with Halliburton for integrated consulting services and logistical management supporting its 2026 onshore drilling campaign in the Jameson Land Basin. The agreement covers planning, coordination, handling and transportation of equipment, services and goods, and includes comprehensive well and drilling services, forming a key part of the Company’s integrated Arctic operations strategy alongside prior agreements with Stampede Drilling and Desgagnés. To view the full press release, visit https://ibn.fm/ghllI About Greenland Energy Company Greenland Energy Company is an energy exploration company focused on responsibly developing Greenland’s hydrocarbon resources, with an emphasis on the Jameson Land Basin. It aims to advance oil and gas exploration and create a publicly traded platform for Arctic energy development. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law
LOS ANGELES, CA - April 27, 2026 (NEWMEDIAWIRE) - Cardiovascular disease remains one of the most serious and costly health challenges worldwide, driving an urgent need for earlier detection and more precise, personalized treatment strategies. Cardio Diagnostics Holdings (NASDAQ: CDIO) is focused on addressing this need by developing advanced solutions that leverage artificial intelligence (“AI”) and multi-omic biomarkers to deliver actionable insights from a simple blood sample, enabling more informed and timely care cardiac care decisions. The scale and impact of cardiovascular disease underscore why innovation in this area is so critical. Advances in genomics and epigenetics are making it possible to better understand how genetic predisposition and environmental influences interact to drive disease progression. By utilizing a simple blood test, Cardio Diagnostics is lowering barriers to advanced cardiovascular testing. The scale and impact of cardiovascular disease underscore why innovation in this area is so critical. According to the Centers for Disease Control and Prevention, heart disease remains the leading cause of death in the United States, responsible for approximately one in every three deaths. Beyond mortality… Read More Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer The latest news and updates relating to CDIO are available in the company’s newsroom at https://ibn.fm/CDIO Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law View the original release on www.newmediawire.com
LOS ANGELES, CA - April 27, 2026 (NEWMEDIAWIRE) - LIXTE Biotechnology Holdings (NASDAQ: LIXT) is advancing the precision oncology landscape, developing therapies that complement existing cancer treatments while integrating cutting-edge data solutions. “The company’s lead program, LB-100, is a novel small-molecule compound designed to enhance the efficacy of chemotherapy and radiation, aiming to improve patient outcomes while reducing treatment-related side effects,” reads a recent article. “By focusing on improving the therapeutic index of existing cancer modalities, the company is tackling a recurrent challenge in the field of oncology: maximizing treatment impact while cutting down risks to healthy tissue.” To view the full article, visit https://ibn.fm/EE6ya About LIXTE Biotechnology Holdings Inc. LIXTE Biotechnology Holdings is a clinical-stage pharmaceutical company focused on new targets for cancer drug development and developing and commercializing cancer therapies. LIXTE has demonstrated that its first-in-class lead clinical PP2A inhibitor, LB-100, is well-tolerated in cancer patients at doses associated with anti-cancer activity. Based on extensive published preclinical data (see www.lixte.com ), LB-100 has the potential to significantly enhance chemotherapies and immunotherapies and improve outcomes for patients with cancer. LIXTE’s lead compound, LB-100, is part of a pioneering effort in an entirely new field of cancer biology - activation lethality - that is advancing a new treatment paradigm. LIXTE’s new approach is covered by a comprehensive patent portfolio. Proof-of-concept clinical trials are currently in progress for ovarian clear cell carcinoma and metastatic colon cancer. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law View the original release on www.newmediawire.com
MONTREAL, QUEBEC - April 27, 2026 (NEWMEDIAWIRE) - Scandium Canada Ltd. (TSX-V: SCD) (the “Company") announces the grant of 2,100,000 incentive stock options to its full team of directors, officers and key personnel under the Share Option Plan approved by shareholders at the April 21, 2026 Annual General and Special Meeting. At a meeting held on April 24, 2026, the Board of Directors of the Company approved the grant of an aggregate of 2,100,000 incentive stock options (the "Options") pursuant to the Company's Share Option Plan, reflecting a broad alignment of the Company's Board, management and key personnel with shareholder interests. The Options are exercisable at a price of $0.22 per common share for a period of five (5) years from the date of grant. The exercise price matches the price of the Company's recently completed $17.25 million oversubscribed public offering closed on March 17, 2026, and represents a meaningful premium to the Company's current trading price. The Options were granted as follows: Chairman of the Board - Jeffrey Swinoga: 750,000 Options Independent Directors - Robert Kitchen: 150,000 Options - Jean Lafleur: 150,000 Options - Cindy Valence: 150,000 Options Management and Key Personnel - Guy Bourassa, Chief Executive Officer: 150,000 Options - Pierre Neatby, President and Chief Operating Officer: 150,000 Options - Luc Duchesne, Chief Scientific Officer: 150,000 Options - Steve Nadeau, Chief Financial Officer: 150,000 Options - Jean-François Magnan, Chief Technology Officer: 150,000 Options - Arnaud Bourassa Francoeur, Director, Communications and Marketing: 150,000 Options The Options vest in accordance with the following schedule: 25% vest on the date that is three (3) months from the date of grant; 25% vest on the date that is six (6) months from the date of grant; 25% vest on the date that is nine (9) months from the date of grant; and the remaining 25% vest on the date that is twelve (12) months from the date of grant, resulting in full vesting within one year. The grant remains subject to the approval of the TSX Venture Exchange. ABOUT SCANDIUM CANADA LTD. Scandium Canada (TSX-V: SCD) is a public company whose ultimate goal is to bring the world's leading primary source of scandium into production, enabling the development and commercialization of aluminum-scandium (Al-Sc) alloys. The Company is leveraging its Al-Sc alloy development division and the development of its Crater Lake mining project to meet the growing need for lighter, greener, longer-lasting, high-performance materials. The Company aims to become a market leader in scandium, while committing itself to building a more responsible economy through innovation and agility. FORWARD-LOOKING STATEMENTS The information contained herein contains "forward-looking information" within the meaning of applicable Canadian securities legislation, including statements regarding the receipt of final approval from the TSX Venture Exchange for the grant of the Options described herein. Forward-looking statements are based on assumptions considered reasonable by the Company at the time they are made but are subject to risks and uncertainties that may cause actual results to differ materially. The Company disclaims any intention or obligation to update or revise any forward-looking statement, except as required by applicable law. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by the Company as of the time of such statements, are inherently subject to significant business, economic and competitive uncertainties, and contingencies. These estimates and assumptions may prove to be incorrect. Many of these uncertainties and contingencies can directly or indirectly affect, and could cause, actual results to differ materially from those expressed or implied in any forward-looking statements and future events, could differ materially from those anticipated in such statements. A description of assumptions used to develop such forward-looking information and a description of risk factors that may cause actual results to differ materially from forward-looking information can be found in the Company’s disclosure documents on the SEDAR+ website at www.sedarplus.ca. By their very nature, forward-looking statements involve inherent risks and uncertainties, both general and specific, and risks exist that estimates, forecasts, projections and other forward-looking statements will not be achieved or that assumptions do not reflect future experience. Forward-looking statements are provided for the purpose of providing information about management’s endeavors to develop the Crater Lake project, and, more generally, its expectations and plans relating to the future. Readers are cautioned not to place undue reliance on these forward-looking statements as a number of important risk factors and future events could cause the actual outcomes to differ materially from the beliefs, plans, objectives, expectations, anticipations, estimates, assumptions and intentions expressed in such forward-looking statements. All of the forward-looking statements made in this press release are qualified by these cautionary statements and those made in our other filings with the securities regulators of Canada. The Company disclaims any intention or obligation to update or revise any forward-looking statement or to explain any material difference between subsequent actual events and such forward-looking statements, except to the extent required by applicable law. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. For additional information, please contact: Scandium Canada Ltd. Guy Bourassa Chief Executive Officer Phone: +1 (418) 580-2320 Email: info@scandium-canada.com Website: www.scandium-canada.com LinkedIn: Scandium Canada Ltd. X: @ScandiumCanada Facebook: Scandium Canada Instagram: @scandiumcanada
LAS VEGAS, NV - April 27, 2026 (NEWMEDIAWIRE) - Meridian Holdings Inc. (NASDAQ: MRDN) ("Meridian Holdings" or the "Company"), a leading global operator and licensor of online sports betting and gaming platforms across over 20 regulated markets, today announced the Company will report its first quarter 2026 financial results before the market opens on Tuesday, April 28, 2026. Management will host a conference call the same day at 8:00 AM ET to discuss the results. The live audio webcast and an accompanying investor presentation will be made available on Meridian Holdings’ investor relations website at https://meridian-holdings.com/investors/. About Meridian Holdings Meridian Holdings Inc. (NASDAQ: MRDN), based in Las Vegas, Nevada, is an established B2B and B2C gaming technology company operating across multiple international markets. The Company's B2C division is represented by Meridianbet Group, a leading online sports betting and gaming operator founded in 2001, licensed in multiple jurisdictions across Europe, Africa, and South America. MRDN's B2B division, comprised of game developer Expanse Studios and iGaming platform GMAG, develops, licenses and distributes proprietary gaming platforms to an extensive list of global clients. Meridian Holding’s other subsidiaries include RKings Competitions, which operates a high-volume eCommerce site enabling end users to enter paid-for competitions on its proprietary platform in authorized markets., Mexplay, a regulated online casino in Mexico, and Classics for a Cause, Australia's leading subscription-based digital memberships and trade promotion lottery. The Company's sophisticated software automatically declines any gaming or redemption requests from within the United States, in strict compliance with current U.S. law. For more information, visit www.meridian-holdings.com or email us at ir@meridian-holdings.com Contact: Investors & Press ir@meridian-holdings.com View the original release on www.newmediawire.com
CARACAS, VENEZUELA - April 27, 2026 (NEWMEDIAWIRE) - Catalyst Crew Technologies Corp. (OTC: CCTC) (the “Company”), a digital health and artificial intelligence technology company developing telehealth infrastructure and healthcare analytics platforms for emerging markets, today announced that Dr. Kevin Rodan Levy, Chief Executive Officer of the Company, plans to attend HLTH Europe 2026, an international healthcare conference focused on digital health, healthcare innovation, and emerging technologies. HLTH Europe 2026 is scheduled to take place in Amsterdam from June 15-18. Dr. Levy’s attendance is intended to support the Company’s broader strategic initiatives, including engagement with healthcare industry participants, evaluation of emerging technologies and market developments, and exploration of strategic relationships that may support the continued development and expansion of the Company’s evolving digital health ecosystem. The Company believes that attendance at major international healthcare conferences may provide valuable opportunities to observe industry developments, strengthen professional networks, and support its broader efforts to advance its telehealth and artificial intelligence healthcare platform strategy HLTH Europe is expected to convene healthcare executives, innovators, investors, and technology leaders from across global markets to discuss healthcare transformation, digital infrastructure, and advancements in healthcare delivery, providing the Company with valuable opportunities to observe industry developments and engage with broader healthcare innovation trends. Dr. Levy stated: “As we continue advancing our digital health and artificial intelligence initiatives, attending major international healthcare events provides valuable opportunities to observe emerging industry trends, engage with healthcare innovators, and further strengthen our long-term strategic positioning.” The Company continues to advance the development of its telehealth platform infrastructure, artificial intelligence healthcare modules, and broader digital health strategy across Latin America and emerging markets. For more information, please visit https://catalystcrewai.com or review the Company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov. About Catalyst Crew Technologies Corp. Catalyst Crew Technologies Corp. is an artificial intelligence-driven healthcare technology company focused on developing scalable digital health solutions for emerging markets, with an initial emphasis on Latin America. The Company is actively executing its strategic transition into AI-enabled healthcare and pursuing opportunities across telehealth infrastructure, remote patient monitoring, healthcare data analytics, and integrated digital care platforms designed to improve access, efficiency, and care coordination. Through technology development initiatives, strategic partnerships, and targeted acquisitions, CCTC is building an integrated healthcare technology platform positioned to address the growing demand for modernized healthcare delivery systems across emerging markets. Forward-Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements include, but are not limited to, statements regarding the Company’s business strategy, leadership initiatives, strategic transactions, operational execution, regulatory matters, and future operations. Forward-looking statements are based on current expectations and assumptions that involve risks and uncertainties. Actual results may differ materially from those expressed or implied due to various factors, including but not limited to the Company’s ability to successfully implement its business plan, secure financing, complete acquisitions, comply with regulatory requirements, and general market and economic conditions. The Company undertakes no obligation to update any forward-looking statements except as required by applicable law. Disclaimer This press release is provided for informational purposes only and does not constitute an offer to sell or the solicitation of an offer to buy any securities of the Company. The Company is a development-stage enterprise and has not generated revenues from its newly announced business direction. There can be no assurance that the Company will successfully implement its business plan, complete acquisitions, secure financing, obtain regulatory approvals, or generate revenues. Any investment decision should be made solely on the basis of information contained in the Company’s filings with the U.S. Securities and Exchange Commission and other publicly available documents. The Company’s securities involve a high degree of risk. Prospective investors are urged to carefully review all risk factors and disclosures contained in the Company’s SEC filings before making any investment decision. No representation or warranty, express or implied, is made as to the accuracy or completeness of the information contained herein. Investor Relations Contact +1 (787) 476-2350 ir@catalystcrew.ai
VANCOUVER, BC - April 27, 2026 (NEWMEDIAWIRE) - Blende Silver Corp. (the “Company”) (TSX.V: BAG) (OTC: BAGGF) (WKN: A2QKT9) (FSE: BCW1) is pleased to announce that it has engaged Ronacher McKenzie Geoscience Inc. (“RMG”), a leading Canadian geoscience consulting firm, to complete an integrated geological, geochemical, and geophysical interpretation and targeting program at its 100%-owned Blende Silver-Zinc-Lead Project in north-central Yukon. The engagement is driven by compelling initial results from an in-house desktop review of a 3D induced polarization (IP) survey completed over a portion of the project. The survey was designed to calibrate the geophysical signature over the known West Zone mineralization (the anchor of the Company’s existing mineral resource) and to test for potential extensions and new targets across a broader portion of the property, including the approximately 2 km “Central Zone” gap between the West Zone and East Zone deposits, as well as areas to the north of the West and Central Zones. Key observations from the initial plot-up and inversion of the 3D IP data include: Strong correlation between the IP chargeability response over the West Zone and the known silver-zinc-lead mineralization, providing a reliable calibration benchmark for the property. Identification of multiple significantly larger-scale untested chargeability anomalies, notably in the Lower Central Zone and New Mountain Top areas. These anomalies appear to be several times larger than the chargeability response associated with the defined West Zone mineralization. The Lower Central Zone anomaly and the New Mountain Top anomaly both extend to the edges of the surveyed grid, suggesting potential for greater extent beyond current coverage. Historical drilling in the Central Zone (13 holes drilled along and down the spine of the ridge toward the East Zone) appears, based on the initial inversion data review, to have been positioned between two distinct chargeability anomalies (the Lower Central and Backside Central Zone anomalies) rather than directly testing the strongest responses. These findings suggest the potential for greater system scale and continuity than previously recognized, including possible extensions of mineralization from the West Zone through the Central Zone area toward the East Zone, as well as additional mineralized zones across the district-scale property. “Blende already hosts the largest carbonate-hosted silver-zinc-lead deposit in the Yukon (M. Robinson and C.I. Godwin, Economic Geology, 1995) with a substantial existing mineral resource,” commented Andrew H. Rees, President and CEO. “The 3D IP survey appears to have delivered a clear calibration at the West Zone while revealing multiple untested chargeability anomalies in the Lower Central and New Mountain Top areas that are notably larger in scale than the West Zone response. This is a significant development that warrants expert interpretation.” “We engaged RMG to integrate all available datasets and propose robust targets. Their work will help us better understand mineralization controls, assess potential continuity between the known zones, and prioritize technically supported targets for future exploration. We view this as a major step forward in unlocking the district-scale potential of the Blende Project.” RMG’s Mandate RMG will compile and integrate the Company’s historical geological, geochemical, and drilling data with the new 3D IP results. The program includes geophysical quality control, integrated 3D interpretation, and the identification of high-priority targets. Deliverables will include a 3D data workspace, technical report, and presentation. The work is expected to be completed within approximately eight weeks. Project Context and Mineral Resource Base The Blende Project hosts the largest carbonate-hosted silver-zinc-lead deposit in the Yukon. A 2021 mineral resource estimate (prepared in accordance with National Instrument 43-101 at a 1.5% ZnEq cutoff) outlines a substantial silver-zinc-lead system: Historical exploration defined the East and West Zones, two primary mineralized zones approximately two kilometers apart along a >6km corridor. The new 3D IP data provides important new context for evaluating potential continuity and the overall scale of the mineralized system. Next Steps With permitting progress advancing and high-quality 3D geophysical data in hand, the Company is well positioned to advance systematic exploration. The integrated interpretation from RMG will guide future programs, including the potential to update the mineral resource estimate to reflect current commodity prices and new exploration results. Qualified Person The technical information in this news release has been reviewed and approved by Dr. Sarah Palmer, P.Geo., an independent consultant commissioned by the Company, who is a Qualified Person as defined by National Instrument 43-101 Standards of Disclosure for Mineral Projects. About Blende Silver Corp. Blende Silver Corp. is a Vancouver-based junior resource company focused on silver-zinc-lead exploration and development at its flagship Blende Project in north-central Yukon. The 100% owned property is the largest carbonate-hosted Ag-Zn-Pb deposit in Yukon and one of the largest undeveloped carbonate-hosted Ag-Zn-Pb deposits in Western Canada. The property covers 5,345 hectares, is winter road accessible, and is located approximately 63 km northeast of Keno Hill, Yukon. The Blende property lies within the Keno Hill silver district, one of Canada’s highest-grade historic silver producing districts, currently being advanced by Hecla Mining Company. The property has undergone more than $9.2 million in past exploration ($5.2 million by Blende Silver), including 25,195 meters of drilling in 132 drill holes. A current review of historical and recent data acquisition has demonstrated extensive potential to increase the mineralized envelope to the west, north and east-southeast of the project. On behalf of the Board of Directors “Andrew H. Rees” Andrew H. Rees President & CEO For further information, please contact: Andrew H. Rees, President & CEO Tel: 604-669-6463 NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE. This news release contains forward-looking statements and forward-looking information within the meaning of applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements regarding exploration results, interpretations, targets, future work programs, potential mineral resource updates, and the Company’s plans and expectations. These statements are based on assumptions management believes to be reasonable and are subject to known and unknown risks, uncertainties, and other factors, including risks related to mineral exploration and development, that may cause actual results to differ materially from those expressed or implied. Readers are cautioned not to place undue reliance on forward-looking information. Except as required by applicable securities legislation, the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. Mineral resources that are not mineral reserves do not have demonstrated economic viability. Inferred mineral resources are considered too speculative geologically to have economic considerations applied to them, and there is no certainty that all or any part of such resources will ever be upgraded to a higher category. View the original release on www.newmediawire.com
Positioned to Enhance Efficacy of Checkpoint Inhibitors and Next-Generation Oncology Modalities Across Solid Tumors ATLANTA, GA - April 27, 2026 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today highlighted the strategic positioning of its oncology asset, Gedeptin® (Ad/PNP), in the context of accelerating industry investment in next-generation in vivo cancer therapies. Recent high-profile transactions and investments across the biopharmaceutical sector underscore a growing focus on therapies designed to simplify delivery, improve scalability, and expanding therapeutic reach. As these approaches advance, a central challenge remains: many tumors are immunologically “cold,” limiting the effectiveness of even the most advanced therapeutic modalities. GeoVax believes Gedeptin is uniquely positioned to address this challenge. “While the industry is investing heavily in next-generation cell and gene therapies, the ability to positively modify the local tumor environment is believed to be one of the critical determinants of clinical success,” said David A. Dodd, Chairman and Chief Executive Officer of GeoVax. “Gedeptin is designed to directly destroy both proliferating and non-proliferating tumors, while also demonstrating high bystander activity due to the ability of the in situ generated cytotoxic agent ability to diffuse into neighboring tumor cells.” Gedeptin is a gene-directed enzyme prodrug therapy (GDEPT), delivered intratumorally, designed to generate PNP, selectively destroy both proliferating and non-proliferating tumor cells within the treated tumor. In vivo preclinical experiments have shown PNP treatment to be additive or synergistic with checkpoint blockade–type agents. For example, studies in preclinical in vivo tumor models of metastasis, have demonstrated treatment of a single lesion can robustly sensitize tumors to checkpoint blockade inhibitors, presumably by destroying tumor tissue (including the tumor microenvironment), exposing neoantigens, and enhancing immune response and activity of immune check point inhibitors (ICIs) at distant PNP-untreated lesions This dual mechanism - localized cytotoxicity combined with enhancing the immune response and activity of immune check point inhibitors against both Gedeptin treated and untreated tumors - has the potential to offer an improved therapeutic approach to addressing solid tumor metastatic disease. GeoVax has generated preclinical, clinical and translational data supporting Gedeptin’s ability to: Induce localized tumor cell death against both proliferating and non-proliferating tumors, while minimizing systemic toxicity Potentially improve response rates when combined with immune checkpoint inhibitors Aligned with the Next Phase of Immuno-Oncology Innovation As checkpoint inhibitors continue to move earlier in treatment paradigms, including neoadjuvant and first-line settings, the need for complementary approaches that enhance response rates is becoming increasingly evident. GeoVax is advancing Gedeptin in combination with checkpoint inhibition in a planned Phase 2 clinical trial in first-line head and neck cancer therapy, with additional solid tumor indications under evaluation. “Checkpoint inhibitors have transformed cancer care, but many patients still do not achieve durable responses,” said Kelly T. McKee, M.D., Chief Medical Officer of GeoVax. “We believe Gedeptin is well positioned as a combination-enabling platform designed to enhance therapeutic response across checkpoint inhibitors and other emerging oncology modalities.” About Gedeptin® Gedeptin® is a gene-directed enzyme prodrug therapy (GDEPT) delivered intratumorally using a non-replicating viral vector encoding purine nucleoside phosphorylase (PNP). Following administration of a systemically delivered prodrug, the encoded enzyme converts the prodrug into a cytotoxic agent directly within the tumor microenvironment. This localized approach is designed to selectively destroy tumor cells while promoting immune recognition and minimizing systemic toxicity. Gedeptin has received Orphan Drug Designation for oral and pharyngeal cancers. The Company continues to evaluate strategic partnerships and collaborations to advance the clinical development and potential commercialization of Gedeptin-based combination therapies. About GeoVax GeoVax Labs, Inc. is a clinical-stage biotechnology company focused on the development of vaccines and immunotherapies addressing high-consequence infectious diseases and solid tumor cancers. GeoVax’s priority program is GEO-MVA, a Modified Vaccinia Ankara (MVA)–based vaccine targeting mpox and smallpox. The program is advancing under an expedited regulatory pathway, with plans to initiate a pivotal Phase 3 clinical trial in the second half of 2026, to address critical global needs for expanded orthopoxvirus vaccine supply and biodefense preparedness. In oncology, GeoVax is developing Gedeptin®, a gene-directed enzyme prodrug therapy (GDEPT) designed to enhance immune checkpoint inhibitor activity. Gedeptin has completed a multicenter Phase 1/2 clinical trial in advanced head and neck cancer and is being advanced into combination strategies, including planned neoadjuvant and first-line settings. GeoVax’s broader pipeline includes the development of GEO-CM04S1, a next-generation COVID-19 vaccine candidate being evaluated in immunocompromised and other patient populations. GeoVax maintains a global intellectual property portfolio supporting its infectious disease and oncology programs and continues to evaluate strategic partnerships and funding opportunities aligned with its development priorities. For more information, visit www.geovax.com. Forward-Looking Statements This release contains forward-looking statements regarding GeoVax’s business plans. The words “believe,” “look forward to,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Actual results may differ materially from those included in these statements due to a variety of factors, including whether: GeoVax is able to obtain acceptable results from ongoing or future clinical trials of its investigational products, GeoVax’s immuno-oncology products and preventative vaccines can provoke the desired responses, and those products or vaccines can be used effectively, GeoVax’s viral vector technology adequately amplifies immune responses to cancer antigens, GeoVax can develop and manufacture its immuno-oncology products and preventative vaccines with the desired characteristics in a timely manner, GeoVax’s immuno-oncology products and preventative vaccines will be safe for human use, GeoVax’s vaccines will effectively prevent targeted infections in humans, GeoVax’s immuno-oncology products and preventative vaccines will receive regulatory approvals necessary to be licensed and marketed, GeoVax raises required capital to complete development, there is development of competitive products that may be more effective or easier to use than GeoVax’s products, GeoVax will be able to enter into favorable manufacturing and distribution agreements, and other factors, over which GeoVax has no control. Further information on our risk factors is contained in our periodic reports on Form 10-Q and Form 10-K that we have filed and will file with the SEC. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law. Company Contact: info@geovax.com 678-384-7220 Media Contact: Jessica Starman media@geovax.com
CALGARY, ALBERTA - April 27, 2026 (NEWMEDIAWIRE) - Upside Gold Corp. (“Upside” or the “Company”) (CSE: UG) (FSE: 47I) (OTCQB: UGODF) is pleased to announce the signing of a Letter of Intent (“LOI”) with a local prospector to acquire seven mineral claims totalling approximately 273 hectares located on the northwest side of the Company’s Kena Gold-Copper Property (“Kena” or the “Property”) in southeastern British Columbia. This proposed acquisition is intended to strengthen the continuity of the Kena land package by bringing together adjacent ground along a prospective trend. The claims cover historically mineralized areas and support the Company’s strategy of building scale across the Kena system. The claims encompass the original six reverted Crown grants that formed the historic Venus-Juno Group, which recorded past production of approximately 5,411 tonnes grading an average of 19.8 g/t gold and 17.7 g/t silver *, with minor copper and lead, during the first half of the 20th century. This history of high-grade production supports the presence of mineralization within the broader district and reinforces the exploration potential of this largely under-explored portion of the property. Geologically, the claims are underlain by altered mafic volcanic rocks of the Elise Formation adjacent to the Nelson granodiorite intrusion - the same regional geological setting that hosts gold and copper mineralization at Kena. Mineralization on the newly acquired claims is characterized by quartz veins and stringers containing pyrite, galena, sphalerite, and copper sulphides, consistent with mineralization styles observed elsewhere across the Kena Property. The Company plans to conduct a systematic surface evaluation program to assess the extent and continuity of gold-silver mineralization across the newly acquired claims and to determine their potential contribution to the broader Kena exploration model. The information in this press release has been reviewed and approved by Trevor Boyd, P.Geo., Vice President, Exploration of the Company and a Qualified Person for the technical information under NI 43-101 standards. Upside Gold Corp. On behalf of Upside Gold Corp. Sophy Cesar CEO and Director info@upsidegoldcorp.com www.upsidegoldcorp.com About Upside Gold Corp. Upside Gold Corp. is a Canadian gold-copper exploration company that has entered into an option agreement to acquire a 100% interest in the Kena Gold-Copper Project, located in southeastern British Columbia, approximately 7 kilometres southwest of Nelson. The Kena Project consists of 198 mineral claims covering 10,114.8 hectares, together with 11 crown grants covering approximately 92 hectares. The Corporation is focused on advancing the Kena Gold-Copper Project through systematic exploration and drilling programs. The Kena Project hosts a historical gold resource comprising an Indicated Mineral Resource of 32,146,000 tonnes at an average grade of 0.544 g/t Au for 0.561 million ounces of gold, and an Inferred Mineral Resource of 177,507,000 tonnes at an average grade of 0.486 g/t Au for 2.77 million ounces of gold. The historical resource estimate is disclosed in the technical report entitled “NI 43-101 Resource Estimate for the Kena and Daylight Properties” prepared by Sue Bird, P.Eng. of Moose Mountain Technical Services, dated May 3, 2021, and filed on SEDAR on behalf of West Mining Corp. A Qualified Person, as defined by National Instrument 43-101, has not done sufficient work to classify the historical estimate as current mineral resources, and Upside Gold Corp. is not treating the historical estimate as current mineral resources. The historical estimate is provided for information purposes only and should not be relied upon. To upgrade the historical estimate as current mineral resource additional drilling needs to be completed. The historical estimate uses the categories set out in section 1.2 of the NI-43-101. The parameters and assumptions used are outlined in Bird 2021 and are provided as follows: 1. Resources are reported using the 2014 CIM Definition Standards and were estimated using the 2019 CIM Best Practices Guidelines. 2. Mineral Resources that are not Mineral Reserves do not have demonstrated economic viability. 3. The Mineral Resource has been confined by a “reasonable prospects of eventual economic extraction” pit using the following assumptions: US $2,000/oz. Au at a currency exchange rate of 0.77 US$ per $CDN; 99.95% payable Au; $4.30/oz Au offsite costs (refining, transport and insurance); a 3% NSR royalty; and uses a 88% metallurgical recovery for gold. 4. Pit slope angles are assumed at 45 degrees. 5. The specific gravity of the deposit has been assigned as 2.8 based on sg measurements in the Kena deposit. Caution Regarding Forward-Looking Information This news release contains forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Upside Gold. Forward-looking statements include estimates and statements that describe Upside Gold's future plans, objectives or goals, including words to the effect that Upside Gold or its management expects a stated condition or result to occur. Forward-looking statements may be identified by such terms as "believes", "anticipates", "expects", "estimates", "may", "could", "would", "will", or "plan". Since forward-looking statements are based on assumptions and address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although these statements are based on information currently available to Upside Gold, Upside Gold provides no assurance that actual results will meet management's expectations. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Forward looking information in this news release includes, but is not limited to, Upside Gold’s objectives, goals or future plans, statements, details of the exploration results, potential mineralization, Upside Gold’s portfolio, treasury, management team and enhanced capital markets profile, the estimation of mineral resources, exploration and mine development plans, timing of the commencement of operations and estimates of market conditions. Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to, failure or inability to complete the Transaction on the terms as announced or at all, regulatory approval processes, failure to identify mineral resources, delays in obtaining or failures to obtain required governmental, regulatory, environmental or other project approvals, political risks, inability to fulfil the duty to accommodate First Nations and other indigenous peoples, uncertainties relating to the availability and costs of financing needed in the future, changes in equity markets, inflation, changes in exchange rates, fluctuations in commodity prices, delays in the development of projects, capital and operating costs varying significantly from estimates and the other risks involved in the mineral exploration and development industry, and those risks set out in Upside Gold public documents filed on SEDAR. Although Upside Gold believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Upside Gold disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law. Neither the CSE nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this news release. View the original release on www.newmediawire.com
VANCOUVER, BC - April 27, 2026 (NEWMEDIAWIRE) - Trailbreaker Resources Ltd. (TBK.V) (“Trailbreaker” or “the Company”) is pleased to announce the appointment of Mr. Charlie Greig, MSc, P. Geo, as a Technical Advisor to the Company. Mr. Greig is a British Columbia (BC)-based professional geologist with an extensive career and successful track record in mineral exploration. He has been involved in numerous projects ranging from grassroots-stage to production-stage development. Charlie’s involvement in projects put into production include: La India in Mexico (Grayd–Agnico Eagle), Wolverine in Yukon (Atna-Westmin, Yukon Zinc), Alamo Dorado in Mexico (Corner Bay-Pan American Silver), Brucejack Lake (Pretium), and Bisha in Eritrea (Nevsun). His involvement in advanced-stage projects includes: Ike (Amarc Resources), Red Mountain (Lac Minerals, Seabridge, Ascot Resources), Casino (Western Copper and Gold), and Silbak Premier-Big Missouri (Westmin, Ascot Resources). Mr. Greig served as Vice President of Exploration for GT Gold Corp. and was instrumental in leading the team to discover the Saddle North copper-gold (Cu-Au) porphyry deposit and the high-grade gold-silver mineralized zone at Saddle South. GT Gold was acquired by Newmont Corporation in 2021 for C$456 million. Most recently, Charlie has been the lead technical advisor for American Eagle Gold’s NAK project, a Cu-Au porphyry project near Smithers, BC, in partnership with Teck Resources and South32 Ltd. He has also acted as a technical advisor for Kingfisher Metals, Happy Creek Minerals, and Hercules Metals. He is currently Executive Chairman at Evergold Corp. and CEO of Metal Energy Corp. Daithi Mac Gearailt, CEO of Trailbreaker, commented, “We are delighted to welcome Charlie to the Trailbreaker team. His experience working in BC Cu-Au porphyry deposits will be instrumental in guiding exploration at our Coho, Atsutla, and Liberty projects.” As compensation for his role as Technical Advisor, Trailbreaker has issued Charlie Greig 100,000 stock options with a strike price of C$0.40 per share for a period of five years (see April 16, 2026 news release). About Trailbreaker Resources Trailbreaker Resources is a mining exploration company focused primarily on mining-friendly British Columbia and Yukon Territory, Canada. Trailbreaker is committed to continuous exploration and research, allowing maintenance of a portfolio of quality mineral properties which in turn provides value for shareholders. The company has an experienced management team with a proven track record as explorers and developers throughout the Yukon Territory, British Columbia, Alaska and Nevada. ON BEHALF OF THE BOARD Daithi Mac Gearailt President and Chief Executive Officer Carl Schulze, P. Geo., Consulting Geologist with Aurora Geosciences Ltd, is a qualified person as defined by National Instrument 43-101 for Trailbreaker's BC and Yukon exploration projects, and has reviewed and approved the technical information in this release. Other For new information about the Company’s projects, please visit Trailbreaker’s website at TrailbreakerResources.com and sign up to receive news. For further information, follow Trailbreaker’s tweets at Twitter.com/TrailbreakerLtd, use the ‘Contact’ section of our website, or contact us at (604) 681-1820 or at info@trailbreakerresources.com. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Forward-Looking Statements Statements contained in this news release that are not historical facts are "forward-looking information" or "forward-looking statements" (collectively, "Forward-Looking Information") within the meaning of applicable Canadian securities legislation and the United States Private Securities Litigation Reform Act of 1995. Forward-Looking Information includes, but is not limited to, disclosure regarding possible events, conditions or financial performance that is based on assumptions about future economic conditions and courses of action; expectations regarding future exploration and drilling programs and receipt of related permitting. In certain cases, Forward-Looking Information can be identified by the use of words and phrases such as "anticipates", "expects", "understanding", "has agreed to" or variations of such words and phrases or statements that certain actions, events or results "would", "occur" or "be achieved". Although Trailbreaker has attempted to identify important factors that could affect Trailbreaker and may cause actual actions, events or results to differ materially from those described in Forward-Looking Information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. In making the forward-looking statements in this news release, if any, Trailbreaker has applied several material assumptions, including the assumption that general business and economic conditions will not change in a materially adverse manner. There can be no assurance that Forward-Looking Information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on Forward-Looking Information. Except as required by law, Trailbreaker does not assume any obligation to release publicly any revisions to Forward-Looking Information contained in this news release to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. View the original release on www.newmediawire.com
Funding Advances 1,000-qubit Perspective System, 2D Design and Next-generation Optical Control Technologies NESS ZIONA, ISRAEL - April 27, 2026 (NEWMEDIAWIRE) - Quantum Art, a developer of full-stack trapped-ion quantum computers, today announced that it has extended its recently announced Series A financing to $140 million led by Bedford Ridge Capital alongside new investors, Hudson Bay Capital, Poalim Equity, LIP Ventures, Wolverine Global Ventures, and IDA Ventures. Strong investor demand drove the extension, building on Quantum Art’s $100 million Series A announced in December 2025 as the company moves toward large-scale, commercially viable quantum systems. The new funding will be used to accelerate development of Perspective, Quantum Art’s 1,000-qubit multi-core system designed to enable commercial-scale quantum computing. The capital will also support development of advanced optical technologies required for massive qubit scaling, expansion of the company’s 2D architecture roadmap, and accelerate global business development. “This extension of our Series A reflects strong investor confidence in Quantum Art’s architecture and long-term vision for scalable commercial quantum computing,” said Dr. Tal David, CEO and co-founder of Quantum Art. “The funding will accelerate development of our 1,000-qubit multi-core system, Perspective, and enable us to strengthen the core technologies behind our architecture while continuing to grow our global team as we move forward with commercialization.” “Our continued investment in Quantum Art reflects our view that scalability remains the defining challenge in quantum computing,” said Michael Reidler, Investment Partner at Bedford Ridge Capital. “Most approaches still run into scaling limitations, while Quantum Art’s architecture is designed to overcome those constraints. We believe that gives the company a meaningful advantage as the market matures.” “Quantum Art is tackling one of the most important challenges in the field: how to scale without compromising performance,” said Etai Kramer, Managing Director, Poalim Equity “We believe their approach and pace of execution to date position the company well within Israel’s growing quantum ecosystem and the broader global market and we are happy to support the development of quantum technologies here in Israel .” Quantum Art is entering its commercialization phase, transitioning from advanced technology development to market deployment. As part of this evolution, the company is preparing to launch its Quantum as a Service (QaaS) offering, which will serve as a central pillar of its go-to-market strategy. The QaaS platform is designed to bridge early-stage use-case development with customers to scalable access to quantum hardware, and ultimately to the commercialization of stand-alone quantum computing systems. Through this staged model, customers can progress seamlessly from algorithm exploration and co-development, to execution on live quantum systems. In parallel, Quantum Art is expanding its global footprint, establishing a presence in key international markets and building strategic partnerships to support customer engagement, business development, and long-term growth. About Quantum Art Quantum Art, an Israeli company founded in 2022 as a spin-off from the Weizmann Institute of Science, is a full-stack trapped-ion quantum computing company developing systems and solutions for complex computational problems. Its architecture combines scalable hardware with software designed for real-world applications in optimization, simulation, and advanced computing. For more information, visit https://www.quantum-art.tech/ Quantum Art Media Contact Kyle Porter EVP, Managing Director Virgo Public Relations Quantumart@virgo-pr.com 212.584.4289 View the original release on www.newmediawire.com
PITTSBURGH - April 27, 2026 (NEWMEDIAWIRE) - More than half of people who experience cardiac arrest outside a hospital don’t receive cardiopulmonary resuscitation (CPR) before emergency responders arrive, leaving a critical gap in survival. On Friday, April 24, nearly 1,300 people learned Hands-Only CPR during the NFL Draft, helping close that gap. During day two of the NFL Draft at Acrisure Stadium, Pittsburgh, Pa., American Heart Association instructors taught 1,293 people Hands-Only CPR in one hour, earning a GUINNESS WORLD RECORDS® title and expanding the Heart Association’s Nation of Lifesavers movement, focused on doubling the survival of sudden cardiac arrest by 2030 through CPR education and training. This effort, led by the American Heart Association, devoted to a world of healthier lives for all, alongside the National Football League, Damar Hamlin’s Chasing M’s Foundation and the most followed doctor on social media, Doctor Mike, brought together fans, volunteers and community members to build confidence and skills that can help save lives when it matters most. “Immediate CPR can double or even triple a person’s chance of survival,” said Nancy Brown, chief executive officer of the American Heart Association. “This record-setting moment with our incredible collaborators is about more than a number - it represents nearly 1,300 people who are now prepared to step in and help save a life. That’s how we build a Nation of Lifesavers.” Cardiac arrest remains a leading cause of death in the United States, affecting 350,000 people every year. Only 10% survive. But ordinary people have extraordinary power with this simple, two-step skill. Hands‑Only CPR takes as little as 90 seconds to learn, requires no formal training, and can double or even triple someone’s chances of surviving sudden cardiac arrest. Participants joined the growing Nation of Lifesavers™, a global movement launched by the American Heart Association in 2023 following the sudden cardiac arrest of NFL player Damar Hamlin during Monday Night Football™. Since its launch, the initiative has focused on expanding CPR education, increasing access to automated external defibrillators (AEDs) and building confidence to act in an emergency. “As my experience with cardiac arrest has shown, CPR really does save lives,” said Hamlin, Buffalo Bills Safety and National Ambassador for the Nation of Lifesavers. “To see my hometown come together to set this record and learn this skill is incredibly meaningful, and I’m proud to see the NFL, the American Heart Association, and our community come together to build a life-saving legacy.” The record-setting effort was inspired by longtime American Heart Association volunteer, leading health influencer and board-certified family medicine physician, Dr. Mike Varshavski, known as Doctor Mike to his 30 million social media followers. “Breaking this record shows how quickly people can learn a lifesaving skill,” said Doctor Mike. “In just one hour, nearly 1,300 people learned what the American Heart Association and I say every day, which is ‘chest compressions, chest compressions, chest compressions.’ Providing CPR gives someone the best chance of survival. It can be the difference between life and death for thousands of people every year. Now these people know, the power is in their hands.” The collaboration between the American Heart Association and the NFL continues year-round through community-based CPR education, youth health programs and national advocacy efforts. Through support from the NFL Foundation, teams across the country are helping expand access to CPR training and AED in local communities, helping them better prepare for cardiac emergencies where people live, work and play. “Today’s record reflects what’s possible when we come together around a shared purpose,” said Anna Isaacson, NFL SVP of Social Responsibility. “We’re thrilled to stand alongside the American Heart Association and the Chasing M’s Foundation as we successfully set a world record, and, more importantly, equip thousands of people with the skills to make a lifesaving difference.” Nearly 3 out of 4 cardiac arrests happen at home, making it important for more people to know how to respond. If a teen or adult collapses, witnesses should immediately take action calling 9-1-1 emergency services and beginning chest compressions at a rate of 100-120 beats per minute and a depth of approximately two inches. Hands-Only CPR is chest compression-only CPR for adults. Infants and children require traditional CPR with breaths. Learn CPR today, visit www.heart.org/nation. Additional Resources: Multimedia is available on the right column of this release link. Bystander CPR | Bystander CPR Infographic (PDF) Hands-Only CPR Resources Hands-Only CPR vs CPR with Breaths Cardiac Arrest vs. Heart Attack Take 90 seconds to learn how to save a life at www.heart.org/HandsOnlyCPR. About the American Heart Association The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public’s health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on heart.org, Facebook, X or by calling 1-800-AHA-USA1. For Media Inquiries: American Heart Association: Linzy Cotaya, linzy.cotaya@heart.org National Football League: Ian Martin, Ian.Martin@nfl.com Damar Hamlin’s Chasing M’s Foundation: Kelley Denny, kdenny@ghadv.com For Public Inquiries: 1-800-AHA-USA1 (242-8721) heart.org and stroke.org View the original release on www.newmediawire.com
Research Highlights: Researchers studied the link between cardiovascular-kidney-metabolic syndrome (CKM syndrome) and risk of cancer. CKM syndrome refers to several connected health conditions, including heart disease, stroke, kidney disease, obesity and diabetes. They compared people with no risk factors for CKM syndrome to those with early- and late-stage CKM syndrome. Later-stages of CKM syndrome were linked with a 25-30% higher risk of cancer in a study of nearly 1.4 million adults. DALLAS - April 27, 2026 (NEWMEDIAWIRE) - People with advanced heart, kidney and metabolic disease may face a higher risk of developing cancer, according to new research published today in the American Heart Association’s peer-reviewed scientific journal Circulation: Population Health and Outcomes. The combination of heart, kidney and metabolic conditions (diabetes and obesity) is known as cardiovascular-kidney-metabolic syndrome, or CKM syndrome. The biggest dangers from CKM syndrome are death and disability from heart disease and stroke. However, nearly every major organ system is affected by CKM syndrome, linking it to kidney failure, dementia, fatty liver disease, obstructive sleep apnea and increased risk for cancer. According to American Heart Association statistics, nearly 9 out of 10 adults in the U.S. have at least one component of CKM syndrome, which includes high blood pressure, abnormal cholesterol, high blood glucose (sugar), excess weight and reduced kidney function. “The study findings suggest that it is important to consider not only cardiovascular disease risk, but also cancer risk in people with CKM syndrome,” said Hidehiro Kaneko, M.D., Ph.D., the study’s lead author and associate professor in the department of cardiovascular medicine at the University of Tokyo in Japan. CKM syndrome is broken down into stages by severity, ranging from stage 0 with no risk factors to stage 4 with cardiovascular disease such as heart attack, stroke or heart failure. Researchers at the University of Tokyo in Japan investigated the link between CKM syndrome and cancer, and whether CKM syndrome stage could shed light on someone’s risk for cancer. They reviewed national insurance claims data to determine the CKM syndrome stage for nearly 1.4 million people based on the framework in the American Heart Association's Cardiovascular-Kidney-Metabolic Health presidential advisory. The researchers then tracked participants for around 3 ½ years, noting any new cancer diagnoses. Study results: Compared with healthy participants (CKM syndrome stage 0), cancer risk increased sharply only in the later stages of CKM syndrome: Stage 1 – 3% higher risk of developing cancer Stage 2 – 2% higher risk of developing cancer Stage 3 – 25% higher risk of developing cancer Stage 4 – 30% higher risk of developing cancer “CKM syndrome represents a complex interplay among the cardiovascular, kidney and metabolic systems, where dysfunction in one area may trigger or exacerbate dysfunction in others,” Kaneko said. “Dysfunction in each of these systems is independently associated with cancer risk due to shared risk factors. This study suggests that the accumulation of risk factors within the framework of CKM syndrome may contribute to the development of various types of cancer.” “We already know that cancer and its therapies can lead to cardiotoxicities and cardiovascular disease,” said American Heart Association volunteer, Tochukwu Okwuosa, D.O., who is director of cardio-oncology services at Rush University Medical Center in Chicago. “The study highlights the bidirectional relationship and underscores the concept of reverse cardio-oncology where cardiovascular disease and its risk factors also increase cancer risk. Consequently, healthy lifestyle choices potentially impact both conditions that are the leading causes of death in the United States. For those with established cardiovascular risk, the CKM syndrome staging framework may be a useful tool to flag high risk individuals for potential cancer screenings and evaluations.” According to the manuscript, a limitation of the study is that results from a Japanese population may not be fully generalizable to other countries. However, other studies have “consistently reported that metabolic and kidney dysfunction are associated with increased risk of cancer,” supporting the possibility that the findings apply in other populations. Co-authors, disclosures and funding sources are listed in the manuscript. Studies published in the American Heart Association’s scientific journals are peer-reviewed. The statements and conclusions in each manuscript are solely those of the study authors and do not necessarily reflect the Association’s policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. The Association receives more than 85% of its revenue from sources other than corporations. These sources include contributions from individuals, foundations and estates, as well as investment earnings and revenue from the sale of our educational materials. Corporations (including pharmaceutical, device manufacturers and other companies) also make donations to the Association. The Association has strict policies to prevent any donations from influencing its science content and policy positions. Overall financial information is available here. More than 8 in 10 (82%) U.S. adults say they are confident in the American Heart Association to provide trustworthy information related to public health, according to a recent Annenberg Policy Center poll. The Association ranked second only to an individual’s personal health care provider. Additional Resources: Multimedia is available on the right column of release link. Spanish news release After Monday, April 27, view the manuscript online. Also, view the accompanying editorial, CKM Syndrome: A Usable Framework in Cancer Risk Assessment? American Heart Association news release: Millions are unaware of heart risks that don’t start in the heart (Feb. 2026) American Heart Association’s CKM Health Initiative Follow American Heart Association/American Stroke Association news on X @HeartNews Follow news from the American Heart Association’s Circulation: Population Health and Outcomes journal @CircOutcomes. About the American Heart Association The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public’s health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on heart.org, Facebook, X or by calling 1-800-AHA-USA1. For Media Inquiries and American Heart Association Expert Perspective: 214-706-1173 Maggie Francis: Maggie.Francis@heart.org For Public Inquiries: 1-800-AHA-USA1 (242-8721) heart.org and stroke.org View the original release on www.newmediawire.com
LOS ANGELES, CA - April 24, 2026 (NEWMEDIAWIRE) - Datavault AI (NASDAQ: DVLT) announced the live deployment of its ADIO(R) athlete engagement platform at the NFL Draft, delivering real-world validation of the technology in a high-profile, high-demand environment through its partnership with the NFL Alumni Health initiative. The company said the activation is generating strong engagement among draftees, alumni and league stakeholders, reinforcing the platform’s scalability and commercial viability, while supporting its push toward the launch of DataVault NILX, a name, image and likeness monetization platform targeting a rapidly growing multi-billion-dollar market opportunity across collegiate NIL and global sports sponsorship. To view the full press release, visit https://ibn.fm/PrSv0 About Datavault AI Inc. Datavault AI is leading the way in AI experience, valuation, and monetization of assets in the Web 3.0 environment. The company’s cloud-based platform provides comprehensive solutions with a collaborative focus in its Acoustic Science and Data Science Divisions. Datavault AI’s Acoustic Science Division features WiSA(R), ADIO(R) and Sumerian(R) patented technologies and industry first foundational spatial and multichannel wireless HD sound transmission technologies with IP covering audio timing, synchronization and multi-channel interference cancellation. The Data Science Division leverages the power of Web 3.0 and high-performance computing to provide solutions for experiential data perception, valuation and secure monetization. Datavault AI’s cloud-based platform provides comprehensive solutions serving multiple industries, including HPC software licensing for sports & entertainment, events & venues, biotech, education, fintech, real estate, healthcare, energy and more. The Information Data Exchange(R) (IDE) enables Digital Twins, licensing of name, image, and likeness (NIL) by securely attaching physical real-world objects to immutable metadata objects, fostering responsible AI with integrity. Datavault AI’s technology suite is completely customizable and offers AI and Machine Learning (ML) automation, third-party integration, detailed analytics and data, marketing automation and advertising monitoring. The Company is headquartered in Philadelphia, PA. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law View the original release on www.newmediawire.com
LOS ANGELES, CA - April 24, 2026 (NEWMEDIAWIRE) - Onshore basins of genuine scale that remain undrilled are increasingly rare. Most of the world’s major hydrocarbon-producing regions have been systematically tested over the past half-century, leaving frontier opportunities concentrated in geographies with challenging logistics, complex permitting, or historically limiting macroeconomic conditions. Greenland Energy holds rights to up to 70% working interest across three onshore licenses covering more than 2 million acres in East Greenland’s Jameson Land Basin. The company has contracted Stampede Drilling for Arctic-rated rig services alongside agreements with Halliburton, Desgagnés, and IPT Well Solutions to support its 2026 drilling campaign. Where such basins remain, they carry a combination of technical risk and optionality that draws a specific type of investor interest. The Jameson Land Basin in East Greenland, a petroleum basin historically evaluated by a Large Multinational US Petroleum company but never drilled, represents one of the most prominent examples of that profile. Greenland Energy (NASDAQ: GLND) is the publicly traded… Read More Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law. View the original release on www.newmediawire.com
LOS ANGELES, CA - April 24, 2026 (NEWMEDIAWIRE) - HeartBeam (NASDAQ: BEAT) was featured in a recent article that discussed its collaboration with Mount Sinai aimed at advancing artificial intelligence-driven electrocardiogram technology. The publication indicates that the move, “highlights HeartBeam’s growing focus on artificial intelligence (‘AI’)-enabled analysis and reinforces the relevance of its technology as healthcare increasingly shifts toward data-driven, remote monitoring solutions. The announcement outlines a strategic collaboration between HeartBeam and Mount Sinai to develop and validate high value, AI-based ECG algorithms that can be deployed broadly across HeartBeam’s platform. These AI models may include patient-relevant wellness insights, condition-focused assessments, and applications for chronic condition management.” To view the full article, visit https://ibn.fm/oTJHB About HeartBeam Inc. HeartBeam is a medical technology company dedicated to transforming cardiac care by providing powerful cardiac insights wherever the patient is. The company is creating the first-ever cable-free 12-lead ECG capable of capturing the heart’s electrical signals from three dimensions. This platform technology is designed to be used in portable devices that can be used wherever the patient is to deliver actionable heart intelligence. Physicians will be able to identify cardiac health trends and acute conditions and direct patients to the appropriate care - all outside of a medical facility, thus redefining the future of cardiac health management. The company holds 13 U.S. and 4 international-issued patents related to technology enablement. For more information, visit www.HeartBeam.com. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer The latest news and updates relating to BEAT are available in the company’s newsroom at https://ibn.fm/BEAT Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law View the original release on www.newmediawire.com
LOS ANGELES, CA - April 24, 2026 (NEWMEDIAWIRE) - Versus Systems (NASDAQ: VS) is a technology company focused on enhancing the way audiences interact with content across digital and live environments. “The company’s platform enables brands, teams, and content creators to integrate interactive elements directly into their experiences, allowing users to participate in games and earn real-world rewards while engaging with media,” reads an article discussing the company. “By combining gameplay mechanics with promotional functionality, Versus provides a framework for turning passive audiences into active participants. Its patented earned-rewards system is designed to operate across mobile, web, broadcast, and in-venue formats, supporting both audience participation and measurable brand interaction without requiring significant development resources.” To view the full article, visit https://ibn.fm/a654j About Versus Systems Inc. Versus Systems is a leading provider of gamification and audience engagement technology. Its platform enables brands, teams, and entertainment partners to create rewarding interactive experiences that transform how they connect with consumers worldwide. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law
LOS ANGELES, CA - April 24, 2026 (NEWMEDIAWIRE) - D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave” or the “Company”), the only dual-platform quantum computing company providing both annealing and gate-model systems, software and services, today announced it will release its financial results for the first quarter of fiscal year 2026 ended March 31, 2026 on Tuesday, May 12, 2026 before market open. The press release will be available on the D-Wave Investor Relations website: https://ir.dwavequantum.com. In conjunction with this announcement, D-Wave will host a conference call on Tuesday, May 12, 2026, at 8:00 a.m. (Eastern Time), to discuss the Company’s financial results and business outlook. The live dial-in number is 1-833-890-9920 (domestic) or 1-412-564-6463 (international). Participants can use those dial-in numbers or can click this link for instant telephone access to the event. The link will be made active 15 minutes prior to the call’s scheduled start time. An on-demand webcast will be available and a transcript of the conference call will be posted on the D-Wave Investor Relations website after the call. Participating in the call will be Chief Executive Officer Dr. Alan Baratz and Chief Financial Officer John Markovich. To view the full press release, visit https://ibn.fm/ZwlUJ About D-Wave Quantum Inc. D-Wave is a leader in the development and delivery of quantum computing systems, software, and services. It is the world’s first commercial supplier of quantum computers, and the first and only to offer dual-platform quantum computing products and services, spanning both annealing and gate-model quantum computing technologies. D-Wave’s mission is to help customers realize the value of quantum today through enterprise-grade systems available on-premises and via its LeapTM quantum cloud service, which offers 99.9% availability and uptime. More than 100 organizations across commercial, government and research sectors trust D-Wave to address complex computational challenges using quantum computing. Learn more about realizing the value of quantum computing today and how D-Wave is shaping the quantum-driven industrial and societal advancements of tomorrow: www.dwavequantum.com. Forward-Looking Statements Certain statements in this press release are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by the following words: “believe,” “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “trend,” “estimate,” “predict,” “project,” “potential,” “seem,” “seek,” “future,” “outlook,” “forecast,” “projection,” “continue,” “ongoing,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management’s control, including the risks discussed under the caption “Item 1A. Risk Factors” in Part I of our most recent Annual Report on Form 10-K or any updates discussed under the caption “Item 1A. Risk Factors” in Part II of our Quarterly Reports on Form 10-Q and in our other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this press release in making an investment decision, which are based on information available to us on the date hereof. We undertake no duty to update this information unless required by law. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law View the original release on www.newmediawire.com
By Meg Flippin, Benzinga DETROIT, MICHIGAN - April 24, 2026 (NEWMEDIAWIRE) - Feeling safe is more than a state of mind; it is the foundation of freedom for countless women around the country. Without the confidence to move freely, women tend to limit their activities, change when and where they travel and curtail their social interactions. For some women, a lack of personal safety can be paralyzing, preventing them from living a full and independent life. That is particularly true among women between the ages of 18 and 25. A recent survey by LogicMark, Inc. (OTC: LGMK), a leading provider of personal emergency response systems and developer of the Aster safety app, found that 44% of women between the ages of 18 and 25 reported moderate to significant limitations to their lives due to safety concerns. That includes avoiding routes, activities, travel and social events. Overall, 38% of women surveyed said safety concerns limit their daily activities. These concerns can quietly shape careers, fitness and social choices. After all, women may forgo pursuing a specific field because of late-night shifts or travel requirements, opt not to jog out of safety concerns and skip evening social events if it means traveling home alone. Over time, everyday decisions compound into something much larger: a gradual erosion of mobility, independence and overall quality of life. When safety anxiety consistently dictates where someone can go, when they can leave or how they get home, it limits not just movement, but opportunity. Career paths that require travel or late hours become less accessible. Fitness routines, like running outdoors or going to the gym at night, are adjusted or abandoned. Social lives shrink as spontaneity is replaced with calculation. What begins as precaution quietly becomes restriction, shaping life choices in ways that are often invisible but deeply impactful. As highlighted in LogicMark’s survey, safety concerns don’t just create fear - they actively limit participation, particularly among younger women navigating formative years of independence and identity. These limitations aren’t driven by perception alone. Of the women surveyed by LogicMark, over half said they have experienced situations where they felt unsafe, with younger women indicating they have felt this way repeatedly. Yet when they felt unsafe, they couldn’t reach help. That’s because the safety devices they rely on - high-decibel personal sirens, oversized pepper spray canisters or heavy flashlights - aren’t easily accessible, practical to carry or capable of contacting emergency services. Always-On Safety With Aster For women to feel safe and participate in life to the fullest, they need a safety device that is reliable and always available. That kind of consistent access doesn’t just provide protection - it builds confidence and reduces the need for constant vigilance. That’s what LogicMark is delivering with its Aster app and Aster SOS Safety button. The Aster app transforms a smartphone into a connected safety tool with multiple ways to access help quickly and discreetly. Users can trigger support via a home-screen slider for immediate emergency access, a Hold Until Safe feature to proactively arm monitoring in uncertain situations and a Follow-Me feature that schedules safety check-ins during travel or activities. If a user becomes unresponsive, the app automatically escalates to emergency support, ensuring help can be dispatched even if they can’t initiate it themselves. Location sharing is activated only during an emergency, balancing faster response with user privacy. Bluetooth Button For Convenient Safety Complementing the app is the Aster Bluetooth button, a compact, wearable device designed for fast, discreet access to help without unlocking a phone or having the app open. The button can be clipped to a purse, keychain, backpack or clothing and connects directly to the Aster app. With three presses, users are connected to a 24/7 monitoring center, where an agent can assess the situation and stay on the line until the user is safe. Coupled with the Aster app, it acts as a quick-access emergency device. The button’s small form factor and long battery life make it easy to carry consistently, ensuring support is always within reach when a phone may not be. Aster and the Aster SOS Safety Button provide women with continuous monitoring that works even when they can’t initiate help on their own. By providing a safety net that doesn't require constant vigilance, Aster can give them the confidence to reclaim their mobility and independence, ensuring they don’t have to shrink their lives or alter their behavior just to feel secure. To learn more about LogicMark and Aster, click here. Featured image from Shutterstock. This content was originally published on Benzinga. Read further disclosures here. This post contains sponsored content and was created in collaboration with a third-party partner. Benzinga is a publisher and does not provide personalized investment advice or act as a broker or dealer. This content is for informational purposes only and is not intended to be investing advice or an offer or solicitation to buy or sell any security. View the original release on www.newmediawire.com
CALGARY, ALBERTA - April 24, 2026 (NEWMEDIAWIRE) - Guardian Exploration Inc. (TSXV: GX) (OTCQB: GXUSF) (Frankfurt: R6B) (“Guardian” or the “Company”) is pleased to announce the formation of its Advisory Board, a strategic initiative designed to strengthen the Company’s leadership capacity as it advances its exploration and development objectives. As part of this initiative, the Company is delighted to welcome Ms. Elena Baranova to its Advisory Board. Ms. Baranova is an accomplished international strategic advisor and cross-border negotiator with extensive experience spanning corporate finance, energy, mining, and large-scale infrastructure projects across global markets. Her expertise includes international legal structuring, sovereign and government negotiations, complex transactions, and the development of large-scale capital-intensive projects. She brings a strong track record of working across Europe, the United Kingdom, the Middle East, Africa, and Asia, with a focus on energy transition and critical minerals. Graydon Kowal, President & Chief Executive Officer of Guardian, commented: “Ms. Baranova brings a rare combination of global transactional expertise and hands-on experience in developing complex energy and resource projects. Her deep understanding of international markets, government negotiations, and capital structuring will be invaluable as Guardian continues to advance its strategic initiatives. We are very pleased to welcome her to our Advisory Board.” About Elena Baranova Elena Baranova is a Solicitor of England & Wales and a highly experienced international advisor in corporate finance, energy, mining, and infrastructure development. She began her legal career at leading international law firms, including Osborne Clarke and Ogier, where she advised on high-value financings, mergers and acquisitions, IPOs, and complex cross-border transactions. Her experience includes involvement in landmark transactions such as UC Rusal’s US$26 billion IPO and Glencore’s US$61 billion dual listing. She has also advised on corporate governance and restructuring, M&A and commercial matters for major global companies, including Rio Tinto, Norilsk Nickel, Randgold Resources (now Barrick Mining Corporation), Erdenes Mongol, Jordan Intrah (Oil & Gas) Group, Jindal Steel, and other multinational organizations. Ms. Baranova is a Co-Founder of IM Power Plc, a UK-based independent power producer. As Executive Director she led the development of major energy infrastructure projects, including US$1.2 billion power plant in Mongolia supporting large-scale mining operations. She has worked extensively with international financial institutions and multinational partners across Asia, the Middle East, and Africa. She is also the Founder and Managing Director of Astera Group, which focuses on strategic opportunities in energy transition and critical minerals, including rare earths, battery storage, and renewable energy infrastructure. Her work involves advising governments, investors, and global industry stakeholders on complex, high-impact projects. Ms. Baranova holds GDL and LPC degrees (awarded with Distinction) from The University of Law (ULaw) in the United Kingdom and is a qualified Solicitor of England & Wales. She is a member of the Law Society of the United Kingdom, serves as a judge for the International Property Awards, and is actively involved in several international organizations, including the Eurasia Critical Minerals Organization and the British-Uzbek Society. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. About Guardian Exploration Inc. Guardian Exploration Inc. is a TSXV-listed company (TSXV: GX) (OTCQB: GXUSF) (Frankfurt: R6B) engaged in oil, gas, and mineral exploration and development. Guardian’s assets include the Sundog and Esker gold projects in Nunavut’s Kivalliq Region, the Mount Cameron Property in Yukon’s Mayo Mining District, and the Kaigani claims in Southeast Alaska. On Behalf of the Board of Guardian Exploration Inc. “Graydon Kowal” Graydon Kowal President & Chief Executive Officer FOR FURTHER INFORMATION PLEASE CONTACT: Graydon Kowal President & Chief Executive Officer Tel: (403) 730-6333 Email: gkowal@guardianex.com CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: Forward-looking statements in this news release are based on management’s expectations as of the date hereof and relate primarily to the Company’s exploration plans, project evaluation activities, and strategic objectives. This news release includes certain “forward-looking statements” within the meaning of applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements regarding planned or future exploration activities, potential follow-up programs, the advancement of exploration targets, potential drilling programs, future permitting, and the Company’s strategic objectives and priorities. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable at the time they are made, are subject to known and unknown risks, uncertainties, and other factors that may cause actual results or future events to differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to, exploration and development risks, results of exploration activities, availability of financing, receipt of regulatory and stock exchange approvals, permitting timelines, environmental and Indigenous consultation processes, operational and logistical challenges, commodity price fluctuations, and general economic and market conditions. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated. Accordingly, readers should not place undue reliance on forward-looking statements. Guardian Exploration Inc. disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by applicable law. View the original release on www.newmediawire.com
CARACAS, VENEZUELA - April 24, 2026 (NEWMEDIAWIRE) - Catalyst Crew Technologies Corp. (OTC: CCTC) (the “Company”), a digital health and artificial intelligence technology company developing telehealth infrastructure and healthcare analytics platforms for emerging markets, today provided an update regarding its ongoing regulatory, compliance, and initial deployment activities related to its telehealth platform in Venezuela. The Company continues to advance early-stage deployment, testing, and refinement of its telehealth platform as part of its broader development process. The platform shall be accessible through its digital interface at https://latamedai.org, where the Company is presently and actively evaluating system performance, user workflows, and operational capabilities as part of its initial launch. The Company’s telehealth platform is designed to support remote patient engagement, care coordination, and the integration of artificial intelligence-driven healthcare analytics tools within a technology-enabled healthcare environment. Current efforts are focused on enhancing platform functionality, improving data integration, and optimizing the overall user experience. In parallel with these development activities, the Company is working with the Ministerio del Poder Popular para la Salud, including the Servicio Autónomo de Contraloría Sanitaria (SACS), in connection with obtaining the required Permiso Sanitario de Funcionamiento para Plataforma Digital. The Company is actively progressing through the applicable regulatory process and coordinating with relevant authorities to address documentation, operational procedures, and compliance standards associated with the platform. Management currently anticipates that the permitting process may be completed in the near term; however, no assurance can be provided as to the timing or outcome of such process. The Company believes that this phase of deployment, testing, and regulatory alignment represents an important step in advancing its telehealth platform toward broader operational rollout across its target markets. Dr. Kevin Rodan Levy, Chief Executive Officer of Catalyst Crew Technologies Corp., stated: “Our focus is on building a scalable telehealth platform that can operate effectively within real-world healthcare environments. We are currently advancing platform testing, refinement, and regulatory alignment as we continue to build the foundation for broader deployment across Latin America. We expect a full launch in short order and upon receiving all regulatory approvals.” The Company continues to advance the development and operational deployment of its digital health and artificial intelligence platform, including its telehealth infrastructure and AI-driven healthcare analytics capabilities. For more information, please visit https://catalystcrewai.com or review the Company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov. About Catalyst Crew Technologies Corp. Catalyst Crew Technologies Corp. is an artificial intelligence-driven healthcare technology company focused on developing scalable digital health solutions for emerging markets, with an initial emphasis on Latin America. The Company is actively executing its strategic transition into AI-enabled healthcare and pursuing opportunities across telehealth infrastructure, remote patient monitoring, healthcare data analytics, and integrated digital care platforms designed to improve access, efficiency, and care coordination. Through technology development initiatives, strategic partnerships, and targeted acquisitions, CCTC is building an integrated healthcare technology platform positioned to address the growing demand for modernized healthcare delivery systems across emerging markets. Forward-Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements include, but are not limited to, statements regarding the Company’s business strategy, leadership initiatives, strategic transactions, operational execution, regulatory matters, and future operations. Forward-looking statements are based on current expectations and assumptions that involve risks and uncertainties. Actual results may differ materially from those expressed or implied due to various factors, including but not limited to the Company’s ability to successfully implement its business plan, secure financing, complete acquisitions, comply with regulatory requirements, and general market and economic conditions. The Company undertakes no obligation to update any forward-looking statements except as required by applicable law. Disclaimer This press release is provided for informational purposes only and does not constitute an offer to sell or the solicitation of an offer to buy any securities of the Company. The Company is a development-stage enterprise and has not generated revenues from its newly announced business direction. There can be no assurance that the Company will successfully implement its business plan, complete acquisitions, secure financing, obtain regulatory approvals, or generate revenues. Any investment decision should be made solely on the basis of information contained in the Company’s filings with the U.S. Securities and Exchange Commission and other publicly available documents. The Company’s securities involve a high degree of risk. Prospective investors are urged to carefully review all risk factors and disclosures contained in the Company’s SEC filings before making any investment decision. No representation or warranty, express or implied, is made as to the accuracy or completeness of the information contained herein. Investor Relations Contact +1 (787) 476-2350 ir@catalystcrew.ai View the original release on www.newmediawire.com
DALLAS - April 24, 2026 (NEWMEDIAWIRE) - Approximately 1 in 5 children in the United States live with obesity - the same number of children who get the recommended 60 minutes of daily physical activity. To support student health and well-being nationwide, the American Heart Association and the National Football League (NFL) recently awarded grants to 188 schools in 45 states through the Association’s school-based programs, Kids Heart Challenge™ and American Heart Challenge™. This is the second round of grants awarded this year from the $350,000 annual funding pool provided by the NFL through NFL PLAY 60, a campaign supported by the American Heart Association to improve the health of young people by getting them active for at least 60 minutes every day. The expanded funding pool builds on the existing school grant program established by the American Heart Association, a relentless force changing the future of health for everyone everywhere, which in this latest cycle funded CPR readiness programs in schools. “Educators know what their students need to thrive, and this grant program is designed to help them get there by providing schools with health-focused and cardiac emergency readiness resources that might not otherwise be attainable,” said Nancy Brown, chief executive officer of the American Heart Association. “We are grateful to the NFL’s support in helping to ensure that children everywhere have equal opportunities to live longer, healthier lives, regardless of who they are or where they live.” NFL PLAY 60 grants support specific areas of need identified by schools and educators, including physical activity equipment, FLAG football, recess enhancements and inclusive physical education, and well-being resources. NFL PLAY 60 is an initiative designed to help children develop healthy habits for a better chance at a longer, healthier life. Rooted in science, the program encourages kids to get a minimum of 60 minutes of vigorous physical activity each day to meet the U.S. Department of Health and Human Services’ Physical Activity Guidelines for Americans. NFL mascots in the NFL PLAY 60 Ambassador Class are also working to inspire kids to move more to support mental and physical well-being. The current ambassador class includes Freddie Falcon, Atlanta Falcons; Gumbo, New Orleans Saints; Rampage, Los Angeles Rams; Roary, Detroit Lions; Rowdy, Dallas Cowboys; Sir Purr, Carolina Panthers; and T-Rac, Tennessee Titans. During the NFL Draft in Pittsburgh, Pennsylvania, the Association and NFL are also working together to claim the GUINNESS WORLD RECORDS® title for most people to complete CPR training in one hour. The feat will be attempted with support from Damar Hamlin’s Chasing M’s foundation and the most followed doctor on social media, Doctor Mike, on Friday, April 24, from 1-2 p.m. ET at Acrisure Stadium. The effort is designed to encourage fans, families and communities to join the Nation of Lifesavers™ by learning the simple, lifesaving skill of Hands-Only CPR. Participation is free and registration is open at heart.org/NFLDraft. Grant applications are accepted year-round, and another group of recipients will be announced in June. More information on NFL PLAY 60 resources and available grant opportunities can be found online at heart.org/NFLPLAY60. About the American Heart Association The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public’s health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on heart.org, Facebook, X or by calling 1-800-AHA-USA1. About NFL PLAY 60 NFL PLAY 60 is the League’s national youth health and wellness platform. For nearly 20 years, the initiative has empowered millions of youth to get physically active for at least 60 minutes a day and provided support for programs and resources so that kids everywhere can lead a healthy lifestyle. Alongside the NFL’s 32 NFL clubs and partners, the PLAY 60 movement will continue to serve and motivate the next generation of youth to get active and PLAY 60. For more information, visit NFL.com/PLAY60. For Media Inquiries: American Heart Association: Linzy Cotaya, linzy.cotaya@heart.org National Football League : Ian Martin, Ian.Martin@nfl.com For Public Inquiries: 1-800-AHA-USA1 (242-8721) heart.org and stroke.org View the original release on www.newmediawire.com
VANCOUVER, BC - April 24, 2026 (NEWMEDIAWIRE) - Trailbreaker Resources Ltd. (TBK.V) (“Trailbreaker” or “the Company) announces that it is adopting semi-annual financial reporting in place of quarterly reporting, effective for the three-month interim period ending (Q1 2026 period end date). This news release is being filed pursuant to Coordinated Blanket Order 51-933 Exemptions to Permit Semi-Annual Reporting for Certain Venture Issuers. The British Columbia Securities Commission recently issued Coordinated Blanket Order 51-933, which allows eligible venture issuers listed on the TSX Venture Exchange or Canadian Securities Exchange to file financial reports twice a year rather than four times. Trailbreaker meets the conditions of the Order and will begin relying on it starting with its Q1 2026 interim period. As a result, the Company will not be filing an interim financial report or related MD&A for the three-month period ending March 31, 2026, nor for its nine-month period ending September 30, 2026. Trailbreaker will continue to file audited annual financial statements and semi-annual interim reports as required. "For a company at our stage, preparing quarterly financial reports is a significant administrative burden relative to the information value they provide to our shareholders," said Daithi Mac Gearailt, President and CEO of Trailbreaker Resources Ltd. "Shifting to semi-annual reporting lets us direct more of our resources toward exploration and creating value in the ground, while still meeting our disclosure obligations to investors." Daithi Mac Gearailt President and Chief Executive Officer For new information about the Company’s projects, please visit Trailbreaker’s website at TrailbreakerResources.com and sign up to receive news. For further information, follow Trailbreaker’s tweets at Twitter.com/TrailbreakerLtd, use the ‘Contact’ section of our website, or contact us at (604) 681-1820 or at info@trailbreakerresources.com. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. View the original release on www.newmediawire.com
Attracting Some 13,000 Global Buyers, Industry Expresses Optimism Regarding Future Sales Prospects HONG KONG - April 24, 2026 (NEWMEDIAWIRE) - The 3rd Smart Lighting Expo and the 17th Hong Kong International Lighting Fair (Spring Edition), organised by the Hong Kong Trade Development Council (HKTDC), successfully concluded today at the Hong Kong Convention and Exhibition Centre. The four-day fairs brought together some 900 exhibitors and attracted some 13,000 buyers from 114 countries and regions for on-site visits and sourcing. Buyer numbers recorded growth, including those from Asian markets such as Malaysia and the Philippines; European markets including France, Germany, the Netherlands, Russia and Türkiye; and North and South American markets, including Brazil, Canada and the US, highlighting Hong Kong’s role as a key global hub for lighting products and technology exchange. Jenny Koo, Deputy Executive Director of the HKTDC, said: "This year’s two lighting fairs attracted industry-leading enterprises who showcased cutting-edge high-performance, smart lighting and sustainable products and solutions. The events also attracted quality buyers from global markets. This helps companies diversify supply chains, explore new markets, and underscores Hong Kong’s strength as an ‘International Exhibition Capital’ which boosts efficient business platforms. The fairs are the preferred platform for the industry to showcase innovation, connect with global buyer networks and accelerate business development.” Survey findings: Respondents were most optimistic about the India and Australia markets To keep abreast of the latest industry developments, the HKTDC conducted an on-site survey during the fairs, interviewing 450 exhibitors and buyers. The findings show that overall confidence among exhibitors and buyers in future business development has shown a general increase. Key market outlook and product trend findings: 49.1% of respondents expect overall sales to increase in the next 12 to 24 months, while 47.6% expect sales to remain stable. Respondents consider India (73.4%), Australia (71%), ASEAN countries (70.4%), and Japan (68.1%) to be promising or very promising target sales markets for lighting products over the next two years in terms of growth.In terms of new market development, exhibitor respondents are actively exploring Middle East (31.8%), Europe (29.5%), ASEAN countries (23.9%), Latin America (17.6%) and North America (14.8%).In the smart lighting segment, respondents identified home automation and intelligent lighting control systems (48.2%), energy saving lighting control solutions (38.2%), and outdoor smart security lighting systems (31.1%) as having the greatest growth potential over the next two years. Compared with conventional lighting products, respondents indicated that consumers are willing to pay an average premium of 29% for lighting products equipped with smart functions. Scenario-based displays and new zones enhance sourcing effectiveness, with positive trade outcomes The newly launched “Light Lab” features various scenario-based and immersive designs, integrating lighting products into landscape, sports, cultural and artistic application settings. Shanghai Sansi Electronic Engineering showcased plant clamp lights and compact downlights suitable for museum applications. Guoli Zhu, Deputy Chief Engineer of the company said: “The Light Lab has effectively enhanced the presentation of our products, enabling buyers to more intuitively and swiftly grasp product features and their real-world application scenarios. This has successfully attracted buyers from Argentina, Canada, Germany, India, Japan and the US to visit our booth for in-depth discussions. We expect this to result in orders worth over US$1 million.” The Smart Lighting Expo also debuted the “Smart Display and Stage Lighting & Sound Zone” which displayed a wide range of intelligent display solutions. Industry leader Absen participated in the fair for the first time. Benjamin Tang, Senior Sales Engineer, said: “The new zone has effectively enhanced product visibility, attracting buyers from Eastern Europe, Oceania, North America, South America, and South Asia to our booth. These inquiries came from new clients across key sectors such as cultural tourism and stage engineering. We have also successfully engaged in several promising collaboration discussions with potential clients from the Dominican Republic, Hong Kong and Thailand, further strengthening the company’s market expansion plan. We estimate the value of orders from the expo will amount to US$930,000. Riding on this momentum, we have decided to join the Hong Kong International Lighting Fair (Autumn Edition) this year.” The newly launched “Leisure Lighting Zone” has injected new momentum into the Spring Lighting Fair. Rebecca Seo, CFO of NIZ, a first-time exhibitor from Korea, said: “The fair has provided us with an excellent platform to connect with international buyers. We have successfully connected with buyers from Denmark, Germany, Japan, and the US, and a well-known Japanese homeware retailer has already placed an on-site order. Thanks to the strong traffic generated by the new zone, we expect the fair to bring up to US$70 million in orders for our company this year." Supported by Zhongshan as the Special Partner City, the fairs featured the Zhongshan Guzhen Pavilion and Zhongshan Henglan Pavilion under the Zhongshan Smart Home Zone, presenting the manufacturing strength and competitiveness of the region’s lighting industry while supporting enterprises in “going global”. Merry Liu, Manager of Bairan Lighting, an industrial enterprise above designated size in Henglan, Zhongshan, said: “The two lighting fairs provide Zhongshan enterprises with an efficient ‘go-global’ gateway, enabling us to connect directly with buyers from Europe, the Middle East, South America, and Southeast Asia. This helps drive our products and brand onto the international stage. We expect to achieve US$2 million in sales.” During the fair, the HKTDC organised a buying mission to Zhongshan for the first time, visiting several lighting factories and participating in business matching meetings. This initiative aimed to deepen exchange and cooperation within the Zhongshan lighting supply chain. The visit successfully facilitated several substantive business collaborations; New Zealand buyer Spark100 Ltd established a connection with a Zhongshan lighting supplier, with a potential order value estimated between US$100,000 and US$300,000. This year’s exhibition also attracted buyers from the Middle East. Patrick Zhang, VP of sales of Tecnon Lighting Technology from the Shenzhen Pavilion, stated: “At this year’s fair, a buyer from the United Arab Emirates and a US buyer from a leading women’s fashion brand are likely to become our cooperation partners. We expect to generate US$2 million in sales turnover for our company.” As construction projects in the ASEAN region accelerate, market demand for smart lighting solutions continues to expand. Sambath HK, Manager of RS Decoration from Cambodia, stated, “I travelled here specifically to source lighting products for 14 new commercial building and luxury residential projects. I have already met with over 20 new suppliers and identified two potential partners offering smart street lights, solar lights, and decorative lighting products. I will initially purchase US$100,000 worth of smart street lights.” Driven by the Belt and Road Initiative, urban development in participating countries and regions are in full swing, fuelling a continuous surge in demand for high-efficiency and smart lighting products. Aigerim Beisekina, Supply Manager of Karelz.kz from Kazakhstan, said: “This is our first time visiting the twin lighting fairs, to find reliable suppliers for a solar-powered stadium and sports lighting for three international schools currently under construction in Kazakhstan. Through the Click2Match business matching platform, we have identified three potential suppliers from the Chinese Mainland and plan to purchase lighting equipment valued between US$600,000 and US$900,000.” During the fairs, multiple professional events were held, including the Asian Lighting Conference and the Smart Lighting Solutions Forum. Designers and industry representatives from different regions shared market trends, application cases and technological developments, providing forward-looking market insight for the industry. EXHIBITION+ model sustains post-fair business opportunities Under the hybrid EXHIBITION+ model, the twin lighting fairs combined in-person sourcing with online meetings via the HKTDC’s Click2Match smart business-matching platform and hktdc.com sourcing platform. Click2Match will be available until 30 April to facilitate discussions between exhibitors and buyers around the world. Photo download: https://bit.ly/42m6sqD Websites Hong Kong International Lighting Fair (Spring Edition): hklightingfairse.hktdc.com/tc Smart Lighting Expo: smartlightingexpo.hktdc.com/tc HKTDC Mediaroom: http://mediaroom.hktdc.com/en Media enquiries HKTDC’s Communications & Public Affairs Department: Stanley So Tel: (852) 2584 4049 Email: stanley.hp.so@hktdc.org Navin Law Tel: (852) 2584 4525 Email: navin.cm.law@hktdc.org Serena Cheung Tel: (852) 2584 4272 Email: serena.hm.cheung@hktdc.org About HKTDC The Hong Kong Trade Development Council (HKTDC) celebrates its 60th anniversary this year. The HKTDC is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in the Chinese Mainland, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus.
BROSSARD, QUEBEC - April 23, 2026 (NEWMEDIAWIRE) - CHARBONE CORPORATION (TSXV: CH; OTCQB: CHHYF; FSE: K47) (“CHARBONE” or the “Company”), a North American producer and distributor specializing in clean Ultra High Purity (“UHP”) hydrogen and strategic industrial gases, following its news release dated March 31, 2026, is pleased to announce that the closing process is progressing on the secured convertible loan (the “Convertible Loan”) that will provide for up to $10 million of financing from Riverfort Global Opportunities PCC Ltd (“RiverFort” or the “Lender”), and confirms that terms have been modified as follows: The first drawdown amount has been increased from $2.15 million to $3 million; Any subsequent drawdowns will be convertible, at the option of the Lender, into Common Shares at a conversion price per common share at a 25% premium to the reference price (defined as the greater of: (i) the average of the five (5) daily VWAPs of the Shares immediately preceding the applicable drawdown date, and (ii) a 5% premium to the market price of the common shares at the time of the issuance of a press release announcing such drawdown); and In respect of any amount not paid when due, only if applicable, default interest shall accrue in such a manner that the total return of this instrument under each drawdown, calculated based on the outstanding principal balance, shall be capped at twenty-four percent (24%) per annum. The first drawdown will become available upon the signature of the definitive agreements with RiverFort and satisfaction of the closing conditions provided for in the Convertible Loan, including the approval by the TSX Venture Exchange. Please find unchanged terms of the first drawdown below: Convertible, at the option of the Lender, into units composed of one common share of the Company and 0.3 of a warrant, at a conversion price of $0.15 per unit. Each whole warrant issued in connection with the first drawdown of $3 million will be exercisable to acquire one additional common share in the capital of CHARBONE, at a price per share of $0.195, for a period of 48 months, subject to a maximum of 5 years from the Convertible Loan closing date. 12% annual interest payable in cash every 4 months. If not converted before, 10% of the first drawdown shall be repaid at the end of six months, 20% at the end of 12 months and 70% on maturity date in 18 months. An implementation fee of 5% of the first drawdown will be paid in cash on closing and a non-refundable $20,000 due diligence fee has already been paid. Secured with a first ranking hypothec over the universality of all present and future movable property of each of Charbone Hydrogène Quebec Inc. (Sorel-Tracy project) and Charbone Hydrogen Corporation. The securities issued upon any conversion of the principal amount of the Convertible Loan will be subject to the statutory four-month hold period in Canada. CHARBONE also announces the completion of the full conversion of the September 2025 Convertible Replacement Debentures, issued and announced on October 1, 2025, for an amount of $2.05M. About CHARBONE CORPORATION CHARBONE is a developer and producer of clean Ultra High Purity (UHP) hydrogen with a growing industrial gas distribution platform. Through a modular approach, CHARBONE is focused on developing a network of clean hydrogen production facilities throughout North America and select markets abroad, starting with its flagship Sorel-Tracy project in Quebec. The Company’s integrated model reduces risk, enhances scalability, and enables diversified revenue streams through partnerships in helium and other specialty gases. CHARBONE is committed to supporting the global transition to a lower-carbon economy by providing accessible, decentralized clean hydrogen and specialty gas solutions while supporting underserved industrial gas customers and accelerating the shift to localized clean energy. CHARBONE is listed on the TSX Venture Exchange (TSXV: CH), the OTC Markets (OTCQB: CHHYF), and the Frankfurt Stock Exchange (FSE: K47). Visit www.charbone.com. Forward-Looking Statements This news release contains statements that are “forward-looking information” as defined under Canadian securities laws (“forward-looking statements”). These forward-looking statements are often identified by words such as “intends”, “anticipates”, “expects”, “believes”, “plans”, “likely”, or similar words. The forward-looking statements reflect management's expectations, estimates, or projections concerning future results or events, based on the opinions, assumptions and estimates considered reasonable by management at the date the statements are made. Although Charbone believes that the expectations reflected in the forward-looking statements are reasonable, forward-looking statements involve risks and uncertainties, and undue reliance should not be placed on forward-looking statements, as unknown or unpredictable factors could cause actual results to be materially different from those reflected in the forward-looking statements. The forward-looking statements may be affected by risks and uncertainties in the business of Charbone. These risks, uncertainties and assumptions include, but are not limited to, those described under “Risk Factors” in the Corporation’s Management’s Discussion & Analysis for the period ended September 30, 2025, which is available on SEDAR+ at www.sedarplus.ca; they could cause actual events or results to differ materially from those projected in any forward-looking statements. Except as required under applicable securities legislation, Charbone undertakes no obligation to publicly update or revise forward-looking information. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Contact Charbone Corporation Telephone: +1 450 678 7171 Email: ir@charbone.com Benoit Veilleux CFO and Corporate Secretary View the original release on www.newmediawire.com
Strong participation with 77.4% of total share capital validly represented All proposals by the Board of Directors were approved with a large majority Yang Xu was newly elected to the Board of Directors (Finance and Audit Committee) BASEL, SWITZERLAND - April 23, 2026 (NEWMEDIAWIRE) - The shareholders of Medartis Holding AG (SIX: MED) today approved all the substantive proposals of the Board of Directors with significant majority exceeding 90.9%. Seven members of the Board of Directors were standing for re-election and received resounding endorsement, with each securing more than 93.8% support from represented votes. Yang Xu was newly elected to the Board of Directors with 99.7% endorsement and will join the Finance and Audit Committee. The Annual General Meeting (AGM) saw significant shareholder participation, with 10,545,669 shares directly or indirectly represented, constituting 77.4% of the total share capital. The Annual General Meeting took place at Medartis headquarters in Basel, continuing the tradition of direct shareholder engagement. Shareholders granted discharge to the Board members for their governance during the 2025 term. The shareholders approved through separate votes the proposed maximum total remuneration for both the Board of Directors and the Executive Management Board, including fixed and variable components. The 2025 management report and annual financial statements received nearly unanimous approval (99.99%), while the remuneration report was approved by 91.0% in a consultative vote. Additionally, the sustainability report gained strong endorsement (99.2%) of represented shares, confirming Medartis' commitment to transparent ESG practices. Chairman Marco Gadola will continue to lead the Board. After two years with Medartis, Jennifer Dean has decided not to stand for re-election. Yang Xu was newly elected to the Board of Directors and will join the Finance and Audit Committee. The assembly also confirmed Damien Tappy and Marco Gadola as members of the Human Resources and Compensation Committee (HRCC), ensuring continuity in the oversight of the company's human capital strategy. As of today’s Annual General Meeting, the Medartis Board of Directors consists of the following members: NAME POSITION COMMITTEE MEMBERSHIP FIRST ELECTED END CURRENT PERIOD Marco Gadola Chairman Member HRCC 2020 2027 Dr. h.c. Thomas Straumann Vice Chairman Member SIC 1998 2027 Willi Miesch Member of the Board Chair SIC 2010 2027 Damien Tappy Member of the Board Chair HRCC / Member SIC 2018 2027 Nadia Tarolli Schmidt Member of the Board Chair FAC 2022 2027 Ciro Roemer Member of the Board Member SIC 2022 2027 Martha Shadan Member of the Board Member FAC 2024 2027 Yang Xu Member of the Board Member FAC 2026 2027 HRCC = Human Resources and Compensation Committee | SIC = Strategy and Innovation Committee | FAC = Finance and Audit Committee In accordance with the proposal of the Board of Directors, the shareholders confirmed the re-election of Neovius AG as independent voting representative and Ernst & Young AG as statutory auditors. For a detailed listing of all resolutions at the 2026 Annual General Meeting, please visit this link. Medartis also confirmed the following upcoming dates for its investor and corporate calendar. On 4 June 2026, Medartis will host an investor event in Basel, held on the fringes of the FESSH Hand Surgery Congress. The event is open to institutional investors and will provide an opportunity to engage with the company's management. The first-half 2026 results will be published on 18 August 2026, followed by the customary analyst and media briefing. The next Annual General Meeting is scheduled for 22 April 2027 at the company's headquarters in Basel. Date Event 4 June 2026 Investor Visitor Day, Basel (FESSH Congress) 18 August 2026 H1 2026 Results Publication 22 April 2027 Annual General Meeting, Basel For further information, please contact: Medartis Holding AG, Hochbergerstrasse 60E, CH-4057 Basel Investor Relations: investor.relations@medartis.com, +41 61 633 37 36 Corporate Communications: corporate.communication@medartis.com, +41 61 633 37 34 About Medartis Founded in 1997 and headquartered in Basel, Switzerland, the Medartis Group is one of the world's leading manufacturers and providers of medical devices for surgical fixation of bone fractures and joint replacement for upper and lower extremities as well as for the craniomaxillofacial region. The Group has manufacturing sites in Switzerland, the United States, Brazil, and France. Medartis employs approx. 1,400 individuals across 12 countries, with products offered in over 60 countries globally. Medartis is committed to providing surgeons and operating theatre personnel with the most innovative implants and instruments as well as best-in-class service. For more information, please visit www.medartis.com. Disclaimer This communication does not constitute an offer or invitation to subscribe for or purchase any securities of Medartis Holding AG. This publication may contain certain forward-looking statements and assessments or intentions concerning the company and its business. Such statements involve certain risks, uncertainties and other factors which could cause the actual results, financial condition, performance or achievements of the company to be materially different from those expressed or implied by such statements. Readers should therefore not place reliance on these statements, particularly in connection with any contract or investment decision. The company disclaims any obligation to update these forward-looking statements, assessments or intentions. Furthermore, neither the company nor any of its directors, officers, employees, agents, counsel or advisers nor any other person makes any representation or warranty, express or implied, as to the accuracy or completeness of the information contained herein or of the views given or implied, and accordingly no reliance should be placed thereon. Address: Medartis Holding AG Hochbergerstrasse 60E CH-4057 Basel View the original release on www.newmediawire.com
MILAN, ITALY - April 23, 2026 (NEWMEDIAWIRE) - Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system (CNS), announces that its shareholders approved all motions on the agenda for the ordinary part of the AGM 2026 held today. Particularly, this included the election of George Garibaldi and Paolo Zocchi as new, independent, and non-executive Board members.The motions on the agenda for the extraordinary part of the meeting were not put to vote, due to the required quorum not being reached. Chris Martin, Chairman of the Board of Directors of Newron, said: “I would like to thank all Newron shareholders for their trust. We welcome our newly elected Board members and are looking forward to their valuable inputs. We once more thank Patrick Langlois and Luca Benatti, who stepped down from the Board after their long-standing service, for their support of Newron.” About Newron Pharmaceuticals Newron (SIX: NWRN, XETRA: NP5) is a biopharmaceutical company focused on the development of innovative therapies for patients with diseases of the central and peripheral nervous system. Headquartered in Bresso near Milan, Italy, the Company has a strong track record of advancing neuroscience-based treatments from discovery to market. Newron’s lead compound, evenamide, is a first-in-class glutamate modulator and has the potential to be the first add-on therapy for treatment-resistant schizophrenia (TRS) and for poorly responding patients with schizophrenia. Evenamide is currently developed in the global pivotal ENIGMA-TRS Phase III development program. Clinical trial results to date demonstrate the benefits of this drug candidate in the TRS as well as poorly responding patient population, with significant improvements across key efficacy measures increasing over time, as well as a favorable safety profile, which is uncommon for available antipsychotic medications. Newron has signed development and commercialization agreements for evenamide with EA Pharma (a subsidiary of Eisai) for Japan and other Asian territories, as well as Myung In Pharm for South Korea. Newron’s first marketed product, Xadago®/safinamide has received marketing authorization for the treatment of Parkinson’s disease in the European Union, Switzerland, the UK, the USA, Australia, Canada, Latin America, Israel, the United Arab Emirates, Japan and South Korea. The product is commercialized by Newron’s partner Zambon, with Supernus Pharmaceuticals holding marketing rights in the U.S., and Meiji Seika responsible for development and commercialization in Japan and other key Asian territories. For more information, please visit: www.newron.com For more information, please contact: Newron Stefan Weber - CEO; +39 02 6103 46 26, pr@newron.com UK/Europe Simon Conway / Ciara Martin / Natalie Garland-Collins, FTI Consulting; +44 20 3727 1000, SCnewron@fticonsulting.com Switzerland Valentin Handschin, IRF; +41 43 244 81 54, handschin@irf-reputation.ch Germany/Europe Anne Hennecke / Maximilian Schur, MC Services; +49 211 52925227, newron@mc-services.eu USA Paul Sagan, LaVoieHealthScience; +1 617 865 0041, psagan@lavoiehealthscience.com View the original release on www.newmediawire.com
Dr. Astrid Skala-Kuhmann, Mag. Gerhard Schwartz and Mag. Helmut Bernkopf re-elected to the Supervisory Board Patrick Lackenbucher re-elected as Chairman of the Supervisory Board LENZING, AUSTRIA - April 23, 2026 (NEWMEDIAWIRE) - At its 82nd Annual General Meeting held on Thursday, April 23, 2026, the Lenzing Group granted formal discharge to the members of the Managing Board and the Supervisory Board for the 2025 financial year and resolved on the remuneration of Supervisory Board members for the 2026 financial year. The Annual General Meeting was presented with the adopted annual financial statements and the consolidated financial statements, including the Corporate Governance Report, as well as the Supervisory Board Report for the 2025 financial year. The Managing Board and the Supervisory Board reported on their activities during the reporting period. KPMG Austria GmbH Wirtschaftsprufungs- und Steuerberatungsgesellschaft was appointed as auditor of the annual and consolidated financial statements as well as auditor of the consolidated sustainability reporting for the 2026 financial year. Elections to the Supervisory Board The Annual General Meeting re-elected Dr. Astrid Skala-Kuhmann, Mag. Gerhard Schwartz and Mag. Helmut Bernkopf as members of the Supervisory Board of the Lenzing Group, each until the end of the Annual General Meeting that will resolve on the discharge for the 2030 financial year. The re-elections underline continuity and stability in the corporate governance of the Lenzing Group. The Supervisory Board of the Lenzing Group therefore continues to comprise ten members elected by the Annual General Meeting: Carlos Aníbal de Almeida Junior, Cornelius Baur, Helmut Bernkopf, Stefan Fida, Markus Furst, Franz Gasselsberger, Leonardo Grimaldi, Patrick Lackenbucher, Gerhard Schwartz and Astrid Skala-Kuhmann. Stefan Ertl, Stephan Gruber, Bonita Haag, Helmut Kirchmair and Michael Bichler were delegated to the Supervisory Board by the Works Council. At the constitutive meeting of the Supervisory Board following the Annual General Meeting, Patrick Lackenbucher was elected Chairman of the Supervisory Board. Carlos de Almeida was elected First Deputy Chairman and Stefan Fida Second Deputy Chairman. Photo download: https://mediadb.lenzing.com/pinaccess/showpin.do?pinCode=l5P1Q9g4Q8q2 Media Relations: Corporate Communications Lenzing Aktiengesellschaft WerkstraBe 2, 4860 Lenzing, Austria Phone +43 7672 701 2743 E-mail media@lenzing.com Web www.lenzing.com Investor Relations: Alexander Schwaiger VP Corporate Treasury & Investor Relations Lenzing Aktiengesellschaft WerkstraBe 2, 4860 Lenzing, Austria Phone +43 7672 701 8947 E-mail a.schwaiger@lenzing.com Web www.lenzing.com About the Lenzing Group The Lenzing Group stands for the responsible production of specialty and premium fibers based on regenerated cellulose. As an innovation leader, Lenzing is a partner of global textile and nonwoven manufacturers and drives many new technological developments. The Lenzing Group’s high-quality fibers are the raw material for a wide range of textile applications – ranging from functional, comfortable, and fashionable clothing through to durable and sustainable home textiles. TÜV-certified biodegradable and compostable Lenzing fibers are also ideal for demanding use in everyday hygiene applications. The Lenzing Group’s business model extends far beyond that of a traditional fiber producer. Together with its customers and partners, Lenzing develops innovative products along the value chain, adding value for consumers. The Lenzing Group strives for efficient utilization and processing of all raw materials and offers solutions for the transition of the textile industry from the current linear economic system to a circular economy. In order to align its commitment to limiting man-made climate change with the goals of the Paris Agreement, Lenzing has a clear, science-based climate action plan that provides for a significant reduction in greenhouse gas emissions (Scopes 1, 2, and 3) by 2030 and a net-zero target by 2050. Key Facts & Figures Lenzing Group 2025 Revenue: EUR 2.60 bn Nominal capacity (fibers): 1,110,000 tonnes Employees (full-time equivalents): 7,738 TENCEL™, LENZING™ ECOVERO™, VEOCEL™, LENZING™ and REFIBRA™ are trademarks of Lenzing AG. View the original release on www.newmediawire.com
LUXEMBOURG - April 23, 2026 (NEWMEDIAWIRE) - HomeToGo SE (Frankfurt Stock Exchange: HTG) will publish its financial results for the first quarter of 2026 (ending 31 March 2026) at 7:00 am CEST on 13 May 2026. Sebastian Bielski, CFO, will present the quarterly results in a conference call at 10:00 am CEST, followed by a Q&A session for research analysts and investors. The presentation will be held in English and accessible via a live audio webcast. Interested participants can register in advance for the conference call - with the opportunity to take part in the Q&A session - at the following address: https://www.appairtime.com/event/2f1d54f7-4f07-4bd2-9b58-610401fbadc1 Following the call, a recording of the audio webcast will be made available on HomeToGo's Investor Relations website: ir.hometogo.de. About HomeToGo HomeToGo was founded in 2014 in Berlin, Germany. Today HomeToGo is Europe’s leading vacation rental group, combining its B2B software & tech-enabled service solutions segment, HomeToGo_PRO, with its AI-powered B2C marketplace. HomeToGo is the official travel partner and top sponsor of German Bundesliga football club 1. FC Union Berlin. HomeToGo_PRO offers innovative software & tech-enabled service solutions for everyone who wants to be successful with vacation rentals. With millions of vacation rental offers across thousands of trusted partners, HomeToGo’s AI-powered B2C Marketplace seamlessly connects travelers with the world’s largest selection of vacation rentals to find the perfect home for any trip. HomeToGo was born and built in Europe. While HomeToGo SE's registered office is located in Luxembourg, HomeToGo GmbH is headquartered in Berlin, Germany. HomeToGo operates localized apps and websites in more than 30 countries. HomeToGo SE is listed on the Frankfurt Stock Exchange under the stock ticker “HTG” (ISIN LU2290523658). For more information visit: www.hometogo.com/about Investor Relations Contact Carsten Fricke, CFA +49 176 768 62 397 IR@hometogo.com View the original release on www.newmediawire.com
DALLAS - April 23, 2026 (NEWMEDIAWIRE) - The American Heart Association mourns the passing of the legendary cardiologist Eugene Braunwald, M.D., widely recognized as one of the most influential figures in the history of cardiovascular medicine. Over seven decades, his work reshaped the understanding and treatment of heart disease, leading many to call him the father of modern cardiology. Braunwald was a lifelong contributor to the American Heart Association, helping advance its research and scientific mission, and was honored with some of the Association’s highest honors for his lasting influence on cardiovascular care and research. His influence extended well beyond his own discoveries, as generations of Association‑supported investigators, clinicians and academic leaders were trained by Braunwald or guided by the clinical trial standards and mentorship models he helped establish. “Few people have shaped cardiovascular medicine so profoundly or for so long as Dr. Eugene Braunwald. For generations of discovery, his contributions helped define modern cardiology and strengthened the foundation on which today’s breakthroughs stand,” said Nancy Brown, Chief Executive Officer of the American Heart Association. “His legacy lives on not only in these medical discoveries, but in the people he inspired and mentored, including many leaders who continue to shape cardiovascular care today.” In recognition of this enduring legacy, the American Heart Association created the Eugene Braunwald Academic Mentorship Award in 1999, honoring his lifelong commitment to advancing science through people as well as ideas. Given annually, the award honors an individual with a sustained record of excellence in teaching and mentoring the next generation of faculty researchers, educators and health care professionals. “The passing of Dr. Eugene Braunwald marks the end of an era for cardiovascular medicine. His relentless pursuit of scientific truth transformed the way we understand and treat cardiovascular disease, saving countless lives across the globe,” said Stacey E. Rosen, M.D., FAHA, volunteer president of the American Heart Association and executive director of the Katz Institute for Women’s Health and senior vice president of women’s health at Northwell Health in New York City. “Beyond his groundbreaking research and definitive textbooks, he was a devoted mentor whose brilliance and humanity inspired generations of clinicians. I was always struck by his genuine warmth and his unwavering interest in the next generation of physicians. The American Heart Association honors his extraordinary life and remains committed to the mission he championed so passionately - a world of longer, healthier lives for all." Former Association volunteer president and one of Braunwald's many mentees, Elliott Antman, M.D. stated “Dr. Braunwald’s accomplishments in cardiology and medicine are immeasurable. However, his greatest joy was setting the highest standards for his mentees, through whom his legacy endures.” Braunwald, who would have turned 97 in August 2026, has more than 1,000 publications in peer-reviewed journals. His work has dramatically expanded knowledge of heart disease in the areas of congestive heart disease, valvular heart disease and coronary artery disease. In 2013, a biographer noted Braunwald "had more publications in the top general medical and cardiology journals than any of the more than 42,000 authors" in PubMed, an online database of medical research. He continued to conduct research and published scientific works throughout his career, including work published in April 2026 in the journal Heart Rhythm. “Dr. Braunwald’s lifetime of passionate work reflects exactly what the American Heart Association strives to advance - science that changes lives, science that saves lives,” Brown said. “He will be greatly missed even as his legacy lives on.” Additional Resources American Heart Association News: How Dr. Eugene Braunwald changed cardiology, again and again and again Circulation Centennial Collection: Cardiology: A Century of Progress by Eugene Braunwald, M.D. Dr. Eugene Braunwald interview: The history and future of cardiology – June 2024 Follow AHA/ASA news on X @HeartNew About the American Heart Association The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public’s health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on heart.org, Facebook, X or by calling 1-800-AHA-USA1. For Media Inquiries: 214-706-1173 or ahacommunications@heart.org For Public Inquiries: 1-800-AHA-USA1 (242-8721) heart.org and stroke.org
By Meg Flippin, Benzinga Ready to trade on more than just earnings and basic fundamental research? Alt Data Consensus gives you insights beyond the status quo. DETROIT, MICHIGAN - April 23, 2026 (NEWMEDIAWIRE) - Everyone has opinions, but when it comes to stocks, investors need more than the conviction of sell-side analysts alone. They need insights and ground truth for how companies are actually performing. Whether it's consumer transaction data which can help show revenue trends or web traffic indicating customer trends, they want access to these signals. Research analysts have largely been limited to sellside analyst estimates – until now. That’s what The BattleFin Group is gearing up to do with its new Alt Data Consensus (ADC) estimates platform, launching May 14th at the BattleFin NYC event aboard the Intrepid aircraft carrier. Previously, alternative data could only be leveraged by sophisticated hedge funds with big budgets and data science teams. The launch of ADC estimates allows buy-side firms to get a sense of which alt datasets relate to which tickers, KPIs and company moving data points. The mapping, tagging, modeling and outputs have been taken care of. ADC aggregates signals from multiple vetted alternative data providers and delivers them in one standardized framework, giving investors a continuously updated consensus built from real-world data. Tracking Wall Street Discrepancies While Supporting Analysts With the platform, investors see where the alternative data sources agree or disagree with Wall Street predictions. Because it updates constantly between official reports, investors can act on information as it happens. Alternative data providers spanning consumer transaction data, workforce intelligence, web traffic, app and mobile intelligence, geolocation data, survey data and more are integrated into the ADC platform. This growing consortium of industry-leading data providers ensures that the consensus is built on the most relevant and high-quality datasets available today, said BattleFin. Since the vendors on ADC have to follow a rigorous vetting process, the company says only datasets demonstrating measurable signal relevance for institutional use cases are included. Investors don’t have to worry about wasting time with needless information. Being able to easily access actionable insights is something particularly important today, with the war in Iran, global tariffs, rising oil prices and heightened market volatility making it more complex to get an edge. Traditional financial reports and analyst estimates may not give investors a clear picture of what’s really happening. Earnings reports are backward-looking, and relying on analyst opinions can prove risky if the call is wrong. “Our new Alt Data Consensus platform is the missing aggregation layer for alternative data,” said Tim Harrington, CEO at The BattleFin Group. ADC was built from the ground up to complement fundamental research, serving as a benchmark and risk management tool designed to empower analysts and guide investment decisions, he said. The platform moves beyond broad predictions to provide insights at the key performance indicator or KPI level, allowing investors to track the specific metrics that actually drive stock prices. Get all the Alt data you need in one place with ADC. Click here to get started on the platform today. Getting That Edge ADC acts as an early warning system too, bridging the gap between official reports and allowing investors to see exactly when the market’s expectations are off. With ADC, investors will be able to do several things, including: See how multiple providers' views on the same company or sector align or diverge. Spot divergences from Street expectations provide a signal investors can investigate. Calibrate conviction between earnings. Reduce vendor management overhead with one integration point. Investors don’t have to worry about maintaining separate onboarding, normalization and QA pipelines for each provider independently. ADC is slated to launch publicly on May 14th at the company’s BattleFin Discovery Day in New York. There, investors and traders can see in-person demonstrations of ADC buy-side investor use cases. Can’t wait until then? ADC has opened a waitlist for interested buy-side investors to get exclusive early access. Investors need more than financial reports and analyst calls to make a decision about a stock. They need a variety of data points they can leverage to make moves in real time. ADC offers them that. To learn more about ADC and BattleFin, click here. Featured image from Shutterstock. This content was originally published on Benzinga. Read further disclosures here. This post contains sponsored content and was created in collaboration with a third-party partner. Benzinga is a publisher and does not provide personalized investment advice or act as a broker or dealer. This content is for informational purposes only and is not intended to be investing advice or an offer or solicitation to buy or sell any security. View the original release on www.newmediawire.com
TORONTO, ONTARIO - April 23, 2026 (NEWMEDIAWIRE) - Hybrid Power Solutions Inc. (CSE: HPSS) (OTC: HPSIF) (FSE: E092) (“Hybrid” or the “Company”), an emerging leader in the delivery of fuel-free clean power solutions, announces a collaboration with Movex Innovation to offer a fully mobile power solution that pairs Hybrid’s Spark platform with Movex Innovation’s ultra-compact, remote-controlled electric equipment platform for defence and commercial use. The collaboration is expected to create a transportable and flexible field power solution for mission-critical and industrial environments by integrating Hybrid’s Spark with Movex Innovation’s mobile equipment line. The collaboration will service diverse end-markets with potential use cases including remote job sites, defence logistics, infrastructure maintenance, emergency response, mining support and other field operations requiring both mobility and dependable off-grid or hybridized power. The resulting solution is expected to offer customers a resilient, cleaner and quieter alternative to legacy mobile generator systems while helping improve operational efficiency in numerous field applications. Movex All-Terrain Track Carrier with Hybrid Spark “This collaboration marks a significant advancement in mobile power innovation,” said Francois Byrne, CEO and Founder of Hybrid Power Solutions. “By integrating our Spark platform with Movex Innovation’s advanced mobility systems, we are delivering a highly versatile solution tailored for customers in both the defence and commercial sectors, where access, safety, emissions, noise, and operational flexibility are critical.” Hybrid also plans to build a custom high-capacity battery system tailored for Movex Innovation’s ultra-compact All-Terrain Track Carrier and associated material handling units, incorporating advanced lithium-ion cells, intelligent hybrid power management, and full compliance with key NATO standards including relevant STANAG requirements for defence interoperability, environmental resilience, and power interface compatibility in coalition operations. The Company is actively advancing manufacturing plans to scale production of this NATO-compliant custom battery, delivering extended runtime, rapid charging, silent electric operation, and rugged performance to support Movex’s remote-controlled electric platforms in demanding defence, mining, and industrial field applications while reducing logistical burden and enhancing mission flexibility. Movex Innovation specializes in ultra-compact, remote-controlled electric industrial handling equipment designed for confined spaces, rough terrain and demanding operating conditions. Its equipment platform is used across a range of industries and includes applications for military and defence operations, where quiet electric operation, compact form factor and reduced physical risk can offer meaningful operational advantages. “Movex Innovation is committed to developing compact, safe, and high-performance electric equipment engineered for the most challenging environments,” said William Lavoie, Director of Business Development at Movex Innovation. “Through this partnership with Hybrid Power Solutions, we are enhancing our platform’s capabilities by incorporating reliable mobile power solutions, thereby ensuring superior access, uptime, and safety for demanding applications.” About Movex Innovation Movex Innovation designs and manufactures ultra-compact, remote-controlled electric material handling equipment for industrial and specialized applications. The Company emphasizes safety, ruggedness, low maintenance, low total cost of ownership, and zero-emission operation across equipment intended for harsh, confined and operationally sensitive environments. Movex Innovation website: https://movexinnovation.com/ About Hybrid Power Solutions Hybrid Power Solutions Inc. is a Canadian clean energy innovator listed on the Canadian Securities Exchange under the symbol "HPSS." The Company specializes in developing portable power systems that eliminate the need for fossil fuels in off-grid and remote applications. With a focus on environmental responsibility and technological innovation, Hybrid Power Solutions is committed to leading the clean energy transition. Hybrid Power Solutions website: https://hybridps.ca/ On Behalf of the Company, Francois Byrne, CEO and Director For further information, inquiries, or media opportunities, please contact: Hybrid Power Solutions E: invest@hybridps.ca T: 866-549-2743 www.investhps.com Investor Relations Dean Stuart E: dean@boardmarker.net T: 403-617-7609 Sophic Capital Sean Peasgood E: Sean@SophicCapital.com T: 437-836-8862 Forward-Looking Statements Certain information contained herein constitutes "forward-looking information" under Canadian securities legislation. Generally, forward-looking information can be identified by terminology such as "will," "expects," "anticipates," or variations of such words and phrases, or by statements that certain actions, events, or results "will" occur. Forward-looking statements are based on management’s estimates as of the date such statements are made and are subject to risks, uncertainties, and other factors that may cause actual results to differ materially from those expressed or implied by such statements. The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release. View the original release on www.newmediawire.com
Adds Revenue-generating DTC Brand, Vertically Integrated Formulations, Experienced Public Company Leadership, and Aligned Growth Capital LANCASTER, PA - April 23, 2026 (NEWMEDIAWIRE) - UNLOCKD Inc. (OTCID: BFCH) (“UNLOCKD” or the “Company”), a public platform focused on acquiring and scaling wellness and functional nutrition brands, today announced it has executed a binding Letter of Intent (“LOI”) to acquire 100% of VerdaGenix, LLC, the operating entity behind the Ancient Extracts USA brand. The transaction contemplates an aggregate purchase price of approximately $490,000, subject to adjustment based on due diligence and final closing conditions. The proposed transaction is structured as an equity-based acquisition and is expected to add revenue-generating operations, proprietary formulations, intellectual property, trade secrets, key personnel, and a fully integrated direct-to-consumer (“DTC”) infrastructure to the UNLOCKD platform. Upon closing, VerdaGenix will operate as a wholly owned subsidiary of the Company. With the binding LOI in place, the parties are aligned on core terms and progressing toward definitive documentation and closing. Ancient Extracts is a DTC wellness brand offering botanical formulations including mushroom coffee, ceremonial-grade matcha, and shilajit-based products, supported by active customer acquisition channels across TikTok, Amazon and META. The platform includes established digital marketing data, repeat customers, and scalable e-commerce infrastructure. The acquisition positions UNLOCKD within multiple high-growth global categories, including functional beverages, adaptogens, and plant-based wellness, which collectively represent a multi-billion-dollar market opportunity driven by increasing demand for performance, energy, and longevity-focused products. “This transaction adds a revenue-generating DTC engine and vertically integrated product capabilities to the platform,” said Jordan P. Balencic, D.O., Chairman and Chief Executive Officer. “This combination strengthens our ability to scale brands, expand margins, and accelerate new product development.” As part of the transaction, John P. Gorst will join UNLOCKD’s executive management team following closing. Mr. Gorst brings over 30 years of experience building and leading public and private companies, including serving as Chairman and Chief Executive Officer of multiple publicly traded companies. Over his career, he has raised more than $100 million in capital and has extensive experience in capital markets, corporate strategy, and scaling consumer-focused businesses. Management believes the addition of Mr. Gorst strengthens UNLOCKD’s leadership with proven capital formation expertise and public market experience, positioning the Company to accelerate execution and access to growth capital. The Company also intends to explore integration of its EVERMIND™ platform into the combined business, including potential product extensions and formulation enhancements across the Ancient Extracts portfolio. Management believes this strategy may unlock additional product innovation and expand the Company’s presence across multiple functional wellness categories. The parties are progressing through due diligence and intend to move expeditiously toward execution of a definitive Purchase and Sale Agreement, subject to customary conditions. In connection with the proposed acquisition, the Company expects to close a financing aligned with the transaction, targeting approximately $300,000 in capital to support inventory expansion, marketing scale, and new product development. Management believes aligning capital with revenue-generating assets is a key driver of scalable growth across the UNLOCKD platform. The transaction remains subject to completion of due diligence, execution of definitive agreements, and satisfaction of customary closing conditions. About Ancient Extracts Ancient Extracts is a direct-to-consumer wellness brand established in the United Kingdom over two years experiencing monthly double digit organic growth. Ancient Extracts specializes in plant-based formulations rooted in traditional practices and modern functional nutrition. Its product portfolio includes mushroom coffee, ceremonial-grade matcha, and premium shilajit-based offerings designed to support energy, focus, and overall performance. The Company operates a vertically integrated e-commerce platform supported by active digital marketing channels, proprietary formulations, and established supplier relationships. For more information, visit: https://www.ancientextracts.com About UNLOCKD Inc. (OTCID: BFCH) UNLOCKD Inc. is a Wyoming-based public platform company headquartered in Lancaster, Pennsylvania, focused on acquiring and scaling emerging wellness, functional-nutrition, and lifestyle brands. Following the elimination of legacy debt and implementation of modern capital frameworks, UNLOCKD is building a transparent, compliant operating platform at the intersection of human optimization, consumer participation, and next-generation brand development. The Company’s platform includes internally developed and acquired brands, including EVERMIND™, a cognitive health beverage platform currently in development. Visit www.UNLOCKDinc.com for corporate information. View current filings on OTC Markets. Follow @BFCHco on X for verified updates. Safe Harbor Statement This press release contains forward-looking statements within the meaning of applicable federal securities laws, including statements regarding commercialization plans, partnership finalization, anticipated news flow, future Regulation A offerings, projected capital formation strategies, and expected synergies from the proposed acquisition. These statements are based on current expectations and involve risks and uncertainties that could cause actual results to differ materially. Such risks include, but are not limited to, delays in transaction execution, capital constraints, regulatory developments, integration challenges, and market conditions. Forward-looking statements speak only as of the date of this release, and the Company undertakes no obligation to update or revise them except as required by law. Investor Relations Contact Jordan P. Balencic, D.O. Chairman & Chief Executive Officer Email: jbalencic@thinkevermind.com Phone: (813) 693-1377